
<html lang="en"     class="pb-page"  data-request-id="650d33b1-9f0a-4147-86af-c3ac645c88f3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-8;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.9b02107;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation" /></meta><meta name="dc.Creator" content="Haixia  Su" /></meta><meta name="dc.Creator" content="Yi  Zou" /></meta><meta name="dc.Creator" content="Guofeng  Chen" /></meta><meta name="dc.Creator" content="Huixia  Dou" /></meta><meta name="dc.Creator" content="Hang  Xie" /></meta><meta name="dc.Creator" content="Xiaojing  Yuan" /></meta><meta name="dc.Creator" content="Xianglei  Zhang" /></meta><meta name="dc.Creator" content="Naixia  Zhang" /></meta><meta name="dc.Creator" content="Minjun  Li" /></meta><meta name="dc.Creator" content="Yechun  Xu" /></meta><meta name="dc.Description" content="Fatty-acid binding protein 4 (FABP4) is a promising therapeutic target for immunometabolic diseases, while its potential for systemic inflammatory response syndrome treatment has not been explored...." /></meta><meta name="Description" content="Fatty-acid binding protein 4 (FABP4) is a promising therapeutic target for immunometabolic diseases, while its potential for systemic inflammatory response syndrome treatment has not been explored...." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 23, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b02107" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02107" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b02107" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02107" /></link>
        
    
    

<title>Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b02107" /></meta><meta property="og:title" content="Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0014.jpeg" /></meta><meta property="og:description" content="Fatty-acid binding protein 4 (FABP4) is a promising therapeutic target for immunometabolic diseases, while its potential for systemic inflammatory response syndrome treatment has not been explored. Here, a series of 2-(phenylamino)benzoic acids as novel and potent FABP4 inhibitors are rationally designed based on an interesting fragment that adopts multiple binding poses within FABP4. A fusion of these binding poses leads to the design of compound 3 with an ∼460-fold improvement in binding affinity compared to the initial fragment. A subsequent structure-aided optimization upon 3 results in a promising lead (17) with the highest binding affinity among all the inhibitors, exerting a significant anti-inflammatory effect in cells and effectively attenuating a systemic inflammatory damage in mice. Our work therefore presents a good example of lead compound discovery derived from the multiple binding poses of a fragment and provides a candidate for development of drugs against inflammation-related diseases." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b02107"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02107">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b02107&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b02107&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b02107&amp;href=/doi/10.1021/acs.jmedchem.9b02107" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 4090-4106</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b02025" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b02129" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Haixia Su</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Haixia Su</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, Beijing 100049, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Haixia++Su">Haixia Su</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yi Zou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yi Zou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yi++Zou">Yi Zou</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6782-9380" title="Orcid link">http://orcid.org/0000-0001-6782-9380</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Guofeng Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Guofeng Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, Beijing 100049, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Guofeng++Chen">Guofeng Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Huixia Dou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Huixia Dou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Huixia++Dou">Huixia Dou</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hang Xie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hang Xie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hang++Xie">Hang Xie</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiaojing Yuan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaojing Yuan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, Beijing 100049, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaojing++Yuan">Xiaojing Yuan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xianglei Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xianglei Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, Beijing 100049, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xianglei++Zhang">Xianglei Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Naixia Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Naixia Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Analytical Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, Beijing 100049, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Naixia++Zhang">Naixia Zhang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4824-5819" title="Orcid link">http://orcid.org/0000-0003-4824-5819</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Minjun Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Minjun Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Synchrotron Radiation Facility, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Minjun++Li">Minjun Li</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Yechun Xu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yechun Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, Beijing 100049, China</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +86-21-50801267. Email: <a href="/cdn-cgi/l/email-protection#324b514a4772415b5f5f1c53511c515c"><span class="__cf_email__" data-cfemail="c3baa0bbb683b0aaaeaeeda2a0eda0ad">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yechun++Xu">Yechun Xu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1581-6155" title="Orcid link">http://orcid.org/0000-0002-1581-6155</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02107&amp;href=/doi/10.1021%2Facs.jmedchem.9b02107" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 4090–4106</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 23, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 December 2019</li><li><span class="item_label"><b>Published</b> online</span>23 March 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 April 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b02107" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02107</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4090%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHaixia%2BSu%252C%2BYi%2BZou%252C%2BGuofeng%2BChen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D8%26contentID%3Dacs.jmedchem.9b02107%26title%3DExploration%2Bof%2BFragment%2BBinding%2BPoses%2BLeading%2Bto%2BEfficient%2BDiscovery%2Bof%2BHighly%2BPotent%2Band%2BOrally%2BEffective%2BInhibitors%2Bof%2BFABP4%2Bfor%2BAnti-inflammation%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4106%26publicationDate%3DApril%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b02107"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1373</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b02107" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Haixia&quot;,&quot;last_name&quot;:&quot;Su&quot;},{&quot;first_name&quot;:&quot;Yi&quot;,&quot;last_name&quot;:&quot;Zou&quot;},{&quot;first_name&quot;:&quot;Guofeng&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Huixia&quot;,&quot;last_name&quot;:&quot;Dou&quot;},{&quot;first_name&quot;:&quot;Hang&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Xiaojing&quot;,&quot;last_name&quot;:&quot;Yuan&quot;},{&quot;first_name&quot;:&quot;Xianglei&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Naixia&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Minjun&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yechun&quot;,&quot;last_name&quot;:&quot;Xu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;4090-4106&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b02107&quot;},&quot;abstract&quot;:&quot;Fatty-acid binding protein 4 (FABP4) is a promising therapeutic target for immunometabolic diseases, while its potential for systemic inflammatory response syndrome treatment has not been explored. Here, a series of 2-(phenylamino)benzoic acids as novel and potent FABP4 inhibitors are rationally designed based on an interesting fragment that adopts multiple binding poses within FABP4. A fusion of these binding poses leads to the design of compound 3 with an ∼460-fold improvement in binding affinity compared to the initial fragment. A subsequent structure-aided optimization upon 3 results in a promising lead (17) with the highest binding affinity among all the inhibitors, exerting a significant anti-inflammatory effect in cells and effectively attenuating a systemic inflammatory damage in mice. Our work therefore presents a good example of lead compound discovery derived from the multiple binding poses of a fragment and provides a candidate for development of drugs against inflammation-related diseases.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02107&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02107" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02107&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02107" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02107&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02107" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02107&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02107&amp;href=/doi/10.1021/acs.jmedchem.9b02107" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b02107" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b02107" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b02107%26sid%3Dliteratum%253Aachs%26pmid%3D32202425%26genre%3Darticle%26aulast%3DSu%26date%3D2020%26atitle%3DExploration%2Bof%2BFragment%2BBinding%2BPoses%2BLeading%2Bto%2BEfficient%2BDiscovery%2Bof%2BHighly%2BPotent%2Band%2BOrally%2BEffective%2BInhibitors%2Bof%2BFABP4%2Bfor%2BAnti-inflammation%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D8%26spage%3D4090%26epage%3D4106%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291880" title="Crystal structure">Crystal structure</a>,</li><li><a href="/action/doSearch?ConceptID=291241" title="Phenyls">Phenyls</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/jmcmar.2020.63.issue-8/20200423/jmcmar.2020.63.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Fatty-acid binding protein 4 (FABP4) is a promising therapeutic target for immunometabolic diseases, while its potential for systemic inflammatory response syndrome treatment has not been explored. Here, a series of 2-(phenylamino)benzoic acids as novel and potent FABP4 inhibitors are rationally designed based on an interesting fragment that adopts multiple binding poses within FABP4. A fusion of these binding poses leads to the design of compound <b>3</b> with an ∼460-fold improvement in binding affinity compared to the initial fragment. A subsequent structure-aided optimization upon <b>3</b> results in a promising lead (<b>17</b>) with the highest binding affinity among all the inhibitors, exerting a significant anti-inflammatory effect in cells and effectively attenuating a systemic inflammatory damage in mice. Our work therefore presents a good example of lead compound discovery derived from the multiple binding poses of a fragment and provides a candidate for development of drugs against inflammation-related diseases.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12326" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12326" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Fatty-acid binding proteins (FABPs) are a class of lipid chaperones involved in regulation of the uptake and intracellular transport of fatty acids (FAs). Currently, 10 different FABPs with tissue-specific expression have been identified.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Among these, FABP4 is predominantly expressed in mature adipocytes and macrophages, acting as an important regulator in inflammatory-related signaling pathways.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> In macrophages, FABP4 aggravates the lipopolysaccharide (LPS)-induced inflammatory response by the formation of a positive feedback loop with c-Jun N-terminal Kinase (JNK) and activate protein 1 (AP-1).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In addition, FABP4 can disturb the eicosanoid homeostasis by regulating the activity of cyclooxygenase 2 (COX2) and the stability of leukotriene A4 (LTA4), ultimately exerting an impact on macrophages functions and inflammatory response.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> It has been reported that FABP4-deficient macrophages exhibit a dramatic decrease in production of inflammatory cytokines including monocyte chemo-attractant protein 1 (MCP-1), interleukin 6 (IL-6), tumor necrosis factor α (TNF-α), and interleukin 1β (IL-1β).<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> In adipocytes, a fat-specific deletion of FABP4 also decreases the expression of inflammatory cytokines.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> FABP4 inhibition or knockout in mice has acquired therapeutic benefits for inflammation-associated diseases, such as atherosclerosis,<a onclick="showRef(event, 'ref8 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref8 ref10 ref11">(8,10,11)</a> renal interstitial fibrosis,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> nonalcoholic steatohepatitis,<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> and acute lung injury.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Accordingly, FABP4 inhibitors provide the therapeutic potential for these diseases.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">It is noteworthy that FABP3-deficient mice suffered from a regional cardiac hypertrophy and stress-intolerability.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The selectivity of inhibitors for FABP4 over FABP3 has to be considered in order to avoid the potential cardiac toxicity. In contrast, FABP4/FABP5 double-knockout mice displayed a more significant protection from insulin resistance, type 2 diabetes, and atherosclerosis compared to FABP4 or FABP5 single-knockout.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> FABP4/FABP5 dual inhibitors are thus expected to have great utility in treating these diseases. Recently, Li et al. reported that it is FABP4 rather than FABP5 that promoted the growth and metastasis of breast cancer.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Accordingly, FABP4 selective inhibitors may afford a better choice for the treatment of cancer. In terms of anti-inflammation, there is no evidence to show that FABP4/FABP5 dual inhibitors would have better efficacy than the FABP4 selective inhibitors do.</div><div class="NLM_p">Currently, several classes of FABP4 inhibitors have been identified for therapeutic intervention in diseases like insulin resistance, type 2 diabetes, and atherosclerosis.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32">(20−32)</a> BMS309403, the prime inhibitor of FABP4 developed by Bristol-Myers Squibb, has been used to explore its anti-inflammatory effect in vitro and in vivo. It was shown that BMS309403 decreased the production of pro-inflammatory cytokines and alleviated the LPS-induced acute lung injury, nonalcoholic steatohepatitis, and renal interstitial fibrosis.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref33 ref34">(12−15,33,34)</a> However, compared to the knockout of FABP4, the anti-inflammatory efficacy of BMS309403 was unsatisfied.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> It is noteworthy that binding affinities of most available inhibitors are equivalent to that of FAs such as palmitic acid and linoleic acid.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> As a result, it is difficult for these inhibitors to compete with FAs, which are often at a high level in vivo. Therefore, it is worth identifying more potent FABP4 inhibitors to systematically explore the effectiveness of FABP4 in anti-inflammation and to provide novel compounds possessing more-drug-like properties.</div><div class="NLM_p last">Herein, with a fragment-based lead discovery strategy, we sought to design and synthesize a new class of potent FABP4 inhibitors, and therapeutic potentials of the inhibitors in treating systemic inflammatory response syndrome were explored. To find a hit with a new scaffold, we screened our in-house 500-fragment library and identified an interesting hit (fragment <b>1</b>) with multiple binding poses shown in the ligand binding pocket of FABP4. With the aid of the determined crystal structures and binding affinities, a series of 2-(phenylamino)benzoic acids as novel and potent FABP4 inhibitors were successfully designed on the basis of this weak fragment binder. In the following, we comprehensively illustrate the hit discovery, a hit-to-lead optimization, and evaluation of potency, selectivity, pharmacokinetic properties, and anti-inflammatory efficacy of the inhibitors.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17215" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17215" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Hit Identification and Characterization</h3><div class="NLM_p">Given the advantage of fragment-screening campaigns in hit/lead discovery,<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> an in-house 500-fragment collection was screened against human FABP4 using the 8-anilino-1-naphthalene-sulfonic acid (1,8-ANS) displacement assay. The concentration of fragments used for the testing is 1 mM. Two analogues of benzoic acid, namely, fragments <b>1</b> (molecular weight (MW) = 214.2, <i>K</i><sub>i</sub> = 50.7 μM) and <b>2</b> (MW = 213.2, <i>K</i><sub>i</sub> > 500 μM), were identified as FABP4 binders. Encouraged by a high ligand-binding efficiency of fragment <b>1</b> (LE = 0.36), we performed a structure-based hit-to-lead optimization on this diphenylamine scaffold to discover novel, highly potent, and selective FABP4 inhibitors. However, the endogenous FAs bound in the ligand binding pocket of FABP4 and the relatively weak binding affinity of <b>1</b> impeded the complex structure determination. In this scenario, we tried to remove the endogenous FAs from FABP4 through a denaturation and refolding of the recombinant FABP4. To solve the structure of FABP4 in complex with fragment <b>1</b>, crystals of apo FABP4 obtained at pH 6.5 and 7.5 were soaked with the fragment. To our surprise, the complex structures show that fragment <b>1</b> adopts more than one binding pose in the ligand binding pocket of FABP4. According to the electron density map, three different but partially overlapped binding poses of <b>1</b> could be fitted (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A and <a class="ref internalNav" href="#notes-1" aria-label="S1">S1</a>). At pH 6.5, two poses (Pose 1 and Pose 2) are found in the pocket (<a class="ref internalNav" href="#notes-1" aria-label="Figure S1A">Figure S1A</a>). Pose 1 presents a classical binding mode, which is utilized by most FABP4 inhibitors. With such a pose, the carboxylic group forms multiple polar interactions with R126 as well as Y128, and the free phenyl ring mainly establishes face-to-edge π-stacking interactions with F16 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). However, in Pose 2, the carboxylic group forms hydrogen bonds (H-bonds) to S53 and T60 directly and to S55, K58, and A75 through water molecules (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C). Besides, the phenyl ring of the benzoic acid group interacts with F57 via a π–π stacking, while the free phenyl ring occupies a position as that seen in Pose 1 to form face-to-edge π-stacking interactions with F16. The difference electron-density map suggests that Pose 2 (occupancy = 0.58) is more stable than Pose 1 (occupancy = 0.42) in the crystal structure determined at pH 6.5 (<a class="ref internalNav" href="#notes-1" aria-label="Figure S1A">Figure S1A</a>). There are also two binding poses of the fragment found in the complex structure determined at pH 7.5. One is Pose 2, although its occupancy (0.41) is relatively low. The second one is a new pose, Pose 3 (occupancy = 0.59) (<a class="ref internalNav" href="#notes-1" aria-label="Figure S1B">Figure S1B</a>). Similar to Pose 1, the carboxylic group of the benzoic acid in Pose 3 forms polar interactions with R126 and Y128, while the free phenyl ring flips up to form hydrophobic interactions with F57 and A75 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D). Taken together, two crystal structures of FABP4 in complex with fragment <b>1</b> reveal three possible binding poses of the fragment, suggesting that this fragment in the ligand binding pocket is mobile and may switch from one pose to another.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Crystal structures of FABP4 in complex with fragment <b>1</b> determined at pH 6.5 and 7.5 (PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJW">6LJW</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJX">6LJX</a>). (A) An overlay of three binding poses of <b>1</b> shown in B–D. (B–D) A representation of Pose 1 (B), Pose 2 (C), and Pose3 (D). Residues interacting with <b>1</b> are shown as gray sticks, and H-bonds are represented by black dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although the occupancy of Pose 1 in the crystal structure is low, it is similar to the typical binding mode utilized by other FABP4 inhibitors, in which F16, R126, and Y128 are the key residues for the ligand binding.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> To further explore the probability of Pose 1 and investigate the dynamic behavior of fragment <b>1</b> inside FABP4, molecular dynamics (MD) simulations were performed on Pose 1 in complex with FABP4.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> As expected, the fragment is mobile during the simulation, and its root-mean-square deviations (RMSDs) fluctuate from 1.0 to 7.0 Å, while the backbone RMSDs of FABP4 have a relatively smooth fluctuation of ∼2.0 Å (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). After a cluster analysis on conformations of the fragment extracted from the MD trajectory, four major conformations (I to IV) are found, and their representative snapshots superimposed to three poses in the crystal structures are displayed in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>. It seems that conformations I and III are very close to Poses 1 and 3, with averaged RMSDs of 2.0 and 1.3 Å, respectively. Conformation II is similar to Pose 2 but with a relatively larger RMSD (2.9 Å). Conformation IV of the fragment is distinctive to three poses (RMSDs > 4.6 Å), although the benzoic acid moiety is similar to that of Pose 3. Accordingly, starting with Pose 1, the fragment can move to conformations almost identical to Pose 2 and Pose 3 during the 600 ns MD simulation, demonstrating again that the binding of fragment <b>1</b> with FABP4 is mobile and that the multiple bound conformations could be exchanged one for the other.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. An overlay of representative conformations of fragment <b>1</b> extracted from the MD trajectory (gray sticks) with three poses shown in the crystal structures (Pose 1: cyan sticks; Pose 2: yellow sticks; Pose 3: pink sticks). RMSDs of backbone atoms of FABP4 (black) and all atoms of fragment <b>1</b> (red) vs the simulation time were calculated based on the MD trajectory.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Micromolar-to-Nanomolar Potency Improvement</h3><div class="NLM_p">Though fragment <b>1</b> employs multiple conformations to interact with FABP4, the essential amino acids participating in binding include F16, S53, F57, R126, and Y128. This gave us a valuable clue to rationally design more potent inhibitors with full consideration of interactions with these residues. In addition, two phenyl rings of the fragment are overlapped by each other in three binding poses, resulting in three locations of the phenyl rings (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). To obtain a new compound containing three phenyl rings so as to simultaneously occupy the overlapped position of phenyl rings in three poses, we added a benzene ring to C13 of Pose <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). The resulting 2-([1,1′-biphenyl]-2-ylamino)benzoic acid (<b>3</b>) has a <i>K</i><sub>i</sub> of 109.3 nM, which is an ∼460-fold increase in <i>K</i><sub>i</sub> compared to that of fragment <b>1</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). It is also more potent than the well-studied BMS309403 with a <i>K</i><sub>i</sub> of 253.4 nM. Attachment of an anilino (<b>4</b>) or a phenoxy group (<b>5</b>) to C13 of <b>1</b> also shows a modest increase in the binding affinity, but they are much less potent than compound <b>3</b>. The complex structure of FABP4 bound with <b>3</b> reveals that three phenyl rings take positions, as they are in three binding poses of fragment <b>1</b>, and the binding pose of compound <b>3</b> is more like a hybrid of Pose 1 and Pose 2 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B). The added phenyl ring extends to a position that was once occupied by the benzoic acid moiety of Pose 2 or the free phenyl ring of Pose 3. This ring of <b>3</b> simultaneously participates in an edge-to-face π–π stacking interaction with F57 and a cation−π interaction with R126. The remaining part of <b>3</b> adopts a conformation similar to that in Pose 1. The carboxylic group makes H-bonds with R126 and Y128 directly and with S53 through a water molecule, while the middle phenyl ring forms face-to-edge π-stacking interactions with F16 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B,C). These interactions between three phenyl rings as well as the carboxylic group of <b>3</b> and five key residues (F16, S53, F57, R126, and Y128) account for the huge improvement of potency for compound <b>3</b> relative to that of fragment <b>1</b>, demonstrating the rationale for the design of compound <b>3</b>. However, inserting an additional NH and O between two phenyl rings in compounds <b>4</b> and <b>5</b>, respectively, might generate clashes with the neighboring residues and result in remarkably reduced potency (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). In summary, the hybrid of the binding poses of fragment <b>1</b> leads to the efficient design of a novel and potent inhibitor of FABP4 by only adding a phenyl ring to the right position of fragment <b>1</b>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Design of new inhibitors based on an overlay of different binding poses of fragment <b>1</b>. (B) An overlay of the binding poses of compound <b>3</b> (purple sticks) and fragment <b>1</b> by superimposing crystal structures of FABP4 in complex with <b>3</b> and <b>1</b>. (C) Interactions of <b>3</b> with the surrounding residues revealed by the crystal structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJS">6LJS</a>). Residues are shown as cyan sticks, and H-bonds are represented by black dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effects of X, Y, and R<sup>1</sup> Substitutions on Binding Affinities of Compounds with FABP4<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0012.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The values of <i>K</i><sub>i</sub> or <i>K</i><sub>d</sub> were expressed as mean ± SD based on three independent experiments and determined via the nonlinear regression analysis using GraphPad Prism software 8.0.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last"><i>K</i><sub>i</sub> measured by the 1,8-ANS displacement assay.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last"><i>K</i><sub>d</sub> measured by ITC.</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Binding Affinities Determined by ITC</h3><div class="NLM_p last">Given that the concentration of FABP4 used in the 1,8-ANS displacement assay is ∼0.8 μM, the detection limit of the half-maximal inhibitory concentration (IC<sub>50</sub>) with this assay is over 0.4 μM. Therefore, this assay usually measures <i>K</i><sub>i</sub> values over 77.4 nM according to the equation <i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + [1,8-ANS]/<i>K</i><sub>d</sub>), where [1,8-ANS] is the concentration of 1,8-ANS used in the assay, and <i>K</i><sub>d</sub> means the dissociating constant for 1,8-ANS with FABP4. We found that the <i>K</i><sub>i</sub> of compound <b>3</b> (109.3 nM) is close to the detection limit of the 1,8-ANS displacement assay. This makes it difficult to use this assay to precisely determine the binding affinity of more potent inhibitors derived from compound <b>3</b>. Isothermal titration calorimetry (ITC), widely known as an invaluable tool to determine thermodynamic parameters of protein–ligand interactions, is also frequently used to obtain <i>K</i><sub>d</sub> values ranging from 10<sup>–3</sup> to 10<sup>–8</sup> M. To gain the accurate binding affinity of the inhibitors with FABP4, ITC measurements were employed to determine the <i>K</i><sub>d</sub> values of the compounds, in particular, for the binding affinities of those compounds (IC<sub>50</sub> < 0.5 μM, <i>K</i><sub>i</sub> < 96.8 nM) close to or even beyond the detection limit of the 1,8-ANS displacement assay. The ITC-measured <i>K</i><sub>d</sub> value of compound <b>3</b> binding to apo FABP4 is 110.6 nM, which is also stronger than that of BMS309403 (252.7 nM).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Optimization Based on Compound <b>3</b></h3><div class="NLM_p">Inspired by the above results, we embarked on an optimization around the [1,1′-biphenyl]-2-amine scaffold rather than the benzoic acid moiety of compound <b>3</b>. The crystal structure of FABP4-<b>3</b> reveals that small cavities appear near atoms C11 and C12. It looks like the substituents with a small size are suitable to fill these cavities. To test this, introducing various substituents at C12 (the X substituent) was conducted in order to find the right substituent matching the hydrophobic cavity defined by M20, T29, and F57 (Site P1) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Compared to the unsubstituted <b>3</b>, introduction of a chloro (compound <b>6</b>) or a methoxy (compound <b>10</b>) group results in higher binding affinities. In particular, the chloro-substituted compound (<b>6</b>, <i>K</i><sub>d</sub> = 34.4 nM) yields an approximately threefold increase in affinity compared to compound <b>3</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). However, introduction of a bromo (compound <b>7</b>), a trifluoromethyl (compound <b>8</b>), or a methyl (compound <b>9</b>) at the same position decreases the binding affinities compared to compound <b>3</b>. The determined crystal structure of FABP4 in complex with <b>6</b> shows the protein–ligand interactions seen in the FABP4-<b>6</b> complex are almost identical to those in the FABP4-<b>3</b> complex, except that the chloro group in <b>6</b> forms favorable hydrophobic interactions with the surrounding residues such as M20, T29, A30, and F57 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). Besides the size of the substituent groups, the compounds attached with the electron-withdrawing substituents tend to be more potent compared to their counterparts, for example, <b>8</b> versus <b>9</b>. Accordingly, the chloro group, with an appropriate size and a negative inductive effect, was identified as the favorable substituent of X for a further optimization.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystal structures of FABP4 in complex with compounds <b>3</b> (purple, A; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJS">6LJS</a>), <b>6</b> (green, B; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJT">6LJT</a>), <b>11</b> (magenta, C; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJU">6LJU</a>), and <b>17</b> (yellow, D; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJV">6LJV</a>). Sites P1, P2, and P3 show the optimization directions. The ligand binding pocket is presented by molecular surface. The dashed lines indicate H-bonds between compounds and residues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Optimization Based on Compound <b>6</b></h3><div class="NLM_p">The crystal structure of FABP4-<b>6</b> also reveals that a region defined by V23 and V25 (Site P2) could potentially accommodate the substituents at C11 of <b>6</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A,B). Considering the synthesis feasibility and the selectivity for FABP4 over FABP3, several aliphatic amine-substituted compounds were designed, synthesized, and evaluated (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The most potent compound is <b>11</b> (<i>K</i><sub>d</sub> = 60.1 nM), which is slightly less potent than <b>6</b>. The determined crystal structure of FABP4 in complex with compound <b>11</b> suggests that this compound adopts a binding pose almost identical to <b>6</b> and that the introduced methyl group establishes hydrophobic interactions with V23 and V25 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). The underlying mechanism accounting for the lower potency of <b>11</b> over <b>6</b> may be ascribed to the electron-donating ability of the aliphatic amine substituents, which are helpful to increase the π-electron density and thereby are harmful to the π–π interactions between the attached benzene ring and F16. However, compounds <b>12</b> and <b>13</b>, decorated with a bulkier <i>N,N</i>-dimethylamino and ethylamino groups, respectively, show a remarkably reduced potency compared to <b>11</b>. It is thus suggested that the <i>N,N</i>-dimethylamino or ethylamino group is too large to be compatible with Site P2.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effects of R<sup>1</sup> and R<sup>2</sup> Substituents on Binding Affinities of Compounds with FABP4<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0013.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The values of <i>K</i><sub>i</sub> or <i>K</i><sub>d</sub> were expressed as mean ± SD from three independent experiments and determined via the nonlinear regression analysis using GraphPad Prism software 8.0.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last"><i>K</i><sub>i</sub> measured by 1,8-ANS displacement assay.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last"><i>K</i><sub>d</sub> measured by ITC.</p></div></div><div></div></div><div class="NLM_p last">Another small region that could be exploited by our inhibitors is Site P3, which is around the free phenyl ring of <b>6</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). Aiming to engage more favorable interactions with the neighboring residues and maintain the binding pose of <b>6</b>, the free phenyl ring of <b>6</b> was replaced by various bicyclic rings. Six synthesized compounds (<b>14</b>–<b>19</b>) retain high binding affinities with FABP4. Among them, the most potent one, compound <b>17</b>, has a <i>K</i><sub>d</sub> of 37.4 nM, which is nearly equal to the <i>K</i><sub>d</sub> of <b>6</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The binding mode of <b>17</b> with FABP4 was also determined by X-ray protein crystallography (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). As expected, the bound pose of <b>17</b> is overlapped well with that of <b>6</b>, and an additional H-bond is observed between the hydroxyl group of S55 and the oxygen atom of the dihydrofuran ring in <b>17</b>. Increase of aromaticity of the bicyclic rings reduces the binding affinities of compounds <b>14</b>, <b>15</b>, <b>18</b>, and <b>19</b> with FABP4. Introducing the second oxygen into the bicyclic ring also results in a lower binding affinity of <b>16</b> compared to <b>17</b> (136.2 vs 37.4 nM). Overall, small modification of the free phenyl ring of <b>6</b> so as to fill the neighboring space leads to discovery of a novel and potent inhibitor (<b>17)</b> with a binding affinity comparable to that of <b>6</b>.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Selectivity</h3><div class="NLM_p">Considering the side effect caused by the inhibitory activity of compounds against the cardiac form of FABP (FABP3), compounds that show a great binding affinity with FABP4 were examined for their affinities with FABP3 by the 1,8-ANS displacement assay. BMS309403 was used as a positive control. The data listed in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> shows that several compounds (<b>3</b>, <b>6</b>, <b>10</b>, <b>11</b>, <b>17</b>, and <b>20</b>) have a good selectivity for FABP4 over FABP3 and that their selectivity indexes are superior or similar to that of BMS309403. In particular, compound <b>11</b> exhibits a 238-fold selectivity for FABP4 over FABP3, which is significantly more selective than BMS309403 (29-fold). To understand the structural basis for the different selectivity index of the compounds, crystal structures of FABP4 and FABP3 were superimposed (<a class="ref internalNav" href="#notes-1" aria-label="Figure S2">Figure S2</a>). Residue V23 is in close proximity to and forms hydrophobic interactions with the methylamino group of <b>11</b> in the FABP4-<b>11</b> complex, while it is a leucine at the same position in FABP3. A larger side chain of L23 in FABP3 might create a steric hindrance for the binding of the methylamino group, resulting in a weak binding of <b>11</b> with FABP3. In contrast, without the methylamino group, compound <b>6</b> has a lower selective index, though it has a stronger binding affinity with FABP4. Stimulated by the high selectivity index of <b>11</b>, the methylamino group was added to the C11 of compound <b>17</b>, whose binding affinity is similar to that of <b>6</b>, to yield compound <b>20</b>. As expected, <b>20</b> does exhibit a much higher selectivity index for FABP4 over FABP3 compared to <b>17</b>, while its binding affinity to FABP4 is slightly less than that of <b>17</b>. Therefore, the methylamino substitution on C11 in the middle phenyl ring plays a key role in improving the selectivity of this series of compounds toward FABP4 over FABP3. Note that other factors can also affect the selectivity index. For example, compound <b>3</b> without such a methylamino substitution also has a selectivity index of 117. Taken together, compounds <b>3</b>, <b>6</b>, <b>10</b>, <b>11</b>, <b>17</b>, and <b>20</b> show high affinity with FABP4 and favorable selectivity for FABP4 over FABP3.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Selectivity of the FABP4 Inhibitors toward FABP3 and FABP5</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">FABP3 <i>K</i><sub>i</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (μM)</th><th class="colsep0 rowsep0" align="center">FABP5 <i>K</i><sub>i</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">FABP3/FABP4<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BMS309403</td><td class="colsep0 rowsep0" align="left">7.45 ± 0.28</td><td class="colsep0 rowsep0" align="left">9.24 ± 0.21</td><td class="colsep0 rowsep0" align="char" char=".">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">12.82 ± 1.91</td><td class="colsep0 rowsep0" align="left">8.23 ± 0.42</td><td class="colsep0 rowsep0" align="char" char=".">117</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">1.00 ± 0.17</td><td class="colsep0 rowsep0" align="left">0.88 ± 0.06</td><td class="colsep0 rowsep0" align="char" char=".">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">1.51 ± 0.02</td><td class="colsep0 rowsep0" align="left">1.20 ± 0.12</td><td class="colsep0 rowsep0" align="char" char=".">34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">14.29 ± 0.24</td><td class="colsep0 rowsep0" align="left">17.75 ± 0.92</td><td class="colsep0 rowsep0" align="char" char=".">238</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">0.74 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.49 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">1.50 ± 0.04</td><td class="colsep0 rowsep0" align="left">0.60 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">0.86 ± 0.08</td><td class="colsep0 rowsep0" align="left">1.07 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">1.40 ± 0.13</td><td class="colsep0 rowsep0" align="left">0.82 ± 0.02</td><td class="colsep0 rowsep0" align="char" char=".">37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">0.35 ± 0.01</td><td class="colsep0 rowsep0" align="left">0.43 ± 0.01</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">1.42 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.60 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">9.62 ± 0.63</td><td class="colsep0 rowsep0" align="left">32.04 ± 1.63</td><td class="colsep0 rowsep0" align="char" char=".">165</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The values of <i>K</i><sub>i</sub> were expressed as mean ± SD based on three independent experiments and determined via the nonlinear regression analysis using GraphPad Prism software 8.0.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Selectivity index was resulted from the <i>K</i><sub>i</sub> of a compound with FABP3 divided by <i>K</i><sub>i</sub> or <i>K</i><sub>d</sub> of the compound with FABP4.</p></div></div></div><div class="NLM_p last">In addition, the binding affinities of these inhibitors with FABP5 were examined. It shows that compounds <b>6</b>, <b>14</b>, <b>15</b>, <b>17</b>, <b>18</b>, and <b>19</b> have a good binding affinity with FABP5.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Anti-inflammatory Effects on THP-1 Macrophages</h3><div class="NLM_p">Genetic ablation or pharmacological inhibition of FABP4 has been demonstrated to attenuate inflammatory responses in macrophages.<a onclick="showRef(event, 'ref8 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref10">(8,10)</a> Therefore, we selected several compounds with high affinity with FABP4 and favorable selectivity for FABP4 over FABP3 to explore their anti-inflammatory effect on the LPS-stimulated THP-1 macrophages. First, the cytotoxicity was evaluated with a CCK-8 assay, and the result shows that all tested compounds (<b>3</b>, <b>6</b>, <b>10</b>, <b>11</b>, <b>17</b>, and <b>20</b>) at 20 and 50 μM have no effect on the cell viability of THP-1 macrophages (<a class="ref internalNav" href="#notes-1" aria-label="Figure S3A">Figure S3A</a>). Next, THP-1 macrophages were incubated with these compounds at 20 μM for 18 h followed by an LPS stimulation for another 6 h. As shown in <a class="ref internalNav" href="#notes-1" aria-label="Figure S3B,C">Figure S3B,C</a>, the application of LPS resulted in a dramatic increase in secretion of pro-inflammatory cytokines MCP-1 and IL-6, and our compounds as well as BMS309403 attenuated the inflammatory responses by reducing the levels of MCP-1 and IL-6. Among these compounds, <b>17</b> exhibits the best in vitro anti-inflammatory efficacy in the LPS-stimulated THP-1 macrophages, and it is thus chosen for a further study. As illustrated in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, compound <b>17</b> inhibited both MCP-1 and IL-6 release from the LPS-stimulated THP-1 macrophages in a dose-dependent manner, and its efficacy is even superior to that of BMS309403. Taken together, these results suggest that our compounds possess an anti-inflammatory effect on the LPS-stimulated THP-1 macrophages and that the efficacy of compound <b>17</b> is even better than that of BMS309403.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of BMS309403 and compound <b>17</b> on the secretion of pro-inflammatory cytokines, MCP-1 (A) and IL-6 (B), in the LPS-stimulated THP-1 macrophages. MCP-1 and IL-6 were measured by the ELISA Kits. Data are given as mean ± SEM of three independent experiments. Statistical analysis is performed by one-way ANOVA. *<i>P</i> < 0.05, ***<i>P</i> < 0.001 vs LPS group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Lipolysis Inhibition in 3T3-L1 Adipocytes</h3><div class="NLM_p">As previously reported, ablation or chemical inhibition of FABP4 decreases lipolysis in adipocytes;<a onclick="showRef(event, 'ref27 ref37'); return false;" href="javascript:void(0);" class="ref ref27 ref37">(27,37)</a> hence, we also investigated the effects of compound <b>17</b> on adipocyte lipolysis. Again, the CCK-8 assay was first performed to test the cytotoxicity of the compounds. It shows that both BMS309403 and <b>17</b> have no significant cytotoxicity on 3T3-L1 adipocytes at any tested concentration (<a class="ref internalNav" href="#notes-1" aria-label="Figure S4">Figure S4</a>). The lipolysis experiment was then conducted at various concentrations of tested compounds, and the result is shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>. The lipolytic inhibition by compound <b>17</b> was more significant than that of the positive control, BMS309403. These results further confirm the efficacy of compound <b>17</b> on the lipolysis inhibition in 3T3-L1 adipocytes by binding to FABP4.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of BMS309403 and compound <b>17</b> on the release of free glycerol from the forskolin-stimulated mature 3T3-L1 adipocytes. Data are given as mean ± SEM of at least three independent experiments, and each is performed in triplicate. Statistical analysis is performed by one-way ANOVA. *<i>P</i> < 0.05, ***<i>P</i> < 0.001 vs control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vitro ADME and In Vivo Pharmacokinetic (PK) Properties of <b>17</b></h3><div class="NLM_p">Compound <b>17</b>, with an excellent inhibitory activity against FABP4 both at the molecular and cellular levels, was progressed to an in vivo efficacy study. Before that, the metabolic stability of <b>17</b> was evaluated using mouse and human liver microsomes. <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> shows that <b>17</b> is relatively stable in the human and mouse liver microsomes. Furthermore, the Caco-2 cell permeability experiment implies that <b>17</b> possesses a good cell permeability in vitro with a low efflux ratio of 0.21.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Metabolic Stability in Liver Microsomes and Caco-2 Permeability of <b>17</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center" char=".">value</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">metabolic stability in liver microsomes</td><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (min, human)</td><td class="colsep0 rowsep0" align="char" char=".">86.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (min, mouse)</td><td class="colsep0 rowsep0" align="char" char=".">112.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">CL<sub>int</sub> (mL/min/gprot, human)</td><td class="colsep0 rowsep0" align="char" char=".">24.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">CL<sub>int</sub> (mL/min/gprot, mouse)</td><td class="colsep0 rowsep0" align="char" char=".">18.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2 permeability</td><td class="colsep0 rowsep0" align="left"><i>P</i><sub>app</sub>(A–B) (10<sup>–6</sup> cm/s)</td><td class="colsep0 rowsep0" align="char" char=".">6.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">efflux ratio</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td></tr></tbody></table></div></div><div class="NLM_p">The PK properties of compound <b>17</b> were preliminarily evaluated in mice with an intravenous (3 mg/kg) and oral (10 and 25 mg/kg) administration. The results are shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>. After an oral delivery of <b>17</b> at a dose of 25 mg/kg, it exhibits an acceptable PK profile with a <i>T</i><sub>1/2</sub> of 3.82 h, a favorable area under curve (AUC) of 43.77 μg·h/mL, a good oral bioavailability of 57.0%, and a good plasma duration (mean residence time, MRT) of 6.55 h. Together, these data imply that compound <b>17</b> is suitable for in vivo efficacy evaluation.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. PK Profile of <b>17</b> in Mice</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">oral administration (p.o.)</th><th class="rowsep1 colsep0" align="center">intravenous injection (i.v.)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">administration</th><th class="colsep0 rowsep0" align="center">(10 mg/kg)</th><th class="colsep0 rowsep0" align="center">(25 mg/kg)</th><th class="colsep0 rowsep0" align="center">(3 mg/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">4.77 ± 0.76</td><td class="colsep0 rowsep0" align="left">3.82 ± 0.29</td><td class="colsep0 rowsep0" align="left">5.76 ± 0.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.25 ± 0.00</td><td class="colsep0 rowsep0" align="left">0.25 ± 0.00</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μg/mL)</td><td class="colsep0 rowsep0" align="left">3.43 ± 1.66</td><td class="colsep0 rowsep0" align="left">12.99 ± 1.78</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–24h</sub> (μg·h/mL)</td><td class="colsep0 rowsep0" align="left">12.8 ± 3.51</td><td class="colsep0 rowsep0" align="left">43.77 ± 5.53</td><td class="colsep0 rowsep0" align="left">9.38 ± 3.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5.80 ± 1.86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Vss (L/kg)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.65 ± 0.46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRT (h)</td><td class="colsep0 rowsep0" align="left">7.59 ± 1.33</td><td class="colsep0 rowsep0" align="left">6.55 ± 0.12</td><td class="colsep0 rowsep0" align="left">4.83 ± 0.69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">40.9</td><td class="colsep0 rowsep0" align="left">57.0</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> In Vivo Anti-Inflammatory Efficacy Study</h3><div class="NLM_p">As compound <b>17</b> exhibits excellent anti-inflammatory effects in the LPS-stimulated THP-1 macrophages and a satisfying performance in liver microsome stability and PK properties, we next explored its anti-inflammatory effect in vivo. C57BL/6J mice were intragastrically administrated with BMS309403 or compound <b>17</b> at a dose of 50 mg/kg 1 h before a single intraperitoneal injection of LPS at a dose of 5 mg/kg. Concentrations of MCP-1 and IL-6 in serum were measured 5 h after LPS injection. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>, LPS treatment dramatically increases the level of inflammatory cytokines such as MCP-1 and IL-6 in the serum of vehicle mice, while an oral administration of BMS309403 or compound <b>17</b> prominently downregulate the secretion of MCP-1 and IL-6. Consistent with the in vitro results noted above, the anti-inflammatory efficacy of compound <b>17</b> in vivo is also more significant than that of BMS309403, demonstrating the anti-inflammatory potential of compound <b>17</b>.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of BMS309403 (50 mg/kg) and compound <b>17</b> (50 mg/kg) on the secretion of pro-inflammatory cytokines, MCP-1 (A) and IL-6 (B), in the serum of LPS-treated C57BL/6J mice (<i>n</i> = 8 mice/group). MCP-1 and IL-6 were measured by the ELISA Kits. Data are given as mean ± SEM, and statistical analysis is performed by one-way ANOVA. ** <i>P</i> < 0.01, ***<i>P</i> < 0.001 vs LPS group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Efficacy of Compound <b>17</b> for Multi-organ Protection</h3><div class="NLM_p">To explore the effect of compound <b>17</b> on organ damage, C57BL/6J mice were intragastrically administrated with BMS309403 (25 mg/kg) or <b>17</b> (10, 25, and 50 mg/kg) once a day for 4 d consecutively prior to a single LPS intraperitoneal injection at a dose of 10 mg/kg. As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A, the levels of liver damage markers, serum aspartate aminotransferase (AST) as well as alanine transaminase (ALT), and of a kidney damage marker, blood urea nitrogen (BUN), are significantly increased after the injection of LPS compared with the vehicle mice. In contrast, administration of compound <b>17</b> decreases the level of these biomarkers in a dose-dependent manner, which is equivalent to or even better than that of BMS309403, indicating a beneficial effect of compound <b>17</b> on hepatorenal function. In addition, the histological staining results can clearly interpret organ damage, which is manifested as the infiltration of inflammatory cells and damaged cells. Compared with the LPS-treated mice, BMS309403 and compound <b>17</b>-treated mice have a limited extent of damage in key organs such as lung, liver, kidney, and spleen, which are close to those of healthy animals (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B). Taken together, these results indicate that compound <b>17</b> is able to effectively attenuate a systemic inflammatory damage and acts as a good candidate for the treatment of inflammation-related diseases.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0008.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>17</b> effectively protects mice from the LPS-induced multiorgan damage. (A) BMS309403 (25 mg/kg) or compound <b>17</b> (10, 25, and 50 mg/kg) administration decreases the level of tissue damage biomarkers (<i>n</i> = 8 mice/group). (B) BMS309403 and compound <b>17</b> show an efficient protection against the LPS-induced injury in different organs. (H&E staining, magnification: ×200) Each image is representative of four mice at least. Data are given as mean ± SEM, and statistical analysis is performed by one-way ANOVA. * <i>P</i> < 0.05, ** <i>P</i> < 0.01, ***<i>P</i> < 0.001, each vs LPS group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemistry</h3><div class="NLM_p">The preparation of compounds <b>3</b>–<b>20</b> is depicted in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a><named-content content-type="anchor" rid="sch2" type="simple"></named-content>–<a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Commercially available compounds <b>1a</b> or <b>1c</b> were first coupled to the phenylboronic acid with different substituents by the Suzuki-Miyaura coupling reaction to yield compounds <b>3a</b> and <b>3d</b>–<b>3r</b>. In addition, compounds <b>3b</b> and <b>3c</b> were synthesized by a nucleophilic substitution reaction of aniline and phenol with 1-fluoro-2-nitrobenzene (<b>1b</b>). Compound <b>1j</b> was prepared by a methylation of 2,3-dichloro-4-nitroaniline (<b>1i</b>) using methyl iodide, and compound <b>1k</b> was a byproduct of this reaction. Compound <b>1l</b> was synthesized by a procedure similar to <b>1j</b>. Different nitrobenzene derivatives <b>3a</b>–<b>3s</b> were then reduced by iron to afford the corresponding amines <b>4a</b>–<b>4r</b>. The target compounds were synthesized from these amines (<b>4a</b>–<b>4r</b>) by a palladium-catalyzed Buchwald-Hartwig amination followed by the hydrolysis of esters <b>6a</b>–<b>6r</b>.</div><figure id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis<sup>a</sup> of Compounds <b>3</b>–<b>5</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O, 15 h, 95 °C; (b) Fe, HAc, NH<sub>4</sub>Cl, EtOH, 50 °C; (c) Pd<sub>2</sub>(dba)<sub>3</sub>, BINAP, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 6 h, 90 °C; (d) NaOH, MeOH, H<sub>2</sub>O, 1 h, 70 °C; (e) NaH, THF, 2 h, 75 °C.</p></p></figure><figure id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis<sup>a</sup> of Compounds <b>6</b>–<b>10</b> and <b>14</b>–<b>19</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O, 15 h, 95 °C; (b) Fe, HAc, NH<sub>4</sub>Cl, EtOH, 50 °C; (c) Pd<sub>2</sub>(dba)<sub>3</sub>, BINAP, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 6 h, 90 °C; (d) NaOH, MeOH, H<sub>2</sub>O, 1 h, 70 °C.</p></p></figure><figure id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis<sup>a</sup> of Compounds <b>11</b>–<b>13</b> and <b>20</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O, 15 h, 95 °C; (b) Fe, HAc, NH<sub>4</sub>Cl, EtOH, 50 °C; (c) Pd<sub>2</sub>(dba)<sub>3</sub>, BINAP, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 6 h, 90 °C; (d) NaOH, MeOH, H<sub>2</sub>O, 1 h, 70 °C; (f) C<sub>2</sub>H<sub>5</sub>I or CH<sub>3</sub>I, CH<sub>3</sub>CN, 2 d, 85 °C.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17307" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17307" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Here we reported the efficient discovery of a new class of highly potent, selective FABP4 inhibitors from an interesting fragment hit, which displays multiple binding poses in the ligand binding pocket of FABP4. Both crystal structures and MD simulations revealed the multiple binding poses of the fragment. On the basis of three distinctive but partially overlapped binding poses of this fragment, compound <b>3</b> was rationally designed, synthesized, and evaluated, demonstrating an ∼460-fold improvement in the binding affinity compared to the initial fragment. The binding affinity of compound <b>3</b> with FABP4 is superior to the well-known inhibitor BMS309403. The protein–ligand structures determination together with the binding affinity precisely measured by ITC renders us to rapidly gain the sufficient knowledge of structure and activity relationship (SAR) and to discover more potent and selective FABP4 inhibitors. As a result, the representative compound (<b>17</b>) with an ∼1400-fold improvement in the binding affinity compared to the initial fragment (<b>1</b>) is able to potently inhibit the production of MCP-1 and IL-6 in THP-1 macrophages as well as the lipolysis in 3T3-L1 adipocytes, with a better performance than BMS309403. Moreover, compound <b>17</b> displays favorable PK profiling for the in vivo study and exhibits a better anti-inflammatory effect and effective protection against multiorgan damage in the LPS-induced inflammatory mice model compared to BMS309403. Given the good efficacy in vivo, application of <b>17</b> in other FABP4-associated indications such as breast cancer and nonalcoholic steatohepatitis will be explored in the future. Overall, the present study demonstrates that an in-depth exploration of fragment binding to the target protein plays a significant role in efficient discovery of novel and potent ligands. It is noteworthy that removing endogenous fatty acids from the purified FABP4 is crucial for elucidation of the multiple binding poses of the fragment, a weak binder, and for accurate determination of the binding affinity of highly potent FABP4 inhibitors by ITC.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74264" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74264" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Materials and Methods for Chemistry</h3><div class="NLM_p last">All chemical reagents and compounds included in our in-house library for screening were used as supplied by standard suppliers without further purification. All reactions were monitored by the thin-layer chromatography (TLC), and visualization was achieved by using ultraviolet light (254 nm). The column chromatography was performed using silica gel (300–400 mesh) in glass columns under proper pressure. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on a BRUKER AVANCE NEO 500 at 500 and 126 MHz, respectively. Coupling constants (<i>J</i>) are expressed in hertz. Chemical shifts (δ) of NMR spectra are reported in parts per million (ppm) units. Mass spectra (MS) of compounds were measured using a Thermo Fisher FINNIGAN LTQ spectrometer. Purity of all compounds used for biological testing was determined to be greater than 95% by high-performance liquid chromatograqphy (HPLC) analysis. Analysis was performed on a SHIMADZU LC-20AD HPLC system under the following analytical method: column, SHIMADZU Shim-pack GIST C18 (5 μm, 4.6 mm × 250 mm); solvent A: water containing 1‰ trifluoroacetic acid (TFA); solvent B: acetonitrile; gradient, 60% B to 100% B over 15 min, 100% B for 5 min, 100% B to 60% B over 5 min; flow rate, 1 mL/min; detective wavelength, 254 nm; column temperature, 10 °C.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Synthesis Procedure for 2-([1,1′-Biphenyl]-2-ylamino)benzoic acid (<b>3</b>)</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-Nitro-1,1′-biphenyl (<b>3a</b>)</h4><div class="NLM_p last">1-Chloro-2-nitrobenzene (<b>1a</b>) (0.1 g, 0.635 mmol), phenylboronic acid (<b>2a</b>) (0.077 g, 0.635 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.059 g, 0.051 mmol), and K<sub>2</sub>CO<sub>3</sub> (0.263 g, 1.90 mmol) were taken up in 1,4-dioxane (8 mL) and water (2 mL) in a flask and purged with N<sub>2</sub> for 5 min. Then, the mixture was heated to 95 °C for 15 h. After it cooled to room temperature, the mixture was filtered by diatomaceous earth, and the filtrate was extracted with ethyl acetate and washed with brine, and the organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed, and the residue was purified by a flash column chromatography on silica (80% petroleum ether (PE) in ethyl acetate (EtOAc) to 50% PE in EtOAc) to give a yellow solid <b>3a</b> (0.102 g, 80.67% yield). <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.63–7.58 (m, 4H), 7.44 (dd, <i>J</i> = 8.4, 7.0 Hz, 3H), 7.40–7.31 (m, 2H).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> [1,1′-Biphenyl]-2-amine (<b>4a</b>)</h4><div class="NLM_p last">Iron powder (561 mg, 10.04 mmol), NH<sub>4</sub>Cl (53.7 mg, 1.004 mmol), and AcOH (0.115 mL, 2.008 mmol) were added into water (2 mL) and stirred at 50 °C for 15 min. A solution of <b>3a</b> (200 mg, 1.004 mmol) in MeOH (3 mL) was added into the above solution quickly, and stirring was continued at 50 °C for 25 min. Then the reaction solution was alkalized to pH = 9 with an aqueous solution of sodium carbonate. The reaction mixture was filtered, and the formed solid was washed with water and ethyl acetate. The combined filtrate was extracted with ethyl acetate. Then the combined organic layers were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give the crude <b>4a</b> (180 mg), which was directly used in the next step without further purification.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Methyl 2-([1,1′-biphenyl]-2-ylamino)benzoate (<b>6a</b>)</h4><div class="NLM_p last">Under nitrogen a solution of Pd<sub>2</sub>(dba)<sub>3</sub> (14.23 mg, 0.016 mmol), 2,2′-bis(diphenylphosphino)-1,1′-binaphthalene (BINAP) (15.48 mg, 0.025 mmol), and [1,1′-biphenyl]-2-amine (<b>4a</b>) (57.8 mg, 0.342 mmol) derivative in dry toluene (5 mL) was stirred for 5 min. To this deep red solution, the corresponding methyl 2-chlorobenzoate (53 mg, 0.311 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (152 mg, 0.466 mmol) were added and stirred at 90 °C. The reaction was continued until the TLC showed the reaction to be completed (usually 12 h). The solid was filtered off, and the filtrate was concentrated in vacuo to afford a residue that was subjected to a chromatography (silica gel, PM/EtOAc: 100/1–10/1) to yield <b>6a</b>, methyl 2-([1,1′-biphenyl]-2-ylamino)benzoate (40 mg, 0.132 mmol, 42.4% yield). <sup>1</sup>H NMR (500 MHz, deuterated dimethyl sulfoxide (DMSO-<i>d</i><sub>6</sub>)) δ 8.03–7.97 (m, 1H), 7.90 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.65 (dd, <i>J</i> = 7.5, 1.6 Hz, 1H), 7.48–7.41 (m, 2H), 7.39–7.29 (m, 7H), 7.29–7.21 (m, 2H), 3.89 (s, 3H).</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-([1,1′-Biphenyl]-2-ylamino)benzoic acid (<b>3</b>)</h4><div class="NLM_p last">To a solution of <b>6a</b> (50 mg, 0.165 mmol) in methanol (4 mL) an aqueous solution of sodium hydroxide (5%, 4 mL) was added, and the reaction mixture was stirred for 1 h at 70 °C. After neutralization with diluted hydrochloric acid (6 N), the solvents were removed, and the product was washed with water and dried to yield the corresponding acid (<b>3</b>, 44 mg, 0.152 mmol, 92% yield). HPLC purity: 99.62% (retention time (RT) = 12.11 min); electrospray ionization (ESI) MS: 288.5 [M-H]<sup>−</sup>, 599.4 [2M-H+Na]<sup>−</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.83 (s, 1H), 9.56 (s, 1H), 7.82 (dd, <i>J</i> = 7.9, 1.7 Hz, 1H), 7.48 (dd, <i>J</i> = 8.1, 1.3 Hz, 1H), 7.41–7.30 (m, 8H), 7.22 (td, <i>J</i> = 7.4, 1.3 Hz, 1H), 7.11 (dd, <i>J</i> = 8.5, 1.1 Hz, 1H), 6.73–6.70 (m, 1H); <sup>13</sup>C NMR (126 MHz, methanol-<i>d</i><sub>4</sub>) δ 170.14, 148.36, 139.27, 137.80, 136.66, 133.58, 131.76, 130.80, 128.68, 127.98, 127.82, 126.87, 124.16, 123.94, 116.42, 113.28, 112.04.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Synthesis Procedure for 2-((2-(Phenylamino)phenyl)amino)benzoic acid (<b>4</b>)</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-Nitro-N-phenylaniline (<b>3b</b>)</h4><div class="NLM_p">To a solution of NaH (170 mg, 4.25 mmol) (60% dispersion in mineral oil) in tetrahydrofuran (THF) (8 mL) was slowly added aniline (198 mg, 2.126 mmol). After 15 min of stirring, 1-fluoro-2-nitrobenzene (300 mg, 2.126 mmol) was added, and the resulting solution was heated to 75 °C for 1 h. The reaction mixture was cooled to room temperature, quenched with water (5 mL), and extracted with EtOAc. The combined organic phases were washed with brine (5 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude residue was purified by flash chromatography (eluent: EtOAc/PE = 50/1) to give the desired product, 2-nitro-<i>N</i>-phenylaniline (<b>3b</b>, 430 mg, 2.007 mmol, 94% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.42 (s, 1H), 8.15 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.39–7.35 (m, 1H), 7.32–7.25 (m, 2H), 7.24–7.21 (m, 2H), 7.19–7.16 (m, 1H), 7.02–6.98 (m, 1H), 6.90 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H).</div><div class="NLM_p last">Compounds <b>4b</b>, <b>6b</b>, and <b>4</b> were prepared following the synthetic procedure similar to that of compounds <b>4a</b>, <b>6a</b>, and <b>3</b>, respectively. 2-((2-(Phenylamino)phenyl)amino)benzoic acid (<b>4</b>, white powder, 32 mg, 72% yield for the last step). HPLC purity: 95.13% (RT = 11.73 min); ESI-MS: 303.6 [M-H]<sup>−</sup>, 629.4 [2M-H+Na]<sup>−</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.85 (s, 1H), 9.43 (s, 1H), 7.86 (dd, <i>J</i> = 8.0, 1.7 Hz, 1H), 7.57 (s, 1H), 7.38–7.33 (m, 2H), 7.27–7.25 (m, 1H), 7.13 (t, <i>J</i> = 7.8 Hz, 2H), 7.10–6.99 (m, 3H), 6.89 (d, <i>J</i> = 8.0 Hz, 2H), 6.76–6.71 (m, 2H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.16, 147.98, 145.01, 137.00, 134.38, 133.04, 132.17, 129.35, 124.60, 123.15, 122.75, 121.15, 119.63, 117.28, 116.83, 114.04, 113.15.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2-((2-Phenoxyphenyl)amino)benzoic acid (<b>5</b>)</h3><div class="NLM_p last">The title compound (white powder, 23 mg, 92% yield for the last step) was prepared analogously to compound <b>4</b>. HPLC purity: 99.03% (RT = 9.47 min); ESI-MS: 304.5 [M-H]<sup>−</sup>, 631.4 [2M-H+Na]<sup>−</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.41 (s, 1H), 9.82 (s, 1H), 7.85 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H), 7.59–7.57 (m, 1H), 7.43–7.40 (m, 1H), 7.33–7.29 (m, 3H), 7.23–7.19 (m, 1H), 7.11–7.05 (m, 3H), 6.92 (d, <i>J</i> = 8.0 Hz, 2H), 6.79 (t, <i>J</i> = 7.5 Hz, 1H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.26, 157.53, 147.54, 146.59, 134.50, 133.19, 132.23, 130.34, 125.29, 123.98, 123.40, 121.64, 121.30, 118.19, 117.45, 114.32, 113.73.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-((6-Chloro-[1,1′-biphenyl]-2-yl)amino)benzoic acid (<b>6</b>)</h3><div class="NLM_p last">The title compound (white powder, 40 mg, 92% yield for the last step) was prepared analogously to compound <b>3</b>. HPLC purity: 97.68% (RT = 19.46 min); ESI-MS: 322.1 [M-H]<sup>−</sup>, 667.1 [2M-H+Na]<sup>−</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.40 (s, 1H), 7.81 (dd, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.43 (t, <i>J</i> = 7.4 Hz, 3H), 7.37–7.35 (m, 1H), 7.29 (t, <i>J</i> = 8.1 Hz, 1H), 7.26–7.20 (m, 3H), 7.18 (d, <i>J</i> = 8.0 Hz, 1H), 7.13 (d, <i>J</i> = 8.0 Hz, 1H), 6.72–6.69 (m, 1H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.43, 145.98, 140.53, 135.47, 134.04, 133.43, 132.95, 131.64, 129.54, 129.25, 128.68, 127.99, 123.33, 118.86, 118.06, 114.19, 113.21.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-((6-Bromo-[1,1′-biphenyl]-2-yl)amino)benzoic acid (<b>7</b>)</h3><div class="NLM_p last">The title compound (white powder, 31 mg, 91% yield for the last step) was prepared analogously to compound <b>3</b>. HPLC purity: 96.18% (RT = 13.38 min); ESI-MS: 366.2 [M-H]<sup>−</sup>, 734.2 [2M-H]<sup>−</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.21 (s, 1H), 7.78 (dd, <i>J</i> = 7.9, 1.8 Hz, 1H), 7.53 (dd, <i>J</i> = 8.1, 0.8 Hz, 1H), 7.47–7.37 (m, 5H), 7.32–7.28 (m, 2H), 7.22–7.20 (m, 2H), 6.80–6.77 (m, 1H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.95, 146.42, 141.03, 137.97, 135.31, 134.39, 132.12, 130.11, 129.90, 129.15, 128.45, 126.87, 124.52, 119.79, 118.53, 114.64, 113.99.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-((6-(Trifluoromethyl)-[1,1′-biphenyl]-2-yl)amino)benzoic acid (<b>8</b>)</h3><div class="NLM_p last">The title compound (white powder, 10 mg, 82% yield for the last step) was prepared analogously to compound <b>3</b>. HPLC purity: 96.62% (RT = 13.03 min); ESI-MS: 356.2 [M-H]<sup>−</sup>, 712.5 [2M-H]<sup>−</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.98 (s, 1H), 9.11 (s, 1H), 7.84–7.76 (m, 2H), 7.58 (t, <i>J</i> = 8.0 Hz, 1H), 7.51–7.49 (m, 1H), 7.46–7.40 (m, 4H), 7.30 (dd, <i>J</i> = 8.5, 1.1 Hz, 1H), 7.24–7.22 (m, 2H), 6.82–6.79 (m, 1H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.87, 146.18, 141.17, 135.02, 134.53, 132.99, 132.89, 132.16, 129.98, 129.22, 128.81, 128.61, 124.11, 119.96, 119.92, 118.79, 114.55, 113.95.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-((6-Methyl-[1,1′-biphenyl]-2-yl)amino)benzoic acid (<b>9</b>)</h3><div class="NLM_p last">The title compound (white powder, 30 mg, 87% yield for the last step) was prepared analogously to compound <b>3</b>. HPLC purity: 99.45% (RT = 13.33 min); ESI-MS: 302.2 [M-H]<sup>−</sup>, 604.6 [2M-H]<sup>−</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.11 (s, 1H), 7.76 (dd, <i>J</i> = 7.9, 1.8 Hz, 1H), 7.42 (t, <i>J</i> = 7.5 Hz, 2H), 7.36–7.32 (m, 3H), 7.27 (t, <i>J</i> = 7.7 Hz, 1H), 7.21–7.16 (m, 3H), 7.05 (d, <i>J</i> = 7.4 Hz, 1H), 6.71–6.68 (m, 1H), 2.02 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.99, 147.69, 138.77, 138.01, 137.53, 135.55, 134.44, 132.11, 129.73, 129.13, 128.14, 127.74, 125.31, 119.35, 117.42, 114.02, 112.72, 21.04.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-((6-Methoxy-[1,1′-biphenyl]-2-yl)amino)benzoic acid (<b>10</b>)</h3><div class="NLM_p last">The title compound (white powder, 41 mg, 91% yield for the last step) was prepared analogously to compound <b>3</b>. HPLC purity: 95.15% (RT = 10.32 min); ESI-MS: 318.3 [M-H]<sup>−</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.84 (s, 1H), 9.19 (s, 1H), 7.77 (dd, <i>J</i> = 7.9, 1.7 Hz, 1H), 7.38–7.27 (m, 5H), 7.23–7.17 (m, 3H), 7.11 (d, <i>J</i> = 7.8 Hz, 1H), 6.86 (d, <i>J</i> = 8.2 Hz, 1H), 6.73–6.70 (m, 1H), 3.69 (s, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.02, 158.04, 147.47, 139.75, 135.03, 134.39, 132.11, 130.66, 129.14, 128.66, 127.55, 124.12, 117.64, 114.36, 114.31, 113.09, 106.80, 56.07.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Synthesis Procedure for 2-((6-Chloro-5-(methylamino)-[1,1′-biphenyl]-2-yl)amino)benzoic acid (<b>11</b>)</h3><div id="sec4_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2,3-Dichloro-N-methyl-4-nitroaniline (<b>1j</b>) and 2,3-dichloro-N,N-dimethyl-4-nitroaniline (<b>1k</b>)</h4><div class="NLM_p">The mixture of 2,3-dichloro-4-nitroaniline (1.2 g, 5.80 mmol), iodomethane (11.55 mL, 185 mmol), K<sub>2</sub>CO<sub>3</sub> (2.403 g, 17.39 mmol), and CH<sub>3</sub>CN (30 mL) was refluxed for 3 d. The solvent was removed and added with water. The solution was extracted with dichloromethane and dried with Na<sub>2</sub>SO<sub>4</sub>. After solvent removal, the crude material was subject to a column chromatography (silica, EtOAc/PE = 1/8) to give 2,3-dichloro-<i>N</i>-methyl-4-nitroaniline (<b>1j</b>, yellow powder, 800 mg, 3.62 mmol, 62.4% yield) as a primary product and 2,3-dichloro-<i>N,N</i>-dimethyl-4-nitroaniline (<b>1k</b>, yellow powder, 50 mg, 0.213 mmol, 3.67% yield) as a byproduct. For <b>1j</b>, <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.93 (d, <i>J</i> = 9.3 Hz, 1H), 6.49 (d, <i>J</i> = 9.3 Hz, 1H), 5.13 (s, 1H), 2.95 (d, <i>J</i> = 5.1 Hz, 3H). For <b>1k</b>, <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 7.81 (d, <i>J</i> = 9.1 Hz, 1H), 6.94 (d, <i>J</i> = 9.1 Hz, 1H), 2.96 (s, 6H).</div><div class="NLM_p last">Compounds <b>3o</b>, <b>4o</b>, <b>6o</b>, and <b>11</b> were prepared following the synthetic procedure similar to that of compounds <b>3a</b>, <b>4a</b>, <b>6a</b>, and <b>3</b>, respectively. <i>2-((6-Chloro-5-(methylamino)-[1,1′-biphenyl]-2-yl)amino)benzoic acid</i> (<b>11</b>). Yellow powder, 40 mg, 69% yield for the last step. HPLC purity: 97.50% (RT = 10.62 min); ESI-MS: 351.0 [M-H]<sup>−</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.67 (s, 1H), 8.93 (s, 1H), 7.68 (dd, <i>J</i> = 8.0, 1.7 Hz, 1H), 7.35–7.24 (m, 5H), 7.13–7.12 (m, 2H), 6.77–6.73 (m, 2H), 6.57 (t, <i>J</i> = 7.4 Hz, 1H), 5.56 (q, <i>J</i> = 5.0 Hz, 1H), 2.83 (d, <i>J</i> = 4.6 Hz, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.21, 149.94, 143.50, 138.54, 137.81, 137.39, 133.58, 131.96, 129.69, 128.48, 127.78, 125.87, 117.92, 115.88, 113.05, 110.30, 30.67.</div></div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Synthesis Procedure for 2-((6-Chloro-5-(dimethylamino)-[1,1′-biphenyl]-2-yl)amino)benzoic acid (<b>12</b>)</h3><div class="NLM_p last">Compound <b>12</b> was synthesized from the byproduct <b>1k</b>, and the preparation of <b>12</b> was similar to that of compound <b>3</b>. Light yellow powder, 8 mg, 82% yield for the last step. HPLC purity: 99.60% (RT = 3.31 min); ESI-MS: 365.3 [M-H]<sup>−</sup>, 729.5 [2M-H]<sup>−</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.80 (s, 1H), 9.06 (s, 1H), 7.74 (dd, <i>J</i> = 7.9, 1.7 Hz, 1H), 7.43–7.39 (m, 3H), 7.36–7.32 (m, 2H), 7.25 (d, <i>J</i> = 8.8 Hz, 1H), 7.18–7.17 (m, 2H), 7.08 (d, <i>J</i> = 8.4 Hz, 1H), 6.70–6.67 (m, 1H), 2.74 (s, 6H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.95, 147.85, 136.85, 136.54, 135.06, 134.60, 134.55, 132.06, 129.83, 128.94, 128.35, 128.19, 121.99, 120.42, 117.50, 113.83, 112.49, 44.30.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-((6-Chloro-5-(ethylamino)-[1,1′-biphenyl]-2-yl)amino)benzoic acid (<b>13</b>)</h3><div class="NLM_p last">The title compound (light yellow powder, 18 mg, 67% yield for the last step) was prepared analogously to compound <b>11</b>. HPLC purity: 98.25% (RT = 8.97 min); ESI-MS: 365.2 [M-H]<sup>−</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.66 (s, 1H), 8.92 (s, 1H), 7.98 (dd, <i>J</i> = 7.9, 1.1 Hz, 1H), 7.72–7.68 (m, 2H), 7.48 (td, <i>J</i> = 7.6, 1.2 Hz, 1H), 7.35–7.32 (m, 1H), 7.30–7.27 (m, 1H), 7.26–7.21 (m, 2H), 7.14–7.12 (m, 1H), 6.80–6.76 (m, 1H), 6.59–6.56 (m, 1H), 5.24 (s, 1H), 3.23 (q, <i>J</i> = 7.1 Hz, 2H), 1.22 (t, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.24, 149.99, 142.45, 137.95, 137.34, 134.01, 131.94, 130.12, 129.63, 128.52, 128.10, 127.83, 125.93, 118.04, 116.03, 113.13, 110.76, 38.02, 14.90.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 2-((3-Chloro-2-(1H-indazol-5-yl)phenyl)amino)benzoic acid (<b>14</b>)</h3><div class="NLM_p last">The title compound (white powder, 12 mg, 76% yield for the last step) was prepared analogously to compound <b>3</b>. HPLC purity: 97.93% (RT = 8.67 min); ESI-MS: 362.3 [M-H]<sup>−</sup>, 724.8 [2M-H]<sup>−</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.98 (s, 2H), 9.27 (s, 1H), 8.09 (s, 1H), 7.75 (dd, <i>J</i> = 7.9, 1.7 Hz, 1H), 7.65 (s, 1H), 7.60 (d, <i>J</i> = 8.5 Hz, 1H), 7.52–7.51 (m, 1H), 7.43–7.34 (m, 3H), 7.26–7.24 (m, 1H), 7.15 (dd, <i>J</i> = 8.5, 1.6 Hz, 1H), 6.78–6.75 (m, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.50, 153.91, 146.46, 145.84, 140.90, 134.14, 133.90, 132.80, 131.70, 130.14, 129.23, 127.70, 125.97, 123.10, 122.54, 118.33, 118.13, 114.15, 113.22, 111.72.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2-((2-(Benzo[<i>c</i>][1,2,5]oxadiazol-5-yl)-3-chlorophenyl)amino)benzoic acid (<b>15</b>)</h3><div class="NLM_p last">The title compound (light yellow powder, 16 mg, 66% yield for the last step) was prepared analogously to compound <b>3</b>. HPLC purity: 98.95% (RT = 13.05 min); ESI-MS: 364.0 [M-H]<sup>−</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.95 (s, 1H), 9.50 (s, 1H), 8.15–8.11 (m, 2H), 7.77 (dd, <i>J</i> = 7.9, 1.4 Hz, 1H), 7.59 (d, <i>J</i> = 8.2 Hz, 1H), 7.50–7.42 (m, 3H), 7.36–7.31 (m, 2H), 6.82–6.79 (m, 1H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.22, 149.45, 148.71, 146.16, 141.02, 140.45, 135.89, 134.67, 133.35, 132.13, 131.14, 130.93, 124.03, 119.69, 118.91, 117.96, 117.09, 114.73, 113.73.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-((2-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-3-chlorophenyl)amino)benzoic acid (<b>16</b>)</h3><div class="NLM_p last">The title compound (white powder, 35 mg, 86% yield for the last step) was prepared analogously to compound <b>3</b>. HPLC purity: 99.68% (RT = 12.59 min); ESI-MS: 366.0 [M-H]<sup>−</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.08 (s, 1H), 9.37 (s, 1H), 7.87 (dd, <i>J</i> = 8.0, 1.7 Hz, 1H), 7.54 (dd, <i>J</i> = 8.1, 1.0 Hz, 1H), 7.47 (ddd, <i>J</i> = 8.7, 7.0, 1.8 Hz, 1H), 7.42–7.36 (m, 2H), 7.28 (dd, <i>J</i> = 8.0, 1.1 Hz, 1H), 7.04 (d, <i>J</i> = 7.9 Hz, 1H), 6.87–6.84 (m, 2H), 6.75 (dd, <i>J</i> = 7.9, 1.8 Hz, 1H), 6.11 (d, <i>J</i> = 7.8 Hz, 2H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.15, 147.92, 147.34, 146.19, 141.62, 134.32, 134.10, 132.70, 132.18, 129.58, 129.47, 123.69, 123.32, 118.59, 118.55, 114.76, 110.49, 109.13, 108.81, 101.56.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2-((3-Chloro-2-(2,3-dihydrobenzofuran-5-yl)phenyl)amino)benzoic acid (<b>17</b>)</h3><div class="NLM_p last">The title compound (light yellow powder, 5.5 g, 81% yield for the last step) was prepared analogously to compound <b>3</b>. HPLC purity: 99.22% (RT = 13.06 min); ESI-MS: 364.0 [M-H]<sup>−</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.62 (s, 1H), 7.82 (dd, <i>J</i> = 7.8, 1.7 Hz, 1H), 7.45 (dd, <i>J</i> = 8.2, 1.1 Hz, 1H), 7.36–7.26 (m, 3H), 7.18 (dd, <i>J</i> = 8.0, 1.1 Hz, 1H), 7.08 (d, <i>J</i> = 1.8 Hz, 1H), 6.93 (dd, <i>J</i> = 8.1, 1.9 Hz, 1H), 6.82–6.75 (m, 2H), 4.55 (t, <i>J</i> = 8.8 Hz, 2H), 3.21–3.16 (m, 2H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.94, 159.85, 146.37, 141.39, 134.52, 134.42, 133.23, 132.19, 129.79, 129.36, 128.17, 127.67, 126.79, 123.57, 118.82, 118.57, 114.75, 113.86, 109.58, 71.48, 29.49.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-((2-(Benzofuran-5-yl)-3-chlorophenyl)amino)benzoic acid (<b>18</b>)</h3><div class="NLM_p last">The title compound (white powder, 18 mg, 91% yield for the last step) was prepared analogously to compound <b>3</b>. HPLC purity: 98.02% (RT = 13.48 min); ESI-MS: 362.1 [M-H]<sup>−</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.91 (s, 1H), 9.26 (s, 1H), 8.03 (d, <i>J</i> = 2.2 Hz, 1H), 7.77 (dd, <i>J</i> = 7.9, 1.7 Hz, 1H), 7.67 (d, <i>J</i> = 8.4 Hz, 1H), 7.55–7.52 (m, 2H), 7.44–7.35 (m, 3H), 7.27–7.26 (m, 1H), 7.15 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 6.98 (dd, <i>J</i> = 2.1, 0.7 Hz, 1H), 6.80–6.77 (m, 1H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 169.88, 154.30, 146.85, 146.23, 141.28, 134.52, 134.28, 133.19, 132.09, 130.53, 129.61, 128.09, 126.36, 123.49, 122.93, 118.72, 118.52, 114.54, 113.61, 112.10, 107.39.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-((3-Chloro-2-(naphthalen-2-yl)phenyl)amino)benzoic acid (<b>19</b>)</h3><div class="NLM_p last">The title compound (white powder, 41 mg, 86% yield for the last step) was prepared analogously to compound <b>3</b>. HPLC purity: 95.05% (RT = 14.77 min); ESI-MS: 372.1 [M-H]<sup>−</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.83 (s, 1H), 9.44 (s, 1H), 8.05–8.00 (m, 3H), 7.92 (s, 1H), 7.81 (dd, <i>J</i> = 8.0, 1.7 Hz, 1H), 7.63–7.58 (m, 3H), 7.48 (t, <i>J</i> = 8.1 Hz, 2H), 7.42–7.39 (m, 2H), 7.36–7.34 (m, 1H), 6.85–6.82 (m, 1H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.10, 146.34, 141.01, 134.85, 134.59, 133.83, 133.32, 132.15, 132.11, 130.11, 129.29, 123.82, 119.30, 118.66, 114.61, 113.67.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 2-((3-Chloro-2-(2,3-dihydrobenzofuran-5-yl)-4-(methylamino)phenyl)amino) benzoic acid (<b>20</b>)</h3><div class="NLM_p last">The title compound (light yellow powder, 12 mg, 78% yield for the last step) was prepared analogously to compound <b>11</b>. HPLC purity: 98.19% (RT = 10.07 min); ESI-MS: 393.4 [M-H]<sup>−</sup>; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.67 (s, 1H), 8.94 (s, 1H), 7.71 (dd, <i>J</i> = 8.0, 1.7 Hz, 1H), 7.28–7.23 (m, 2H), 6.96 (d, <i>J</i> = 1.8 Hz, 1H), 6.83–6.79 (m, 2H), 6.70 (d, <i>J</i> = 8.4 Hz, 2H), 6.60–6.57 (m, 1H), 5.51 (q, <i>J</i> = 4.6 Hz, 1H), 4.51 (t, <i>J</i> = 8.8 Hz, 2H), 3.20–3.14 (m, 1H), 3.09–3.03 (m, 1H), 2.82 (d, <i>J</i> = 4.8 Hz, 3H); <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.10, 159.38, 150.16, 143.61, 137.68, 134.42, 134.36, 131.94, 129.34, 129.07, 128.21, 127.39, 126.44, 125.73, 118.43, 116.14, 113.27, 109.89, 108.96, 71.33, 30.66, 29.48.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Protein Expression and Purification</h3><div class="NLM_p last">The cDNA of full-length FABP3, FABP4, and FABP5 were cloned into the PET28a vector with an N-terminal 6His tag. The plasmid was then transformed into BL21 (DE3) cells for protein expression. The expressed protein was purified by a Ni-NTA column (GE) followed by size exclusion chromatography (Superdex 200, GE Healthcare). The purified FABP3, FABP4, and FABP5 were stored in a solution (50 mM NaCl, 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.5). To obtain apo FABP3, apo FABP4, and apo FABP5, purified FABP3, FABP4, and FABP5 were delipidated as previously reported.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Briefly, the protein was concentrated to 10 mg/mL. For each 1 mL of protein, 3.75 mL of mixture of chloroform and methanol (1:2) was added. After it was thoroughly vortexed, 1.25 mL of chloroform was added followed by another mixing step. Afterward, 1.25 mL of distilled water was added and vortexed well. The suspension was centrifuged at 1000 rpm for 5 min at room temperature to give a two-phase system. The precipitated protein at the bottom was denatured in a buffer containing 50 mM Tris-HCl (pH 8.0), 6 M guanidinium chloride, and 2 mM dithiothreitol (DTT), and refolded by a fast dilution at 4 °C in 250 mL of buffer composed of 20 mM Tris-HCl (pH 8.5), 1.7 M urea, 4% glycerol, and 2 mM DTT. Then the concentration of urea in the buffer was adjusted to 2 M with addition of 8 M urea. Refolded protein was concentrated and dialyzed against phosphate-buffered solution (PBS) at 4 °C overnight followed by a further purification via size exclusion chromatography.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Protein Crystallization and Structure Determination</h3><div class="NLM_p last">The purified FABP4 protein was concentrated to 5 mg/mL for crystallization. Crystals of apo FABP4 were obtained at 20 °C by mixing equal volumes of FABP4 and reservoir (1.6 M trisodium citrate, pH 6.5 or 7.5) with a handing-drop vapor diffusion method. Complex crystals were obtained by soaking apo crystals into the reservoir solution containing 2–10 mM of compounds overnight. Crystals were flash frozen in liquid nitrogen in the presence of the reservoir solution supplemented with 20% ethylene glycol. X-ray diffraction data were collected at beamline BL17U1, BL18U1, or BL19U1 at the Shanghai Synchrotron Radiation Facility.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The data were processed with HKL3000 software packages.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The complex structures were solved by molecular replacement using the program PHASER<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> with a search model of PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NNT">4NNT</a>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The models were built using COOT<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and refined with a simulated-annealing protocol implemented in the program PHENIX.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The refined structures were deposited to Protein Data Bank with accession codes listed in Table S1 in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. The complete statistics as well as the quality of solved structures are also shown in <a class="ref internalNav" href="#notes-1" aria-label="Table S1">Table S1</a>.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 1,8-ANS (8-anilino-1-naphthalene-sulfonic acid) Displacement Assay</h3><div class="NLM_p last">The 1,8-ANS displacement assay developed by Kurian et al.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> was used to determine binding affinities of compounds with FABP4, FABP5, or FABP3. Briefly, compounds at various concentrations were incubated in the 96-well plate in dark with the recombinant apo FABP4, apo FABP5, or apo FABP3 for 10 min. Next, 10 μM 1,8-ANS was added and incubated for another 3 min at room temperature in dark. The fluorescence signal at 370 nm (excitation)/470 nm (emission) was measured with Bio-Tek Synergy4 plate reader. It was reported that 1,8-ANS is sensitive to light and slight differences in the amount of cosolvent in the assay.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> To deal with this, 2 mM 1,8-ANS in dimethyl sulfoxide (DMSO) was divided into 100 μL/tube and stored at −80 °C in dark. In addition, inhibition ratios of BMS309403 at three concentrations (0.5, 1, and 2 μM) were tested as a control for each 96-well plate. For each compound, at least three independent experiments were performed for the determination of IC<sub>50</sub>. All experimental data were analyzed using GraphPad Prism, version 8.0 (GraphPad Inc.). <i>K</i><sub>i</sub> values were calculated according to the equation <i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + [1,8-ANS]/<i>K</i><sub>d</sub>), where [1,8-ANS] means the concentration of 1,8-ANS used in the assay, and <i>K</i><sub>d</sub> means the dissociating constant for 1,8-ANS with FABP4 or FABP3. The <i>K</i><sub>d</sub> values of 1,8-ANS with FABP3, FABP4, or FABP5 were measured by monitoring the maximal fluorescence signal of 1 μM 1,8-ANS with increasing protein concentrations ranging from 100 nM to 140 μM, and the determined value is 11.7 ± 0.4, 2.4 ± 0.0, and 10.7 ± 0.6 μM, respectively, using the nonlinear regression in GraphPad Prism software.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Three independent experiments were performed to determine these <i>K</i><sub>d</sub> values.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> ITC Measurements</h3><div class="NLM_p last">All measurements were performed in an ITC buffer (20 mM HEPES, pH 7.5, 150 mM NaCl) by the iTC200 calorimeter (General Electric Co.). The compounds were diluted in the ITC buffer to final concentrations of 0.2–0.5 mM. The purified apo FABP4 was diluted in the ITC buffer to final concentrations of 0.02–0.05 mM. The final concentration of DMSO in a reaction is less than 3%. All titrations were performed using an initial injection of 0.4 μL followed by 19 identical injections of 2 μL with a duration of 4 s per injection and a spacing of 120 s between injections. The last eight data were averaged as the heat of dilution and subtracted from each titration. Three independent experiments were performed to obtain the <i>K</i><sub>d</sub> value of each compound with apo FABP4.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> MD Simulations</h3><div class="NLM_p last">The crystal structure of FABP4 in complex with fragment <b>1</b> in Pose 1 was used for MD simulations. The protein model was prepared in the Schrödinger suite with the OPLS3 force field.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Hydrogen atoms were added to the protein using the PROPKA tool implemented in the Schrödinger suite. The structure of fragment <b>1</b> was optimized using Gaussian 09 program<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> at the B3LYP/6-31G* level before assigning its atomic charges and atom types with Antechamber implemented in Ambertools14.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The Amber ff14SB<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> and general Amber force field (GAFF)<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> were applied to FABP4 and fragment <b>1</b>, respectively. Sodium ions were added to neutralize the system. The complex structure was then solvated in a rectangular box of TIP3P water molecules with ∼8 A° between the box edge and the protein. The system was first minimized and then equilibrated using Amber14 in the NPT ensemble at 300 K and 1 bar, and the harmonic-position restraints were applied to the heavy atoms of FABP4 as well as fragment <b>1</b>. These restraints were tapered off gradually over the equilibration process. Periodic boundary conditions were applied to the simulation system. Bonds containing hydrogen atoms were restrained with the SHAKE algorithm to allow an integration time step of 2 fs.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Electrostatic interactions were calculated using the particle-mesh Ewald (PME) summation algorithm.<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52,53)</a> In the production run, the Langevin thermostat and the Monte Carlo barostat were used to maintain a constant temperature of 300 K and a constant pressure of 1 bar, respectively. Finally, a 600 ns production run resulted.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> MD Trajectories Analysis</h3><div class="NLM_p last">Trajectories were converted into formats compatible with Gromacs v5.1.2 and then analyzed using tools implemented in Gromacs.<a onclick="showRef(event, 'ref48 ref54'); return false;" href="javascript:void(0);" class="ref ref48 ref54">(48,54)</a> The root-mean-square deviations (RMSDs) between the simulated and poses of <b>1</b> revealed by crystal structures were calculated using the gmx rms tool after an alignment of heavy atoms of FABP4. Conformations of <b>1</b> resulting from the MD simulations were clustered using the gmx cluster tool with the GROMOS algorithm and an RMSD cutoff of 0.3 nm.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Metabolic Stability in Liver Microsomes</h3><div class="NLM_p last">Microsomes in 0.1 M Tris buffer at pH 7.4 (a final concentration of 0.33 mg/mL), cofactor MgCl<sub>2</sub> (a final concentration of 5 mM), tested compounds (a final concentration of 0.1 μM), cosolvent (0.01% DMSO), and 0.005% bovine serum albumin were incubated at 37 °C for 10 min. The reaction was started by the addition of the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) (a final concentration of 1 mM). Aliquots were sampled at 0, 7, 17, 30, and 60 min, respectively, and methanol (cold in 4 °C) was added to terminate the reaction. Samples were then analyzed by liquid chromatography–mass spectrometry (LC-MS)/MS.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Caco-2 Permeability Assay</h3><div class="NLM_p last">The Caco-2 monolayer assays were conducted according to the standard procedure as previously reported.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Briefly, the transport of compounds from the apical side to the basolateral side (A–B) and from the opposite direction (B–A) were measured under the same conditions simultaneously. Propranolol and nadolol were used as the controls of hypertonic and hypotonic, respectively. Digoxin was used as a positive control for P-gp mediated drug efflux. The compound was diluted and added to the appropriate well (pH 6.8 for the apical side and pH 7.4 for the basolateral side) after the monolayer was washed three times with Hanks’ Balanced Salt Solution (HBSS, Sigma-Aldrich). After incubating the plates at 37 °C for 95 min, samples were collected from the donor side at 5 and 95 min and from the receiver side at 35 and 95 min. The concentration of samples was determined by the (LC-MS)/MS.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> In Vivo PK Study of Compound <b>17</b> in Institute of Cancer Research (ICR) mice</h3><div class="NLM_p last">Nine ICR male mice, weighting 18–22 g each, were randomly divided into three groups. Compound <b>17</b> dissolved in phosphate-buffered saline containing 5% DMSO, and 0.5% hydroxypropyl methylcellulose (HPMC) was administered orally at a dose 25 or 10 mg/kg to two groups of mice. Another group of three mice was injected with a single dose (3 mg/kg) of compound <b>17</b> dissolved in DMSO/ethanol (EtOH)/PEG300/NaCl (5/5/40/50, v/v/v/v). Blood samples at seven time points (0.25, 0.5, 1.0, 2.0, 4.0, 8.0, and 24 h) were collected. Plasma concentrations of compound <b>17</b> were analyzed by LC-MS/MS (Agilent 1260 Infinity LC system and Agilent 6460 Triple Quad Mass Spectrometer System).</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Cell Culture and Differentiation</h3><div class="NLM_p last">Human monocytic leukemia THP-1 cells and 3T3-L1 preadipocytes were purchased from American Type Culture Collection (ATCC) and maintained in a humid incubator with 5% CO<sub>2</sub> at 37 °C. THP-1 monocytes were cultured in ATCC formulated RPMI-1640 medium supplemented with fetal bovine serum (FBS; Invitrogen) and 0.05 mM 2-mercaptoethanol. THP-1 monocytes were seeded on 96-well plates at a density of 5 × 10<sup>4</sup> cells/well and simultaneously incubated with 100 nM phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich) for 24 h, and then suspended THP-1 monocytes were differentiated into adherent THP-1 macrophages. 3T3-L1 preadipocytes were cultured in high glucose concentration in Dulbecco’s Modified Eagle Medium (H-DMEM, Gibco) plus 10% new-born calf serum (NCS; Invitrogen) and differentiated into mature adipocytes as previously described.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Briefly, cells were stimulated with 0.5 mmol/L 3-isobutyl-1-methylxanthine, 1 μmol/L dexamethasone, and 5 μg/mL insulin in H-DMEM plus 10% FBS 2 d after confluence. 48 hours later, cells were switched to a differentiation medium (H-DMEM plus 10% FBS and 5 μg/mL insulin). Thereafter, cells were switched into a medium (H-DMEM plus 10% FBS), and the medium was replaced every 2 d until full differentiation, which is characterized by the increase of cell volume and the appearance of clusters of fat droplets in cell.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Cell Viability Assay</h3><div class="NLM_p last">THP-1 macrophages or 3T3-L1 preadipocytes were incubated with tested concentrations of compounds for 24 h before addition of the CCK-8 reagent (Beyotime). After incubation for 1 h, absorbance at a wavelength of 450 nm was measured using the BIO-TEK SYNERGY4 reader.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Lipolysis Assay</h3><div class="NLM_p last">For the forskolin-stimulated lipolysis, fully differentiated 3T3-L1 cells were incubated with compounds at various concentrations for 24 h. Then the cells were washed twice with Krebs-Ringer HEPES buffer (KRBH) followed by stimulation with 20 μM forskolin diluted in KRBH buffer for 2 h. After that, culture supernatants were collected and assayed for glycerol levels using a free glycerol reagent kit (Applygen Technologies Inc.).</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> MCP-1 and IL-6 Release from THP-1 Macrophages</h3><div class="NLM_p last">After THP-1 cells were differentiated into macrophages with 100 nM PMA for 24 h, THP-1 macrophages were washed twice with PBS gently enough to aviod cells shedding from the bottom of the plate. Then cells were incubated with various concentrations of compounds for 18 h prior to 100 ng/mL LPS (Sigma-Aldrich) stimulation for another 6 h. Then the supernatants were collected for measurement of the level of MCP-1 and IL-6 using the Human MCP-1 ELISA Kit and the Human IL-6 ELISA Kit (Abcam), respectively. Cellular proteins were also collected and measured using the BCA Protein Assay Kit (Beyotime) for calibration.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Animal Treatment</h3><div class="NLM_p last">Six-week-old male C57BL/6J mice were purchased from Model Animal Research Center of Nanjing University and adaptively fed for one week in a 12 h light-dark cycle with free access to water and standard animal chow. Then mice were grouped randomly (<i>n</i> = 8 for each group) and given BMS309403 (CSN22610, CSNpharm) or compound <b>17</b> at a dose of 50 mg/kg by a gavage administration 1 h before intraperitoneally injected with LPS in normal saline at a dose of 5 mg/mL. Vehicle group mice received an identical amount of CMC-Na and saline. Five hours later, serum was collected for measurement of the level of MCP-1 and IL-6 using the Mouse MCP-1 ELISA Kit and the Mouse IL-6 ELISA Kit (Abcam), respectively. For tissue damage studies, mice were randomly grouped (<i>n</i> = 8) and intragastrically administrated once a day with BMS309403 (25 mg/kg) or compound <b>17</b> (10, 25, and 50 mg/kg) for 4 d prior to a single intraperitoneal injection of LPS at a dose of 10 mg/kg. On the fifth day, blood samples and tissue samples were collected for the following analysis. Serum ALT, AST, and BUN levels were assayed with commercial enzyme assay kits (Jiancheng). All animal experiments were approved by the Institutional Animal Care and Use Committee of Shanghai Institute of Materia Medica (Accreditation No. 2019-07-XYC-02).</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Histology</h3><div class="NLM_p last">For histology analysis, mice were sacrificed, and liver, kidney, lung, and spleen were separated immediately and fixed in 4% paraformaldehyde for 24 h at room temperature. The fixed tissues were dehydrated by grading ethanol, cleared in xylene, and embedded in paraffin blocks. Tissues were cut and stained with hematoxylin and eosin (H&E). The images were made with an ortho optical microscope (Nikon Eclipse E100).</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Statistical Analysis</h3><div class="NLM_p last">The values of <i>K</i><sub>i</sub> or <i>K</i><sub>d</sub> were expressed as mean ± standard deviation (SD) from three independent experiments and determined via the nonlinear regression analysis using GraphPad Prism software 8.0 (GraphPad Software, Inc.). Pharmacological data were represented as mean ± standard error of the mean (SEM) of at least three independent experiments for cellular study and mean ± SEM of eight mice per group for animal research. Statistical significance of the differences observed between the LPS and the test-compound-treated groups was assessed by the one-way analysis of variance (ANOVA) method followed by a post hoc Tukey’s test to make multiple comparisons. Calculations were made with GraphPad Prism software 8.0. <i>P</i> values less than 0.05 were considered statistically significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67"><a href="/doi/suppl/10.1021/acs.jmedchem.9b02107" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00146" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00146" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b02107?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02107</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Figures of multiple X-ray crystal structures, tables, HPLC spectra, NMR spectra, and MS spectra (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02107/suppl_file/jm9b02107_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02107/suppl_file/jm9b02107_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02107/suppl_file/jm9b02107_si_001.pdf">jm9b02107_si_001.pdf (3.72 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02107/suppl_file/jm9b02107_si_002.csv">jm9b02107_si_002.csv (1.48 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The atomic coordinates and structure factors have been deposited into the Protein Data Bank with accession codes 6LJW (FABP4-<b>1</b>), 6LJX (FABP4-<b>1</b>), 6LJS (FABP4-<b>3</b>), 6LJT (FABP4-<b>6</b>), 6LJU (FABP4-<b>11</b>), and 6LJV (FABP4-<b>17</b>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b02107" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14856" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14856" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yechun Xu</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, Beijing 100049, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1581-6155" title="Orcid link">http://orcid.org/0000-0002-1581-6155</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#29504a515c695a40444407484a074a47"><span class="__cf_email__" data-cfemail="156c766d6055667c78783b74763b767b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haixia Su</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi Zou</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, Shanghai 201203, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6782-9380" title="Orcid link">http://orcid.org/0000-0001-6782-9380</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guofeng Chen</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huixia Dou</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hang Xie</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaojing Yuan</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xianglei Zhang</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy
of Sciences, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naixia Zhang</span> - <span class="hlFld-Affiliation affiliation">Department
of Analytical Chemistry, Shanghai Institute
of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, Beijing 100049, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4824-5819" title="Orcid link">http://orcid.org/0000-0003-4824-5819</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Minjun Li</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Synchrotron Radiation Facility, Shanghai
Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>These authors contributed equally. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3716-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07785" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07785" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was supported by the National Key R&D Program of China (No. 2016YFA0502301), the National Natural Science Foundation of China (81661148046, 21877122 and 21807104), and the National Science & Technology Major Project “Key New Drug Creation and Manufacturing Program” of China (Grant No. 2018ZX09711002).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">FABP</td><td class="NLM_def"><p class="first last">Fatty-acid binding protein</p></td></tr><tr><td class="NLM_term">FAs</td><td class="NLM_def"><p class="first last">fatty Acids</p></td></tr><tr><td class="NLM_term">ITC</td><td class="NLM_def"><p class="first last">isothermal titration calorimetry</p></td></tr><tr><td class="NLM_term">Chloroform-<i>d</i></td><td class="NLM_def"><p class="first last">deuterated chloroform</p></td></tr><tr><td class="NLM_term">DMSO-<i>d</i><sub>6</sub></td><td class="NLM_def"><p class="first last">dimethyl sulfoxide-<i>d</i><sub>6</sub></p></td></tr><tr><td class="NLM_term">dichloromethane</td><td class="NLM_def"><p class="first last">DCM</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">PE</td><td class="NLM_def"><p class="first last">petroleum ether</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">BINAP</td><td class="NLM_def"><p class="first last">2,2′-Bis(diphenylphosphino)-1,1′-binaphthalene</p></td></tr><tr><td class="NLM_term">RT</td><td class="NLM_def"><p class="first last">retention time</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14642" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14642" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 55 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furuhashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotamisligil, G. S.</span></span> <span> </span><span class="NLM_article-title">Fatty Acid-Binding Proteins: Role in Metabolic Diseases and Potential as Drug Targets</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">489</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1038/nrd2589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1038%2Fnrd2589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=18511927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVOjsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=489-503&author=M.+Furuhashiauthor=G.+S.+Hotamisligil&title=Fatty+Acid-Binding+Proteins%3A+Role+in+Metabolic+Diseases+and+Potential+as+Drug+Targets&doi=10.1038%2Fnrd2589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets</span></div><div class="casAuthors">Furuhashi, Masato; Hotamisligil, Goekhan S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">489-503</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Fatty acid-binding proteins (FABPs) are members of a highly conserved family of proteins central to lipid-mediated processes and related metabolic and immune response pathways.  Here, the authors review the functions of individual FABP family members, emphasizing the potential of FABP inhibition as a novel strategy in the treatment of disorders of the metabolic syndrome including obesity, diabetes and atherosclerosis.  Lipids are vital components of many biol. processes and crucial in the pathogenesis of numerous common diseases, but the specific mechanisms coupling intracellular lipids to biol. targets and signaling pathways are not well understood.  This is particularly the case for cells burdened with high lipid storage, trafficking and signaling capacity such as adipocytes and macrophages.  Here, we discuss the central role of lipid chaperones - the fatty acid-binding proteins (FABPs) - in lipid-mediated biol. processes and systemic metabolic homeostasis through the regulation of diverse lipid signals, and highlight their therapeutic significance.  Pharmacol. agents that modify FABP function may provide tissue-specific or cell-type-specific control of lipid signaling pathways, inflammatory responses and metabolic regulation, potentially providing a new class of drugs for diseases such as obesity, diabetes and atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-rosC-QIORrVg90H21EOLACvtfcHk0lhb631Ai03ysw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVOjsbk%253D&md5=494faeda8bfb0f50433c86f36ea1cebd</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd2589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2589%26sid%3Dliteratum%253Aachs%26aulast%3DFuruhashi%26aufirst%3DM.%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26atitle%3DFatty%2520Acid-Binding%2520Proteins%253A%2520Role%2520in%2520Metabolic%2520Diseases%2520and%2520Potential%2520as%2520Drug%2520Targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D489%26epage%3D503%26doi%3D10.1038%2Fnrd2589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazemi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigenaga, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunfeld, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feingold, K. R.</span></span> <span> </span><span class="NLM_article-title">Adipocyte Fatty Acid-Binding Protein Expression and Lipid Accumulation are Increased during Activation of Murine Macrophages by Loll-like Receptor Agonists</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1220</span>– <span class="NLM_lpage">1224</span>, <span class="refDoi"> DOI: 10.1161/01.ATV.0000159163.52632.1b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1161%2F01.ATV.0000159163.52632.1b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=15705927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksVWru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=1220-1224&author=M.+R.+Kazemiauthor=C.+M.+McDonaldauthor=J.+K.+Shigenagaauthor=C.+Grunfeldauthor=K.+R.+Feingold&title=Adipocyte+Fatty+Acid-Binding+Protein+Expression+and+Lipid+Accumulation+are+Increased+during+Activation+of+Murine+Macrophages+by+Loll-like+Receptor+Agonists&doi=10.1161%2F01.ATV.0000159163.52632.1b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Adipocyte Fatty Acid-Binding Protein Expression and Lipid Accumulation Are Increased During Activation of Murine Macrophages by Toll-Like Receptor Agonists</span></div><div class="casAuthors">Kazemi, Mahmood R.; McDonald, Carol M.; Shigenaga, Judy K.; Grunfeld, Carl; Feingold, Kenneth R.</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1220-1224</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: Toll-like receptors (TLRs) recognize pathogens and mediate signaling pathways important for host defense.  Recent studies implicate TLR polymorphisms in atherosclerosis risk in humans.  Adipocyte fatty acid-binding protein (aP2) is present in macrophages and has an important role in atherosclerotic plaque development.  The authors investigated aP2 expression in RAW 264.7 cells treated with lipopolysaccharide (LPS) and other TLR agonists and assessed lipid accumulation in these activated murine macrophages.  Methods and Results: Stimulation with LPS, a TLR4 ligand, resulted in a 56-fold increase in aP2 mRNA expression, and zymosan, a TLR2 ligand, induced an ≈1500-fold increase.  Polyinosine:polycytidylic acid (poly I:C), a TLR3 ligand, led to a 9-fold increase.  Levels of aP2 protein were significantly increased in LPS or zymosan-treated macrophages compared with control or poly I:C-treated cells.  In addn., the cholesteryl ester content of LPS or zymosan-treated macrophages was ≈5-fold greater in the presence of low-d. lipoprotein, and triglyceride content was ≈2-fold greater in the absence of exogenous lipid than control or poly I:C-treated cells.  Conclusions: Expression of macrophage aP2 is induced on TLR activation and parallels increases in cholesteryl ester and triglyceride levels.  These results provide a mol. link between the known roles of TLR and aP2 in foam cell formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptBLDcxuT-WLVg90H21EOLACvtfcHk0lhb631Ai03ysw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksVWru7g%253D&md5=f2037e606412e286078e8ffb9c418aad</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.0000159163.52632.1b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.0000159163.52632.1b%26sid%3Dliteratum%253Aachs%26aulast%3DKazemi%26aufirst%3DM.%2BR.%26aulast%3DMcDonald%26aufirst%3DC.%2BM.%26aulast%3DShigenaga%26aufirst%3DJ.%2BK.%26aulast%3DGrunfeld%26aufirst%3DC.%26aulast%3DFeingold%26aufirst%3DK.%2BR.%26atitle%3DAdipocyte%2520Fatty%2520Acid-Binding%2520Protein%2520Expression%2520and%2520Lipid%2520Accumulation%2520are%2520Increased%2520during%2520Activation%2520of%2520Murine%2520Macrophages%2520by%2520Loll-like%2520Receptor%2520Agonists%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D1220%26epage%3D1224%26doi%3D10.1161%2F01.ATV.0000159163.52632.1b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boord, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babaev, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linton, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotamisligil, G. S.</span></span> <span> </span><span class="NLM_article-title">Combined Adipocyte-Macrophage Fatty Acid-Binding Protein Deficiency Improves Metabolism, Atherosclerosis, and Survival in Apolipoprotein E-Deficient Mice</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">1492</span>– <span class="NLM_lpage">1498</span>, <span class="refDoi"> DOI: 10.1161/01.CIR.0000141735.13202.B6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1161%2F01.CIR.0000141735.13202.B6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=15353487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt12isro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2004&pages=1492-1498&author=J.+B.+Boordauthor=K.+Maedaauthor=L.+Makowskiauthor=V.+R.+Babaevauthor=S.+Fazioauthor=M.+F.+Lintonauthor=G.+S.+Hotamisligil&title=Combined+Adipocyte-Macrophage+Fatty+Acid-Binding+Protein+Deficiency+Improves+Metabolism%2C+Atherosclerosis%2C+and+Survival+in+Apolipoprotein+E-Deficient+Mice&doi=10.1161%2F01.CIR.0000141735.13202.B6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Combined Adipocyte-Macrophage Fatty Acid-Binding Protein Deficiency Improves Metabolism, Atherosclerosis, and Survival in Apolipoprotein E-Deficient Mice</span></div><div class="casAuthors">Boord, Jeffrey B.; Maeda, Kazuhisa; Makowski, Liza; Babaev, Vladimir R.; Fazio, Sergio; Linton, MacRae F.; Hotamisligil, Goekhan S.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1492-1498</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The adipocyte fatty acid-binding protein (FABP) aP2 is expressed by adipocytes and macrophages and modulates insulin resistance, glucose and lipid metab., and atherosclerosis.  Insulin sensitivity is improved in obese but not in lean aP2-deficient mice.  A second fatty acid-binding protein, mal1, also is expressed in adipocytes and macrophages, and mal1 deficiency produces similar effects on insulin resistance.  The authors tested the hypothesis that combined aP2 and mal1 deficiency would produce synergistic effects on metab. and reduce atherosclerosis in apolipoprotein E-deficient (apoE-/-) mice.  Male and female apoE-/- mice null for both aP2 and mal1 (3KO) and apoE-/- controls were fed a low-fat chow diet for 16 or 56 wk.  Lean 3KO mice had significantly lower serum cholesterol and triglycerides as well as improved insulin and glucose tolerance as compared with controls.  Anal. of atherosclerotic lesions in the 3KO mice showed dramatic redns. in both early (20 wk) and late-stage (60 wk) atherosclerosis.  Strikingly, survival in the 3KO mice was improved by 67% as compared with apoE-/- controls when challenged with the Western diet for 1 yr.  Combined aP2 and mal1 deficiency improved glucose and lipid metab., reduced atherosclerosis, and improved survival in apoE-/- mice, making these proteins important therapeutic targets for the prevention of the cardiovascular consequences of the metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKCkXOJjrOe7Vg90H21EOLACvtfcHk0lhb631Ai03ysw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt12isro%253D&md5=0dfe2919de968bd36dcc75cdfdd89fe6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.0000141735.13202.B6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.0000141735.13202.B6%26sid%3Dliteratum%253Aachs%26aulast%3DBoord%26aufirst%3DJ.%2BB.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DMakowski%26aufirst%3DL.%26aulast%3DBabaev%26aufirst%3DV.%2BR.%26aulast%3DFazio%26aufirst%3DS.%26aulast%3DLinton%26aufirst%3DM.%2BF.%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26atitle%3DCombined%2520Adipocyte-Macrophage%2520Fatty%2520Acid-Binding%2520Protein%2520Deficiency%2520Improves%2520Metabolism%252C%2520Atherosclerosis%252C%2520and%2520Survival%2520in%2520Apolipoprotein%2520E-Deficient%2520Mice%26jtitle%3DCirculation%26date%3D2004%26volume%3D110%26spage%3D1492%26epage%3D1498%26doi%3D10.1161%2F01.CIR.0000141735.13202.B6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoutte, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span> <span> </span><span class="NLM_article-title">Adipocyte Fatty Acid-Binding Protein Modulates Inflammatory Responses in Macrophages through a Positive Feedback Loop Involving c-Jun NH2-Terminal Kinases and Activator Protein-1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">10273</span>– <span class="NLM_lpage">10280</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.097907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1074%2Fjbc.M109.097907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=20145251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFajt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=10273-10280&author=X.+Huiauthor=H.+Liauthor=Z.+Zhouauthor=K.+S.+Lamauthor=Y.+Xiaoauthor=D.+Wuauthor=K.+Dingauthor=Y.+Wangauthor=P.+M.+Vanhoutteauthor=A.+Xu&title=Adipocyte+Fatty+Acid-Binding+Protein+Modulates+Inflammatory+Responses+in+Macrophages+through+a+Positive+Feedback+Loop+Involving+c-Jun+NH2-Terminal+Kinases+and+Activator+Protein-1&doi=10.1074%2Fjbc.M109.097907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Adipocyte Fatty Acid-binding Protein Modulates Inflammatory Responses in Macrophages through a Positive Feedback Loop Involving c-Jun NH2-terminal Kinases and Activator Protein-1</span></div><div class="casAuthors">Hui, Xiaoyan; Li, Huiying; Zhou, Zhiguang; Lam, Karen S. L.; Xiao, Yang; Wu, Donghai; Ding, Ke; Wang, Yu; Vanhoutte, Paul M.; Xu, Aimin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">10273-10280</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Adipocyte fatty acid-binding protein (A-FABP) has emerged as an important mediator of inflammation in macrophages.  Macrophage-selective ablation of A-FABP alone is sufficient to prevent the development of high cholesterol diet-induced atherosclerosis in apoE-deficient mice.  However, the precise mechanisms whereby A-FABP modulates inflammation remain elusive.  Here, we report that A-FABP forms a finely tuned pos. loop between JNK and activator protein-1 (AP-1) to exacerbate lipopolysaccharide (LPS)-induced inflammatory responses in macrophages.  Real time PCR and luciferase reporter anal. showed that LPS induced A-FABP expression through transcriptional activation.  This effect was mediated by JNK, which promoted the recruitment of c-Jun to a highly conserved AP-1 consensus binding motif located within the proximal region of the A-FABP promoter.  LPS-induced transactivation of the A-FABP gene was diminished by either pharmacol. inhibition of JNK or knocking down c-Jun or by mutating the AP-1 recognition site within the proximal region (-122 to -116 bp) of the A-FABP promoter.  Conversely, the LPS-evoked phosphorylation of JNK, activation of AP-1, and prodn. of pro-inflammatory cytokines were markedly attenuated by pharmacol. or genetic suppression of A-FABP in macrophages.  Furthermore, the LPS-induced elevation in A-FABP expression could also be prevented by the selective A-FABP inhibitor BMS309403.  These findings support the notion that pharmacol. inhibition of A-FABP represents a valid strategy for treating inflammation-related disorders such as atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCUuBwP0ozdLVg90H21EOLACvtfcHk0ljmr4nzXX0FRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFajt7o%253D&md5=78b82b46f5a98ebf9bd755fbdd702316</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.097907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.097907%26sid%3Dliteratum%253Aachs%26aulast%3DHui%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DLam%26aufirst%3DK.%2BS.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DVanhoutte%26aufirst%3DP.%2BM.%26aulast%3DXu%26aufirst%3DA.%26atitle%3DAdipocyte%2520Fatty%2520Acid-Binding%2520Protein%2520Modulates%2520Inflammatory%2520Responses%2520in%2520Macrophages%2520through%2520a%2520Positive%2520Feedback%2520Loop%2520Involving%2520c-Jun%2520NH2-Terminal%2520Kinases%2520and%2520Activator%2520Protein-1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D10273%26epage%3D10280%26doi%3D10.1074%2Fjbc.M109.097907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hotamisligil, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernlohr, D. A.</span></span> <span> </span><span class="NLM_article-title">Metabolic Functions of FABPs Mechanisms and Therapeutic Implications</span>. <i>Nat. Rev. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">592</span>– <span class="NLM_lpage">605</span>, <span class="refDoi"> DOI: 10.1038/nrendo.2015.122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1038%2Fnrendo.2015.122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=26260145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlGgtL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=592-605&author=G.+S.+Hotamisligilauthor=D.+A.+Bernlohr&title=Metabolic+Functions+of+FABPs+Mechanisms+and+Therapeutic+Implications&doi=10.1038%2Fnrendo.2015.122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic functions of FABPs-mechanisms and therapeutic implications</span></div><div class="casAuthors">Hotamisligil, Gokhan S.; Bernlohr, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Endocrinology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">592-605</span>CODEN:
                <span class="NLM_cas:coden">NREABD</span>;
        ISSN:<span class="NLM_cas:issn">1759-5029</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Intracellular and extracellular interactions with proteins enables the functional and mechanistic diversity of lipids.  Fatty acid-binding proteins (FABPs) were originally described as intracellular proteins that can affect lipid fluxes, metab. and signalling within cells.  As the functions of this protein family have been further elucidated, it has become evident that they are crit. mediators of metab. and inflammatory processes, both locally and systemically, and therefore are potential therapeutic targets for immunometabolic diseases.  In particular, genetic deficiency and small mol.-mediated inhibition of FABP4 (also known as aP2) and FABP5 can potently improve glucose homeostasis and reduce atherosclerosis in mouse models.  Further research has shown that in addn. to their intracellular roles, some FABPs are found outside the cells, and FABP4 undergoes regulated, vesicular secretion.  The circulating form of FABP4 has crucial hormonal functions in systemic metab.  In this Review we discuss the roles and regulation of both intracellular and extracellular FABP actions, highlighting new insights that might direct drug discovery efforts and opportunities for management of chronic metabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDNhNF5UCKRLVg90H21EOLACvtfcHk0ljmr4nzXX0FRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlGgtL3K&md5=2fa6080f65e70d3cb8729e5a75acec56</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrendo.2015.122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrendo.2015.122%26sid%3Dliteratum%253Aachs%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26aulast%3DBernlohr%26aufirst%3DD.%2BA.%26atitle%3DMetabolic%2520Functions%2520of%2520FABPs%2520Mechanisms%2520and%2520Therapeutic%2520Implications%26jtitle%3DNat.%2520Rev.%2520Endocrinol.%26date%3D2015%26volume%3D11%26spage%3D592%26epage%3D605%26doi%3D10.1038%2Fnrendo.2015.122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson
Zimmer, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyckes, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernlohr, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. C.</span></span> <span> </span><span class="NLM_article-title">Fatty Acid Binding Proteins Stabilize Leukotriene A4: Competition with Arachidonic Acid but not Other Lipoxygenase Products</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">2138</span>– <span class="NLM_lpage">2144</span>, <span class="refDoi"> DOI: 10.1194/jlr.M400240-JLR200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1194%2Fjlr.M400240-JLR200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=15342681" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=2138-2144&author=J.+S.+Dickinson%0AZimmerauthor=D.+F.+Dyckesauthor=D.+A.+Bernlohrauthor=R.+C.+Murphy&title=Fatty+Acid+Binding+Proteins+Stabilize+Leukotriene+A4%3A+Competition+with+Arachidonic+Acid+but+not+Other+Lipoxygenase+Products&doi=10.1194%2Fjlr.M400240-JLR200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M400240-JLR200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M400240-JLR200%26sid%3Dliteratum%253Aachs%26aulast%3DDickinson%2BZimmer%26aufirst%3DJ.%2BS.%26aulast%3DDyckes%26aufirst%3DD.%2BF.%26aulast%3DBernlohr%26aufirst%3DD.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26atitle%3DFatty%2520Acid%2520Binding%2520Proteins%2520Stabilize%2520Leukotriene%2520A4%253A%2520Competition%2520with%2520Arachidonic%2520Acid%2520but%2520not%2520Other%2520Lipoxygenase%2520Products%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2004%26volume%3D45%26spage%3D2138%26epage%3D2144%26doi%3D10.1194%2Fjlr.M400240-JLR200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brittingham, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suttles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotamisligil, G. S.</span></span> <span> </span><span class="NLM_article-title">The Fatty Acid-Binding Protein, AP2, Coordinates Macrophage Cholesterol Trafficking and Inflammatory Activity. Macrophage Expression of AP2 Impacts Peroxisome Proliferator-Activated Receptor Gamma and IkappaB Kinase Activities</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">12888</span>– <span class="NLM_lpage">12895</span>, <span class="refDoi"> DOI: 10.1074/jbc.M413788200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1074%2Fjbc.M413788200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=15684432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislygsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=12888-12895&author=L.+Makowskiauthor=K.+C.+Brittinghamauthor=J.+M.+Reynoldsauthor=J.+Suttlesauthor=G.+S.+Hotamisligil&title=The+Fatty+Acid-Binding+Protein%2C+AP2%2C+Coordinates+Macrophage+Cholesterol+Trafficking+and+Inflammatory+Activity.+Macrophage+Expression+of+AP2+Impacts+Peroxisome+Proliferator-Activated+Receptor+Gamma+and+IkappaB+Kinase+Activities&doi=10.1074%2Fjbc.M413788200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The Fatty Acid-binding Protein, aP2, Coordinates Macrophage Cholesterol Trafficking and Inflammatory Activity: Macrophage Expression of aP2 Impacts Peroxisome Proliferator-activated Receptor γ and IκB Kinase Activities</span></div><div class="casAuthors">Makowski, Liza; Brittingham, Katherine C.; Reynolds, Joseph M.; Suttles, Jill; Hotamisligil, Goekhan S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">12888-12895</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Fatty acid-binding proteins are cytosolic fatty acid chaperones, and the adipocyte isoform, aP2, plays an important role in obesity and glucose metab.  Recently, this protein has been detected in macrophages where it strongly contributes to the development of atherosclerosis.  Here, the authors investigated the role of aP2 in macrophage biol. and the mol. mechanisms underlying its actions.  The authors demonstrate that aP2-deficient macrophages display defects in cholesterol accumulation and alterations in pro-inflammatory responsiveness.  Deficiency of aP2 alters the lipid compn. in macrophages and enhances peroxisome proliferator-activated receptor γ activity, leading to elevated CD36 expression and enhanced uptake of modified low d. lipoprotein.  The increased peroxisome proliferator-activated receptor γ activity in aP2-deficient macrophages is also accompanied by a significant stimulation of the liver X receptor α-ATP-binding cassette transporter A1-mediated cholesterol efflux pathway.  In parallel, aP2-deficient macrophages display reduced IκB kinase and NF-κB activity, resulting in suppression of inflammatory function including reduced cyclooxygenase-2 and inducible nitric-oxide synthase expression and impaired prodn. of inflammatory cytokines.  The authors' results demonstrate that aP2 regulates two central mol. pathways to coordinate macrophage cholesterol trafficking and inflammatory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT1ikDVjKwa7Vg90H21EOLACvtfcHk0li0uSHRToFTQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislygsLw%253D&md5=afdd4582ef13bb4b76c1ed518489ccc3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M413788200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M413788200%26sid%3Dliteratum%253Aachs%26aulast%3DMakowski%26aufirst%3DL.%26aulast%3DBrittingham%26aufirst%3DK.%2BC.%26aulast%3DReynolds%26aufirst%3DJ.%2BM.%26aulast%3DSuttles%26aufirst%3DJ.%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26atitle%3DThe%2520Fatty%2520Acid-Binding%2520Protein%252C%2520AP2%252C%2520Coordinates%2520Macrophage%2520Cholesterol%2520Trafficking%2520and%2520Inflammatory%2520Activity.%2520Macrophage%2520Expression%2520of%2520AP2%2520Impacts%2520Peroxisome%2520Proliferator-Activated%2520Receptor%2520Gamma%2520and%2520IkappaB%2520Kinase%2520Activities%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D12888%26epage%3D12895%26doi%3D10.1074%2Fjbc.M413788200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furuhashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuncman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorgun, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atsumi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaillancourt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kono, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babaev, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linton, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulsky, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robl, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotamisligil, G. S.</span></span> <span> </span><span class="NLM_article-title">Treatment of Diabetes and Atherosclerosis by Inhibiting Fatty-Acid-Binding Protein AP2</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>447</i></span>,  <span class="NLM_fpage">959</span>– <span class="NLM_lpage">965</span>, <span class="refDoi"> DOI: 10.1038/nature05844</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1038%2Fnature05844" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=17554340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2sXms1yqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2007&pages=959-965&author=M.+Furuhashiauthor=G.+Tuncmanauthor=C.+Z.+Gorgunauthor=L.+Makowskiauthor=G.+Atsumiauthor=E.+Vaillancourtauthor=K.+Konoauthor=V.+R.+Babaevauthor=S.+Fazioauthor=M.+F.+Lintonauthor=R.+Sulskyauthor=J.+A.+Roblauthor=R.+A.+Parkerauthor=G.+S.+Hotamisligil&title=Treatment+of+Diabetes+and+Atherosclerosis+by+Inhibiting+Fatty-Acid-Binding+Protein+AP2&doi=10.1038%2Fnature05844"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2</span></div><div class="casAuthors">Furuhashi, Masato; Tuncman, Guerol; Goerguen, Cem Z.; Makowski, Liza; Atsumi, Genichi; Vaillancourt, Eric; Kono, Keita; Babaev, Vladimir R.; Fazio, Sergio; Linton, MacRae F.; Sulsky, Richard; Robl, Jeffrey A.; Parker, Rex A.; Hotamisligil, Goekhan S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">7147</span>),
    <span class="NLM_cas:pages">959-965</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Adipocyte fatty-acid-binding protein, aP2 (FABP4) is expressed in adipocytes and macrophages, and integrates inflammatory and metabolic responses.  Studies in aP2-deficient mice have shown that this lipid chaperone has a significant role in several aspects of metabolic syndrome, including type 2 diabetes and atherosclerosis.  Here we demonstrate that an orally active small-mol. inhibitor of aP2 is an effective therapeutic agent against severe atherosclerosis and type 2 diabetes in mouse models.  In macrophage and adipocyte cell lines with or without aP2, we also show the target specificity of this chem. intervention and its mechanisms of action on metabolic and inflammatory pathways.  Our findings demonstrate that targeting aP2 with small-mol. inhibitors is possible and can lead to a new class of powerful therapeutic agents to prevent and treat metabolic diseases such as type 2 diabetes and atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcBoTTf3wl6LVg90H21EOLACvtfcHk0li0uSHRToFTQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXms1yqu7g%253D&md5=fe0e8ce268a91c4c126eb4161172ea9e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature05844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05844%26sid%3Dliteratum%253Aachs%26aulast%3DFuruhashi%26aufirst%3DM.%26aulast%3DTuncman%26aufirst%3DG.%26aulast%3DGorgun%26aufirst%3DC.%2BZ.%26aulast%3DMakowski%26aufirst%3DL.%26aulast%3DAtsumi%26aufirst%3DG.%26aulast%3DVaillancourt%26aufirst%3DE.%26aulast%3DKono%26aufirst%3DK.%26aulast%3DBabaev%26aufirst%3DV.%2BR.%26aulast%3DFazio%26aufirst%3DS.%26aulast%3DLinton%26aufirst%3DM.%2BF.%26aulast%3DSulsky%26aufirst%3DR.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26atitle%3DTreatment%2520of%2520Diabetes%2520and%2520Atherosclerosis%2520by%2520Inhibiting%2520Fatty-Acid-Binding%2520Protein%2520AP2%26jtitle%3DNature%26date%3D2007%26volume%3D447%26spage%3D959%26epage%3D965%26doi%3D10.1038%2Fnature05844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hotamisligil, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distel, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papaioannou, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegelman, B. M.</span></span> <span> </span><span class="NLM_article-title">Uncoupling of Obesity from Insulin Resistance through a Targeted Mutation in AP2, the Adipocyte Fatty Acid Binding Protein</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">1377</span>– <span class="NLM_lpage">1379</span>, <span class="refDoi"> DOI: 10.1126/science.274.5291.1377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1126%2Fscience.274.5291.1377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=8910278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADyaK28XntFKlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=1377-1379&author=G.+S.+Hotamisligilauthor=R.+S.+Johnsonauthor=R.+J.+Distelauthor=R.+Ellisauthor=V.+E.+Papaioannouauthor=B.+M.+Spiegelman&title=Uncoupling+of+Obesity+from+Insulin+Resistance+through+a+Targeted+Mutation+in+AP2%2C+the+Adipocyte+Fatty+Acid+Binding+Protein&doi=10.1126%2Fscience.274.5291.1377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein</span></div><div class="casAuthors">Hotamisligil, Gokhan S.; Johnson, Randall S.; Distel, Robert J.; Ellis, Ramsey; Papaioannou, Virginia E.; Spiegelman, Bruce M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">5291</span>),
    <span class="NLM_cas:pages">1377-1379</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Fatty acid-binding proteins (FABPs) are small cytoplasmic proteins that are expressed in a highly tissue-specific manner and bind to fatty acids such as oleic and retinoic acid.  Mice with a null mutation in aP2, the gene encoding the adipocyte FABP, were developmentally and metabolically normal.  The aP2-deficient mice developed dietary obesity, but unlike control mice, they did not develop insulin resistance or diabetes.  Also unlike their obese wild-type counterparts, obese aP2-/- animals failed to express in adipose tissue tumor necrosis factor-α (TNF-α), a mol. implicated in obesity-related insulin resistance.  Apparently, aP2 is central to the pathway that links obesity to insulin resistance, possibly by linking fatty acid metab. to expression of TNF-α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrknYL49pk4TrVg90H21EOLACvtfcHk0li0uSHRToFTQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntFKlsrs%253D&md5=edc08a093eb55406baf58b41a73317b1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.274.5291.1377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.274.5291.1377%26sid%3Dliteratum%253Aachs%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26aulast%3DJohnson%26aufirst%3DR.%2BS.%26aulast%3DDistel%26aufirst%3DR.%2BJ.%26aulast%3DEllis%26aufirst%3DR.%26aulast%3DPapaioannou%26aufirst%3DV.%2BE.%26aulast%3DSpiegelman%26aufirst%3DB.%2BM.%26atitle%3DUncoupling%2520of%2520Obesity%2520from%2520Insulin%2520Resistance%2520through%2520a%2520Targeted%2520Mutation%2520in%2520AP2%252C%2520the%2520Adipocyte%2520Fatty%2520Acid%2520Binding%2520Protein%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D1377%26epage%3D1379%26doi%3D10.1126%2Fscience.274.5291.1377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boord, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babaev, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uysal, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suttles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotamisligil, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linton, M. F.</span></span> <span> </span><span class="NLM_article-title">Lack of Macrophage Fatty-Acid-Binding Protein AP2 Protects Mice Deficient in Apolipoprotein E against Atherosclerosis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1038/89076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1038%2F89076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=11385507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlGku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=699-705&author=L.+Makowskiauthor=J.+B.+Boordauthor=K.+Maedaauthor=V.+R.+Babaevauthor=K.+T.+Uysalauthor=M.+A.+Morganauthor=R.+A.+Parkerauthor=J.+Suttlesauthor=S.+Fazioauthor=G.+S.+Hotamisligilauthor=M.+F.+Linton&title=Lack+of+Macrophage+Fatty-Acid-Binding+Protein+AP2+Protects+Mice+Deficient+in+Apolipoprotein+E+against+Atherosclerosis&doi=10.1038%2F89076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis</span></div><div class="casAuthors">Makowski, Liza; Boord, Jeffrey B.; Maeda, Kazuhisa; Babaev, Vladimir R.; Uysal, K. Teoman; Morgan, Maureen A.; Parker, Rex A.; Suttles, Jill; Fazio, Sergio; Hotamisligil, Gokhan S.; Linton, MacRae F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">699-705</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The adipocyte fatty-acid-binding protein, aP2, has an important role in regulating systemic insulin resistance and lipid metab.  Here we demonstrate that aP2 is also expressed in macrophages, has a significant role in their biol. responses and contributes to the development of atherosclerosis.  Apolipoprotein E (ApoE)-deficient mice also deficient for aP2 showed protection from atherosclerosis in the absence of significant differences in serum lipids or insulin sensitivity.  AP2-deficient macrophages showed alterations in inflammatory cytokine prodn. and a reduced ability to accumulate cholesterol esters when exposed to modified lipoproteins.  Apoe-/- mice with Ap2+/+ adipocytes and Ap2-/- macrophages generated by bone-marrow transplantation showed a comparable redn. in atherosclerotic lesions to those with total aP2 deficiency, indicating an independent role for macrophage aP2 in atherogenesis.  Through its distinct actions in adipocytes and macrophages, aP2 provides a link between features of the metabolic syndrome and could be a new therapeutic target for the prevention of atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgAGT0nUnJ5rVg90H21EOLACvtfcHk0lgR9SkFBnrFPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktlGku7w%253D&md5=5209357a5ded78b44b2b06efba9081be</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F89076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F89076%26sid%3Dliteratum%253Aachs%26aulast%3DMakowski%26aufirst%3DL.%26aulast%3DBoord%26aufirst%3DJ.%2BB.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DBabaev%26aufirst%3DV.%2BR.%26aulast%3DUysal%26aufirst%3DK.%2BT.%26aulast%3DMorgan%26aufirst%3DM.%2BA.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DSuttles%26aufirst%3DJ.%26aulast%3DFazio%26aufirst%3DS.%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26aulast%3DLinton%26aufirst%3DM.%2BF.%26atitle%3DLack%2520of%2520Macrophage%2520Fatty-Acid-Binding%2520Protein%2520AP2%2520Protects%2520Mice%2520Deficient%2520in%2520Apolipoprotein%2520E%2520against%2520Atherosclerosis%26jtitle%3DNat.%2520Med.%26date%3D2001%26volume%3D7%26spage%3D699%26epage%3D705%26doi%3D10.1038%2F89076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peeters, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Kleijn, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vink, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Weg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoneveld, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sze, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Spek, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasterkamp, G.</span></span> <span> </span><span class="NLM_article-title">Adipocyte Fatty Acid Binding Protein in Atherosclerotic Plaques is Associated with Local Vulnerability and is Predictive for the Occurrence of Adverse Cardiovascular Events</span>. <i>Eur. Heart J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1758</span>– <span class="NLM_lpage">1768</span>, <span class="refDoi"> DOI: 10.1093/eurheartj/ehq387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1093%2Feurheartj%2Fehq387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=21059735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptFCru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1758-1768&author=W.+Peetersauthor=D.+P.+de+Kleijnauthor=A.+Vinkauthor=S.+van+de+Wegauthor=A.+H.+Schoneveldauthor=S.+K.+Szeauthor=P.+J.+van+der+Spekauthor=J.+P.+de+Vriesauthor=F.+L.+Mollauthor=G.+Pasterkamp&title=Adipocyte+Fatty+Acid+Binding+Protein+in+Atherosclerotic+Plaques+is+Associated+with+Local+Vulnerability+and+is+Predictive+for+the+Occurrence+of+Adverse+Cardiovascular+Events&doi=10.1093%2Feurheartj%2Fehq387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events</span></div><div class="casAuthors">Peeters, Wouter; de Kleijn, Dominique P. V.; Vink, Aryan; van de Weg, Sander; Schoneveld, Arjan H.; Sze, Siu Kwan; van der Spek, Peter J.; de Vries, Jean-Paul P. M.; Moll, Frans L.; Pasterkamp, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">European Heart Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1758-1768</span>CODEN:
                <span class="NLM_cas:coden">EHJODF</span>;
        ISSN:<span class="NLM_cas:issn">0195-668X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">There is an increasing need for translational studies identifying mol. targets contributing to atherosclerotic plaque destabilization.  Local mol. plaque markers that are related to plaque vulnerability may hold predictive value to identify patients who are at increased risk to suffer from cardiovascular events.  Animal studies revealed that adipocyte fatty acid binding protein (FABP4) is assocd. with the progression of atherosclerosis; however, FABP4 expression studies in human atherosclerotic plaques are lacking.  We investigated FABP4 expression in carotid atherosclerotic lesions in relation to plaque compn. and future cardiovascular events.  Atherosclerotic plaques were obtained from 561 patients undergoing carotid endarterectomy (CEA).  Plaques were analyzed for the presence of macrophages, lipid core, smooth-muscle cells, collagen, calcification, and intraplaque hemorrhage.  Patients were followed for 3 years after CEA.  The primary outcome was defined as the composite of vascular death, vascular event, and surgical or percutaneous vascular intervention.  Fatty acid binding protein levels correlated with unstable plaque characteristics and symptomatic lesions.  Patients with increased FABP4 plaque levels showed a two-fold increased risk [HR = 1.99, 95% confidence interval (95% CI) (1.30-3.04)] (P = 0.005) to reach the primary outcome during follow-up.  Increased FABP4 levels related to primary outcome, independent from general cardiovascular risk factors [HR = 1.33, 95% CI (1.08-1.65)] (P = 0.008).  FABP4 levels in atherosclerotic lesions are assocd. with an unstable plaque phenotype and an increased risk for cardiovascular events during follow-up.  Besides risk stratification for adverse future cardiovascular events, the outcome of the present study supports the relevance of exploring FABP4 antagonists as a potential pharmaceutical intervention to treat atherosclerotic disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSyqiHCaUa-rVg90H21EOLACvtfcHk0lgR9SkFBnrFPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptFCru78%253D&md5=bea7043f10736daec49ee11d2e22793f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Feurheartj%2Fehq387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurheartj%252Fehq387%26sid%3Dliteratum%253Aachs%26aulast%3DPeeters%26aufirst%3DW.%26aulast%3Dde%2BKleijn%26aufirst%3DD.%2BP.%26aulast%3DVink%26aufirst%3DA.%26aulast%3Dvan%2Bde%2BWeg%26aufirst%3DS.%26aulast%3DSchoneveld%26aufirst%3DA.%2BH.%26aulast%3DSze%26aufirst%3DS.%2BK.%26aulast%3Dvan%2Bder%2BSpek%26aufirst%3DP.%2BJ.%26aulast%3Dde%2BVries%26aufirst%3DJ.%2BP.%26aulast%3DMoll%26aufirst%3DF.%2BL.%26aulast%3DPasterkamp%26aufirst%3DG.%26atitle%3DAdipocyte%2520Fatty%2520Acid%2520Binding%2520Protein%2520in%2520Atherosclerotic%2520Plaques%2520is%2520Associated%2520with%2520Local%2520Vulnerability%2520and%2520is%2520Predictive%2520for%2520the%2520Occurrence%2520of%2520Adverse%2520Cardiovascular%2520Events%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2011%26volume%3D32%26spage%3D1758%26epage%3D1768%26doi%3D10.1093%2Feurheartj%2Fehq387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Y.</span>; <span class="NLM_string-name">Liu, L.</span>; <span class="NLM_string-name">Yin, L.</span>; <span class="NLM_string-name">Xu, L.</span>; <span class="NLM_string-name">Tang, Z.</span>; <span class="NLM_string-name">Qi, Y.</span>; <span class="NLM_string-name">Mao, Z.</span>; <span class="NLM_string-name">Zhao, Y.</span>; <span class="NLM_string-name">Ma, X.</span>; <span class="NLM_string-name">Peng, J.</span></span> <span> </span><span class="NLM_article-title">FABP4 Contributes to Renal Interstitial Fibrosis via Mediating Inflammation and Lipid Metabolism</span>.  <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume">10</span>,<span class="refDoi"> DOI: 10.1038/s41419-019-1610-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1038%2Fs41419-019-1610-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&author=Y.+Qiao&author=L.+Liu&author=L.+Yin&author=L.+Xu&author=Z.+Tang&author=Y.+Qi&author=Z.+Mao&author=Y.+Zhao&author=X.+Ma&author=J.+Peng&title=FABP4+Contributes+to+Renal+Interstitial+Fibrosis+via+Mediating+Inflammation+and+Lipid+Metabolism&doi=10.1038%2Fs41419-019-1610-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fs41419-019-1610-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-019-1610-5%26sid%3Dliteratum%253Aachs%26aulast%3DQiao%26aufirst%3DY.%26atitle%3DFABP4%2520Contributes%2520to%2520Renal%2520Interstitial%2520Fibrosis%2520via%2520Mediating%2520Inflammation%2520and%2520Lipid%2520Metabolism%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2019%26volume%3D10%26doi%3D10.1038%2Fs41419-019-1610-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoo, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, K. S.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Inhibition of Adipocyte Fatty Acid Binding Protein Alleviates both Acute Liver Injury and non-Alcoholic Steatohepatitis in Mice</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1016/j.jhep.2012.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.jhep.2012.10.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=23108115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovVyiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2013&pages=358-364&author=R.+L.+Hooauthor=I.+P.+Leeauthor=M.+Zhouauthor=J.+Y.+Wongauthor=X.+Huiauthor=A.+Xuauthor=K.+S.+Lam&title=Pharmacological+Inhibition+of+Adipocyte+Fatty+Acid+Binding+Protein+Alleviates+both+Acute+Liver+Injury+and+non-Alcoholic+Steatohepatitis+in+Mice&doi=10.1016%2Fj.jhep.2012.10.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice</span></div><div class="casAuthors">Hoo, Ruby L. C.; Lee, Ida P. C.; Zhou, Mi; Wong, Janice Y. L.; Hui, Xiaoyan; Xu, Aimin; Lam, Karen S. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adipocyte fatty acid binding protein (A-FABP) is a key mediator of inflammatory response in macrophages.  Increased hepatic expression and circulating levels of A-FABP have been obsd. in patients with non-alc. fatty liver disease (NAFLD).  Here, we investigated the role of A-FABP in both lipopolysaccaride (LPS)-induced acute liver injury and high fat high cholesterol (HFHC) diet-induced NAFLD in mice.  Mice with LPS-induced acute liver injury and HFHC diet-induced obesity were treated with the A-FABP inhibitor BMS309403.  Liver tissues of the mice were analyzed by immunohistochem., Western blot or real-time PCR.  A-FABP expression in Kupffer cells was significantly elevated in mice with LPS-induced acute liver injury and HFHC diet-induced obesity, as compared to their healthy controls.  Pretreatment of mice with BMS309403 led to a diminished LPS-induced elevation in serum levels of alanine transaminase and hepatic prodn. of pro-inflammatory cytokines.  Likewise, chronic treatment of HFHC diet-induced obese mice with BMS309403 ameliorated hepatic steatosis, macrophage infiltration, and cellular ballooning of hepatocytes.  Such improvements in liver function and morphol. were accompanied by significantly decreased activation of both c-Jun and NF-κB.  Pretreatment with BMS309403 suppressed both LPS- and palmitate-induced pro-inflammatory responses in isolated rat Kupffer cells.  Adenovirus-mediated ectopic expression of A-FABP alone was sufficient to induce liver injury and inflammation in mice.  These findings suggest that A-FABP is an important contributor to both LPS-induced acute liver injury and diet-induced NAFLD by potentiating inflammation in Kupffer cells.  Pharmacol. inhibition of A-FABP may represent a promising modality for obesity-related non-alc. steatohepatitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn9yty5UsZRbVg90H21EOLACvtfcHk0lg0cZU_imw22A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovVyiuw%253D%253D&md5=5cfa283d6c966010c15d63b910c86887</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2012.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2012.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DHoo%26aufirst%3DR.%2BL.%26aulast%3DLee%26aufirst%3DI.%2BP.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DJ.%2BY.%26aulast%3DHui%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DA.%26aulast%3DLam%26aufirst%3DK.%2BS.%26atitle%3DPharmacological%2520Inhibition%2520of%2520Adipocyte%2520Fatty%2520Acid%2520Binding%2520Protein%2520Alleviates%2520both%2520Acute%2520Liver%2520Injury%2520and%2520non-Alcoholic%2520Steatohepatitis%2520in%2520Mice%26jtitle%3DJ.%2520Hepatol.%26date%3D2013%26volume%3D58%26spage%3D358%26epage%3D364%26doi%3D10.1016%2Fj.jhep.2012.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbacz, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billiar, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramakrishnan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span> <span> </span><span class="NLM_article-title">Fatty Acid Binding Protein-4 (FABP4) is a Hypoxia Inducible Gene that Sensitizes Mice to Liver Ischemia/Reperfusion Injury</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">855</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1016/j.jhep.2015.05.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.jhep.2015.05.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=26070408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Gqsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2015&pages=855-862&author=B.+Huauthor=Y.+Guoauthor=W.+G.+Garbaczauthor=M.+Jiangauthor=M.+Xuauthor=H.+Huangauthor=A.+Tsungauthor=T.+R.+Billiarauthor=S.+K.+Ramakrishnanauthor=Y.+M.+Shahauthor=K.+S.+Lamauthor=M.+Huangauthor=W.+Xie&title=Fatty+Acid+Binding+Protein-4+%28FABP4%29+is+a+Hypoxia+Inducible+Gene+that+Sensitizes+Mice+to+Liver+Ischemia%2FReperfusion+Injury&doi=10.1016%2Fj.jhep.2015.05.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Fatty acid binding protein-4 (FABP4) is a hypoxia inducible gene that sensitizes mice to liver ischemia/reperfusion injury</span></div><div class="casAuthors">Hu, Bingfang; Guo, Yan; Garbacz, Wojciech G.; Jiang, Mengxi; Xu, Meishu; Huang, Hai; Tsung, Allan; Billiar, Timothy R.; Ramakrishnan, Sadeesh K.; Shah, Yatrik M.; Lam, Karen S. L.; Huang, Min; Xie, Wen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">855-862</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fatty acid binding protein 4 (FABP4) has been known as a mediator of inflammatory response in the macrophages and adipose tissue, but its hepatic function is poorly understood.  The goal of this study is to investigate the role of FABP4 in liver ischemia/reperfusion (I/R), a clin. condition that involves both hypoxia and inflammation.To examine the I/R regulation of FABP4, mice were subjected to I/R surgery before being measured for FABP4 gene expression.  Both loss-of-function (by using a pharmacol. FABP4 inhibitor) and gain-of-function (by adenoviral overexpression of FABP4) were used to det. the functional relevance of FABP4 expression and its regulation during I/R.  To det. the hypoxia responsive regulation of FABP4, primary mouse hepatocytes were exposed to hypoxia.  The FABP4 gene promoter was cloned and its regulation by hypoxia inducible factor 1α (HIF-1α) was characterized by luciferase reporter gene, electrophoretic mobility shift, and chromatin immunopptn. assays.We found that the hepatic expression of FABP4 was markedly induced by I/R.  At the functional level, pharmacol. inhibition of FABP4 alleviated the I/R injury, whereas adenoviral overexpression of FABP4 sensitized mice to I/R injury.  We also showed that exposure of primary hepatocytes to hypoxia or transgenic overexpression of HIF-1α in the mouse liver was sufficient to induce the expression of FABP4.  Our promoter anal. established FABP4 as a novel transcriptional target of HIF-1α.FABP4 is a hypoxia inducible gene that sensitizes mice to liver I/R injury.  FABP4 may represent a novel therapeutic target, and FABP4 inhibitors may be used as therapeutic agents to manage hepatic I/R injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTgUVFbrTjUbVg90H21EOLACvtfcHk0lg0cZU_imw22A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Gqsr%252FL&md5=7be72017b530b5374c7d1171b4c6e3d4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2015.05.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2015.05.030%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DGarbacz%26aufirst%3DW.%2BG.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DTsung%26aufirst%3DA.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26aulast%3DRamakrishnan%26aufirst%3DS.%2BK.%26aulast%3DShah%26aufirst%3DY.%2BM.%26aulast%3DLam%26aufirst%3DK.%2BS.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DW.%26atitle%3DFatty%2520Acid%2520Binding%2520Protein-4%2520%2528FABP4%2529%2520is%2520a%2520Hypoxia%2520Inducible%2520Gene%2520that%2520Sensitizes%2520Mice%2520to%2520Liver%2520Ischemia%252FReperfusion%2520Injury%26jtitle%3DJ.%2520Hepatol.%26date%3D2015%26volume%3D63%26spage%3D855%26epage%3D862%26doi%3D10.1016%2Fj.jhep.2015.05.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, B.</span></span> <span> </span><span class="NLM_article-title">FABP4 Inhibitors Suppress Inflammation and Oxidative Stress in Murine and Cell Models of Acute Lung Injury</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>496</i></span>,  <span class="NLM_fpage">1115</span>– <span class="NLM_lpage">1121</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2018.01.150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.bbrc.2018.01.150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=29409946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSgtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=496&publication_year=2018&pages=1115-1121&author=Y.+Gongauthor=Z.+Yuauthor=Y.+Gaoauthor=L.+Dengauthor=M.+Wangauthor=Y.+Chenauthor=J.+Liauthor=B.+Cheng&title=FABP4+Inhibitors+Suppress+Inflammation+and+Oxidative+Stress+in+Murine+and+Cell+Models+of+Acute+Lung+Injury&doi=10.1016%2Fj.bbrc.2018.01.150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">FABP4 inhibitors suppress inflammation and oxidative stress in murine and cell models of acute lung injury</span></div><div class="casAuthors">Gong, Yuanqi; Yu, Zhihong; Gao, Yi; Deng, Linlin; Wang, Meng; Chen, Yu; Li, Jingying; Cheng, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">496</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1115-1121</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Acute lung injury (ALI) is a severe disease with high morbidity and mortality, and is characterized by devastating inflammation of the lung and increased prodn. of reactive oxygen species (ROS).  Recent studies have indicated that fatty acid binding protein (FABP4) is important in the regulation of inflammation.  However, the role of FABP4 in sepsis-related ALI, and the specific mechanism of action have not been examd.  In vitro, the exposure of human alveolar epithelial A549cells to lipopolysaccharide (LPS) and recombinant FABP4 (hrFABP4) resulted in the prodn. of pro-inflammatory cytokines, inflammatory cytokines, and ROS, while these changes were ameliorated by pretreatment with the FABP4 inhibitor BMS309403 and FABP4 siRNA.  Sequentially, treatment of A549cells with N-acetylcysteine (NAC) significantly attenuated LPS and hrFABP4-induced the generation of ROS and the release of inflammatory cytokines.  In vivo, a cecal ligation and puncture (CLP)-induced ALI murine model was successfully established.  Then, the mice were treated with FABP4 inhibitor BMS309403.  The results showed treatment with BMS309403 improved the survival rate of CLP-induced ALI mice, and prevented lung inflammation, histopathol. changes, and increase of FABP4 induced by CLP.  These data indicate that FABP4 plays an important role in lung inflammation of sepsis-induced ALI.  Blockade of FABP4 signaling exhibits a protective effect in a CLP-induced ALI mouse model, and in A549cell LPS specifically induces enhanced expression of FABP4, which then causes inflammatory cytokine prodn. by elevating the ROS level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaETbdfCTn7LVg90H21EOLACvtfcHk0lg0cZU_imw22A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSgtb8%253D&md5=cb5862daf07caa0d22792f0a3b2b34d7</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2018.01.150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2018.01.150%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DB.%26atitle%3DFABP4%2520Inhibitors%2520Suppress%2520Inflammation%2520and%2520Oxidative%2520Stress%2520in%2520Murine%2520and%2520Cell%2520Models%2520of%2520Acute%2520Lung%2520Injury%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2018%26volume%3D496%26spage%3D1115%26epage%3D1121%26doi%3D10.1016%2Fj.bbrc.2018.01.150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Floresta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pistara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amata, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dichiara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrazzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prezzavento, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescifina, A.</span></span> <span> </span><span class="NLM_article-title">Adipocyte Fatty Acid Binding Protein 4 (FABP4) Inhibitors. A Comprehensive Systematic Review</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">854</span>– <span class="NLM_lpage">873</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.07.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.ejmech.2017.07.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=28738306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Wlt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2017&pages=854-873&author=G.+Florestaauthor=V.+Pistaraauthor=E.+Amataauthor=M.+Dichiaraauthor=A.+Marrazzoauthor=O.+Prezzaventoauthor=A.+Rescifina&title=Adipocyte+Fatty+Acid+Binding+Protein+4+%28FABP4%29+Inhibitors.+A+Comprehensive+Systematic+Review&doi=10.1016%2Fj.ejmech.2017.07.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review</span></div><div class="casAuthors">Floresta, Giuseppe; Pistara, Venerando; Amata, Emanuele; Dichiara, Maria; Marrazzo, Agostino; Prezzavento, Orazio; Rescifina, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">854-873</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Small mol. inhibitors of adipocyte fatty acid binding protein 4 (FABP4) have attracted interest following the recent publications of beneficial pharmacol. effects of these compds.  FABP4 is predominantly expressed in macrophages and adipose tissue where it regulates fatty acids (FAs) storage and lipolysis and is an important mediator of inflammation.  In the past years, hundreds FABP4 inhibitors have been synthesized for effective atherosclerosis and diabetes treatments, including derivs. of niacin, quinoxaline, aryl-quinoline, bicyclic pyridine, urea, arom. compds. and other novel heterocyclic compds.  This review provides an overview of the synthesized and discovered mols. as adipocyte fatty acid binding protein 4 inhibitors (FABP4is) since the synthesis of the putative FABP4i, BMS309403, highlighting the interactions of the different classes of inhibitors with the targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6yvkt3g7wurVg90H21EOLACvtfcHk0lhTRgbsf4posw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Wlt77L&md5=a7e1866d1726bf8d9df083dd0a826d55</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.07.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.07.022%26sid%3Dliteratum%253Aachs%26aulast%3DFloresta%26aufirst%3DG.%26aulast%3DPistara%26aufirst%3DV.%26aulast%3DAmata%26aufirst%3DE.%26aulast%3DDichiara%26aufirst%3DM.%26aulast%3DMarrazzo%26aufirst%3DA.%26aulast%3DPrezzavento%26aufirst%3DO.%26aulast%3DRescifina%26aufirst%3DA.%26atitle%3DAdipocyte%2520Fatty%2520Acid%2520Binding%2520Protein%25204%2520%2528FABP4%2529%2520Inhibitors.%2520A%2520Comprehensive%2520Systematic%2520Review%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D138%26spage%3D854%26epage%3D873%26doi%3D10.1016%2Fj.ejmech.2017.07.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Binas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danneberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWhir, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. J.</span></span> <span> </span><span class="NLM_article-title">Requirement for the Heart-Type Fatty Acid Binding Protein in Cardiac Fatty Acid Utilization</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">812</span>, <span class="refDoi"> DOI: 10.1096/fasebj.13.8.805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1096%2Ffasebj.13.8.805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10224224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADyaK1MXjtFGksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=805-812&author=B.+Binasauthor=H.+Dannebergauthor=J.+McWhirauthor=L.+Mullinsauthor=A.+J.+Clark&title=Requirement+for+the+Heart-Type+Fatty+Acid+Binding+Protein+in+Cardiac+Fatty+Acid+Utilization&doi=10.1096%2Ffasebj.13.8.805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization</span></div><div class="casAuthors">Binas, Bert; Danneberg, Heike; McWhir, Jim; Mullins, Linda; Clark, A. John</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">805-812</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Nonenzymic cytosolic fatty acid binding proteins (FABPs) are abundantly expressed in many animal tissues with high rates of fatty acid metab.  No physiol. role has been demonstrated for any FABP, although these proteins have been implicated in transport of free long-chain fatty acids (LCFAs) and protection against LCFA toxicity.  We report here that mice lacking heart-type FABP (H-FABP) exhibit a severe defect of peripheral (non-hepatic, non-fat) LCFA utilization.  In these mice, the heart is unable to efficiently take up plasma LCFAs, which are normally its main fuel, and switches to glucose usage.  Altered plasma levels of LCFAs, glucose, lactate and β-hydroxybutyrate are consistent with depressed peripheral LCFA utilization, intensified carbohydrate usage, and increased hepatic LCFA oxidn.; these changes are most pronounced under conditions favoring LCFA oxidn.  H-FABP deficiency is only incompletely compensated, however, causing acute exercise intolerance and, at old age, a localized cardiac hypertrophy.  These data establish a requirement for H-FABP in cardiac intracellular lipid transport and fuel selection and a major role in metabolic homeostasis.  This new animal model should be particularly useful for investigating the significance of peripheral LCFA utilization for heart function, insulin sensitivity, and blood pressure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMAVnSXdMiF7Vg90H21EOLACvtfcHk0lhTRgbsf4posw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtFGksrk%253D&md5=e512198cd86e9a4057e1f025b10ce6fc</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.13.8.805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.13.8.805%26sid%3Dliteratum%253Aachs%26aulast%3DBinas%26aufirst%3DB.%26aulast%3DDanneberg%26aufirst%3DH.%26aulast%3DMcWhir%26aufirst%3DJ.%26aulast%3DMullins%26aufirst%3DL.%26aulast%3DClark%26aufirst%3DA.%2BJ.%26atitle%3DRequirement%2520for%2520the%2520Heart-Type%2520Fatty%2520Acid%2520Binding%2520Protein%2520in%2520Cardiac%2520Fatty%2520Acid%2520Utilization%26jtitle%3DFASEB%2520J.%26date%3D1999%26volume%3D13%26spage%3D805%26epage%3D812%26doi%3D10.1096%2Ffasebj.13.8.805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uysal, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorgun, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atsumi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzel, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernlohr, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotamisligil, G. S.</span></span> <span> </span><span class="NLM_article-title">Role of the Fatty Acid Binding Protein Mal1 in Obesity and Insulin Resistance</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">307</span>, <span class="refDoi"> DOI: 10.2337/diabetes.52.2.300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.2337%2Fdiabetes.52.2.300" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=12540600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtFansr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=300-307&author=K.+Maedaauthor=K.+T.+Uysalauthor=L.+Makowskiauthor=C.+Z.+Gorgunauthor=G.+Atsumiauthor=R.+A.+Parkerauthor=J.+Bruningauthor=A.+V.+Hertzelauthor=D.+A.+Bernlohrauthor=G.+S.+Hotamisligil&title=Role+of+the+Fatty+Acid+Binding+Protein+Mal1+in+Obesity+and+Insulin+Resistance&doi=10.2337%2Fdiabetes.52.2.300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the fatty acid binding protein mal-1 in obesity and insulin resistance</span></div><div class="casAuthors">Maeda, Kazuhisa; Uysal, K. Teoman; Makowski, Liza; Gorgun, Cem Z.; Atsumi, Genichi; Parker, Rex A.; Bruning, Jens; Hertzel, Ann Vogel; Bernlohr, David A.; Hotamisligil, Gokhan S.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">300-307</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association</span>)
        </div><div class="casAbstract">The metabolic syndrome is a cluster of metabolic and inflammatory abnormalities including obesity, insulin resistance, type 2 diabetes, hypertension, dyslipidemia, and atherosclerosis.  The fatty acid binding proteins aP2 (fatty acid binding protein [FABP]-4) and mal1 (FABP5) are closely related and both are expressed in adipocytes.  Previous studies in aP2-deficient mice have indicated a significant role for aP2 in obesity-related insulin resistance, type 2 diabetes, and atherosclerosis.  However, the biol. functions of mal-1 are not known.  Here, we report the generation of mice with targeted null mutations in the mal-1 gene as well as transgenic mice overexpressing mal1 from the aP2 promoter/enhancer to address the role of this FABP in metabolic regulation in the presence or absence of obesity.  To address the role of the second adipocyte FABP in metabolic regulation in the presence and deficiency of obesity, absence of mal1 resulted in increased systemic insulin sensitivity in two models of obesity and insulin resistance.  Adipocytes isolated from mal-1-deficient mice also exhibited enhanced insulin-stimulated glucose transport capacity.  In contrast, mice expressing high levels of mal1 in adipose tissue display reduced systemic insulin sensitivity.  Hence, our results demonstrate that mal1 modulates adipose tissue function and contributes to systemic glucose metab. and constitutes a potential therapeutic target in insulin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVlFbDG7STK7Vg90H21EOLACvtfcHk0lhTRgbsf4posw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtFansr8%253D&md5=a533740457043d257d20983a02dc8b07</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.52.2.300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.52.2.300%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DUysal%26aufirst%3DK.%2BT.%26aulast%3DMakowski%26aufirst%3DL.%26aulast%3DGorgun%26aufirst%3DC.%2BZ.%26aulast%3DAtsumi%26aufirst%3DG.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DBruning%26aufirst%3DJ.%26aulast%3DHertzel%26aufirst%3DA.%2BV.%26aulast%3DBernlohr%26aufirst%3DD.%2BA.%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26atitle%3DRole%2520of%2520the%2520Fatty%2520Acid%2520Binding%2520Protein%2520Mal1%2520in%2520Obesity%2520and%2520Insulin%2520Resistance%26jtitle%3DDiabetes%26date%3D2003%26volume%3D52%26spage%3D300%26epage%3D307%26doi%3D10.2337%2Fdiabetes.52.2.300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waigel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraig, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egilmez, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suttles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleary, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span> <span> </span><span class="NLM_article-title">Circulating Adipose Fatty Acid Binding Protein is a New Link Underlying Obesity-Associated Breast/Mammary Tumor Development</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2018.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.cmet.2018.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=30100196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOksr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=689-705&author=J.+Haoauthor=Y.+Zhangauthor=X.+Yanauthor=F.+Yanauthor=Y.+Sunauthor=J.+Zengauthor=S.+Waigelauthor=Y.+Yinauthor=M.+M.+Fraigauthor=N.+K.+Egilmezauthor=J.+Suttlesauthor=M.+Kongauthor=S.+Liuauthor=M.+P.+Clearyauthor=E.+Sauterauthor=B.+Li&title=Circulating+Adipose+Fatty+Acid+Binding+Protein+is+a+New+Link+Underlying+Obesity-Associated+Breast%2FMammary+Tumor+Development&doi=10.1016%2Fj.cmet.2018.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Circulating Adipose Fatty Acid Binding Protein Is a New Link Underlying Obesity-Associated Breast/Mammary Tumor Development</span></div><div class="casAuthors">Hao, Jiaqing; Zhang, Yuwen; Yan, Xiaofang; Yan, Fei; Sun, Yanwen; Zeng, Jun; Waigel, Sabine; Yin, Yanhui; Fraig, Mostafa M.; Egilmez, Nejat K.; Suttles, Jill; Kong, Maiying; Liu, Shujun; Cleary, Margot P.; Sauter, Edward; Li, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">689-705.e5</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">It is clear that obesity increases the risk of many types of cancer, including breast cancer.  However, the underlying mol. mechanisms by which obesity is linked to cancer risk remain to be defined.  Herein, we report that circulating adipose fatty acid binding protein (A-FABP) promotes obesity-assocd. breast cancer development.  Using clin. samples, we demonstrated that circulating A-FABP levels were significantly increased in obese patients with breast cancer in comparison with those without breast cancer.  Circulating A-FABP released by adipose tissue directly targeted mammary tumor cells, enhancing tumor stemness and aggressiveness through activation of the IL-6/STAT3/ALDH1 pathway.  Importantly, genetic deletion of A-FABP successfully reduced tumor ALHD1 activation and obesity-assocd. mammary tumor growth and development in different mouse models.  Collectively, these data suggest circulating A-FABP as a new link between obesity and breast cancer risk, thereby revealing A-FABP as a potential new therapeutic target for treatment of obesity-assocd. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVmcRODA9czLVg90H21EOLACvtfcHk0lgF0y33uDU61Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOksr3P&md5=a9a7f4e9d473702e115242b48826b2f9</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2018.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2018.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DWaigel%26aufirst%3DS.%26aulast%3DYin%26aufirst%3DY.%26aulast%3DFraig%26aufirst%3DM.%2BM.%26aulast%3DEgilmez%26aufirst%3DN.%2BK.%26aulast%3DSuttles%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCleary%26aufirst%3DM.%2BP.%26aulast%3DSauter%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DB.%26atitle%3DCirculating%2520Adipose%2520Fatty%2520Acid%2520Binding%2520Protein%2520is%2520a%2520New%2520Link%2520Underlying%2520Obesity-Associated%2520Breast%252FMammary%2520Tumor%2520Development%26jtitle%3DCell%2520Metab.%26date%3D2018%26volume%3D28%26spage%3D689%26epage%3D705%26doi%3D10.1016%2Fj.cmet.2018.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sulsky, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnin, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpkins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stouch, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassolino-Klimas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrity, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoffel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavoie, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kish, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheriff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robl, J. A.</span></span> <span> </span><span class="NLM_article-title">Potent and Selective Biphenyl Azole Inhibitors of Adipocyte Fatty Acid Binding Protein (aFABP)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3511</span>– <span class="NLM_lpage">3515</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.12.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.bmcl.2006.12.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=17502136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtValsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3511-3515&author=R.+Sulskyauthor=D.+R.+Magninauthor=Y.+Huangauthor=L.+Simpkinsauthor=P.+Taunkauthor=M.+Patelauthor=Y.+Zhuauthor=T.+R.+Stouchauthor=D.+Bassolino-Klimasauthor=R.+Parkerauthor=T.+Harrityauthor=R.+Stoffelauthor=D.+S.+Taylorauthor=T.+B.+Lavoieauthor=K.+Kishauthor=B.+L.+Jacobsonauthor=S.+Sheriffauthor=L.+P.+Adamauthor=W.+R.+Ewingauthor=J.+A.+Robl&title=Potent+and+Selective+Biphenyl+Azole+Inhibitors+of+Adipocyte+Fatty+Acid+Binding+Protein+%28aFABP%29&doi=10.1016%2Fj.bmcl.2006.12.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP)</span></div><div class="casAuthors">Sulsky, Richard; Magnin, David R.; Huang, Yanting; Simpkins, Ligaya; Taunk, Prakash; Patel, Manorama; Zhu, Yeheng; Stouch, Terry R.; Bassolino-Klimas, Donna; Parker, Rex; Harrity, Thomas; Stoffel, Robert; Taylor, David S.; Lavoie, Thomas B.; Kish, Kevin; Jacobson, Bruce L.; Sheriff, Steven; Adam, Leonard P.; Ewing, William R.; Robl, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3511-3515</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Herein we report the first disclosure of biphenyl azoles that are nanomolar binders of adipocyte fatty acid binding protein (aFABP or aP2) with up to thousand-fold selectivity against muscle fatty acid binding protein and epidermal fatty acid binding protein.  In addn. a new radio-ligand to det. binding against the three fatty acid binding proteins was also synthesized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhQXAZfTUCbLVg90H21EOLACvtfcHk0lgF0y33uDU61Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtValsbc%253D&md5=464a2d308418f1824decc25c0575110b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.044%26sid%3Dliteratum%253Aachs%26aulast%3DSulsky%26aufirst%3DR.%26aulast%3DMagnin%26aufirst%3DD.%2BR.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DSimpkins%26aufirst%3DL.%26aulast%3DTaunk%26aufirst%3DP.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DStouch%26aufirst%3DT.%2BR.%26aulast%3DBassolino-Klimas%26aufirst%3DD.%26aulast%3DParker%26aufirst%3DR.%26aulast%3DHarrity%26aufirst%3DT.%26aulast%3DStoffel%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DD.%2BS.%26aulast%3DLavoie%26aufirst%3DT.%2BB.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DJacobson%26aufirst%3DB.%2BL.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DAdam%26aufirst%3DL.%2BP.%26aulast%3DEwing%26aufirst%3DW.%2BR.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26atitle%3DPotent%2520and%2520Selective%2520Biphenyl%2520Azole%2520Inhibitors%2520of%2520Adipocyte%2520Fatty%2520Acid%2520Binding%2520Protein%2520%2528aFABP%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3511%26epage%3D3515%26doi%3D10.1016%2Fj.bmcl.2006.12.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haile, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uppenberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundback, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondahl, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barf, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of Inhibitors of Human Adipocyte Fatty Acid-Binding Protein, a Potential Type 2 Diabetes Target</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4445</span>– <span class="NLM_lpage">4448</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.06.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.bmcl.2004.06.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=15357969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Kitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4445-4448&author=F.+Lehmannauthor=S.+Haileauthor=E.+Axenauthor=C.+Medinaauthor=J.+Uppenbergauthor=S.+Svenssonauthor=T.+Lundbackauthor=L.+Rondahlauthor=T.+Barf&title=Discovery+of+Inhibitors+of+Human+Adipocyte+Fatty+Acid-Binding+Protein%2C+a+Potential+Type+2+Diabetes+Target&doi=10.1016%2Fj.bmcl.2004.06.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target</span></div><div class="casAuthors">Lehmann, Fredik; Haile, Saba; Axen, Eva; Medina, Carmen; Uppenberg, Jonas; Svensson, Stefan; Lundbaeck, Thomas; Rondahl, Lena; Barf, Tjeerd</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4445-4448</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Low micromolar human A-FABP inhibitors were found by utilizing a fluorescence polarization assay, x-ray crystallog. and modeling.  The carbazole- and indole-based inhibitors displayed approx. 10-fold preferences over human H-FABP and E-FABP, and are highly selective against I-FABP.  This communication describes the SAR for drug-like synthetic inhibitors of human A-FABP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDaEKm61NwK7Vg90H21EOLACvtfcHk0lhvqKiL5Nq5aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Kitbo%253D&md5=86ed8d295ff0dfdafdf13ccad420d796</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.06.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.06.057%26sid%3Dliteratum%253Aachs%26aulast%3DLehmann%26aufirst%3DF.%26aulast%3DHaile%26aufirst%3DS.%26aulast%3DAxen%26aufirst%3DE.%26aulast%3DMedina%26aufirst%3DC.%26aulast%3DUppenberg%26aufirst%3DJ.%26aulast%3DSvensson%26aufirst%3DS.%26aulast%3DLundback%26aufirst%3DT.%26aulast%3DRondahl%26aufirst%3DL.%26aulast%3DBarf%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520Inhibitors%2520of%2520Human%2520Adipocyte%2520Fatty%2520Acid-Binding%2520Protein%252C%2520a%2520Potential%2520Type%25202%2520Diabetes%2520Target%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4445%26epage%3D4448%26doi%3D10.1016%2Fj.bmcl.2004.06.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haile, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uppenberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondahl, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundback, T.</span></span> <span> </span><span class="NLM_article-title">N-Benzyl-indolo carboxylic acids: Design and Synthesis of Potent and Selective Adipocyte Fatty-Acid Binding Protein (A-FABP) Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1745</span>– <span class="NLM_lpage">1748</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.01.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.bmcl.2009.01.084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=19217286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1745-1748&author=T.+Barfauthor=F.+Lehmannauthor=K.+Hammerauthor=S.+Haileauthor=E.+Axenauthor=C.+Medinaauthor=J.+Uppenbergauthor=S.+Svenssonauthor=L.+Rondahlauthor=T.+Lundback&title=N-Benzyl-indolo+carboxylic+acids%3A+Design+and+Synthesis+of+Potent+and+Selective+Adipocyte+Fatty-Acid+Binding+Protein+%28A-FABP%29+Inhibitors&doi=10.1016%2Fj.bmcl.2009.01.084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">N-Benzylindolocarboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors</span></div><div class="casAuthors">Barf, Tjeerd; Lehmann, Fredrik; Hammer, Kristin; Haile, Saba; Axen, Eva; Medina, Carmen; Uppenberg, Jonas; Svensson, Stefan; Rondahl, Lena; Lundbaeck, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1745-1748</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Small mol. inhibitors of adipocyte fatty-acid binding protein (A-FABP) have gained renewed interest following the recent publication of pharmacol. beneficial effects of such inhibitors.  Despite the potential utility of selective A-FABP inhibitors within the fields of metabolic disease, inflammation and atherosclerosis, there are few examples of useful A-FABP inhibitors in the public domain.  The optimization of N-benzy-tetrahydrocarbazole derivs. through the use of co-crystal structure guided medicinal chem. efforts is described.  This led to the identification of a potent and selective class of A-FABP inhibitors as illustrated by N-benzylhexahydrocyclohepta[b]indole I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5iydyKyirabVg90H21EOLACvtfcHk0lhvqKiL5Nq5aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSltL8%253D&md5=1bd54a829937f3e4ab30bebf79256310</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.01.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.01.084%26sid%3Dliteratum%253Aachs%26aulast%3DBarf%26aufirst%3DT.%26aulast%3DLehmann%26aufirst%3DF.%26aulast%3DHammer%26aufirst%3DK.%26aulast%3DHaile%26aufirst%3DS.%26aulast%3DAxen%26aufirst%3DE.%26aulast%3DMedina%26aufirst%3DC.%26aulast%3DUppenberg%26aufirst%3DJ.%26aulast%3DSvensson%26aufirst%3DS.%26aulast%3DRondahl%26aufirst%3DL.%26aulast%3DLundback%26aufirst%3DT.%26atitle%3DN-Benzyl-indolo%2520carboxylic%2520acids%253A%2520Design%2520and%2520Synthesis%2520of%2520Potent%2520and%2520Selective%2520Adipocyte%2520Fatty-Acid%2520Binding%2520Protein%2520%2528A-FABP%2529%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1745%26epage%3D1748%26doi%3D10.1016%2Fj.bmcl.2009.01.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tagami, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ejima, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeshita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyanaga, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokumasu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashiwagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizukoshi, T.</span></span> <span> </span><span class="NLM_article-title">Interaction Analysis of FABP4 Inhibitors by X-ray Crystallography and Fragment Molecular Orbital Analysis</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00040</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFGntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=435-439&author=U.+Tagamiauthor=K.+Takahashiauthor=S.+Igarashiauthor=C.+Ejimaauthor=T.+Yoshidaauthor=S.+Takeshitaauthor=W.+Miyanagaauthor=M.+Sugikiauthor=M.+Tokumasuauthor=T.+Hatanakaauthor=T.+Kashiwagiauthor=K.+Ishikawaauthor=H.+Miyanoauthor=T.+Mizukoshi&title=Interaction+Analysis+of+FABP4+Inhibitors+by+X-ray+Crystallography+and+Fragment+Molecular+Orbital+Analysis&doi=10.1021%2Facsmedchemlett.6b00040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction Analysis of FABP4 Inhibitors by X-ray Crystallography and Fragment Molecular Orbital Analysis</span></div><div class="casAuthors">Tagami, Uno; Takahashi, Kazutoshi; Igarashi, Shunsuke; Ejima, Chieko; Yoshida, Tomomi; Takeshita, Sen; Miyanaga, Wataru; Sugiki, Masayuki; Tokumasu, Munetaka; Hatanaka, Toshihiro; Kashiwagi, Tatsuki; Ishikawa, Kohki; Miyano, Hiroshi; Mizukoshi, Toshimi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">435-439</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">X-ray crystal structural detn. of FABP4 in complex with four inhibitors revealed the complex binding modes, and the resulting observations led to improvement of the inhibitory potency of FABP4 inhibitors.  However, the detailed structure-activity relationship (SAR) could not be explained from these structural observations.  For a more detailed understanding of the interactions between FABP4 and inhibitors, fragment MO analyses were performed.  These analyses revealed that the total interfragment interaction energies of FABP4 and each inhibitor correlated with the ranking of the Ki value for the four inhibitors.  Furthermore, interactions between each inhibitor and amino acid residues in FABP4 were identified.  The oxygen atom of Lys58 in FABP4 was found to be very important for strong interactions with FABP4.  These results might provide useful information for the development of novel potent FABP4 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdOU8yYHj0WrVg90H21EOLACvtfcHk0lhbg5c-3Un5-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFGntbg%253D&md5=4a0f406d4a3a4342e2a33f1f52be05cc</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00040%26sid%3Dliteratum%253Aachs%26aulast%3DTagami%26aufirst%3DU.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DIgarashi%26aufirst%3DS.%26aulast%3DEjima%26aufirst%3DC.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DTakeshita%26aufirst%3DS.%26aulast%3DMiyanaga%26aufirst%3DW.%26aulast%3DSugiki%26aufirst%3DM.%26aulast%3DTokumasu%26aufirst%3DM.%26aulast%3DHatanaka%26aufirst%3DT.%26aulast%3DKashiwagi%26aufirst%3DT.%26aulast%3DIshikawa%26aufirst%3DK.%26aulast%3DMiyano%26aufirst%3DH.%26aulast%3DMizukoshi%26aufirst%3DT.%26atitle%3DInteraction%2520Analysis%2520of%2520FABP4%2520Inhibitors%2520by%2520X-ray%2520Crystallography%2520and%2520Fragment%2520Molecular%2520Orbital%2520Analysis%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D435%26epage%3D439%26doi%3D10.1021%2Facsmedchemlett.6b00040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation of Thiazole- and Indole-Based Derivatives for the Treatment of Type II Diabetes</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.ejmech.2012.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=22483089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlSks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=70-81&author=Q.+Xuauthor=L.+Huangauthor=J.+Liuauthor=L.+Maauthor=T.+Chenauthor=J.+Chenauthor=F.+Pengauthor=D.+Caoauthor=Z.+Yangauthor=N.+Qiuauthor=J.+Qiuauthor=G.+Wangauthor=X.+Liangauthor=A.+Pengauthor=M.+Xiangauthor=Y.+Weiauthor=L.+Chen&title=Design%2C+Synthesis+and+Biological+Evaluation+of+Thiazole-+and+Indole-Based+Derivatives+for+the+Treatment+of+Type+II+Diabetes&doi=10.1016%2Fj.ejmech.2012.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of thiazole- and indole-based derivatives for the treatment of type II diabetes</span></div><div class="casAuthors">Xu, Qinyuan; Huang, Li; Liu, Juan; Ma, Liang; Chen, Tao; Chen, Jinying; Peng, Fei; Cao, Dong; Yang, Zhuang; Qiu, Neng; Qiu, Jingxiang; Wang, Guangcheng; Liang, Xiaolin; Peng, Aihua; Xiang, Mingli; Wei, Yuquan; Chen, Lijuan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">70-81</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Present studies have shown that the lipid carrier has a significant role in several aspects of metabolic syndrome in A-FABP/ap2-deficient mice, including type 2 diabetes and atherosclerosis.  Thiazole- and indole-based derivs. were synthesized and investigated for their inhibitory effects on the prodn. of LPS-stimulated TNF-α.  Among them, (E)-1-(2-fluorobenzyl)-1H-indole-3-acrylic acid (I) exhibited an excellent inhibitory efficiency compared to BMS309403 (95% vs. 85%) at the concn. of 10 μM and a binding affinity for ap2 with the apparent Ki values 33 nM.  Oral administration of I at a dosage of 50 mg/kg effectively reduced the levels of plasma blood glucose, triglycerides, insulin, total cholesterol and alanine aminotransferase in high-fat/diet-induced obesity model.  The results highlighted that I was a potent anti-diabetic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_l5BLkyy5XrVg90H21EOLACvtfcHk0lhbg5c-3Un5-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlSks7g%253D&md5=70378aef257370e72017a6cc00e3e539</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DF.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DN.%26aulast%3DQiu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DA.%26aulast%3DXiang%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Thiazole-%2520and%2520Indole-Based%2520Derivatives%2520for%2520the%2520Treatment%2520of%2520Type%2520II%2520Diabetes%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D52%26spage%3D70%26epage%3D81%26doi%3D10.1016%2Fj.ejmech.2012.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. X.</span></span> <span> </span><span class="NLM_article-title">Benzbromarone, an Old Uricosuric Drug, Inhibits Human Fatty Acid Binding Protein 4 <i>in vitro</i> and Lowers the Blood Glucose Level in <i>db/db</i> Mice</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1397</span>– <span class="NLM_lpage">1402</span>, <span class="refDoi"> DOI: 10.1038/aps.2013.97</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1038%2Faps.2013.97" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=24077632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslajsLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1397-1402&author=H.+Y.+Caiauthor=T.+Wangauthor=J.+C.+Zhaoauthor=P.+Sunauthor=G.+R.+Yanauthor=H.+P.+Dingauthor=Y.+X.+Liauthor=H.+Y.+Wangauthor=W.+L.+Zhuauthor=K.+X.+Chen&title=Benzbromarone%2C+an+Old+Uricosuric+Drug%2C+Inhibits+Human+Fatty+Acid+Binding+Protein+4+in+vitro+and+Lowers+the+Blood+Glucose+Level+in+db%2Fdb+Mice&doi=10.1038%2Faps.2013.97"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Benzbromarone, an old uricosuric drug, inhibits human fatty acid binding protein 4 in vitro and lowers the blood glucose level in db/db mice</span></div><div class="casAuthors">Cai, Hai-yan; Wang, Ting; Zhao, Jian-chun; Sun, Peng; Yan, Gui-rui; Ding, Hai-peng; Li, Ying-xia; Wang, He-yao; Zhu, Wei-liang; Chen, Kai-xian</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1397-1402</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aim: Fatty acid-binding protein 4 (FABP4) plays an important role in maintaining glucose and lipid homeostasis.  The aim of this study was to find new inhibitors of FABP4 for the treatment of type 2 diabetes.  Methods: Human FABP4 protein was expressed, and its inhibitors were detected in 1,8-ANS displacement assay.  The effect of the inhibitor on lipolysis activity was examd. in mouse 3T3-L1 preadipocytes.  The db/db mice were used to evaluate the anti-diabetic activity of the inhibitor.  Mol. docking and site-directed mutagenesis studies were carried out to explore the binding mode between the inhibitor and FABP4.  Results: From 232 compds. tested, benzbromarone (BBR), an old uricosuric drug, was discovered to be the best inhibitor of FABP4 with an IC50 value of 14.8 μmol/L.  Furthermore, BBR (25 μmol/L) significantly inhibited forskolin-stimulated lipolysis in 3T3-L1 cells.  Oral administration of BBR (25 or 50 mg/kg, for 4 wk) dose-dependently reduced the blood glucose level and improved glucose tolerance and insulin resistance in db/db mice.  Mol. docking revealed that the residues Ser55, Asp76, and Arg126 of FABP4 formed important interactions with BBR, which was confirmed by site-directed mutagenesis studies.  Conclusion: BBR is an inhibitor of FABP4 and a potential drug candidate for the treatment of type 2 diabetes and atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPc1KuHAqyu7Vg90H21EOLACvtfcHk0lhq330nQTf-xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslajsLbO&md5=1b74d2a1ef0044929dbc6fd35addda51</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Faps.2013.97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2013.97%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%2BY.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DJ.%2BC.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DG.%2BR.%26aulast%3DDing%26aufirst%3DH.%2BP.%26aulast%3DLi%26aufirst%3DY.%2BX.%26aulast%3DWang%26aufirst%3DH.%2BY.%26aulast%3DZhu%26aufirst%3DW.%2BL.%26aulast%3DChen%26aufirst%3DK.%2BX.%26atitle%3DBenzbromarone%252C%2520an%2520Old%2520Uricosuric%2520Drug%252C%2520Inhibits%2520Human%2520Fatty%2520Acid%2520Binding%2520Protein%25204%2520in%2520vitro%2520and%2520Lowers%2520the%2520Blood%2520Glucose%2520Level%2520in%2520db%252Fdb%2520Mice%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2013%26volume%3D34%26spage%3D1397%26epage%3D1402%26doi%3D10.1038%2Faps.2013.97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span> <span> </span><span class="NLM_article-title">Novel Fatty Acid Binding Protein 4 (FABP4) Inhibitors: Virtual Screening, Synthesis and Crystal Structure Determination</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.11.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.ejmech.2014.11.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=25461324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFWis7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2015&pages=241-250&author=H.+Caiauthor=Q.+Liuauthor=D.+Gaoauthor=T.+Wangauthor=T.+Chenauthor=G.+Yanauthor=K.+Chenauthor=Y.+Xuauthor=H.+Wangauthor=Y.+Liauthor=W.+Zhu&title=Novel+Fatty+Acid+Binding+Protein+4+%28FABP4%29+Inhibitors%3A+Virtual+Screening%2C+Synthesis+and+Crystal+Structure+Determination&doi=10.1016%2Fj.ejmech.2014.11.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Novel fatty acid binding protein 4 (FABP4) inhibitors: Virtual screening, synthesis and crystal structure determination</span></div><div class="casAuthors">Cai, Haiyan; Liu, Qiufeng; Gao, Dingding; Wang, Ting; Chen, Tiantian; Yan, Guirui; Chen, Kaixian; Xu, Yechun; Wang, Heyao; Li, Yingxia; Zhu, Weiliang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">241-250</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Fatty acid binding protein 4 (FABP4) is a potential drug target for diabetes and atherosclerosis.  For discovering new chem. entities as FABP4 inhibitors, structure-based virtual screening (VS) was performed, bioassay demonstrated that 16 of 251 tested compds. are FABP4 inhibitors, among which compd. m1 are more active than endogenous ligand linoleic acid (LA).  Based on the structure of m1, new derivs. were designed and prepd., leading to the discovery of two more potent inhibitors, compds. 9 and 10.  To further explore the binding mechanisms of these new inhibitors, we detd. the X-ray structures of the complexes of FABP4-9 and FABP4-10, which revealed similar binding conformations of the two compds.  Residue Ser53 and Arg126 formed direct hydrogen bonding with the ligands.  We also found that 10 could significantly reduce the levels of lipolysis on mouse 3T3-L1 adipocytes.  Taken together, in silico, in vitro and crystallog. data provide useful hints for future development of novel inhibitors against FABP4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE7DhX10SNGLVg90H21EOLACvtfcHk0lhq330nQTf-xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFWis7%252FL&md5=a308af0c76eb61b2d91ec79b06c0a4ce</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.11.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.11.020%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DGao%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DW.%26atitle%3DNovel%2520Fatty%2520Acid%2520Binding%2520Protein%25204%2520%2528FABP4%2529%2520Inhibitors%253A%2520Virtual%2520Screening%252C%2520Synthesis%2520and%2520Crystal%2520Structure%2520Determination%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D90%26spage%3D241%26epage%3D250%26doi%3D10.1016%2Fj.ejmech.2014.11.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hertzel, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juhlmann, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlendorf, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suttles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernlohr, D. A.</span></span> <span> </span><span class="NLM_article-title">Identification and Characterization of a Small Molecule Inhibitor of Fatty Acid Binding Proteins</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6024</span>– <span class="NLM_lpage">6031</span>, <span class="refDoi"> DOI: 10.1021/jm900720m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900720m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjtrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6024-6031&author=A.+V.+Hertzelauthor=K.+Hellbergauthor=J.+M.+Reynoldsauthor=A.+C.+Kruseauthor=B.+E.+Juhlmannauthor=A.+J.+Smithauthor=M.+A.+Sandersauthor=D.+H.+Ohlendorfauthor=J.+Suttlesauthor=D.+A.+Bernlohr&title=Identification+and+Characterization+of+a+Small+Molecule+Inhibitor+of+Fatty+Acid+Binding+Proteins&doi=10.1021%2Fjm900720m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of a Small Molecule Inhibitor of Fatty Acid Binding Proteins</span></div><div class="casAuthors">Hertzel, Ann V.; Hellberg, Kristina; Reynolds, Joseph M.; Kruse, Andrew C.; Juhlmann, Brittany E.; Smith, Anne J.; Sanders, Mark A.; Ohlendorf, Douglas H.; Suttles, Jill; Bernlohr, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6024-6031</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. disruption of the lipid carrier AFABP/aP2 in mice results in improved insulin sensitivity and protection from atherosclerosis.  Because small mol. inhibitors may be efficacious in defining the mechanism(s) of AFABP/aP2 action, a chem. library was screened and identified HTS01037 as a pharmacol. ligand capable of displacing the fluorophore 1-anilinonaphthalene 8-sulfonic acid from the lipid binding cavity.  The X-ray crystal structure of HTS01037 bound to AFABP/aP2 revealed that the ligand binds at a structurally similar position to a long-chain fatty acid.  Similar to AFABP/aP2 knockout mice, 1 inhibits lipolysis in 3T3-L1 adipocytes and reduces LPS-stimulated inflammation in cultured macrophages.  HT01037 acts as an antagonist of the protein-protein interaction between AFABP/aP2 and hormone sensitive lipase but does not activate PPARγ in macrophage or CV-1 cells.  These results identify HT01037 as an inhibitor of fatty acid binding and a competitive antagonist of protein-protein interactions mediated by AFABP/aP2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVrYehE6FSarVg90H21EOLACvtfcHk0lhq330nQTf-xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjtrjM&md5=8df9c672c8f589be20febcc34c1f266f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm900720m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900720m%26sid%3Dliteratum%253Aachs%26aulast%3DHertzel%26aufirst%3DA.%2BV.%26aulast%3DHellberg%26aufirst%3DK.%26aulast%3DReynolds%26aufirst%3DJ.%2BM.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DJuhlmann%26aufirst%3DB.%2BE.%26aulast%3DSmith%26aufirst%3DA.%2BJ.%26aulast%3DSanders%26aufirst%3DM.%2BA.%26aulast%3DOhlendorf%26aufirst%3DD.%2BH.%26aulast%3DSuttles%26aufirst%3DJ.%26aulast%3DBernlohr%26aufirst%3DD.%2BA.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520a%2520Small%2520Molecule%2520Inhibitor%2520of%2520Fatty%2520Acid%2520Binding%2520Proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6024%26epage%3D6031%26doi%3D10.1021%2Fjm900720m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ringom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uppenberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundback, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondahl, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barf, T.</span></span> <span> </span><span class="NLM_article-title">Substituted Benzylamino-6-(trifluoromethyl)pyrimidin-4(1<i>H</i>)-ones: a Novel Class of Selective Human A-FABP Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4449</span>– <span class="NLM_lpage">4452</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.06.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.bmcl.2004.06.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=15357970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Kitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4449-4452&author=R.+Ringomauthor=E.+Axenauthor=J.+Uppenbergauthor=T.+Lundbackauthor=L.+Rondahlauthor=T.+Barf&title=Substituted+Benzylamino-6-%28trifluoromethyl%29pyrimidin-4%281H%29-ones%3A+a+Novel+Class+of+Selective+Human+A-FABP+Inhibitors&doi=10.1016%2Fj.bmcl.2004.06.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted benzylamino-6-(trifluoromethyl)pyrimidin-4(1H)-ones: a novel class of selective human A-FABP inhibitors</span></div><div class="casAuthors">Ringom, Rune; Axen, Eva; Uppenberg, Jonas; Lundbaeck, Thomas; Rondahl, Lena; Barf, Tjeerd</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4449-4452</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and evaluation of human A-FABP inhibitors based on 6-(trifluoromethyl)pyrimidine-4(1H)-ones, e.g., I, is described.  Two series of compds., bearing either an amino or carbon substituent in the 2-position of the pyrimidine ring were investigated.  Modification of substituents and chain length optimization led to compds. with low micromolar activity and good selectivity for human A-FABP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLWvuxTS4SfbVg90H21EOLACvtfcHk0lgcaDD9vDz4aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Kitbs%253D&md5=7d94da2afbacfabb843edea968e4e488</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.06.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.06.058%26sid%3Dliteratum%253Aachs%26aulast%3DRingom%26aufirst%3DR.%26aulast%3DAxen%26aufirst%3DE.%26aulast%3DUppenberg%26aufirst%3DJ.%26aulast%3DLundback%26aufirst%3DT.%26aulast%3DRondahl%26aufirst%3DL.%26aulast%3DBarf%26aufirst%3DT.%26atitle%3DSubstituted%2520Benzylamino-6-%2528trifluoromethyl%2529pyrimidin-4%25281H%2529-ones%253A%2520a%2520Novel%2520Class%2520of%2520Selective%2520Human%2520A-FABP%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4449%26epage%3D4452%26doi%3D10.1016%2Fj.bmcl.2004.06.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhne, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obst-Sander, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceccarelli, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidhart, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottaviani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, M.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Selective, Dual Fatty Acid Binding Protein 4 and 5 Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5092</span>– <span class="NLM_lpage">5097</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.08.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.bmcl.2016.08.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=27658368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFems77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5092-5097&author=H.+Kuhneauthor=U.+Obst-Sanderauthor=B.+Kuhnauthor=A.+Conteauthor=S.+M.+Ceccarelliauthor=W.+Neidhartauthor=M.+G.+Rudolphauthor=G.+Ottavianiauthor=R.+Gasserauthor=S.+S.+Soauthor=S.+Liauthor=X.+Zhangauthor=L.+Gaoauthor=M.+Myers&title=Design+and+Synthesis+of+Selective%2C+Dual+Fatty+Acid+Binding+Protein+4+and+5+Inhibitors&doi=10.1016%2Fj.bmcl.2016.08.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitors</span></div><div class="casAuthors">Kuhne, Holger; Obst-Sander, Ulrike; Kuhn, Bernd; Conte, Aurelia; Ceccarelli, Simona M.; Neidhart, Werner; Rudolph, Markus G.; Ottaviani, Giorgio; Gasser, Rodolfo; So, Sung-Sau; Li, Shirley; Zhang, Xiaolei; Gao, Lin; Myers, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5092-5097</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dual inhibition of fatty acid binding proteins 4 and 5 (FABP4 and FABP5) is expected to provide beneficial effects on a no. of metabolic parameters such as insulin sensitivity and blood glucose levels and should protect against atherosclerosis.  Starting from a FABP4 selective focused screening hit, biostructure information was used to modulate the selectivity profile in the desired way and to design potent dual FABP4/5 inhibitors with good selectivity against FABP3.  With very good pharmacokinetic properties and no major safety alerts, compd. 12 was identified as a suitable tool compd. for further in vivo investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowTC5cLtieLLVg90H21EOLACvtfcHk0lgcaDD9vDz4aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFems77F&md5=10a14beab261cb39e28d89dfaaa3e669</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.071%26sid%3Dliteratum%253Aachs%26aulast%3DKuhne%26aufirst%3DH.%26aulast%3DObst-Sander%26aufirst%3DU.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DConte%26aufirst%3DA.%26aulast%3DCeccarelli%26aufirst%3DS.%2BM.%26aulast%3DNeidhart%26aufirst%3DW.%26aulast%3DRudolph%26aufirst%3DM.%2BG.%26aulast%3DOttaviani%26aufirst%3DG.%26aulast%3DGasser%26aufirst%3DR.%26aulast%3DSo%26aufirst%3DS.%2BS.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DMyers%26aufirst%3DM.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Selective%252C%2520Dual%2520Fatty%2520Acid%2520Binding%2520Protein%25204%2520and%25205%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5092%26epage%3D5097%26doi%3D10.1016%2Fj.bmcl.2016.08.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorbenko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span> <span> </span><span class="NLM_article-title">Discovery of Highly Selective Inhibitors of Human Fatty Acid Binding Protein 4 (FABP4) by Virtual Screening</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3675</span>– <span class="NLM_lpage">3679</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.04.095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.bmcl.2010.04.095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=20471252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVCmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3675-3679&author=H.+Caiauthor=G.+Yanauthor=X.+Zhangauthor=O.+Gorbenkoauthor=H.+Wangauthor=W.+Zhu&title=Discovery+of+Highly+Selective+Inhibitors+of+Human+Fatty+Acid+Binding+Protein+4+%28FABP4%29+by+Virtual+Screening&doi=10.1016%2Fj.bmcl.2010.04.095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screening</span></div><div class="casAuthors">Cai, Haiyan; Yan, Guirui; Zhang, Xiaodong; Gorbenko, Olena; Wang, Heyao; Zhu, Weiliang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3675-3679</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this study, a series of small mol. inhibitors of human FABP4 were identified through virtual screening.  Compd. 1 (I) is the most potent hit against FABP4 with a selectivity of more than 144-fold preferences over human FABP3.  In addn., MD simulation and mutation studies revealed key residues for inhibitory potency and selectivity, which provides a guideline for further drug design against obesity, diabetes and atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNCYdJr0F3mLVg90H21EOLACvtfcHk0lgcaDD9vDz4aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVCmtLs%253D&md5=78f0b24702a07af5b811de2099416ed0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.04.095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.04.095%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGorbenko%26aufirst%3DO.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520Highly%2520Selective%2520Inhibitors%2520of%2520Human%2520Fatty%2520Acid%2520Binding%2520Protein%25204%2520%2528FABP4%2529%2520by%2520Virtual%2520Screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3675%26epage%3D3679%26doi%3D10.1016%2Fj.bmcl.2010.04.095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalski, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas-Triana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bober, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipps, G. W.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, J. A.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of FABP4/5 Ameliorate Dyslipidemia but not Insulin Resistance in Mice with Diet-Induced Obesity</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1194/jlr.M012757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1194%2Fjlr.M012757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=21296956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVOlt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=646-656&author=H.+Lanauthor=C.+C.+Chengauthor=T.+J.+Kowalskiauthor=L.+Pangauthor=L.+Shanauthor=C.+C.+Chuangauthor=J.+Jacksonauthor=A.+Rojas-Trianaauthor=L.+Boberauthor=L.+Liuauthor=J.+Voigtauthor=P.+Orthauthor=X.+Yangauthor=G.+W.+Shippsauthor=J.+A.+Hedrick&title=Small-Molecule+Inhibitors+of+FABP4%2F5+Ameliorate+Dyslipidemia+but+not+Insulin+Resistance+in+Mice+with+Diet-Induced+Obesity&doi=10.1194%2Fjlr.M012757"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity</span></div><div class="casAuthors">Lan, Hong; Cheng, Cliff C.; Kowalski, Timothy J.; Pang, Ling; Shan, Lixin; Chuang, Cheng-Chi; Jackson, James; Rojas-Triana, Alberto; Bober, Loretta; Liu, Li; Voigt, Johannes; Orth, Peter; Yang, Xianshu; Shipps, Gerald W., Jr.; Hedrick, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">646-656</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">Fatty acid binding protein-4 (FABP4) and FABP5 are two closely related FA binding proteins expressed primarily in adipose tissue and/or macrophages.  The small-mol. FABP4 inhibitor BMS309403 was previously reported to improve insulin sensitivity in leptin-deficient Lepob/Lepob (ob/ob) mice.  However, this compd. was not extensively characterized in the more physiol. relevant animal model of mice with diet-induced obesity (DIO).  Here, we report the discovery and characterization of a novel series of FABP4/5 dual inhibitors represented by Compds. 1-3.  Compared with BMS309403, the compds. had significant in vitro potency toward both FABP4 and FABP5.  In cell-based assays, Compds. 2 and 3 were more potent than BMS309403 to inhibit lipolysis in 3T3-L1 adipocytes and in primary human adipocytes.  They also inhibited MCP-1 release from THP-1 macrophages as well as from primary human macrophages.  When chronically administered to DIO mice, BMS309403 and Compd. 3 reduced plasma triglyceride and free FA levels.  Compd. 3 reduced plasma free FAs at a lower dose level than BMS309403.  However, no significant change was obsd. in insulin, glucose, or glucose tolerance.  Our results indicate that the FABP4/5 inhibitors ameliorate dyslipidemia but not insulin resistance in DIO mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyZVUoUyaoRLVg90H21EOLACvtfcHk0liRzPQ_CCDjcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVOlt74%253D&md5=3e1d382cd198d4904a8d9b3974cf195d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M012757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M012757%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DC.%2BC.%26aulast%3DKowalski%26aufirst%3DT.%2BJ.%26aulast%3DPang%26aufirst%3DL.%26aulast%3DShan%26aufirst%3DL.%26aulast%3DChuang%26aufirst%3DC.%2BC.%26aulast%3DJackson%26aufirst%3DJ.%26aulast%3DRojas-Triana%26aufirst%3DA.%26aulast%3DBober%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DShipps%26aufirst%3DG.%2BW.%26aulast%3DHedrick%26aufirst%3DJ.%2BA.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520FABP4%252F5%2520Ameliorate%2520Dyslipidemia%2520but%2520not%2520Insulin%2520Resistance%2520in%2520Mice%2520with%2520Diet-Induced%2520Obesity%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2011%26volume%3D52%26spage%3D646%26epage%3D656%26doi%3D10.1194%2Fjlr.M012757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. X.</span></span> <span> </span><span class="NLM_article-title">From Hit to Lead: Structure-Based Discovery of Naphthalene-1-Sulfonamide Derivatives as Potent and Selective Inhibitors of Fatty Acid Binding Protein 4</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.ejmech.2018.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=29775936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVShtb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2018&pages=44-59&author=D.+D.+Gaoauthor=H.+X.+Douauthor=H.+X.+Suauthor=M.+M.+Zhangauthor=T.+Wangauthor=Q.+F.+Liuauthor=H.+Y.+Caiauthor=H.+P.+Dingauthor=Z.+Yangauthor=W.+L.+Zhuauthor=Y.+C.+Xuauthor=H.+Y.+Wangauthor=Y.+X.+Li&title=From+Hit+to+Lead%3A+Structure-Based+Discovery+of+Naphthalene-1-Sulfonamide+Derivatives+as+Potent+and+Selective+Inhibitors+of+Fatty+Acid+Binding+Protein+4&doi=10.1016%2Fj.ejmech.2018.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">From hit to lead: Structure-based discovery of naphthalene-1-sulfonamide derivatives as potent and selective inhibitors of fatty acid binding protein 4</span></div><div class="casAuthors">Gao, Ding-Ding; Dou, Hui-Xia; Su, Hai-Xia; Zhang, Ming-Ming; Wang, Ting; Liu, Qiu-Feng; Cai, Hai-Yan; Ding, Hai-Peng; Yang, Zhuo; Zhu, Wei-Liang; Xu, Ye-Chun; Wang, He-Yao; Li, Ying-Xia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44-59</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Fatty acid binding protein 4 (FABP4) plays a crit. role in metab. and inflammatory processes and therefore is a potential therapeutic target for immunometabolic diseases such as diabetes and atherosclerosis.  Herein, the authors reported the identification of naphthalene-1-sulfonamide derivs. as novel, potent and selective FABP4 inhibitors by applying a structure-based design strategy.  The binding affinities of compds. 16dk (2-fluoro-5-((4-methoxynaphthalene)-1-sulfonamido)benzoic acid), 16do (4-fluoro-3-((4-methoxynaphthalene)-1-sulfonamido)benzoic acid) and 16du (2,4-difluoro-5-((4-methoxynaphthalene)-1-sulfonamido)benzoic acid) to FABP4, at the mol. level, are equiv. to or even better than that of BMS309403.  The x-ray crystallog. complemented by the isothermal titrn. calorimetry studies revealed the binding mode of this series of inhibitors and the pivotal network of ordered water mols. in the binding pocket of FABP4.  Moreover, compds. 16dk and 16do showed good metabolic stabilities in liver microsomes.  Further extensive in vivo study demonstrated that 16dk and 16do exhibited a dramatic improvement in glucose and lipid metab., by decreasing fasting blood glucose and serum lipid levels, enhancing insulin sensitivity, and ameliorating hepatic steatosis in obese diabetic (db/db) mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYH7hb6xtVpbVg90H21EOLACvtfcHk0liRzPQ_CCDjcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVShtb7N&md5=ef54a76e0af9794d9a04ebe4998b4944</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DD.%2BD.%26aulast%3DDou%26aufirst%3DH.%2BX.%26aulast%3DSu%26aufirst%3DH.%2BX.%26aulast%3DZhang%26aufirst%3DM.%2BM.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%2BF.%26aulast%3DCai%26aufirst%3DH.%2BY.%26aulast%3DDing%26aufirst%3DH.%2BP.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DW.%2BL.%26aulast%3DXu%26aufirst%3DY.%2BC.%26aulast%3DWang%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DY.%2BX.%26atitle%3DFrom%2520Hit%2520to%2520Lead%253A%2520Structure-Based%2520Discovery%2520of%2520Naphthalene-1-Sulfonamide%2520Derivatives%2520as%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Fatty%2520Acid%2520Binding%2520Protein%25204%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D154%26spage%3D44%26epage%3D59%26doi%3D10.1016%2Fj.ejmech.2018.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span> <span> </span><span class="NLM_article-title">Hepatic Induction of Fatty Acid Binding Protein 4 Plays a Pathogenic Role in Sepsis in Mice</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>187</i></span>,  <span class="NLM_fpage">1059</span>– <span class="NLM_lpage">1067</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2017.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.ajpath.2017.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=28279656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvFWqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2017&pages=1059-1067&author=B.+Huauthor=Y.+Liauthor=L.+Gaoauthor=Y.+Guoauthor=Y.+Zhangauthor=X.+Chaiauthor=M.+Xuauthor=J.+Yanauthor=P.+Luauthor=S.+Renauthor=S.+Zengauthor=Y.+Liuauthor=W.+Xieauthor=M.+Huang&title=Hepatic+Induction+of+Fatty+Acid+Binding+Protein+4+Plays+a+Pathogenic+Role+in+Sepsis+in+Mice&doi=10.1016%2Fj.ajpath.2017.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic Induction of Fatty Acid Binding Protein 4 Plays a Pathogenic Role in Sepsis in Mice</span></div><div class="casAuthors">Hu, Bingfang; Li, Yujin; Gao, Li; Guo, Yan; Zhang, Yiwen; Chai, Xiaojuan; Xu, Meishu; Yan, Jiong; Lu, Peipei; Ren, Songrong; Zeng, Su; Liu, Yulan; Xie, Wen; Huang, Min</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1059-1067</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sepsis is defined as the host's deleterious systemic inflammatory response to microbial infections.  Herein, we report an essential role of the fatty acid binding protein 4 (FABP4; alias adipocyte protein 2 or aP2), a lipid-binding chaperone, in sepsis response.  Bioinformatic anal. of the Gene Expression Omnibus data sets showed the level of FABP4 was higher in the nonsurvival sepsis patients' whole blood compared to the survival cohorts.  The expression of Fabp4 was induced in a liver-specific manner in cecal ligation and puncture (CLP) and lipopolysaccharide treatment models of sepsis.  The induction of Fabp4 may have played a pathogenic role, because ectopic expression of Fabp4 in the liver sensitized mice to CLP-induced inflammatory response and worsened the animal's survival.  In contrast, pharmacol. inhibition of Fabp4 markedly alleviated the CLP responsive inflammation and tissue damage and improved survival.  We conclude that FABP4 is an important mediator of the sepsis response.  Early intervention by pharmacol. inhibition of FABP4 may help to manage sepsis in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocEZNvsJ9zwbVg90H21EOLACvtfcHk0lg5__ecsfc3UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvFWqs7o%253D&md5=42c6a37bc368e02b39cba39187a1b0aa</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2017.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2017.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChai%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DRen%26aufirst%3DS.%26aulast%3DZeng%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DM.%26atitle%3DHepatic%2520Induction%2520of%2520Fatty%2520Acid%2520Binding%2520Protein%25204%2520Plays%2520a%2520Pathogenic%2520Role%2520in%2520Sepsis%2520in%2520Mice%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2017%26volume%3D187%26spage%3D1059%26epage%3D1067%26doi%3D10.1016%2Fj.ajpath.2017.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R.</span>; <span class="NLM_string-name">Shi, M.</span>; <span class="NLM_string-name">Guo, F.</span>; <span class="NLM_string-name">Feng, Y.</span>; <span class="NLM_string-name">Feng, Y.</span>; <span class="NLM_string-name">Liu, J.</span>; <span class="NLM_string-name">Li, L.</span>; <span class="NLM_string-name">Liang, Y.</span>; <span class="NLM_string-name">Xiang, J.</span>; <span class="NLM_string-name">Lei, S.</span>; <span class="NLM_string-name">Ma, L.</span>; <span class="NLM_string-name">Fu, P.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Inhibition of Fatty Acid-Binding Protein 4 (FABP4) Protects Against Rhabdomyolysis-Induced Acute Kidney Injury</span>.  <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume">9</span>.<span class="refDoi"> DOI: 10.3389/fphar.2018.00917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.3389%2Ffphar.2018.00917" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&author=R.+Huang&author=M.+Shi&author=F.+Guo&author=Y.+Feng&author=Y.+Feng&author=J.+Liu&author=L.+Li&author=Y.+Liang&author=J.+Xiang&author=S.+Lei&author=L.+Ma&author=P.+Fu&title=Pharmacological+Inhibition+of+Fatty+Acid-Binding+Protein+4+%28FABP4%29+Protects+Against+Rhabdomyolysis-Induced+Acute+Kidney+Injury&doi=10.3389%2Ffphar.2018.00917"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.00917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.00917%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DR.%26atitle%3DPharmacological%2520Inhibition%2520of%2520Fatty%2520Acid-Binding%2520Protein%25204%2520%2528FABP4%2529%2520Protects%2520Against%2520Rhabdomyolysis-Induced%2520Acute%2520Kidney%2520Injury%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26doi%3D10.3389%2Ffphar.2018.00917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beneton, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berdini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudit, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grondin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manas, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMenamin, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potvain, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trottet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10738</span>– <span class="NLM_lpage">10749</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01427</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01427" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVCjsL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10738-10749&author=A.+J.+Woolfordauthor=P.+J.+Dayauthor=V.+Benetonauthor=V.+Berdiniauthor=J.+E.+Coyleauthor=Y.+Duditauthor=P.+Grondinauthor=P.+Huetauthor=L.+Y.+Leeauthor=E.+S.+Manasauthor=R.+L.+McMenaminauthor=C.+W.+Murrayauthor=L.+W.+Pageauthor=V.+K.+Patelauthor=F.+Potvainauthor=S.+J.+Richauthor=Y.+Sangauthor=D.+O.+Somersauthor=L.+Trottetauthor=Z.+Wanauthor=X.+Zhang&title=Fragment-Based+Approach+to+the+Development+of+an+Orally+Bioavailable+Lactam+Inhibitor+of+Lipoprotein-Associated+Phospholipase+A2+%28Lp-PLA2%29&doi=10.1021%2Facs.jmedchem.6b01427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)</span></div><div class="casAuthors">Woolford, Alison J.-A.; Day, Philip J.; Beneton, Veronique; Berdini, Valerio; Coyle, Joseph E.; Dudit, Yann; Grondin, Pascal; Huet, Pascal; Lee, Lydia Y. W.; Manas, Eric S.; McMenamin, Rachel L.; Murray, Christopher W.; Page, Lee W.; Patel, Vipulkumar K.; Potvain, Florent; Rich, Sharna J.; Sang, Yingxia; Somers, Don O.; Trottet, Lionel; Wan, Zehong; Zhang, Xiaomin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10738-10749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lp-PLA2 has been explored as a target for a no. of inflammation assocd. diseases, including cardiovascular disease and dementia.  This article describes the discovery of a new fragment derived chemotype that interacts with the active site of Lp-PLA2.  The starting fragment hit was discovered through an x-ray fragment screen and showed no activity in the bioassay (IC50 > 1 mM).  The fragment hit was optimized using a variety of structure-based drug design techniques, including virtual screening, fragment merging, and improvement of shape complementarity.  A novel series of Lp-PLA2 inhibitors was generated with low lipophilicity and a promising pharmacokinetic profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7XfI60qIk2bVg90H21EOLACvtfcHk0lg5__ecsfc3UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVCjsL7E&md5=01a8c762daf07c10f2928d41d1ff8257</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01427%26sid%3Dliteratum%253Aachs%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DBeneton%26aufirst%3DV.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DDudit%26aufirst%3DY.%26aulast%3DGrondin%26aufirst%3DP.%26aulast%3DHuet%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DL.%2BY.%26aulast%3DManas%26aufirst%3DE.%2BS.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DPage%26aufirst%3DL.%2BW.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DPotvain%26aufirst%3DF.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DSang%26aufirst%3DY.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DTrottet%26aufirst%3DL.%26aulast%3DWan%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DFragment-Based%2520Approach%2520to%2520the%2520Development%2520of%2520an%2520Orally%2520Bioavailable%2520Lactam%2520Inhibitor%2520of%2520Lipoprotein-Associated%2520Phospholipase%2520A2%2520%2528Lp-PLA2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10738%26epage%3D10749%26doi%3D10.1021%2Facs.jmedchem.6b01427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">10231</span>– <span class="NLM_lpage">10244</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01530</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01530" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWhsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=10231-10244&author=Q.+Liuauthor=F.+Huangauthor=X.+Yuanauthor=K.+Wangauthor=Y.+Zouauthor=J.+Shenauthor=Y.+Xu&title=Structure-Guided+Discovery+of+Novel%2C+Potent%2C+and+Orally+Bioavailable+Inhibitors+of+Lipoprotein-Associated+Phospholipase+A2&doi=10.1021%2Facs.jmedchem.7b01530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2</span></div><div class="casAuthors">Liu, Qiufeng; Huang, Fubao; Yuan, Xiaojing; Wang, Kai; Zou, Yi; Shen, Jianhua; Xu, Yechun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10231-10244</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipoprotein-assocd. phospholipase A2 (Lp-PLA2) is a promising therapeutic target for atherosclerosis, Alzheimer's disease, and diabetic macular edema.  Here the authors report the identification of novel sulfonamide scaffold Lp-PLA2 inhibitors derived from a relatively weak fragment.  Similarity searching on this fragment followed by mol. docking leads to the discovery of a micromolar inhibitor with a 300-fold potency improvement.  Subsequently, by the application of a structure-guided design strategy, a successful hit-to-lead optimization was achieved and a no. of Lp-PLA2 inhibitors with single-digit nanomolar potency were obtained.  After preliminary evaluation of the properties of drug-likeness in vitro and in vivo, compd. 37 (4-amino-N-(4-(4-chloro-3-(trifluoromethyl)phenoxy)-3-cyanophenyl)benzenesulfonamide) stands out from this congeneric series of inhibitors for good inhibitory activity and favorable oral bioavailability in male Sprague-Dawley rats, providing a quality candidate for further development.  The present study thus clearly demonstrates the power and advantage of integrally employing fragment screening, crystal structures detn., virtual screening, and medicinal chem. in an efficient lead discovery project, providing a good example for structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFXkQQ6O1QT7Vg90H21EOLACvtfcHk0lhDFUOrM9QXEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWhsrrP&md5=e17653f44c820a3feb70a1883ca53ff2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01530%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DStructure-Guided%2520Discovery%2520of%2520Novel%252C%2520Potent%252C%2520and%2520Orally%2520Bioavailable%2520Inhibitors%2520of%2520Lipoprotein-Associated%2520Phospholipase%2520A2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D10231%26epage%3D10244%26doi%3D10.1021%2Facs.jmedchem.7b01530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coe, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernlohr, D. A.</span></span> <span> </span><span class="NLM_article-title">Targeted Disruption of the Adipocyte Lipid-Binding Protein (AP2 Protein) Gene Impairs Fat Cell Lipolysis and Increases Cellular Fatty Acid Levels</span>. <i>J. Lipid. Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">967</span>– <span class="NLM_lpage">972</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10224167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADyaK1MXjtlahurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1999&pages=967-972&author=N.+R.+Coeauthor=M.+A.+Simpsonauthor=D.+A.+Bernlohr&title=Targeted+Disruption+of+the+Adipocyte+Lipid-Binding+Protein+%28AP2+Protein%29+Gene+Impairs+Fat+Cell+Lipolysis+and+Increases+Cellular+Fatty+Acid+Levels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels</span></div><div class="casAuthors">Coe, Natalie Ribarik; Simpson, Melanie A.; Bernlohr, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">967-972</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">Lipid Research, Inc.</span>)
        </div><div class="casAbstract">The availability of mice contg. an adipocyte lipid-binding protein (ALBP/aP2) gene disruption allowed for a direct examn. of the presumed role of lipid-binding proteins in the mobilization and trafficking of intracellular fatty acids.  Total body and epididymal fat pad wts., as well as adipose cell morphol., were unaltered in male ALBP/aP2 disrupted mice when compared to their wild-type littermates.  Anal. of adipocytes isolated from wild-type and ALBP/aP2 null mice revealed that a selective 40- and 13-fold increase in the level of the keratinocyte lipid-binding protein (KLBP) mRNA and protein, resp., accompanied the ALBP/aP2 gene disruption.  Although KLBP protein was significantly up-regulated, the total lipid-binding protein level decreased 8-fold as a consequence of the disruption.  There was no appreciable difference in the rate of fatty acid influx or esterification in adipocytes of wild-type and ALBP/aP2 null animals.  To the contrary, basal lipolysis decreased approx. 40% in ALBP/aP2 nulls as compared to wild-type littermates.  The glycerol release from isoproterenol-stimulated ALBP/aP2 null fat cells was similarly reduced by ∼35%.  Consistent with a decrease in basal efflux, the non-esterified fatty acid (NEFA) level was nearly 3-fold greater in adipocytes from ALBP/aP2 nulls as compared to wild-type animals.  The significant decrease in both basal and isoproterenol-stimulated lipolysis in adipose tissue of ALBP/aP2 null mice supports the model whereby intracellular lipid-binding proteins function as lipid chaperones, facilitating the movement of fatty acids out of the fat cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvn0G3RYr_XLVg90H21EOLACvtfcHk0lhDFUOrM9QXEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtlahurc%253D&md5=1e41d854fee4aa974db6c42e4f929d2b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoe%26aufirst%3DN.%2BR.%26aulast%3DSimpson%26aufirst%3DM.%2BA.%26aulast%3DBernlohr%26aufirst%3DD.%2BA.%26atitle%3DTargeted%2520Disruption%2520of%2520the%2520Adipocyte%2520Lipid-Binding%2520Protein%2520%2528AP2%2520Protein%2529%2520Gene%2520Impairs%2520Fat%2520Cell%2520Lipolysis%2520and%2520Increases%2520Cellular%2520Fatty%2520Acid%2520Levels%26jtitle%3DJ.%2520Lipid.%2520Res.%26date%3D1999%26volume%3D40%26spage%3D967%26epage%3D972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortlund, E. A.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for Ligand Regulation of the Fatty Acid-Binding Protein 5, Peroxisome Proliferator-Activated Receptor Beta/Delta (FABP5-PPARBeta/Delta) Signaling Pathway</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">14941</span>– <span class="NLM_lpage">14954</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.514646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1074%2Fjbc.M113.514646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=24692551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BB3MXms1Kntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=14941-14954&author=E.+H.+Armstrongauthor=D.+Goswamiauthor=P.+R.+Griffinauthor=N.+Noyauthor=E.+A.+Ortlund&title=Structural+Basis+for+Ligand+Regulation+of+the+Fatty+Acid-Binding+Protein+5%2C+Peroxisome+Proliferator-Activated+Receptor+Beta%2FDelta+%28FABP5-PPARBeta%2FDelta%29+Signaling+Pathway&doi=10.1074%2Fjbc.M113.514646"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="#"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=&md5=9874b665cc7a056b8e2f928dd3112440</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.514646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.514646%26sid%3Dliteratum%253Aachs%26aulast%3DArmstrong%26aufirst%3DE.%2BH.%26aulast%3DGoswami%26aufirst%3DD.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26aulast%3DNoy%26aufirst%3DN.%26aulast%3DOrtlund%26aufirst%3DE.%2BA.%26atitle%3DStructural%2520Basis%2520for%2520Ligand%2520Regulation%2520of%2520the%2520Fatty%2520Acid-Binding%2520Protein%25205%252C%2520Peroxisome%2520Proliferator-Activated%2520Receptor%2520Beta%252FDelta%2520%2528FABP5-PPARBeta%252FDelta%2529%2520Signaling%2520Pathway%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D14941%26epage%3D14954%26doi%3D10.1074%2Fjbc.M113.514646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J. H.</span></span> <span> </span><span class="NLM_article-title">Upgrade of Macromolecular Crystallography Beamline BL17U1 at SSRF</span>. <i>Nucl. Sci. Tech.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">681</span>– <span class="NLM_lpage">687</span>, <span class="refDoi"> DOI: 10.1007/s41365-018-0398-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1007%2Fs41365-018-0398-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=681-687&author=Q.+S.+Wangauthor=K.+H.+Zhangauthor=Y.+Cuiauthor=Z.+J.+Wangauthor=Q.+Y.+Panauthor=K.+Liuauthor=B.+Sunauthor=H.+Zhouauthor=M.+J.+Liauthor=Q.+Xuauthor=C.+Y.+Xuauthor=F.+Yuauthor=J.+H.+He&title=Upgrade+of+Macromolecular+Crystallography+Beamline+BL17U1+at+SSRF&doi=10.1007%2Fs41365-018-0398-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs41365-018-0398-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs41365-018-0398-9%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%2BS.%26aulast%3DZhang%26aufirst%3DK.%2BH.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%2BJ.%26aulast%3DPan%26aufirst%3DQ.%2BY.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DSun%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DC.%2BY.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DHe%26aufirst%3DJ.%2BH.%26atitle%3DUpgrade%2520of%2520Macromolecular%2520Crystallography%2520Beamline%2520BL17U1%2520at%2520SSRF%26jtitle%3DNucl.%2520Sci.%2520Tech.%26date%3D2018%26volume%3D29%26spage%3D681%26epage%3D687%26doi%3D10.1007%2Fs41365-018-0398-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minor, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cymborowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otwinowski, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chruszcz, M.</span></span> <span> </span><span class="NLM_article-title">HKL-3000: the Integration of Data Reduction and Structure Solution–from Diffraction Images to an Initial Model in Minutes</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">859</span>– <span class="NLM_lpage">866</span>, <span class="refDoi"> DOI: 10.1107/S0907444906019949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1107%2FS0907444906019949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=16855301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVWksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=859-866&author=W.+Minorauthor=M.+Cymborowskiauthor=Z.+Otwinowskiauthor=M.+Chruszcz&title=HKL-3000%3A+the+Integration+of+Data+Reduction+and+Structure+Solution%E2%80%93from+Diffraction+Images+to+an+Initial+Model+in+Minutes&doi=10.1107%2FS0907444906019949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">HKL-3000: the integration of data reduction and structure solution - from diffraction images to an initial model in minutes</span></div><div class="casAuthors">Minor, Wladek; Cymborowski, Marcin; Otwinowski, Zbyszek; Chruszcz, Maksymilian</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">859-866</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A new approach that integrates data collection, data redn., phasing and model building significantly accelerates the process of structure detn. and on av. minimizes the no. of data sets and synchrotron time required for structure soln.  Initial testing of the HKL-3000 system (the beta version was named HKL-2000_ph) with more than 140 novel structure detns. has proven its high value for MAD/SAD expts.  The heuristics for choosing the best computational strategy at different data resoln. limits of phasing signal and crystal diffraction are being optimized.  The typical end result is an interpretable electron-d. map with a partially built structure and, in some cases, an almost complete refined model.  The current development is oriented towards very fast structure soln. in order to provide feedback during the diffraction expt.  Work is also proceeding towards improving the quality of phasing calcn. and model building.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0c0DYtjFP7rVg90H21EOLACvtfcHk0lgX1GRTY-JkAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVWksL8%253D&md5=2cd2fe288f954837abb4acae4c008a2f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1107%2FS0907444906019949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444906019949%26sid%3Dliteratum%253Aachs%26aulast%3DMinor%26aufirst%3DW.%26aulast%3DCymborowski%26aufirst%3DM.%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DChruszcz%26aufirst%3DM.%26atitle%3DHKL-3000%253A%2520the%2520Integration%2520of%2520Data%2520Reduction%2520and%2520Structure%2520Solution%25E2%2580%2593from%2520Diffraction%2520Images%2520to%2520an%2520Initial%2520Model%2520in%2520Minutes%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D859%26epage%3D866%26doi%3D10.1107%2FS0907444906019949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser Crystallographic Software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+Crystallographic+Software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lgX1GRTY-JkAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520Crystallographic%2520Software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Coot: Model-Building Tools for Molecular Graphics</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+Model-Building+Tools+for+Molecular+Graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lgX1GRTY-JkAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520Model-Building%2520Tools%2520for%2520Molecular%2520Graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauter, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span> <span> </span><span class="NLM_article-title">PHENIX: Building New Software for Automated Crystallographic Structure Determination</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1948</span>– <span class="NLM_lpage">1954</span>, <span class="refDoi"> DOI: 10.1107/S0907444902016657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1107%2FS0907444902016657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=12393927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVCksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=1948-1954&author=P.+D.+Adamsauthor=R.+W.+Grosse-Kunstleveauthor=L.+W.+Hungauthor=T.+R.+Ioergerauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+J.+Readauthor=J.+C.+Sacchettiniauthor=N.+K.+Sauterauthor=T.+C.+Terwilliger&title=PHENIX%3A+Building+New+Software+for+Automated+Crystallographic+Structure+Determination&doi=10.1107%2FS0907444902016657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: building new software for automated crystallographic structure determination</span></div><div class="casAuthors">Adams, Paul D.; Grosse-Kunstleve, Ralf W.; Hung, Li Wei; Ioerger, Thomas R.; McCoy, Airlie J.; Moriarty, Nigel W.; Read, Randy J.; Sacchettini, James C.; Sauter, Nicholas K.; Terwilliger, Thomas C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">D58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1948-1954</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">Structural genomics seeks to rapidly expand the no. of protein structures to ext. the max. amt. of information from genomic sequence databases.  The advent of several large-scale projects worldwide leads to many new challenges in the field of crystallog. macromol. structure detn.  A novel software package, called PHENIX (Python-based Hierarchical Environment for Integrated Xtallog.), is therefore being developed.  This new software will provide the necessary algorithms to proceed from reduced intensity data to a refined mol. model and to facilitate structure soln. for both the novice and expert crystallographer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOtuUfHXPmCbVg90H21EOLACvtfcHk0lgLaqkiLbBe_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVCksbc%253D&md5=9a3b66e1f7d064183f7a9ce108cb4e5e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0907444902016657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444902016657%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DSauter%26aufirst%3DN.%2BK.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26atitle%3DPHENIX%253A%2520Building%2520New%2520Software%2520for%2520Automated%2520Crystallographic%2520Structure%2520Determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2002%26volume%3D58%26spage%3D1948%26epage%3D1954%26doi%3D10.1107%2FS0907444902016657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurian, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prendergast, F. G.</span></span> <span> </span><span class="NLM_article-title">Affinity of Fatty Acid for rRat Intestinal Fatty Acid Binding Protein: Further Examination</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">3865</span>– <span class="NLM_lpage">3874</span>, <span class="refDoi"> DOI: 10.1021/bi952589y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi952589y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADyaK28XhsVGnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1996&pages=3865-3874&author=E.+Kurianauthor=W.+R.+Kirkauthor=F.+G.+Prendergast&title=Affinity+of+Fatty+Acid+for+rRat+Intestinal+Fatty+Acid+Binding+Protein%3A+Further+Examination&doi=10.1021%2Fbi952589y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Affinity of fatty acid for rat intestinal fatty acid binding protein: further examination</span></div><div class="casAuthors">Kurian, E.; Kirk, W. R.; Prendergast, F. G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3865-74</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The enhancement of the fluorescence quantum yield of 1,8-anilinonaphthalenesulfonic acid (ANS) upon binding to intestinal fatty acid protein (I-FABP) was exploited to devise an assay for free I-FABP.  With this assay, competition for free I-FABP between ANS and fatty acids was monitored and values for the dissocn. consts. (KFA) of fatty acids was for I-FABP were extd..  These consts. were obtained for the I-FABP ligands oleic acid, arachidonic acid, and palmitic acid.  In addn., the dependence of KFA for oleic acid upon temp. and at two pH values was measured.  From these data, the van't Hoff enthalpy of oleic acid binding was calcd..  This enthalpy was compared with the enthalpies of binding obtained directly from titrn. calorimetry.  The expts. with the fluorescence-based assay generate values of KFA disagreeing with older values obtained from calorimetry and other methods.  The calorimetric data were analyzed with a view to improving the technique involved in subtraction of a "ref." diln. of the ligand into soln. in the absence of the protein.  Thus, "cor." titrns. were obtained which could be fitted to values of KFA more in agreement with the values the authors detd. via the fluorescence-based assay than were the older literature values.  The new values for KFA also agree substantially with values derived using a complementary assay technique, one measuring the concn. of free fatty acid, that was developed recently by Richieri et al. [Richieri et al. (1995) J. Biol. Chem. 270, 15076-15084].  The values of ΔH°, ΔS°, and ΔCp° for fatty acid binding obtained in this work were compared with those the authors found in earlier work with ANS binding to I-FABP [Kirk et al. (1996) Biophys. J. 70, 69-83].  The interpretation of the origin of the thermodn. changes for ANS binding in the earlier work is here substantiated and extended to include an evaluation in phys. terms of the interaction of I-FABP with fatty acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5RbkwayP7XbVg90H21EOLACvtfcHk0lgLaqkiLbBe_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhsVGnsLo%253D&md5=af841cc11327ad918dadb4ce6ede2143</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fbi952589y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi952589y%26sid%3Dliteratum%253Aachs%26aulast%3DKurian%26aufirst%3DE.%26aulast%3DKirk%26aufirst%3DW.%2BR.%26aulast%3DPrendergast%26aufirst%3DF.%2BG.%26atitle%3DAffinity%2520of%2520Fatty%2520Acid%2520for%2520rRat%2520Intestinal%2520Fatty%2520Acid%2520Binding%2520Protein%253A%2520Further%2520Examination%26jtitle%3DBiochemistry%26date%3D1996%26volume%3D35%26spage%3D3865%26epage%3D3874%26doi%3D10.1021%2Fbi952589y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuatrecasas, P.</span></span> <span> </span><span class="NLM_article-title">Estimation of Hormone Receptor Affinity by Competitive Displacement of Labeled Ligand–Effect of Concentration of Receptor and of Labeled Ligand</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(75)90564-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2F0006-291X%2875%2990564-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=170929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADyaE28Xht1Oitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1975&pages=687-692&author=S.+Jacobsauthor=K.+J.+Changauthor=P.+Cuatrecasas&title=Estimation+of+Hormone+Receptor+Affinity+by+Competitive+Displacement+of+Labeled+Ligand%E2%80%93Effect+of+Concentration+of+Receptor+and+of+Labeled+Ligand&doi=10.1016%2F0006-291X%2875%2990564-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of hormone receptor affinity by competitive displacement of labeled ligand.  Effect of concentration of receptor and of labeled ligand</span></div><div class="casAuthors">Jacobs, Steven; Chang, Kwen-Jen; Cuatrecasas, Pedro</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">687-92</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">For both epidermal growth factor and insulin [9004-10-8], the concn. of unlabeled hormone at which a given fraction of bound labeled hormone was displaced from placenta membranes was increased by increasing the labeled hormone concn. or the placenta membrane concn.  The ligand concn. at which 50% of the bound, labeled ligand was displaced gave spuriously high ests. of the dissocn. consts. for these hormones if measured at high labeled hormone or binding site concns.  These considerations also have important implications for comparative studies of receptors in different species or metabolic states, and for the feasibility of radioreceptor assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8z6dWv8LiyLVg90H21EOLACvtfcHk0lgLaqkiLbBe_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28Xht1Oitg%253D%253D&md5=60db9b12656f6ac2f121e2f4737c9156</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2875%2990564-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252875%252990564-1%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DK.%2BJ.%26aulast%3DCuatrecasas%26aufirst%3DP.%26atitle%3DEstimation%2520of%2520Hormone%2520Receptor%2520Affinity%2520by%2520Competitive%2520Displacement%2520of%2520Labeled%2520Ligand%25E2%2580%2593Effect%2520of%2520Concentration%2520of%2520Receptor%2520and%2520of%2520Labeled%2520Ligand%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1975%26volume%3D66%26spage%3D687%26epage%3D692%26doi%3D10.1016%2F0006-291X%2875%2990564-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupyan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaus, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerutti, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krilov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+Y.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS3%3A+A+Force+Field+Providing+Broad+Coverage+of+Drug-like+Small+Molecules+and+Proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0lgbYrP8nax5Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS3%253A%2520A%2520Force%2520Field%2520Providing%2520Broad%2520Coverage%2520of%2520Drug-like%2520Small%2520Molecules%2520and%2520Proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frisch, M. J.</span>; <span class="NLM_string-name">Trucks, G. W.</span>; <span class="NLM_string-name">Schlegel, H. B.</span>; <span class="NLM_string-name">Scuseria, G. E.</span>; <span class="NLM_string-name">Robb, M. A.</span>; <span class="NLM_string-name">Cheeseman, J. R.</span>; <span class="NLM_string-name">Scalmani, G.</span>; <span class="NLM_string-name">Barone, V.</span>; <span class="NLM_string-name">Mennucci, B.</span>; <span class="NLM_string-name">Petersson, G. A.</span>; <span class="NLM_string-name">Nakatsuji, H.</span>; <span class="NLM_string-name">Caricato, M.</span>; <span class="NLM_string-name">Li, X.</span>; <span class="NLM_string-name">Hratchian, H. P.</span>; <span class="NLM_string-name">Izmaylov, A. F.</span>; <span class="NLM_string-name">Bloino, J.</span>; <span class="NLM_string-name">Zheng, G.</span>; <span class="NLM_string-name">Sonnenberg, J. L.</span>; <span class="NLM_string-name">Hada, M.</span>; <span class="NLM_string-name">Ehara, M.</span>; <span class="NLM_string-name">Toyota, K.</span>; <span class="NLM_string-name">Fukuda, R.</span>; <span class="NLM_string-name">Hasegawa, J.</span>; <span class="NLM_string-name">Ishida, M.</span>; <span class="NLM_string-name">Nakajima, T.</span>; <span class="NLM_string-name">Honda, Y.</span>; <span class="NLM_string-name">Kitao, O.</span>; <span class="NLM_string-name">Nakai, H.</span>; <span class="NLM_string-name">Vreven, T.</span>; <span class="NLM_string-name">Montgomery, J. A.,  Jr.</span>; <span class="NLM_string-name">Peralta, J. E.</span>; <span class="NLM_string-name">Ogliaro, F.</span>; <span class="NLM_string-name">Bearpark, M.</span>; <span class="NLM_string-name">Heyd, J. J.</span>; <span class="NLM_string-name">Brothers, E.</span>; <span class="NLM_string-name">Kudin, K. N.</span>; <span class="NLM_string-name">Staroverov, V. N.</span>; <span class="NLM_string-name">Keith, T.</span>; <span class="NLM_string-name">Kobayashi, R.</span>; <span class="NLM_string-name">Normand, J.</span>; <span class="NLM_string-name">Raghavachari, K.</span>; <span class="NLM_string-name">Rendell, A.</span>; <span class="NLM_string-name">Burant, J. C.</span>; <span class="NLM_string-name">Iyengar, S. S.</span>; <span class="NLM_string-name">Tomasi, J.</span>; <span class="NLM_string-name">Cossi, M.</span>; <span class="NLM_string-name">Rega, N.</span>; <span class="NLM_string-name">Millam, J. M.</span>; <span class="NLM_string-name">Klene, M.</span>; <span class="NLM_string-name">Knox, J. E.</span>; <span class="NLM_string-name">Cross, J. B.</span>; <span class="NLM_string-name">Bakken, V.</span>; <span class="NLM_string-name">Adamo, C.</span>; <span class="NLM_string-name">Jaramillo, J.</span>; <span class="NLM_string-name">Gomperts, R.</span>; <span class="NLM_string-name">Stratmann, R. E.</span>; <span class="NLM_string-name">Yazyev, O.</span>; <span class="NLM_string-name">Austin, A. J.</span>; <span class="NLM_string-name">Cammi, R.</span>; <span class="NLM_string-name">Pomelli, C.</span>; <span class="NLM_string-name">Ochterski, J. W.</span>; <span class="NLM_string-name">Martin, R. L.</span>; <span class="NLM_string-name">Morokuma, K.</span>; <span class="NLM_string-name">Zakrzewski, V. G.</span>; <span class="NLM_string-name">Voth, G. A.</span>; <span class="NLM_string-name">Salvador, P.</span>; <span class="NLM_string-name">Dannenberg, J. J.</span>; <span class="NLM_string-name">Dapprich, S.</span>; <span class="NLM_string-name">Daniels, A. D.</span>; <span class="NLM_string-name">Farkas, O.</span>; <span class="NLM_string-name">Foresman, J. B.</span>; <span class="NLM_string-name">Ortiz, J. V.</span>; <span class="NLM_string-name">Cioslowski, J.</span>; <span class="NLM_string-name">Fox, D. J.</span></span> <i>Gaussian 09</i><i>,</i> rev. D.01; <span class="NLM_publisher-name">Gaussian, Inc.</span>: <span class="NLM_publisher-loc">Wallingford, CT</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+J.+Frisch&author=G.+W.+Trucks&author=H.+B.+Schlegel&author=G.+E.+Scuseria&author=M.+A.+Robb&author=J.+R.+Cheeseman&author=G.+Scalmani&author=V.+Barone&author=B.+Mennucci&author=G.+A.+Petersson&author=H.+Nakatsuji&author=M.+Caricato&author=X.+Li&author=H.+P.+Hratchian&author=A.+F.+Izmaylov&author=J.+Bloino&author=G.+Zheng&author=J.+L.+Sonnenberg&author=M.+Hada&author=M.+Ehara&author=K.+Toyota&author=R.+Fukuda&author=J.+Hasegawa&author=M.+Ishida&author=T.+Nakajima&author=Y.+Honda&author=O.+Kitao&author=H.+Nakai&author=T.+Vreven&author=J.+A.+Montgomery&author=J.+E.+Peralta&author=F.+Ogliaro&author=M.+Bearpark&author=J.+J.+Heyd&author=E.+Brothers&author=K.+N.+Kudin&author=V.+N.+Staroverov&author=T.+Keith&author=R.+Kobayashi&author=J.+Normand&author=K.+Raghavachari&author=A.+Rendell&author=J.+C.+Burant&author=S.+S.+Iyengar&author=J.+Tomasi&author=M.+Cossi&author=N.+Rega&author=J.+M.+Millam&author=M.+Klene&author=J.+E.+Knox&author=J.+B.+Cross&author=V.+Bakken&author=C.+Adamo&author=J.+Jaramillo&author=R.+Gomperts&author=R.+E.+Stratmann&author=O.+Yazyev&author=A.+J.+Austin&author=R.+Cammi&author=C.+Pomelli&author=J.+W.+Ochterski&author=R.+L.+Martin&author=K.+Morokuma&author=V.+G.+Zakrzewski&author=G.+A.+Voth&author=P.+Salvador&author=J.+J.+Dannenberg&author=S.+Dapprich&author=A.+D.+Daniels&author=O.+Farkas&author=J.+B.+Foresman&author=J.+V.+Ortiz&author=J.+Cioslowski&author=D.+J.+Fox&title=Gaussian+09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DFrisch%26aufirst%3DM.%2BJ.%26jtitle%3DGaussian%252009%26pub%3DGaussian%252C%2520Inc%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheatham, T. E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohlke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, K. M.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onufriev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmerling, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, R. J.</span></span> <span> </span><span class="NLM_article-title">The Amber Biomolecular Simulation Programs</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1668</span>– <span class="NLM_lpage">1688</span>, <span class="refDoi"> DOI: 10.1002/jcc.20290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1002%2Fjcc.20290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=16200636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=1668-1688&author=D.+A.+Caseauthor=T.+E.+Cheathamauthor=T.+Dardenauthor=H.+Gohlkeauthor=R.+Luoauthor=K.+M.+Merzauthor=A.+Onufrievauthor=C.+Simmerlingauthor=B.+Wangauthor=R.+J.+Woods&title=The+Amber+Biomolecular+Simulation+Programs&doi=10.1002%2Fjcc.20290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The amber biomolecular simulation programs</span></div><div class="casAuthors">Case, David A.; Cheatham, Thomas E., III; Darden, Tom; Gohlke, Holger; Luo, Ray; Merz, Kenneth M., Jr.; Onufriev, Alexey; Simmerling, Carlos; Wang, Bing; Woods, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1668-1688</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The authors describe the development, current features, and some directions for future development of the Amber package of computer programs.  This package evolved from a program that was constructed in the late 1970s to do Assisted Model Building with Energy Refinement, and now contains a group of programs embodying a no. of powerful tools of modern computational chem., focused on mol. dynamics and free energy calcns. of proteins, nucleic acids, and carbohydrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre0tZP_Umb7rVg90H21EOLACvtfcHk0lgbYrP8nax5Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbM&md5=93be29ff894bab96c783d24e9886c7d0</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20290%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26aulast%3DCheatham%26aufirst%3DT.%2BE.%26aulast%3DDarden%26aufirst%3DT.%26aulast%3DGohlke%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DR.%26aulast%3DMerz%26aufirst%3DK.%2BM.%26aulast%3DOnufriev%26aufirst%3DA.%26aulast%3DSimmerling%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWoods%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520Amber%2520Biomolecular%2520Simulation%2520Programs%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2005%26volume%3D26%26spage%3D1668%26epage%3D1688%26doi%3D10.1002%2Fjcc.20290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maier, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasavajhala, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickstrom, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmerling, C.</span></span> <span> </span><span class="NLM_article-title">ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3696</span>– <span class="NLM_lpage">3713</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00255</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00255" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFequ7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=3696-3713&author=J.+A.+Maierauthor=C.+Martinezauthor=K.+Kasavajhalaauthor=L.+Wickstromauthor=K.+E.+Hauserauthor=C.+Simmerling&title=ff14SB%3A+Improving+the+Accuracy+of+Protein+Side+Chain+and+Backbone+Parameters+from+ff99SB&doi=10.1021%2Facs.jctc.5b00255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB</span></div><div class="casAuthors">Maier, James A.; Martinez, Carmenza; Kasavajhala, Koushik; Wickstrom, Lauren; Hauser, Kevin E.; Simmerling, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3696-3713</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. mechanics is powerful for its speed in atomistic simulations, but an accurate force field is required.  The Amber ff99SB force field improved protein secondary structure balance and dynamics from earlier force fields like ff99, but weaknesses in side chain rotamer and backbone secondary structure preferences have been identified.  Here, we performed a complete refit of all amino acid side chain dihedral parameters, which had been carried over from ff94.  The training set of conformations included multidimensional dihedral scans designed to improve transferability of the parameters.  Improvement in all amino acids was obtained as compared to ff99SB.  Parameters were also generated for alternate protonation states of ionizable side chains.  Av. errors in relative energies of pairs of conformations were under 1.0 kcal/mol as compared to QM, reduced 35% from ff99SB.  We also took the opportunity to make empirical adjustments to the protein backbone dihedral parameters as compared to ff99SB.  Multiple small adjustments of φ and ψ parameters were tested against NMR scalar coupling data and secondary structure content for short peptides.  The best results were obtained from a phys. motivated adjustment to the φ rotational profile that compensates for lack of ff99SB QM training data in the β-ppII transition region.  Together, these backbone and side chain modifications (hereafter called ff14SB) not only better reproduced their benchmarks, but also improved secondary structure content in small peptides and reprodn. of NMR χ1 scalar coupling measurements for proteins in soln.  We also discuss the Amber ff12SB parameter set, a preliminary version of ff14SB that includes most of its improvements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgntnN9ES97rVg90H21EOLACvtfcHk0lhAg-TK45Jk1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFequ7rN&md5=7b803577b3b6912cc6750cfbd356596e</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00255%26sid%3Dliteratum%253Aachs%26aulast%3DMaier%26aufirst%3DJ.%2BA.%26aulast%3DMartinez%26aufirst%3DC.%26aulast%3DKasavajhala%26aufirst%3DK.%26aulast%3DWickstrom%26aufirst%3DL.%26aulast%3DHauser%26aufirst%3DK.%2BE.%26aulast%3DSimmerling%26aufirst%3DC.%26atitle%3Dff14SB%253A%2520Improving%2520the%2520Accuracy%2520of%2520Protein%2520Side%2520Chain%2520and%2520Backbone%2520Parameters%2520from%2520ff99SB%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2015%26volume%3D11%26spage%3D3696%26epage%3D3713%26doi%3D10.1021%2Facs.jctc.5b00255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollman, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span></span> <span> </span><span class="NLM_article-title">Automatic Atom Type and Bond Type Perception in Molecular Mechanical Calculations</span>. <i>J. Mol. Graphics Modell.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">260</span>, <span class="refDoi"> DOI: 10.1016/j.jmgm.2005.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.jmgm.2005.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=16458552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1Gis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=247-260&author=J.+Wangauthor=W.+Wangauthor=P.+A.+Kollmanauthor=D.+A.+Case&title=Automatic+Atom+Type+and+Bond+Type+Perception+in+Molecular+Mechanical+Calculations&doi=10.1016%2Fj.jmgm.2005.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Automatic atom type and bond type perception in molecular mechanical calculations</span></div><div class="casAuthors">Wang, Junmei; Wang, Wei; Kollman, Peter A.; Case, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-260</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">In mol. mechanics (MM) studies, atom types and/or bond types of mols. are needed to det. prior to energy calcns.  The authors present here an automatic algorithm of perceiving atom types that are defined in a description table, and an automatic algorithm of assigning bond types just based on at. connectivity.  The algorithms have been implemented in a new module of the AMBER packages.  This auxiliary module, antechamber (roughly meaning "before AMBER"), can be applied to generate necessary inputs of leap-the AMBER program to generate topologies for minimization, mol. dynamics, etc., for most org. mols.  The algorithms behind the manipulations may be useful for other mol. mech. packages as well as applications that need to designate atom types and bond types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqizj6F18nBYbVg90H21EOLACvtfcHk0lhAg-TK45Jk1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1Gis7g%253D&md5=8031a21d2784d5dea12e70868522aa61</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.jmgm.2005.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmgm.2005.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DAutomatic%2520Atom%2520Type%2520and%2520Bond%2520Type%2520Perception%2520in%2520Molecular%2520Mechanical%2520Calculations%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2006%26volume%3D25%26spage%3D247%26epage%3D260%26doi%3D10.1016%2Fj.jmgm.2005.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hess, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bekker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berendsen, H. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraaije, J.</span></span> <span> </span><span class="NLM_article-title">LINCS: A Linear Constraint Solver for Molecular Simulations</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1463</span>– <span class="NLM_lpage">1472</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1002%2F%28SICI%291096-987X%28199709%2918%3A12%3C1463%3A%3AAID-JCC4%3E3.0.CO%3B2-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADyaK2sXlvV2nu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=1463-1472&author=B.+Hessauthor=H.+Bekkerauthor=H.+J.+C.+Berendsenauthor=J.+Fraaije&title=LINCS%3A+A+Linear+Constraint+Solver+for+Molecular+Simulations&doi=10.1002%2F%28SICI%291096-987X%28199709%2918%3A12%3C1463%3A%3AAID-JCC4%3E3.0.CO%3B2-H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">LINCS: a linear constraint solver for molecular simulations</span></div><div class="casAuthors">Hess, Berk; Bekker, Henk; Berendsen, Herman J. C.; Fraaije, Johannes G. E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1463-1472</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">We present a new LINear Constraint Solver (LINCS) for mol. simulations with bond constraints using the enzyme lysozyme and a 32-residue peptide as test systems.  The algorithm is inherently stable, as the constraints themselves are reset instead of derivs. of the constraints, thereby eliminating drift.  Although the derivation of the algorithm is presented in terms of matrixes, no matrix matrix multiplications are needed and only the nonzero matrix elements have to be stored, making the method useful for very large mols.  At the same accuracy, the LINCS algorithm is 3-4 times faster than the SHAKE algorithm.  Parallelization of the algorithm is straightforward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk6h4pdV0Nx7Vg90H21EOLACvtfcHk0lhAg-TK45Jk1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvV2nu7g%253D&md5=890f8af0d2ca1f65aa93db5a3a0bacf2</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%28199709%2918%3A12%3C1463%3A%3AAID-JCC4%3E3.0.CO%3B2-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%2528199709%252918%253A12%253C1463%253A%253AAID-JCC4%253E3.0.CO%253B2-H%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DB.%26aulast%3DBekker%26aufirst%3DH.%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26aulast%3DFraaije%26aufirst%3DJ.%26atitle%3DLINCS%253A%2520A%2520Linear%2520Constraint%2520Solver%2520for%2520Molecular%2520Simulations%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1997%26volume%3D18%26spage%3D1463%26epage%3D1472%26doi%3D10.1002%2F%28SICI%291096-987X%28199709%2918%3A12%3C1463%3A%3AAID-JCC4%3E3.0.CO%3B2-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">York, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, L.</span></span> <span> </span><span class="NLM_article-title">Particle Mesh Ewald - an N.Log(N) Method for Ewald Sums in Large Systems</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">10089</span>– <span class="NLM_lpage">10092</span>, <span class="refDoi"> DOI: 10.1063/1.464397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1063%2F1.464397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADyaK3sXks1Ohsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1993&pages=10089-10092&author=T.+Dardenauthor=D.+Yorkauthor=L.+Pedersen&title=Particle+Mesh+Ewald+-+an+N.Log%28N%29+Method+for+Ewald+Sums+in+Large+Systems&doi=10.1063%2F1.464397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Particle mesh Ewald: an N·log(N) method for Ewald sums in large systems</span></div><div class="casAuthors">Darden, Tom; York, Darrin; Pedersen, Lee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">10089-92</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">An N·log(N) method for evaluating electrostatic energies and forces of large periodic systems is presented.  The method is based on interpolation of the reciprocal space Ewald sums and evaluation of the resulting convolution using fast Fourier transforms.  Timings and accuracies are presented for three large cryst. ionic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDIJavf7AZPbVg90H21EOLACvtfcHk0ljxyh7fTXxMCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1Ohsr0%253D&md5=3c9f230bd01b7b714fd096d4d2e755f6</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1063%2F1.464397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.464397%26sid%3Dliteratum%253Aachs%26aulast%3DDarden%26aufirst%3DT.%26aulast%3DYork%26aufirst%3DD.%26aulast%3DPedersen%26aufirst%3DL.%26atitle%3DParticle%2520Mesh%2520Ewald%2520-%2520an%2520N.Log%2528N%2529%2520Method%2520for%2520Ewald%2520Sums%2520in%2520Large%2520Systems%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1993%26volume%3D98%26spage%3D10089%26epage%3D10092%26doi%3D10.1063%2F1.464397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Essmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkowitz, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, L. G.</span></span> <span> </span><span class="NLM_article-title">A Smooth Particle Mesh Ewald Method</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">8577</span>– <span class="NLM_lpage">8593</span>, <span class="refDoi"> DOI: 10.1063/1.470117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1063%2F1.470117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADyaK2MXptlehtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1995&pages=8577-8593&author=U.+Essmannauthor=L.+Pereraauthor=M.+L.+Berkowitzauthor=T.+Dardenauthor=H.+Leeauthor=L.+G.+Pedersen&title=A+Smooth+Particle+Mesh+Ewald+Method&doi=10.1063%2F1.470117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A smooth particle mesh Ewald method</span></div><div class="casAuthors">Essmann, Ulrich; Perera, Lalith; Berkowitz, Max L.; Darden, Tom; Lee, Hsing; Pedersen, Lee G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8577-93</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">The previously developed particle mesh Ewald method is reformulated in terms of efficient B-spline interpolation of the structure factors.  This reformulation allows a natural extension of the method to potentials of the form 1/rp with p ≥ 1.  Furthermore, efficient calcn. of the virial tensor follows.  Use of B-splines in the place of Lagrange interpolation leads to analytic gradients as well as a significant improvement in the accuracy.  The authors demonstrate that arbitrary accuracy can be achieved, independent of system size N, at a cost that scales as N log(N).  For biomol. systems with many thousands of atoms and this method permits the use of Ewald summation at a computational cost comparable to that of a simple truncation method of 10 Å or less.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Bp1XlSY32LVg90H21EOLACvtfcHk0ljxyh7fTXxMCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptlehtrw%253D&md5=092a679dd3bee08da28df41e302383a7</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1063%2F1.470117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.470117%26sid%3Dliteratum%253Aachs%26aulast%3DEssmann%26aufirst%3DU.%26aulast%3DPerera%26aufirst%3DL.%26aulast%3DBerkowitz%26aufirst%3DM.%2BL.%26aulast%3DDarden%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DPedersen%26aufirst%3DL.%2BG.%26atitle%3DA%2520Smooth%2520Particle%2520Mesh%2520Ewald%2520Method%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1995%26volume%3D103%26spage%3D8577%26epage%3D8593%26doi%3D10.1063%2F1.470117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pronk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjelkmar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apostolov, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirts, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasson, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Spoel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindahl, E.</span></span> <span> </span><span class="NLM_article-title">GROMACS 4.5: a High-Throughput and Highly Parallel Open Source Molecular Simulation Toolkit</span>. <i>Bioinformatics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">845</span>– <span class="NLM_lpage">854</span>, <span class="refDoi"> DOI: 10.1093/bioinformatics/btt055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1093%2Fbioinformatics%2Fbtt055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=23407358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFWmsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2013&pages=845-854&author=S.+Pronkauthor=S.+Pallauthor=R.+Schulzauthor=P.+Larssonauthor=P.+Bjelkmarauthor=R.+Apostolovauthor=M.+R.+Shirtsauthor=J.+C.+Smithauthor=P.+M.+Kassonauthor=D.+van+der%0ASpoelauthor=B.+Hessauthor=E.+Lindahl&title=GROMACS+4.5%3A+a+High-Throughput+and+Highly+Parallel+Open+Source+Molecular+Simulation+Toolkit&doi=10.1093%2Fbioinformatics%2Fbtt055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit</span></div><div class="casAuthors">Pronk, Sander; Pall, Szilard; Schulz, Roland; Larsson, Per; Bjelkmar, Paer; Apostolov, Rossen; Shirts, Michael R.; Smith, Jeremy C.; Kasson, Peter M.; van der Spoel, David; Hess, Berk; Lindahl, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">845-854</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Motivation: Mol. simulation has historically been a low-throughput technique, but faster computers and increasing amts. of genomic and structural data are changing this by enabling large-scale automated simulation of, for instance, many conformers or mutants of biomols. with or without a range of ligands.  At the same time, advances in performance and scaling now make it possible to model complex biomol. interaction and function in a manner directly testable by expt.  These applications share a need for fast and efficient software that can be deployed on massive scale in clusters, web servers, distributed computing or cloud resources.  Results: Here, we present a range of new simulation algorithms and features developed during the past 4 years, leading up to the GROMACS 4.5 software package.  The software now automatically handles wide classes of biomols., such as proteins, nucleic acids and lipids, and comes with all commonly used force fields for these mols. built-in.  GROMACS supports several implicit solvent models, as well as new free-energy algorithms, and the software now uses multithreading for efficient parallelization even on low-end systems, including windows-based workstations.  Together with hand-tuned assembly kernels and state-of-the-art parallelization, this provides extremely high performance and cost efficiency for high-throughput as well as massively parallel simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr71lQgYMm017Vg90H21EOLACvtfcHk0ljxyh7fTXxMCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFWmsrg%253D&md5=4b25fd6ab4e33725ae56b5da63f4ad68</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbtt055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbtt055%26sid%3Dliteratum%253Aachs%26aulast%3DPronk%26aufirst%3DS.%26aulast%3DPall%26aufirst%3DS.%26aulast%3DSchulz%26aufirst%3DR.%26aulast%3DLarsson%26aufirst%3DP.%26aulast%3DBjelkmar%26aufirst%3DP.%26aulast%3DApostolov%26aufirst%3DR.%26aulast%3DShirts%26aufirst%3DM.%2BR.%26aulast%3DSmith%26aufirst%3DJ.%2BC.%26aulast%3DKasson%26aufirst%3DP.%2BM.%26aulast%3Dvan%2Bder%2BSpoel%26aufirst%3DD.%26aulast%3DHess%26aufirst%3DB.%26aulast%3DLindahl%26aufirst%3DE.%26atitle%3DGROMACS%25204.5%253A%2520a%2520High-Throughput%2520and%2520Highly%2520Parallel%2520Open%2520Source%2520Molecular%2520Simulation%2520Toolkit%26jtitle%3DBioinformatics%26date%3D2013%26volume%3D29%26spage%3D845%26epage%3D854%26doi%3D10.1093%2Fbioinformatics%2Fbtt055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skolnik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span> <span> </span><span class="NLM_article-title">Towards Prediction of in vivo Intestinal Absorption Using a 96-well Caco-2 Assay</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">3246</span>– <span class="NLM_lpage">3265</span>, <span class="refDoi"> DOI: 10.1002/jps.22080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1002%2Fjps.22080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=20166204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSrsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2010&pages=3246-3265&author=S.+Skolnikauthor=X.+Linauthor=J.+Wangauthor=X.+H.+Chenauthor=T.+Heauthor=B.+Zhang&title=Towards+Prediction+of+in+vivo+Intestinal+Absorption+Using+a+96-well+Caco-2+Assay&doi=10.1002%2Fjps.22080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay</span></div><div class="casAuthors">Skolnik, Suzanne; Lin, Xuena; Wang, Jianling; Chen, Xiao-Hui; He, Timothy; Zhang, Bailin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3246-3265</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">We systematically validated a robust 96-well Caco-2 assay via an extended set of 93 marketed drugs with diverse transport mechanisms and quantified by LC/MS/MS, to investigate its predictive utility while dealing with challenging discovery compds.  Utilizing nonlinear fit, the validation led to a good correlation (R2 = 0.76) between absorptive permeability, log Papp(A-B), from in vitro Caco-2 assay and reported human fraction of dose absorbed.  We obsd. that paracellular compds. could be flagged by log Papp(A-B) (<-5.5 cm/s) and physicochem. property space (c log P < 1).  Of 8000 Novartis discovery compds. examd. 13% were subject to low recovery (<30%).  Compd. loss was investigated by comparing cell monolayer and artificial membrane, while 0.5% bovine serum albumin (in both donor and acceptor compartments) was utilized to improve recovery.  The second focus of this study was to investigate the advantages and limitations of the current Caco-2 assay for predicting in vivo intestinal absorption.  Caco-2 measurements for compds. with high aq. soly. and low in vitro metabolic clearance were compared to 88 in vivo rat bioavailability studies.  Despite the challenges posed by discovery compds. with suboptimal physicochem. properties, Caco-2 data successfully projected low intestinal absorption.  This platform sets the stage for mechanistically evaluating compds. towards improving in vitro-in vivo correlations. © 2010 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci 99:3246-3265, 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqio9beUaITm7Vg90H21EOLACvtfcHk0lieaLc8sDgyrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSrsr0%253D&md5=43f7e35544e7b4a348271a53e958d3b9</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fjps.22080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22080%26sid%3Dliteratum%253Aachs%26aulast%3DSkolnik%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%2BH.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DB.%26atitle%3DTowards%2520Prediction%2520of%2520in%2520vivo%2520Intestinal%2520Absorption%2520Using%2520a%252096-well%2520Caco-2%2520Assay%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2010%26volume%3D99%26spage%3D3246%26epage%3D3265%26doi%3D10.1002%2Fjps.22080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-Long  He</span>, <span class="hlFld-ContribAuthor ">Meng-Ting  Chen</span>, <span class="hlFld-ContribAuthor ">Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Ming-Ming  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying-Xia  Li</span>, <span class="hlFld-ContribAuthor ">He-Yao  Wang</span>, <span class="hlFld-ContribAuthor ">Ning  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Development of FABP4/5 inhibitors with potential therapeutic effect on type 2 Diabetes Mellitus. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>224 </em>, 113720. <a href="https://doi.org/10.1016/j.ejmech.2021.113720" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113720%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BFABP4%25252F5%252Binhibitors%252Bwith%252Bpotential%252Btherapeutic%252Beffect%252Bon%252Btype%252B2%252BDiabetes%252BMellitus%26aulast%3DHe%26aufirst%3DYu-Long%26date%3D2021%26volume%3D224%26spage%3D113720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T.  Laurita</span>, <span class="hlFld-ContribAuthor ">I.  Pappalardo</span>, <span class="hlFld-ContribAuthor ">L.  Chiummiento</span>, <span class="hlFld-ContribAuthor ">R.  D'Orsi</span>, <span class="hlFld-ContribAuthor ">M.  Funicello</span>, <span class="hlFld-ContribAuthor ">A.  Santarsiero</span>, <span class="hlFld-ContribAuthor ">M.  Marsico</span>, <span class="hlFld-ContribAuthor ">V.  Infantino</span>, <span class="hlFld-ContribAuthor ">S.  Todisco</span>, <span class="hlFld-ContribAuthor ">P.  Lupattelli</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of new methoxy derivatives of trans 2,3-diaryl-2,3-dihydrobenzofurans and evaluation of their anti-inflammatory activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>10 </em>, 128264. <a href="https://doi.org/10.1016/j.bmcl.2021.128264" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128264%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252Bnew%252Bmethoxy%252Bderivatives%252Bof%252Btrans%252B2%25252C3-diaryl-2%25252C3-dihydrobenzofurans%252Band%252Bevaluation%252Bof%252Btheir%252Banti-inflammatory%252Bactivity%26aulast%3DLaurita%26aufirst%3DT.%26date%3D2021%26volume%3D10%26spage%3D128264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Blake T.  Riley</span>, <span class="hlFld-ContribAuthor ">Stephanie A.  Wankowicz</span>, <span class="hlFld-ContribAuthor ">Saulo H. P.  Oliveira</span>, <span class="hlFld-ContribAuthor ">Gydo C. P.  Zundert</span>, <span class="hlFld-ContribAuthor ">Daniel W.  Hogan</span>, <span class="hlFld-ContribAuthor ">James S.  Fraser</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Keedy</span>, <span class="hlFld-ContribAuthor ">Henry  Bedem</span>. </span><span class="cited-content_cbyCitation_article-title">qFit
              3: Protein and ligand multiconformer modeling for X‐ray crystallographic and single‐particle
              cryo‐EM
              density maps. </span><span class="cited-content_cbyCitation_journal-name">Protein Science</span><span> <strong>2021,</strong> <em>30 </em>
                                    (1)
                                     , 270-285. <a href="https://doi.org/10.1002/pro.4001" title="DOI URL">https://doi.org/10.1002/pro.4001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pro.4001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpro.4001%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Science%26atitle%3DqFit%252B3%25253A%252BProtein%252Band%252Bligand%252Bmulticonformer%252Bmodeling%252Bfor%252BX%2525E2%252580%252590ray%252Bcrystallographic%252Band%252Bsingle%2525E2%252580%252590particle%252Bcryo%2525E2%252580%252590EM%252Bdensity%252Bmaps%26aulast%3DRiley%26aufirst%3DBlake%2BT.%26date%3D2021%26date%3D2020%26volume%3D30%26issue%3D1%26spage%3D270%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Crystal structures of FABP4 in complex with fragment <b>1</b> determined at pH 6.5 and 7.5 (PDB codes: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJW">6LJW</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJX">6LJX</a>). (A) An overlay of three binding poses of <b>1</b> shown in B–D. (B–D) A representation of Pose 1 (B), Pose 2 (C), and Pose3 (D). Residues interacting with <b>1</b> are shown as gray sticks, and H-bonds are represented by black dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. An overlay of representative conformations of fragment <b>1</b> extracted from the MD trajectory (gray sticks) with three poses shown in the crystal structures (Pose 1: cyan sticks; Pose 2: yellow sticks; Pose 3: pink sticks). RMSDs of backbone atoms of FABP4 (black) and all atoms of fragment <b>1</b> (red) vs the simulation time were calculated based on the MD trajectory.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Design of new inhibitors based on an overlay of different binding poses of fragment <b>1</b>. (B) An overlay of the binding poses of compound <b>3</b> (purple sticks) and fragment <b>1</b> by superimposing crystal structures of FABP4 in complex with <b>3</b> and <b>1</b>. (C) Interactions of <b>3</b> with the surrounding residues revealed by the crystal structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJS">6LJS</a>). Residues are shown as cyan sticks, and H-bonds are represented by black dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystal structures of FABP4 in complex with compounds <b>3</b> (purple, A; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJS">6LJS</a>), <b>6</b> (green, B; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJT">6LJT</a>), <b>11</b> (magenta, C; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJU">6LJU</a>), and <b>17</b> (yellow, D; PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJV">6LJV</a>). Sites P1, P2, and P3 show the optimization directions. The ligand binding pocket is presented by molecular surface. The dashed lines indicate H-bonds between compounds and residues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of BMS309403 and compound <b>17</b> on the secretion of pro-inflammatory cytokines, MCP-1 (A) and IL-6 (B), in the LPS-stimulated THP-1 macrophages. MCP-1 and IL-6 were measured by the ELISA Kits. Data are given as mean ± SEM of three independent experiments. Statistical analysis is performed by one-way ANOVA. *<i>P</i> < 0.05, ***<i>P</i> < 0.001 vs LPS group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of BMS309403 and compound <b>17</b> on the release of free glycerol from the forskolin-stimulated mature 3T3-L1 adipocytes. Data are given as mean ± SEM of at least three independent experiments, and each is performed in triplicate. Statistical analysis is performed by one-way ANOVA. *<i>P</i> < 0.05, ***<i>P</i> < 0.001 vs control group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of BMS309403 (50 mg/kg) and compound <b>17</b> (50 mg/kg) on the secretion of pro-inflammatory cytokines, MCP-1 (A) and IL-6 (B), in the serum of LPS-treated C57BL/6J mice (<i>n</i> = 8 mice/group). MCP-1 and IL-6 were measured by the ELISA Kits. Data are given as mean ± SEM, and statistical analysis is performed by one-way ANOVA. ** <i>P</i> < 0.01, ***<i>P</i> < 0.001 vs LPS group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0008.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>17</b> effectively protects mice from the LPS-induced multiorgan damage. (A) BMS309403 (25 mg/kg) or compound <b>17</b> (10, 25, and 50 mg/kg) administration decreases the level of tissue damage biomarkers (<i>n</i> = 8 mice/group). (B) BMS309403 and compound <b>17</b> show an efficient protection against the LPS-induced injury in different organs. (H&E staining, magnification: ×200) Each image is representative of four mice at least. Data are given as mean ± SEM, and statistical analysis is performed by one-way ANOVA. * <i>P</i> < 0.05, ** <i>P</i> < 0.01, ***<i>P</i> < 0.001, each vs LPS group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis<sup>a</sup> of Compounds <b>3</b>–<b>5</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O, 15 h, 95 °C; (b) Fe, HAc, NH<sub>4</sub>Cl, EtOH, 50 °C; (c) Pd<sub>2</sub>(dba)<sub>3</sub>, BINAP, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 6 h, 90 °C; (d) NaOH, MeOH, H<sub>2</sub>O, 1 h, 70 °C; (e) NaH, THF, 2 h, 75 °C.</p></p></figure><figure data-id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis<sup>a</sup> of Compounds <b>6</b>–<b>10</b> and <b>14</b>–<b>19</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O, 15 h, 95 °C; (b) Fe, HAc, NH<sub>4</sub>Cl, EtOH, 50 °C; (c) Pd<sub>2</sub>(dba)<sub>3</sub>, BINAP, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 6 h, 90 °C; (d) NaOH, MeOH, H<sub>2</sub>O, 1 h, 70 °C.</p></p></figure><figure data-id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/medium/jm9b02107_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis<sup>a</sup> of Compounds <b>11</b>–<b>13</b> and <b>20</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b02107/20200416/images/large/jm9b02107_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02107&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, H<sub>2</sub>O, 15 h, 95 °C; (b) Fe, HAc, NH<sub>4</sub>Cl, EtOH, 50 °C; (c) Pd<sub>2</sub>(dba)<sub>3</sub>, BINAP, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 6 h, 90 °C; (d) NaOH, MeOH, H<sub>2</sub>O, 1 h, 70 °C; (f) C<sub>2</sub>H<sub>5</sub>I or CH<sub>3</sub>I, CH<sub>3</sub>CN, 2 d, 85 °C.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76854" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76854" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 55 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furuhashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotamisligil, G. S.</span></span> <span> </span><span class="NLM_article-title">Fatty Acid-Binding Proteins: Role in Metabolic Diseases and Potential as Drug Targets</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">489</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1038/nrd2589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1038%2Fnrd2589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=18511927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVOjsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=489-503&author=M.+Furuhashiauthor=G.+S.+Hotamisligil&title=Fatty+Acid-Binding+Proteins%3A+Role+in+Metabolic+Diseases+and+Potential+as+Drug+Targets&doi=10.1038%2Fnrd2589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets</span></div><div class="casAuthors">Furuhashi, Masato; Hotamisligil, Goekhan S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">489-503</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Fatty acid-binding proteins (FABPs) are members of a highly conserved family of proteins central to lipid-mediated processes and related metabolic and immune response pathways.  Here, the authors review the functions of individual FABP family members, emphasizing the potential of FABP inhibition as a novel strategy in the treatment of disorders of the metabolic syndrome including obesity, diabetes and atherosclerosis.  Lipids are vital components of many biol. processes and crucial in the pathogenesis of numerous common diseases, but the specific mechanisms coupling intracellular lipids to biol. targets and signaling pathways are not well understood.  This is particularly the case for cells burdened with high lipid storage, trafficking and signaling capacity such as adipocytes and macrophages.  Here, we discuss the central role of lipid chaperones - the fatty acid-binding proteins (FABPs) - in lipid-mediated biol. processes and systemic metabolic homeostasis through the regulation of diverse lipid signals, and highlight their therapeutic significance.  Pharmacol. agents that modify FABP function may provide tissue-specific or cell-type-specific control of lipid signaling pathways, inflammatory responses and metabolic regulation, potentially providing a new class of drugs for diseases such as obesity, diabetes and atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-rosC-QIORrVg90H21EOLACvtfcHk0lhsT1T3tEyEsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVOjsbk%253D&md5=494faeda8bfb0f50433c86f36ea1cebd</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd2589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2589%26sid%3Dliteratum%253Aachs%26aulast%3DFuruhashi%26aufirst%3DM.%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26atitle%3DFatty%2520Acid-Binding%2520Proteins%253A%2520Role%2520in%2520Metabolic%2520Diseases%2520and%2520Potential%2520as%2520Drug%2520Targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D489%26epage%3D503%26doi%3D10.1038%2Fnrd2589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kazemi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigenaga, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunfeld, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feingold, K. R.</span></span> <span> </span><span class="NLM_article-title">Adipocyte Fatty Acid-Binding Protein Expression and Lipid Accumulation are Increased during Activation of Murine Macrophages by Loll-like Receptor Agonists</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1220</span>– <span class="NLM_lpage">1224</span>, <span class="refDoi"> DOI: 10.1161/01.ATV.0000159163.52632.1b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1161%2F01.ATV.0000159163.52632.1b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=15705927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksVWru7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=1220-1224&author=M.+R.+Kazemiauthor=C.+M.+McDonaldauthor=J.+K.+Shigenagaauthor=C.+Grunfeldauthor=K.+R.+Feingold&title=Adipocyte+Fatty+Acid-Binding+Protein+Expression+and+Lipid+Accumulation+are+Increased+during+Activation+of+Murine+Macrophages+by+Loll-like+Receptor+Agonists&doi=10.1161%2F01.ATV.0000159163.52632.1b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Adipocyte Fatty Acid-Binding Protein Expression and Lipid Accumulation Are Increased During Activation of Murine Macrophages by Toll-Like Receptor Agonists</span></div><div class="casAuthors">Kazemi, Mahmood R.; McDonald, Carol M.; Shigenaga, Judy K.; Grunfeld, Carl; Feingold, Kenneth R.</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1220-1224</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: Toll-like receptors (TLRs) recognize pathogens and mediate signaling pathways important for host defense.  Recent studies implicate TLR polymorphisms in atherosclerosis risk in humans.  Adipocyte fatty acid-binding protein (aP2) is present in macrophages and has an important role in atherosclerotic plaque development.  The authors investigated aP2 expression in RAW 264.7 cells treated with lipopolysaccharide (LPS) and other TLR agonists and assessed lipid accumulation in these activated murine macrophages.  Methods and Results: Stimulation with LPS, a TLR4 ligand, resulted in a 56-fold increase in aP2 mRNA expression, and zymosan, a TLR2 ligand, induced an ≈1500-fold increase.  Polyinosine:polycytidylic acid (poly I:C), a TLR3 ligand, led to a 9-fold increase.  Levels of aP2 protein were significantly increased in LPS or zymosan-treated macrophages compared with control or poly I:C-treated cells.  In addn., the cholesteryl ester content of LPS or zymosan-treated macrophages was ≈5-fold greater in the presence of low-d. lipoprotein, and triglyceride content was ≈2-fold greater in the absence of exogenous lipid than control or poly I:C-treated cells.  Conclusions: Expression of macrophage aP2 is induced on TLR activation and parallels increases in cholesteryl ester and triglyceride levels.  These results provide a mol. link between the known roles of TLR and aP2 in foam cell formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptBLDcxuT-WLVg90H21EOLACvtfcHk0lgve1Ghw6jdlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksVWru7g%253D&md5=f2037e606412e286078e8ffb9c418aad</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1161%2F01.ATV.0000159163.52632.1b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.ATV.0000159163.52632.1b%26sid%3Dliteratum%253Aachs%26aulast%3DKazemi%26aufirst%3DM.%2BR.%26aulast%3DMcDonald%26aufirst%3DC.%2BM.%26aulast%3DShigenaga%26aufirst%3DJ.%2BK.%26aulast%3DGrunfeld%26aufirst%3DC.%26aulast%3DFeingold%26aufirst%3DK.%2BR.%26atitle%3DAdipocyte%2520Fatty%2520Acid-Binding%2520Protein%2520Expression%2520and%2520Lipid%2520Accumulation%2520are%2520Increased%2520during%2520Activation%2520of%2520Murine%2520Macrophages%2520by%2520Loll-like%2520Receptor%2520Agonists%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D1220%26epage%3D1224%26doi%3D10.1161%2F01.ATV.0000159163.52632.1b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boord, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babaev, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linton, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotamisligil, G. S.</span></span> <span> </span><span class="NLM_article-title">Combined Adipocyte-Macrophage Fatty Acid-Binding Protein Deficiency Improves Metabolism, Atherosclerosis, and Survival in Apolipoprotein E-Deficient Mice</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">1492</span>– <span class="NLM_lpage">1498</span>, <span class="refDoi"> DOI: 10.1161/01.CIR.0000141735.13202.B6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1161%2F01.CIR.0000141735.13202.B6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=15353487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt12isro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2004&pages=1492-1498&author=J.+B.+Boordauthor=K.+Maedaauthor=L.+Makowskiauthor=V.+R.+Babaevauthor=S.+Fazioauthor=M.+F.+Lintonauthor=G.+S.+Hotamisligil&title=Combined+Adipocyte-Macrophage+Fatty+Acid-Binding+Protein+Deficiency+Improves+Metabolism%2C+Atherosclerosis%2C+and+Survival+in+Apolipoprotein+E-Deficient+Mice&doi=10.1161%2F01.CIR.0000141735.13202.B6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Combined Adipocyte-Macrophage Fatty Acid-Binding Protein Deficiency Improves Metabolism, Atherosclerosis, and Survival in Apolipoprotein E-Deficient Mice</span></div><div class="casAuthors">Boord, Jeffrey B.; Maeda, Kazuhisa; Makowski, Liza; Babaev, Vladimir R.; Fazio, Sergio; Linton, MacRae F.; Hotamisligil, Goekhan S.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1492-1498</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The adipocyte fatty acid-binding protein (FABP) aP2 is expressed by adipocytes and macrophages and modulates insulin resistance, glucose and lipid metab., and atherosclerosis.  Insulin sensitivity is improved in obese but not in lean aP2-deficient mice.  A second fatty acid-binding protein, mal1, also is expressed in adipocytes and macrophages, and mal1 deficiency produces similar effects on insulin resistance.  The authors tested the hypothesis that combined aP2 and mal1 deficiency would produce synergistic effects on metab. and reduce atherosclerosis in apolipoprotein E-deficient (apoE-/-) mice.  Male and female apoE-/- mice null for both aP2 and mal1 (3KO) and apoE-/- controls were fed a low-fat chow diet for 16 or 56 wk.  Lean 3KO mice had significantly lower serum cholesterol and triglycerides as well as improved insulin and glucose tolerance as compared with controls.  Anal. of atherosclerotic lesions in the 3KO mice showed dramatic redns. in both early (20 wk) and late-stage (60 wk) atherosclerosis.  Strikingly, survival in the 3KO mice was improved by 67% as compared with apoE-/- controls when challenged with the Western diet for 1 yr.  Combined aP2 and mal1 deficiency improved glucose and lipid metab., reduced atherosclerosis, and improved survival in apoE-/- mice, making these proteins important therapeutic targets for the prevention of the cardiovascular consequences of the metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKCkXOJjrOe7Vg90H21EOLACvtfcHk0lgve1Ghw6jdlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt12isro%253D&md5=0dfe2919de968bd36dcc75cdfdd89fe6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.0000141735.13202.B6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.0000141735.13202.B6%26sid%3Dliteratum%253Aachs%26aulast%3DBoord%26aufirst%3DJ.%2BB.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DMakowski%26aufirst%3DL.%26aulast%3DBabaev%26aufirst%3DV.%2BR.%26aulast%3DFazio%26aufirst%3DS.%26aulast%3DLinton%26aufirst%3DM.%2BF.%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26atitle%3DCombined%2520Adipocyte-Macrophage%2520Fatty%2520Acid-Binding%2520Protein%2520Deficiency%2520Improves%2520Metabolism%252C%2520Atherosclerosis%252C%2520and%2520Survival%2520in%2520Apolipoprotein%2520E-Deficient%2520Mice%26jtitle%3DCirculation%26date%3D2004%26volume%3D110%26spage%3D1492%26epage%3D1498%26doi%3D10.1161%2F01.CIR.0000141735.13202.B6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoutte, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span> <span> </span><span class="NLM_article-title">Adipocyte Fatty Acid-Binding Protein Modulates Inflammatory Responses in Macrophages through a Positive Feedback Loop Involving c-Jun NH2-Terminal Kinases and Activator Protein-1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">10273</span>– <span class="NLM_lpage">10280</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.097907</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1074%2Fjbc.M109.097907" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=20145251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFajt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=10273-10280&author=X.+Huiauthor=H.+Liauthor=Z.+Zhouauthor=K.+S.+Lamauthor=Y.+Xiaoauthor=D.+Wuauthor=K.+Dingauthor=Y.+Wangauthor=P.+M.+Vanhoutteauthor=A.+Xu&title=Adipocyte+Fatty+Acid-Binding+Protein+Modulates+Inflammatory+Responses+in+Macrophages+through+a+Positive+Feedback+Loop+Involving+c-Jun+NH2-Terminal+Kinases+and+Activator+Protein-1&doi=10.1074%2Fjbc.M109.097907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Adipocyte Fatty Acid-binding Protein Modulates Inflammatory Responses in Macrophages through a Positive Feedback Loop Involving c-Jun NH2-terminal Kinases and Activator Protein-1</span></div><div class="casAuthors">Hui, Xiaoyan; Li, Huiying; Zhou, Zhiguang; Lam, Karen S. L.; Xiao, Yang; Wu, Donghai; Ding, Ke; Wang, Yu; Vanhoutte, Paul M.; Xu, Aimin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">10273-10280</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Adipocyte fatty acid-binding protein (A-FABP) has emerged as an important mediator of inflammation in macrophages.  Macrophage-selective ablation of A-FABP alone is sufficient to prevent the development of high cholesterol diet-induced atherosclerosis in apoE-deficient mice.  However, the precise mechanisms whereby A-FABP modulates inflammation remain elusive.  Here, we report that A-FABP forms a finely tuned pos. loop between JNK and activator protein-1 (AP-1) to exacerbate lipopolysaccharide (LPS)-induced inflammatory responses in macrophages.  Real time PCR and luciferase reporter anal. showed that LPS induced A-FABP expression through transcriptional activation.  This effect was mediated by JNK, which promoted the recruitment of c-Jun to a highly conserved AP-1 consensus binding motif located within the proximal region of the A-FABP promoter.  LPS-induced transactivation of the A-FABP gene was diminished by either pharmacol. inhibition of JNK or knocking down c-Jun or by mutating the AP-1 recognition site within the proximal region (-122 to -116 bp) of the A-FABP promoter.  Conversely, the LPS-evoked phosphorylation of JNK, activation of AP-1, and prodn. of pro-inflammatory cytokines were markedly attenuated by pharmacol. or genetic suppression of A-FABP in macrophages.  Furthermore, the LPS-induced elevation in A-FABP expression could also be prevented by the selective A-FABP inhibitor BMS309403.  These findings support the notion that pharmacol. inhibition of A-FABP represents a valid strategy for treating inflammation-related disorders such as atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCUuBwP0ozdLVg90H21EOLACvtfcHk0lgve1Ghw6jdlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFajt7o%253D&md5=78b82b46f5a98ebf9bd755fbdd702316</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.097907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.097907%26sid%3Dliteratum%253Aachs%26aulast%3DHui%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DLam%26aufirst%3DK.%2BS.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DVanhoutte%26aufirst%3DP.%2BM.%26aulast%3DXu%26aufirst%3DA.%26atitle%3DAdipocyte%2520Fatty%2520Acid-Binding%2520Protein%2520Modulates%2520Inflammatory%2520Responses%2520in%2520Macrophages%2520through%2520a%2520Positive%2520Feedback%2520Loop%2520Involving%2520c-Jun%2520NH2-Terminal%2520Kinases%2520and%2520Activator%2520Protein-1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D10273%26epage%3D10280%26doi%3D10.1074%2Fjbc.M109.097907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hotamisligil, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernlohr, D. A.</span></span> <span> </span><span class="NLM_article-title">Metabolic Functions of FABPs Mechanisms and Therapeutic Implications</span>. <i>Nat. Rev. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">592</span>– <span class="NLM_lpage">605</span>, <span class="refDoi"> DOI: 10.1038/nrendo.2015.122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1038%2Fnrendo.2015.122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=26260145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlGgtL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=592-605&author=G.+S.+Hotamisligilauthor=D.+A.+Bernlohr&title=Metabolic+Functions+of+FABPs+Mechanisms+and+Therapeutic+Implications&doi=10.1038%2Fnrendo.2015.122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic functions of FABPs-mechanisms and therapeutic implications</span></div><div class="casAuthors">Hotamisligil, Gokhan S.; Bernlohr, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Endocrinology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">592-605</span>CODEN:
                <span class="NLM_cas:coden">NREABD</span>;
        ISSN:<span class="NLM_cas:issn">1759-5029</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Intracellular and extracellular interactions with proteins enables the functional and mechanistic diversity of lipids.  Fatty acid-binding proteins (FABPs) were originally described as intracellular proteins that can affect lipid fluxes, metab. and signalling within cells.  As the functions of this protein family have been further elucidated, it has become evident that they are crit. mediators of metab. and inflammatory processes, both locally and systemically, and therefore are potential therapeutic targets for immunometabolic diseases.  In particular, genetic deficiency and small mol.-mediated inhibition of FABP4 (also known as aP2) and FABP5 can potently improve glucose homeostasis and reduce atherosclerosis in mouse models.  Further research has shown that in addn. to their intracellular roles, some FABPs are found outside the cells, and FABP4 undergoes regulated, vesicular secretion.  The circulating form of FABP4 has crucial hormonal functions in systemic metab.  In this Review we discuss the roles and regulation of both intracellular and extracellular FABP actions, highlighting new insights that might direct drug discovery efforts and opportunities for management of chronic metabolic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDNhNF5UCKRLVg90H21EOLACvtfcHk0lgUkwQ2V_XiDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlGgtL3K&md5=2fa6080f65e70d3cb8729e5a75acec56</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrendo.2015.122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrendo.2015.122%26sid%3Dliteratum%253Aachs%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26aulast%3DBernlohr%26aufirst%3DD.%2BA.%26atitle%3DMetabolic%2520Functions%2520of%2520FABPs%2520Mechanisms%2520and%2520Therapeutic%2520Implications%26jtitle%3DNat.%2520Rev.%2520Endocrinol.%26date%3D2015%26volume%3D11%26spage%3D592%26epage%3D605%26doi%3D10.1038%2Fnrendo.2015.122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson
Zimmer, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyckes, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernlohr, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. C.</span></span> <span> </span><span class="NLM_article-title">Fatty Acid Binding Proteins Stabilize Leukotriene A4: Competition with Arachidonic Acid but not Other Lipoxygenase Products</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">2138</span>– <span class="NLM_lpage">2144</span>, <span class="refDoi"> DOI: 10.1194/jlr.M400240-JLR200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1194%2Fjlr.M400240-JLR200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=15342681" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=2138-2144&author=J.+S.+Dickinson%0AZimmerauthor=D.+F.+Dyckesauthor=D.+A.+Bernlohrauthor=R.+C.+Murphy&title=Fatty+Acid+Binding+Proteins+Stabilize+Leukotriene+A4%3A+Competition+with+Arachidonic+Acid+but+not+Other+Lipoxygenase+Products&doi=10.1194%2Fjlr.M400240-JLR200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M400240-JLR200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M400240-JLR200%26sid%3Dliteratum%253Aachs%26aulast%3DDickinson%2BZimmer%26aufirst%3DJ.%2BS.%26aulast%3DDyckes%26aufirst%3DD.%2BF.%26aulast%3DBernlohr%26aufirst%3DD.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BC.%26atitle%3DFatty%2520Acid%2520Binding%2520Proteins%2520Stabilize%2520Leukotriene%2520A4%253A%2520Competition%2520with%2520Arachidonic%2520Acid%2520but%2520not%2520Other%2520Lipoxygenase%2520Products%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2004%26volume%3D45%26spage%3D2138%26epage%3D2144%26doi%3D10.1194%2Fjlr.M400240-JLR200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brittingham, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suttles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotamisligil, G. S.</span></span> <span> </span><span class="NLM_article-title">The Fatty Acid-Binding Protein, AP2, Coordinates Macrophage Cholesterol Trafficking and Inflammatory Activity. Macrophage Expression of AP2 Impacts Peroxisome Proliferator-Activated Receptor Gamma and IkappaB Kinase Activities</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">12888</span>– <span class="NLM_lpage">12895</span>, <span class="refDoi"> DOI: 10.1074/jbc.M413788200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1074%2Fjbc.M413788200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=15684432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislygsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=12888-12895&author=L.+Makowskiauthor=K.+C.+Brittinghamauthor=J.+M.+Reynoldsauthor=J.+Suttlesauthor=G.+S.+Hotamisligil&title=The+Fatty+Acid-Binding+Protein%2C+AP2%2C+Coordinates+Macrophage+Cholesterol+Trafficking+and+Inflammatory+Activity.+Macrophage+Expression+of+AP2+Impacts+Peroxisome+Proliferator-Activated+Receptor+Gamma+and+IkappaB+Kinase+Activities&doi=10.1074%2Fjbc.M413788200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The Fatty Acid-binding Protein, aP2, Coordinates Macrophage Cholesterol Trafficking and Inflammatory Activity: Macrophage Expression of aP2 Impacts Peroxisome Proliferator-activated Receptor γ and IκB Kinase Activities</span></div><div class="casAuthors">Makowski, Liza; Brittingham, Katherine C.; Reynolds, Joseph M.; Suttles, Jill; Hotamisligil, Goekhan S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">12888-12895</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Fatty acid-binding proteins are cytosolic fatty acid chaperones, and the adipocyte isoform, aP2, plays an important role in obesity and glucose metab.  Recently, this protein has been detected in macrophages where it strongly contributes to the development of atherosclerosis.  Here, the authors investigated the role of aP2 in macrophage biol. and the mol. mechanisms underlying its actions.  The authors demonstrate that aP2-deficient macrophages display defects in cholesterol accumulation and alterations in pro-inflammatory responsiveness.  Deficiency of aP2 alters the lipid compn. in macrophages and enhances peroxisome proliferator-activated receptor γ activity, leading to elevated CD36 expression and enhanced uptake of modified low d. lipoprotein.  The increased peroxisome proliferator-activated receptor γ activity in aP2-deficient macrophages is also accompanied by a significant stimulation of the liver X receptor α-ATP-binding cassette transporter A1-mediated cholesterol efflux pathway.  In parallel, aP2-deficient macrophages display reduced IκB kinase and NF-κB activity, resulting in suppression of inflammatory function including reduced cyclooxygenase-2 and inducible nitric-oxide synthase expression and impaired prodn. of inflammatory cytokines.  The authors' results demonstrate that aP2 regulates two central mol. pathways to coordinate macrophage cholesterol trafficking and inflammatory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT1ikDVjKwa7Vg90H21EOLACvtfcHk0lgUkwQ2V_XiDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislygsLw%253D&md5=afdd4582ef13bb4b76c1ed518489ccc3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M413788200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M413788200%26sid%3Dliteratum%253Aachs%26aulast%3DMakowski%26aufirst%3DL.%26aulast%3DBrittingham%26aufirst%3DK.%2BC.%26aulast%3DReynolds%26aufirst%3DJ.%2BM.%26aulast%3DSuttles%26aufirst%3DJ.%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26atitle%3DThe%2520Fatty%2520Acid-Binding%2520Protein%252C%2520AP2%252C%2520Coordinates%2520Macrophage%2520Cholesterol%2520Trafficking%2520and%2520Inflammatory%2520Activity.%2520Macrophage%2520Expression%2520of%2520AP2%2520Impacts%2520Peroxisome%2520Proliferator-Activated%2520Receptor%2520Gamma%2520and%2520IkappaB%2520Kinase%2520Activities%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D12888%26epage%3D12895%26doi%3D10.1074%2Fjbc.M413788200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furuhashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuncman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorgun, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atsumi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaillancourt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kono, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babaev, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linton, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulsky, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robl, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotamisligil, G. S.</span></span> <span> </span><span class="NLM_article-title">Treatment of Diabetes and Atherosclerosis by Inhibiting Fatty-Acid-Binding Protein AP2</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>447</i></span>,  <span class="NLM_fpage">959</span>– <span class="NLM_lpage">965</span>, <span class="refDoi"> DOI: 10.1038/nature05844</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1038%2Fnature05844" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=17554340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2sXms1yqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2007&pages=959-965&author=M.+Furuhashiauthor=G.+Tuncmanauthor=C.+Z.+Gorgunauthor=L.+Makowskiauthor=G.+Atsumiauthor=E.+Vaillancourtauthor=K.+Konoauthor=V.+R.+Babaevauthor=S.+Fazioauthor=M.+F.+Lintonauthor=R.+Sulskyauthor=J.+A.+Roblauthor=R.+A.+Parkerauthor=G.+S.+Hotamisligil&title=Treatment+of+Diabetes+and+Atherosclerosis+by+Inhibiting+Fatty-Acid-Binding+Protein+AP2&doi=10.1038%2Fnature05844"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2</span></div><div class="casAuthors">Furuhashi, Masato; Tuncman, Guerol; Goerguen, Cem Z.; Makowski, Liza; Atsumi, Genichi; Vaillancourt, Eric; Kono, Keita; Babaev, Vladimir R.; Fazio, Sergio; Linton, MacRae F.; Sulsky, Richard; Robl, Jeffrey A.; Parker, Rex A.; Hotamisligil, Goekhan S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">7147</span>),
    <span class="NLM_cas:pages">959-965</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Adipocyte fatty-acid-binding protein, aP2 (FABP4) is expressed in adipocytes and macrophages, and integrates inflammatory and metabolic responses.  Studies in aP2-deficient mice have shown that this lipid chaperone has a significant role in several aspects of metabolic syndrome, including type 2 diabetes and atherosclerosis.  Here we demonstrate that an orally active small-mol. inhibitor of aP2 is an effective therapeutic agent against severe atherosclerosis and type 2 diabetes in mouse models.  In macrophage and adipocyte cell lines with or without aP2, we also show the target specificity of this chem. intervention and its mechanisms of action on metabolic and inflammatory pathways.  Our findings demonstrate that targeting aP2 with small-mol. inhibitors is possible and can lead to a new class of powerful therapeutic agents to prevent and treat metabolic diseases such as type 2 diabetes and atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcBoTTf3wl6LVg90H21EOLACvtfcHk0li7I9dV0H26aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXms1yqu7g%253D&md5=fe0e8ce268a91c4c126eb4161172ea9e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature05844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05844%26sid%3Dliteratum%253Aachs%26aulast%3DFuruhashi%26aufirst%3DM.%26aulast%3DTuncman%26aufirst%3DG.%26aulast%3DGorgun%26aufirst%3DC.%2BZ.%26aulast%3DMakowski%26aufirst%3DL.%26aulast%3DAtsumi%26aufirst%3DG.%26aulast%3DVaillancourt%26aufirst%3DE.%26aulast%3DKono%26aufirst%3DK.%26aulast%3DBabaev%26aufirst%3DV.%2BR.%26aulast%3DFazio%26aufirst%3DS.%26aulast%3DLinton%26aufirst%3DM.%2BF.%26aulast%3DSulsky%26aufirst%3DR.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26atitle%3DTreatment%2520of%2520Diabetes%2520and%2520Atherosclerosis%2520by%2520Inhibiting%2520Fatty-Acid-Binding%2520Protein%2520AP2%26jtitle%3DNature%26date%3D2007%26volume%3D447%26spage%3D959%26epage%3D965%26doi%3D10.1038%2Fnature05844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hotamisligil, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distel, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papaioannou, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegelman, B. M.</span></span> <span> </span><span class="NLM_article-title">Uncoupling of Obesity from Insulin Resistance through a Targeted Mutation in AP2, the Adipocyte Fatty Acid Binding Protein</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">1377</span>– <span class="NLM_lpage">1379</span>, <span class="refDoi"> DOI: 10.1126/science.274.5291.1377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1126%2Fscience.274.5291.1377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=8910278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADyaK28XntFKlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=1377-1379&author=G.+S.+Hotamisligilauthor=R.+S.+Johnsonauthor=R.+J.+Distelauthor=R.+Ellisauthor=V.+E.+Papaioannouauthor=B.+M.+Spiegelman&title=Uncoupling+of+Obesity+from+Insulin+Resistance+through+a+Targeted+Mutation+in+AP2%2C+the+Adipocyte+Fatty+Acid+Binding+Protein&doi=10.1126%2Fscience.274.5291.1377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein</span></div><div class="casAuthors">Hotamisligil, Gokhan S.; Johnson, Randall S.; Distel, Robert J.; Ellis, Ramsey; Papaioannou, Virginia E.; Spiegelman, Bruce M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">5291</span>),
    <span class="NLM_cas:pages">1377-1379</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Fatty acid-binding proteins (FABPs) are small cytoplasmic proteins that are expressed in a highly tissue-specific manner and bind to fatty acids such as oleic and retinoic acid.  Mice with a null mutation in aP2, the gene encoding the adipocyte FABP, were developmentally and metabolically normal.  The aP2-deficient mice developed dietary obesity, but unlike control mice, they did not develop insulin resistance or diabetes.  Also unlike their obese wild-type counterparts, obese aP2-/- animals failed to express in adipose tissue tumor necrosis factor-α (TNF-α), a mol. implicated in obesity-related insulin resistance.  Apparently, aP2 is central to the pathway that links obesity to insulin resistance, possibly by linking fatty acid metab. to expression of TNF-α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrknYL49pk4TrVg90H21EOLACvtfcHk0li7I9dV0H26aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntFKlsrs%253D&md5=edc08a093eb55406baf58b41a73317b1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.274.5291.1377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.274.5291.1377%26sid%3Dliteratum%253Aachs%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26aulast%3DJohnson%26aufirst%3DR.%2BS.%26aulast%3DDistel%26aufirst%3DR.%2BJ.%26aulast%3DEllis%26aufirst%3DR.%26aulast%3DPapaioannou%26aufirst%3DV.%2BE.%26aulast%3DSpiegelman%26aufirst%3DB.%2BM.%26atitle%3DUncoupling%2520of%2520Obesity%2520from%2520Insulin%2520Resistance%2520through%2520a%2520Targeted%2520Mutation%2520in%2520AP2%252C%2520the%2520Adipocyte%2520Fatty%2520Acid%2520Binding%2520Protein%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D1377%26epage%3D1379%26doi%3D10.1126%2Fscience.274.5291.1377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boord, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babaev, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uysal, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suttles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotamisligil, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linton, M. F.</span></span> <span> </span><span class="NLM_article-title">Lack of Macrophage Fatty-Acid-Binding Protein AP2 Protects Mice Deficient in Apolipoprotein E against Atherosclerosis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">699</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1038/89076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1038%2F89076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=11385507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlGku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=699-705&author=L.+Makowskiauthor=J.+B.+Boordauthor=K.+Maedaauthor=V.+R.+Babaevauthor=K.+T.+Uysalauthor=M.+A.+Morganauthor=R.+A.+Parkerauthor=J.+Suttlesauthor=S.+Fazioauthor=G.+S.+Hotamisligilauthor=M.+F.+Linton&title=Lack+of+Macrophage+Fatty-Acid-Binding+Protein+AP2+Protects+Mice+Deficient+in+Apolipoprotein+E+against+Atherosclerosis&doi=10.1038%2F89076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis</span></div><div class="casAuthors">Makowski, Liza; Boord, Jeffrey B.; Maeda, Kazuhisa; Babaev, Vladimir R.; Uysal, K. Teoman; Morgan, Maureen A.; Parker, Rex A.; Suttles, Jill; Fazio, Sergio; Hotamisligil, Gokhan S.; Linton, MacRae F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">699-705</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The adipocyte fatty-acid-binding protein, aP2, has an important role in regulating systemic insulin resistance and lipid metab.  Here we demonstrate that aP2 is also expressed in macrophages, has a significant role in their biol. responses and contributes to the development of atherosclerosis.  Apolipoprotein E (ApoE)-deficient mice also deficient for aP2 showed protection from atherosclerosis in the absence of significant differences in serum lipids or insulin sensitivity.  AP2-deficient macrophages showed alterations in inflammatory cytokine prodn. and a reduced ability to accumulate cholesterol esters when exposed to modified lipoproteins.  Apoe-/- mice with Ap2+/+ adipocytes and Ap2-/- macrophages generated by bone-marrow transplantation showed a comparable redn. in atherosclerotic lesions to those with total aP2 deficiency, indicating an independent role for macrophage aP2 in atherogenesis.  Through its distinct actions in adipocytes and macrophages, aP2 provides a link between features of the metabolic syndrome and could be a new therapeutic target for the prevention of atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgAGT0nUnJ5rVg90H21EOLACvtfcHk0liLQGV0oRmIog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktlGku7w%253D&md5=5209357a5ded78b44b2b06efba9081be</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F89076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F89076%26sid%3Dliteratum%253Aachs%26aulast%3DMakowski%26aufirst%3DL.%26aulast%3DBoord%26aufirst%3DJ.%2BB.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DBabaev%26aufirst%3DV.%2BR.%26aulast%3DUysal%26aufirst%3DK.%2BT.%26aulast%3DMorgan%26aufirst%3DM.%2BA.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DSuttles%26aufirst%3DJ.%26aulast%3DFazio%26aufirst%3DS.%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26aulast%3DLinton%26aufirst%3DM.%2BF.%26atitle%3DLack%2520of%2520Macrophage%2520Fatty-Acid-Binding%2520Protein%2520AP2%2520Protects%2520Mice%2520Deficient%2520in%2520Apolipoprotein%2520E%2520against%2520Atherosclerosis%26jtitle%3DNat.%2520Med.%26date%3D2001%26volume%3D7%26spage%3D699%26epage%3D705%26doi%3D10.1038%2F89076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peeters, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Kleijn, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vink, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Weg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoneveld, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sze, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Spek, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasterkamp, G.</span></span> <span> </span><span class="NLM_article-title">Adipocyte Fatty Acid Binding Protein in Atherosclerotic Plaques is Associated with Local Vulnerability and is Predictive for the Occurrence of Adverse Cardiovascular Events</span>. <i>Eur. Heart J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1758</span>– <span class="NLM_lpage">1768</span>, <span class="refDoi"> DOI: 10.1093/eurheartj/ehq387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1093%2Feurheartj%2Fehq387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=21059735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptFCru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1758-1768&author=W.+Peetersauthor=D.+P.+de+Kleijnauthor=A.+Vinkauthor=S.+van+de+Wegauthor=A.+H.+Schoneveldauthor=S.+K.+Szeauthor=P.+J.+van+der+Spekauthor=J.+P.+de+Vriesauthor=F.+L.+Mollauthor=G.+Pasterkamp&title=Adipocyte+Fatty+Acid+Binding+Protein+in+Atherosclerotic+Plaques+is+Associated+with+Local+Vulnerability+and+is+Predictive+for+the+Occurrence+of+Adverse+Cardiovascular+Events&doi=10.1093%2Feurheartj%2Fehq387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events</span></div><div class="casAuthors">Peeters, Wouter; de Kleijn, Dominique P. V.; Vink, Aryan; van de Weg, Sander; Schoneveld, Arjan H.; Sze, Siu Kwan; van der Spek, Peter J.; de Vries, Jean-Paul P. M.; Moll, Frans L.; Pasterkamp, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">European Heart Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1758-1768</span>CODEN:
                <span class="NLM_cas:coden">EHJODF</span>;
        ISSN:<span class="NLM_cas:issn">0195-668X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">There is an increasing need for translational studies identifying mol. targets contributing to atherosclerotic plaque destabilization.  Local mol. plaque markers that are related to plaque vulnerability may hold predictive value to identify patients who are at increased risk to suffer from cardiovascular events.  Animal studies revealed that adipocyte fatty acid binding protein (FABP4) is assocd. with the progression of atherosclerosis; however, FABP4 expression studies in human atherosclerotic plaques are lacking.  We investigated FABP4 expression in carotid atherosclerotic lesions in relation to plaque compn. and future cardiovascular events.  Atherosclerotic plaques were obtained from 561 patients undergoing carotid endarterectomy (CEA).  Plaques were analyzed for the presence of macrophages, lipid core, smooth-muscle cells, collagen, calcification, and intraplaque hemorrhage.  Patients were followed for 3 years after CEA.  The primary outcome was defined as the composite of vascular death, vascular event, and surgical or percutaneous vascular intervention.  Fatty acid binding protein levels correlated with unstable plaque characteristics and symptomatic lesions.  Patients with increased FABP4 plaque levels showed a two-fold increased risk [HR = 1.99, 95% confidence interval (95% CI) (1.30-3.04)] (P = 0.005) to reach the primary outcome during follow-up.  Increased FABP4 levels related to primary outcome, independent from general cardiovascular risk factors [HR = 1.33, 95% CI (1.08-1.65)] (P = 0.008).  FABP4 levels in atherosclerotic lesions are assocd. with an unstable plaque phenotype and an increased risk for cardiovascular events during follow-up.  Besides risk stratification for adverse future cardiovascular events, the outcome of the present study supports the relevance of exploring FABP4 antagonists as a potential pharmaceutical intervention to treat atherosclerotic disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSyqiHCaUa-rVg90H21EOLACvtfcHk0ljRqP2Wg7jZyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptFCru78%253D&md5=bea7043f10736daec49ee11d2e22793f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Feurheartj%2Fehq387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurheartj%252Fehq387%26sid%3Dliteratum%253Aachs%26aulast%3DPeeters%26aufirst%3DW.%26aulast%3Dde%2BKleijn%26aufirst%3DD.%2BP.%26aulast%3DVink%26aufirst%3DA.%26aulast%3Dvan%2Bde%2BWeg%26aufirst%3DS.%26aulast%3DSchoneveld%26aufirst%3DA.%2BH.%26aulast%3DSze%26aufirst%3DS.%2BK.%26aulast%3Dvan%2Bder%2BSpek%26aufirst%3DP.%2BJ.%26aulast%3Dde%2BVries%26aufirst%3DJ.%2BP.%26aulast%3DMoll%26aufirst%3DF.%2BL.%26aulast%3DPasterkamp%26aufirst%3DG.%26atitle%3DAdipocyte%2520Fatty%2520Acid%2520Binding%2520Protein%2520in%2520Atherosclerotic%2520Plaques%2520is%2520Associated%2520with%2520Local%2520Vulnerability%2520and%2520is%2520Predictive%2520for%2520the%2520Occurrence%2520of%2520Adverse%2520Cardiovascular%2520Events%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2011%26volume%3D32%26spage%3D1758%26epage%3D1768%26doi%3D10.1093%2Feurheartj%2Fehq387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Y.</span>; <span class="NLM_string-name">Liu, L.</span>; <span class="NLM_string-name">Yin, L.</span>; <span class="NLM_string-name">Xu, L.</span>; <span class="NLM_string-name">Tang, Z.</span>; <span class="NLM_string-name">Qi, Y.</span>; <span class="NLM_string-name">Mao, Z.</span>; <span class="NLM_string-name">Zhao, Y.</span>; <span class="NLM_string-name">Ma, X.</span>; <span class="NLM_string-name">Peng, J.</span></span> <span> </span><span class="NLM_article-title">FABP4 Contributes to Renal Interstitial Fibrosis via Mediating Inflammation and Lipid Metabolism</span>.  <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume">10</span>,<span class="refDoi"> DOI: 10.1038/s41419-019-1610-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1038%2Fs41419-019-1610-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&author=Y.+Qiao&author=L.+Liu&author=L.+Yin&author=L.+Xu&author=Z.+Tang&author=Y.+Qi&author=Z.+Mao&author=Y.+Zhao&author=X.+Ma&author=J.+Peng&title=FABP4+Contributes+to+Renal+Interstitial+Fibrosis+via+Mediating+Inflammation+and+Lipid+Metabolism&doi=10.1038%2Fs41419-019-1610-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fs41419-019-1610-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-019-1610-5%26sid%3Dliteratum%253Aachs%26aulast%3DQiao%26aufirst%3DY.%26atitle%3DFABP4%2520Contributes%2520to%2520Renal%2520Interstitial%2520Fibrosis%2520via%2520Mediating%2520Inflammation%2520and%2520Lipid%2520Metabolism%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2019%26volume%3D10%26doi%3D10.1038%2Fs41419-019-1610-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoo, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, K. S.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Inhibition of Adipocyte Fatty Acid Binding Protein Alleviates both Acute Liver Injury and non-Alcoholic Steatohepatitis in Mice</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">358</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1016/j.jhep.2012.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.jhep.2012.10.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=23108115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovVyiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2013&pages=358-364&author=R.+L.+Hooauthor=I.+P.+Leeauthor=M.+Zhouauthor=J.+Y.+Wongauthor=X.+Huiauthor=A.+Xuauthor=K.+S.+Lam&title=Pharmacological+Inhibition+of+Adipocyte+Fatty+Acid+Binding+Protein+Alleviates+both+Acute+Liver+Injury+and+non-Alcoholic+Steatohepatitis+in+Mice&doi=10.1016%2Fj.jhep.2012.10.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice</span></div><div class="casAuthors">Hoo, Ruby L. C.; Lee, Ida P. C.; Zhou, Mi; Wong, Janice Y. L.; Hui, Xiaoyan; Xu, Aimin; Lam, Karen S. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adipocyte fatty acid binding protein (A-FABP) is a key mediator of inflammatory response in macrophages.  Increased hepatic expression and circulating levels of A-FABP have been obsd. in patients with non-alc. fatty liver disease (NAFLD).  Here, we investigated the role of A-FABP in both lipopolysaccaride (LPS)-induced acute liver injury and high fat high cholesterol (HFHC) diet-induced NAFLD in mice.  Mice with LPS-induced acute liver injury and HFHC diet-induced obesity were treated with the A-FABP inhibitor BMS309403.  Liver tissues of the mice were analyzed by immunohistochem., Western blot or real-time PCR.  A-FABP expression in Kupffer cells was significantly elevated in mice with LPS-induced acute liver injury and HFHC diet-induced obesity, as compared to their healthy controls.  Pretreatment of mice with BMS309403 led to a diminished LPS-induced elevation in serum levels of alanine transaminase and hepatic prodn. of pro-inflammatory cytokines.  Likewise, chronic treatment of HFHC diet-induced obese mice with BMS309403 ameliorated hepatic steatosis, macrophage infiltration, and cellular ballooning of hepatocytes.  Such improvements in liver function and morphol. were accompanied by significantly decreased activation of both c-Jun and NF-κB.  Pretreatment with BMS309403 suppressed both LPS- and palmitate-induced pro-inflammatory responses in isolated rat Kupffer cells.  Adenovirus-mediated ectopic expression of A-FABP alone was sufficient to induce liver injury and inflammation in mice.  These findings suggest that A-FABP is an important contributor to both LPS-induced acute liver injury and diet-induced NAFLD by potentiating inflammation in Kupffer cells.  Pharmacol. inhibition of A-FABP may represent a promising modality for obesity-related non-alc. steatohepatitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn9yty5UsZRbVg90H21EOLACvtfcHk0ljRqP2Wg7jZyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovVyiuw%253D%253D&md5=5cfa283d6c966010c15d63b910c86887</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2012.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2012.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DHoo%26aufirst%3DR.%2BL.%26aulast%3DLee%26aufirst%3DI.%2BP.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DJ.%2BY.%26aulast%3DHui%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DA.%26aulast%3DLam%26aufirst%3DK.%2BS.%26atitle%3DPharmacological%2520Inhibition%2520of%2520Adipocyte%2520Fatty%2520Acid%2520Binding%2520Protein%2520Alleviates%2520both%2520Acute%2520Liver%2520Injury%2520and%2520non-Alcoholic%2520Steatohepatitis%2520in%2520Mice%26jtitle%3DJ.%2520Hepatol.%26date%3D2013%26volume%3D58%26spage%3D358%26epage%3D364%26doi%3D10.1016%2Fj.jhep.2012.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbacz, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billiar, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramakrishnan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span> <span> </span><span class="NLM_article-title">Fatty Acid Binding Protein-4 (FABP4) is a Hypoxia Inducible Gene that Sensitizes Mice to Liver Ischemia/Reperfusion Injury</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">855</span>– <span class="NLM_lpage">862</span>, <span class="refDoi"> DOI: 10.1016/j.jhep.2015.05.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.jhep.2015.05.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=26070408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Gqsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2015&pages=855-862&author=B.+Huauthor=Y.+Guoauthor=W.+G.+Garbaczauthor=M.+Jiangauthor=M.+Xuauthor=H.+Huangauthor=A.+Tsungauthor=T.+R.+Billiarauthor=S.+K.+Ramakrishnanauthor=Y.+M.+Shahauthor=K.+S.+Lamauthor=M.+Huangauthor=W.+Xie&title=Fatty+Acid+Binding+Protein-4+%28FABP4%29+is+a+Hypoxia+Inducible+Gene+that+Sensitizes+Mice+to+Liver+Ischemia%2FReperfusion+Injury&doi=10.1016%2Fj.jhep.2015.05.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Fatty acid binding protein-4 (FABP4) is a hypoxia inducible gene that sensitizes mice to liver ischemia/reperfusion injury</span></div><div class="casAuthors">Hu, Bingfang; Guo, Yan; Garbacz, Wojciech G.; Jiang, Mengxi; Xu, Meishu; Huang, Hai; Tsung, Allan; Billiar, Timothy R.; Ramakrishnan, Sadeesh K.; Shah, Yatrik M.; Lam, Karen S. L.; Huang, Min; Xie, Wen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">855-862</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Fatty acid binding protein 4 (FABP4) has been known as a mediator of inflammatory response in the macrophages and adipose tissue, but its hepatic function is poorly understood.  The goal of this study is to investigate the role of FABP4 in liver ischemia/reperfusion (I/R), a clin. condition that involves both hypoxia and inflammation.To examine the I/R regulation of FABP4, mice were subjected to I/R surgery before being measured for FABP4 gene expression.  Both loss-of-function (by using a pharmacol. FABP4 inhibitor) and gain-of-function (by adenoviral overexpression of FABP4) were used to det. the functional relevance of FABP4 expression and its regulation during I/R.  To det. the hypoxia responsive regulation of FABP4, primary mouse hepatocytes were exposed to hypoxia.  The FABP4 gene promoter was cloned and its regulation by hypoxia inducible factor 1α (HIF-1α) was characterized by luciferase reporter gene, electrophoretic mobility shift, and chromatin immunopptn. assays.We found that the hepatic expression of FABP4 was markedly induced by I/R.  At the functional level, pharmacol. inhibition of FABP4 alleviated the I/R injury, whereas adenoviral overexpression of FABP4 sensitized mice to I/R injury.  We also showed that exposure of primary hepatocytes to hypoxia or transgenic overexpression of HIF-1α in the mouse liver was sufficient to induce the expression of FABP4.  Our promoter anal. established FABP4 as a novel transcriptional target of HIF-1α.FABP4 is a hypoxia inducible gene that sensitizes mice to liver I/R injury.  FABP4 may represent a novel therapeutic target, and FABP4 inhibitors may be used as therapeutic agents to manage hepatic I/R injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTgUVFbrTjUbVg90H21EOLACvtfcHk0lhqrcjRGPbCIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Gqsr%252FL&md5=7be72017b530b5374c7d1171b4c6e3d4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2015.05.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2015.05.030%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DGarbacz%26aufirst%3DW.%2BG.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DTsung%26aufirst%3DA.%26aulast%3DBilliar%26aufirst%3DT.%2BR.%26aulast%3DRamakrishnan%26aufirst%3DS.%2BK.%26aulast%3DShah%26aufirst%3DY.%2BM.%26aulast%3DLam%26aufirst%3DK.%2BS.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DW.%26atitle%3DFatty%2520Acid%2520Binding%2520Protein-4%2520%2528FABP4%2529%2520is%2520a%2520Hypoxia%2520Inducible%2520Gene%2520that%2520Sensitizes%2520Mice%2520to%2520Liver%2520Ischemia%252FReperfusion%2520Injury%26jtitle%3DJ.%2520Hepatol.%26date%3D2015%26volume%3D63%26spage%3D855%26epage%3D862%26doi%3D10.1016%2Fj.jhep.2015.05.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, B.</span></span> <span> </span><span class="NLM_article-title">FABP4 Inhibitors Suppress Inflammation and Oxidative Stress in Murine and Cell Models of Acute Lung Injury</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>496</i></span>,  <span class="NLM_fpage">1115</span>– <span class="NLM_lpage">1121</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2018.01.150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.bbrc.2018.01.150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=29409946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSgtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=496&publication_year=2018&pages=1115-1121&author=Y.+Gongauthor=Z.+Yuauthor=Y.+Gaoauthor=L.+Dengauthor=M.+Wangauthor=Y.+Chenauthor=J.+Liauthor=B.+Cheng&title=FABP4+Inhibitors+Suppress+Inflammation+and+Oxidative+Stress+in+Murine+and+Cell+Models+of+Acute+Lung+Injury&doi=10.1016%2Fj.bbrc.2018.01.150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">FABP4 inhibitors suppress inflammation and oxidative stress in murine and cell models of acute lung injury</span></div><div class="casAuthors">Gong, Yuanqi; Yu, Zhihong; Gao, Yi; Deng, Linlin; Wang, Meng; Chen, Yu; Li, Jingying; Cheng, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">496</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1115-1121</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Acute lung injury (ALI) is a severe disease with high morbidity and mortality, and is characterized by devastating inflammation of the lung and increased prodn. of reactive oxygen species (ROS).  Recent studies have indicated that fatty acid binding protein (FABP4) is important in the regulation of inflammation.  However, the role of FABP4 in sepsis-related ALI, and the specific mechanism of action have not been examd.  In vitro, the exposure of human alveolar epithelial A549cells to lipopolysaccharide (LPS) and recombinant FABP4 (hrFABP4) resulted in the prodn. of pro-inflammatory cytokines, inflammatory cytokines, and ROS, while these changes were ameliorated by pretreatment with the FABP4 inhibitor BMS309403 and FABP4 siRNA.  Sequentially, treatment of A549cells with N-acetylcysteine (NAC) significantly attenuated LPS and hrFABP4-induced the generation of ROS and the release of inflammatory cytokines.  In vivo, a cecal ligation and puncture (CLP)-induced ALI murine model was successfully established.  Then, the mice were treated with FABP4 inhibitor BMS309403.  The results showed treatment with BMS309403 improved the survival rate of CLP-induced ALI mice, and prevented lung inflammation, histopathol. changes, and increase of FABP4 induced by CLP.  These data indicate that FABP4 plays an important role in lung inflammation of sepsis-induced ALI.  Blockade of FABP4 signaling exhibits a protective effect in a CLP-induced ALI mouse model, and in A549cell LPS specifically induces enhanced expression of FABP4, which then causes inflammatory cytokine prodn. by elevating the ROS level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaETbdfCTn7LVg90H21EOLACvtfcHk0lhqrcjRGPbCIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSgtb8%253D&md5=cb5862daf07caa0d22792f0a3b2b34d7</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2018.01.150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2018.01.150%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DB.%26atitle%3DFABP4%2520Inhibitors%2520Suppress%2520Inflammation%2520and%2520Oxidative%2520Stress%2520in%2520Murine%2520and%2520Cell%2520Models%2520of%2520Acute%2520Lung%2520Injury%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2018%26volume%3D496%26spage%3D1115%26epage%3D1121%26doi%3D10.1016%2Fj.bbrc.2018.01.150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Floresta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pistara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amata, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dichiara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrazzo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prezzavento, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescifina, A.</span></span> <span> </span><span class="NLM_article-title">Adipocyte Fatty Acid Binding Protein 4 (FABP4) Inhibitors. A Comprehensive Systematic Review</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">854</span>– <span class="NLM_lpage">873</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.07.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.ejmech.2017.07.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=28738306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Wlt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2017&pages=854-873&author=G.+Florestaauthor=V.+Pistaraauthor=E.+Amataauthor=M.+Dichiaraauthor=A.+Marrazzoauthor=O.+Prezzaventoauthor=A.+Rescifina&title=Adipocyte+Fatty+Acid+Binding+Protein+4+%28FABP4%29+Inhibitors.+A+Comprehensive+Systematic+Review&doi=10.1016%2Fj.ejmech.2017.07.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review</span></div><div class="casAuthors">Floresta, Giuseppe; Pistara, Venerando; Amata, Emanuele; Dichiara, Maria; Marrazzo, Agostino; Prezzavento, Orazio; Rescifina, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">854-873</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Small mol. inhibitors of adipocyte fatty acid binding protein 4 (FABP4) have attracted interest following the recent publications of beneficial pharmacol. effects of these compds.  FABP4 is predominantly expressed in macrophages and adipose tissue where it regulates fatty acids (FAs) storage and lipolysis and is an important mediator of inflammation.  In the past years, hundreds FABP4 inhibitors have been synthesized for effective atherosclerosis and diabetes treatments, including derivs. of niacin, quinoxaline, aryl-quinoline, bicyclic pyridine, urea, arom. compds. and other novel heterocyclic compds.  This review provides an overview of the synthesized and discovered mols. as adipocyte fatty acid binding protein 4 inhibitors (FABP4is) since the synthesis of the putative FABP4i, BMS309403, highlighting the interactions of the different classes of inhibitors with the targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6yvkt3g7wurVg90H21EOLACvtfcHk0lhqrcjRGPbCIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Wlt77L&md5=a7e1866d1726bf8d9df083dd0a826d55</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.07.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.07.022%26sid%3Dliteratum%253Aachs%26aulast%3DFloresta%26aufirst%3DG.%26aulast%3DPistara%26aufirst%3DV.%26aulast%3DAmata%26aufirst%3DE.%26aulast%3DDichiara%26aufirst%3DM.%26aulast%3DMarrazzo%26aufirst%3DA.%26aulast%3DPrezzavento%26aufirst%3DO.%26aulast%3DRescifina%26aufirst%3DA.%26atitle%3DAdipocyte%2520Fatty%2520Acid%2520Binding%2520Protein%25204%2520%2528FABP4%2529%2520Inhibitors.%2520A%2520Comprehensive%2520Systematic%2520Review%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D138%26spage%3D854%26epage%3D873%26doi%3D10.1016%2Fj.ejmech.2017.07.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Binas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danneberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWhir, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. J.</span></span> <span> </span><span class="NLM_article-title">Requirement for the Heart-Type Fatty Acid Binding Protein in Cardiac Fatty Acid Utilization</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">812</span>, <span class="refDoi"> DOI: 10.1096/fasebj.13.8.805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1096%2Ffasebj.13.8.805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10224224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADyaK1MXjtFGksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=805-812&author=B.+Binasauthor=H.+Dannebergauthor=J.+McWhirauthor=L.+Mullinsauthor=A.+J.+Clark&title=Requirement+for+the+Heart-Type+Fatty+Acid+Binding+Protein+in+Cardiac+Fatty+Acid+Utilization&doi=10.1096%2Ffasebj.13.8.805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization</span></div><div class="casAuthors">Binas, Bert; Danneberg, Heike; McWhir, Jim; Mullins, Linda; Clark, A. John</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">805-812</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Nonenzymic cytosolic fatty acid binding proteins (FABPs) are abundantly expressed in many animal tissues with high rates of fatty acid metab.  No physiol. role has been demonstrated for any FABP, although these proteins have been implicated in transport of free long-chain fatty acids (LCFAs) and protection against LCFA toxicity.  We report here that mice lacking heart-type FABP (H-FABP) exhibit a severe defect of peripheral (non-hepatic, non-fat) LCFA utilization.  In these mice, the heart is unable to efficiently take up plasma LCFAs, which are normally its main fuel, and switches to glucose usage.  Altered plasma levels of LCFAs, glucose, lactate and β-hydroxybutyrate are consistent with depressed peripheral LCFA utilization, intensified carbohydrate usage, and increased hepatic LCFA oxidn.; these changes are most pronounced under conditions favoring LCFA oxidn.  H-FABP deficiency is only incompletely compensated, however, causing acute exercise intolerance and, at old age, a localized cardiac hypertrophy.  These data establish a requirement for H-FABP in cardiac intracellular lipid transport and fuel selection and a major role in metabolic homeostasis.  This new animal model should be particularly useful for investigating the significance of peripheral LCFA utilization for heart function, insulin sensitivity, and blood pressure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMAVnSXdMiF7Vg90H21EOLACvtfcHk0lhnHdW-4o2qfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtFGksrk%253D&md5=e512198cd86e9a4057e1f025b10ce6fc</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.13.8.805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.13.8.805%26sid%3Dliteratum%253Aachs%26aulast%3DBinas%26aufirst%3DB.%26aulast%3DDanneberg%26aufirst%3DH.%26aulast%3DMcWhir%26aufirst%3DJ.%26aulast%3DMullins%26aufirst%3DL.%26aulast%3DClark%26aufirst%3DA.%2BJ.%26atitle%3DRequirement%2520for%2520the%2520Heart-Type%2520Fatty%2520Acid%2520Binding%2520Protein%2520in%2520Cardiac%2520Fatty%2520Acid%2520Utilization%26jtitle%3DFASEB%2520J.%26date%3D1999%26volume%3D13%26spage%3D805%26epage%3D812%26doi%3D10.1096%2Ffasebj.13.8.805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uysal, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorgun, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atsumi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzel, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernlohr, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotamisligil, G. S.</span></span> <span> </span><span class="NLM_article-title">Role of the Fatty Acid Binding Protein Mal1 in Obesity and Insulin Resistance</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">307</span>, <span class="refDoi"> DOI: 10.2337/diabetes.52.2.300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.2337%2Fdiabetes.52.2.300" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=12540600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtFansr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=300-307&author=K.+Maedaauthor=K.+T.+Uysalauthor=L.+Makowskiauthor=C.+Z.+Gorgunauthor=G.+Atsumiauthor=R.+A.+Parkerauthor=J.+Bruningauthor=A.+V.+Hertzelauthor=D.+A.+Bernlohrauthor=G.+S.+Hotamisligil&title=Role+of+the+Fatty+Acid+Binding+Protein+Mal1+in+Obesity+and+Insulin+Resistance&doi=10.2337%2Fdiabetes.52.2.300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the fatty acid binding protein mal-1 in obesity and insulin resistance</span></div><div class="casAuthors">Maeda, Kazuhisa; Uysal, K. Teoman; Makowski, Liza; Gorgun, Cem Z.; Atsumi, Genichi; Parker, Rex A.; Bruning, Jens; Hertzel, Ann Vogel; Bernlohr, David A.; Hotamisligil, Gokhan S.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">300-307</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association</span>)
        </div><div class="casAbstract">The metabolic syndrome is a cluster of metabolic and inflammatory abnormalities including obesity, insulin resistance, type 2 diabetes, hypertension, dyslipidemia, and atherosclerosis.  The fatty acid binding proteins aP2 (fatty acid binding protein [FABP]-4) and mal1 (FABP5) are closely related and both are expressed in adipocytes.  Previous studies in aP2-deficient mice have indicated a significant role for aP2 in obesity-related insulin resistance, type 2 diabetes, and atherosclerosis.  However, the biol. functions of mal-1 are not known.  Here, we report the generation of mice with targeted null mutations in the mal-1 gene as well as transgenic mice overexpressing mal1 from the aP2 promoter/enhancer to address the role of this FABP in metabolic regulation in the presence or absence of obesity.  To address the role of the second adipocyte FABP in metabolic regulation in the presence and deficiency of obesity, absence of mal1 resulted in increased systemic insulin sensitivity in two models of obesity and insulin resistance.  Adipocytes isolated from mal-1-deficient mice also exhibited enhanced insulin-stimulated glucose transport capacity.  In contrast, mice expressing high levels of mal1 in adipose tissue display reduced systemic insulin sensitivity.  Hence, our results demonstrate that mal1 modulates adipose tissue function and contributes to systemic glucose metab. and constitutes a potential therapeutic target in insulin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVlFbDG7STK7Vg90H21EOLACvtfcHk0lhnHdW-4o2qfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtFansr8%253D&md5=a533740457043d257d20983a02dc8b07</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.52.2.300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.52.2.300%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DUysal%26aufirst%3DK.%2BT.%26aulast%3DMakowski%26aufirst%3DL.%26aulast%3DGorgun%26aufirst%3DC.%2BZ.%26aulast%3DAtsumi%26aufirst%3DG.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DBruning%26aufirst%3DJ.%26aulast%3DHertzel%26aufirst%3DA.%2BV.%26aulast%3DBernlohr%26aufirst%3DD.%2BA.%26aulast%3DHotamisligil%26aufirst%3DG.%2BS.%26atitle%3DRole%2520of%2520the%2520Fatty%2520Acid%2520Binding%2520Protein%2520Mal1%2520in%2520Obesity%2520and%2520Insulin%2520Resistance%26jtitle%3DDiabetes%26date%3D2003%26volume%3D52%26spage%3D300%26epage%3D307%26doi%3D10.2337%2Fdiabetes.52.2.300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waigel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraig, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egilmez, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suttles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleary, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span> <span> </span><span class="NLM_article-title">Circulating Adipose Fatty Acid Binding Protein is a New Link Underlying Obesity-Associated Breast/Mammary Tumor Development</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2018.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.cmet.2018.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=30100196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOksr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=689-705&author=J.+Haoauthor=Y.+Zhangauthor=X.+Yanauthor=F.+Yanauthor=Y.+Sunauthor=J.+Zengauthor=S.+Waigelauthor=Y.+Yinauthor=M.+M.+Fraigauthor=N.+K.+Egilmezauthor=J.+Suttlesauthor=M.+Kongauthor=S.+Liuauthor=M.+P.+Clearyauthor=E.+Sauterauthor=B.+Li&title=Circulating+Adipose+Fatty+Acid+Binding+Protein+is+a+New+Link+Underlying+Obesity-Associated+Breast%2FMammary+Tumor+Development&doi=10.1016%2Fj.cmet.2018.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Circulating Adipose Fatty Acid Binding Protein Is a New Link Underlying Obesity-Associated Breast/Mammary Tumor Development</span></div><div class="casAuthors">Hao, Jiaqing; Zhang, Yuwen; Yan, Xiaofang; Yan, Fei; Sun, Yanwen; Zeng, Jun; Waigel, Sabine; Yin, Yanhui; Fraig, Mostafa M.; Egilmez, Nejat K.; Suttles, Jill; Kong, Maiying; Liu, Shujun; Cleary, Margot P.; Sauter, Edward; Li, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">689-705.e5</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">It is clear that obesity increases the risk of many types of cancer, including breast cancer.  However, the underlying mol. mechanisms by which obesity is linked to cancer risk remain to be defined.  Herein, we report that circulating adipose fatty acid binding protein (A-FABP) promotes obesity-assocd. breast cancer development.  Using clin. samples, we demonstrated that circulating A-FABP levels were significantly increased in obese patients with breast cancer in comparison with those without breast cancer.  Circulating A-FABP released by adipose tissue directly targeted mammary tumor cells, enhancing tumor stemness and aggressiveness through activation of the IL-6/STAT3/ALDH1 pathway.  Importantly, genetic deletion of A-FABP successfully reduced tumor ALHD1 activation and obesity-assocd. mammary tumor growth and development in different mouse models.  Collectively, these data suggest circulating A-FABP as a new link between obesity and breast cancer risk, thereby revealing A-FABP as a potential new therapeutic target for treatment of obesity-assocd. cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVmcRODA9czLVg90H21EOLACvtfcHk0lhTAK1yYok08g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOksr3P&md5=a9a7f4e9d473702e115242b48826b2f9</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2018.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2018.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DWaigel%26aufirst%3DS.%26aulast%3DYin%26aufirst%3DY.%26aulast%3DFraig%26aufirst%3DM.%2BM.%26aulast%3DEgilmez%26aufirst%3DN.%2BK.%26aulast%3DSuttles%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCleary%26aufirst%3DM.%2BP.%26aulast%3DSauter%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DB.%26atitle%3DCirculating%2520Adipose%2520Fatty%2520Acid%2520Binding%2520Protein%2520is%2520a%2520New%2520Link%2520Underlying%2520Obesity-Associated%2520Breast%252FMammary%2520Tumor%2520Development%26jtitle%3DCell%2520Metab.%26date%3D2018%26volume%3D28%26spage%3D689%26epage%3D705%26doi%3D10.1016%2Fj.cmet.2018.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sulsky, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnin, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpkins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stouch, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassolino-Klimas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrity, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoffel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavoie, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kish, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheriff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robl, J. A.</span></span> <span> </span><span class="NLM_article-title">Potent and Selective Biphenyl Azole Inhibitors of Adipocyte Fatty Acid Binding Protein (aFABP)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3511</span>– <span class="NLM_lpage">3515</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.12.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.bmcl.2006.12.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=17502136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtValsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3511-3515&author=R.+Sulskyauthor=D.+R.+Magninauthor=Y.+Huangauthor=L.+Simpkinsauthor=P.+Taunkauthor=M.+Patelauthor=Y.+Zhuauthor=T.+R.+Stouchauthor=D.+Bassolino-Klimasauthor=R.+Parkerauthor=T.+Harrityauthor=R.+Stoffelauthor=D.+S.+Taylorauthor=T.+B.+Lavoieauthor=K.+Kishauthor=B.+L.+Jacobsonauthor=S.+Sheriffauthor=L.+P.+Adamauthor=W.+R.+Ewingauthor=J.+A.+Robl&title=Potent+and+Selective+Biphenyl+Azole+Inhibitors+of+Adipocyte+Fatty+Acid+Binding+Protein+%28aFABP%29&doi=10.1016%2Fj.bmcl.2006.12.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP)</span></div><div class="casAuthors">Sulsky, Richard; Magnin, David R.; Huang, Yanting; Simpkins, Ligaya; Taunk, Prakash; Patel, Manorama; Zhu, Yeheng; Stouch, Terry R.; Bassolino-Klimas, Donna; Parker, Rex; Harrity, Thomas; Stoffel, Robert; Taylor, David S.; Lavoie, Thomas B.; Kish, Kevin; Jacobson, Bruce L.; Sheriff, Steven; Adam, Leonard P.; Ewing, William R.; Robl, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3511-3515</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Herein we report the first disclosure of biphenyl azoles that are nanomolar binders of adipocyte fatty acid binding protein (aFABP or aP2) with up to thousand-fold selectivity against muscle fatty acid binding protein and epidermal fatty acid binding protein.  In addn. a new radio-ligand to det. binding against the three fatty acid binding proteins was also synthesized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhQXAZfTUCbLVg90H21EOLACvtfcHk0lhTAK1yYok08g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtValsbc%253D&md5=464a2d308418f1824decc25c0575110b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.044%26sid%3Dliteratum%253Aachs%26aulast%3DSulsky%26aufirst%3DR.%26aulast%3DMagnin%26aufirst%3DD.%2BR.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DSimpkins%26aufirst%3DL.%26aulast%3DTaunk%26aufirst%3DP.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DStouch%26aufirst%3DT.%2BR.%26aulast%3DBassolino-Klimas%26aufirst%3DD.%26aulast%3DParker%26aufirst%3DR.%26aulast%3DHarrity%26aufirst%3DT.%26aulast%3DStoffel%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DD.%2BS.%26aulast%3DLavoie%26aufirst%3DT.%2BB.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DJacobson%26aufirst%3DB.%2BL.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DAdam%26aufirst%3DL.%2BP.%26aulast%3DEwing%26aufirst%3DW.%2BR.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26atitle%3DPotent%2520and%2520Selective%2520Biphenyl%2520Azole%2520Inhibitors%2520of%2520Adipocyte%2520Fatty%2520Acid%2520Binding%2520Protein%2520%2528aFABP%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3511%26epage%3D3515%26doi%3D10.1016%2Fj.bmcl.2006.12.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haile, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uppenberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundback, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondahl, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barf, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of Inhibitors of Human Adipocyte Fatty Acid-Binding Protein, a Potential Type 2 Diabetes Target</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4445</span>– <span class="NLM_lpage">4448</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.06.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.bmcl.2004.06.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=15357969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Kitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4445-4448&author=F.+Lehmannauthor=S.+Haileauthor=E.+Axenauthor=C.+Medinaauthor=J.+Uppenbergauthor=S.+Svenssonauthor=T.+Lundbackauthor=L.+Rondahlauthor=T.+Barf&title=Discovery+of+Inhibitors+of+Human+Adipocyte+Fatty+Acid-Binding+Protein%2C+a+Potential+Type+2+Diabetes+Target&doi=10.1016%2Fj.bmcl.2004.06.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target</span></div><div class="casAuthors">Lehmann, Fredik; Haile, Saba; Axen, Eva; Medina, Carmen; Uppenberg, Jonas; Svensson, Stefan; Lundbaeck, Thomas; Rondahl, Lena; Barf, Tjeerd</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4445-4448</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Low micromolar human A-FABP inhibitors were found by utilizing a fluorescence polarization assay, x-ray crystallog. and modeling.  The carbazole- and indole-based inhibitors displayed approx. 10-fold preferences over human H-FABP and E-FABP, and are highly selective against I-FABP.  This communication describes the SAR for drug-like synthetic inhibitors of human A-FABP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDaEKm61NwK7Vg90H21EOLACvtfcHk0lhTAK1yYok08g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Kitbo%253D&md5=86ed8d295ff0dfdafdf13ccad420d796</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.06.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.06.057%26sid%3Dliteratum%253Aachs%26aulast%3DLehmann%26aufirst%3DF.%26aulast%3DHaile%26aufirst%3DS.%26aulast%3DAxen%26aufirst%3DE.%26aulast%3DMedina%26aufirst%3DC.%26aulast%3DUppenberg%26aufirst%3DJ.%26aulast%3DSvensson%26aufirst%3DS.%26aulast%3DLundback%26aufirst%3DT.%26aulast%3DRondahl%26aufirst%3DL.%26aulast%3DBarf%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520Inhibitors%2520of%2520Human%2520Adipocyte%2520Fatty%2520Acid-Binding%2520Protein%252C%2520a%2520Potential%2520Type%25202%2520Diabetes%2520Target%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4445%26epage%3D4448%26doi%3D10.1016%2Fj.bmcl.2004.06.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haile, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uppenberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svensson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondahl, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundback, T.</span></span> <span> </span><span class="NLM_article-title">N-Benzyl-indolo carboxylic acids: Design and Synthesis of Potent and Selective Adipocyte Fatty-Acid Binding Protein (A-FABP) Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1745</span>– <span class="NLM_lpage">1748</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.01.084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.bmcl.2009.01.084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=19217286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1745-1748&author=T.+Barfauthor=F.+Lehmannauthor=K.+Hammerauthor=S.+Haileauthor=E.+Axenauthor=C.+Medinaauthor=J.+Uppenbergauthor=S.+Svenssonauthor=L.+Rondahlauthor=T.+Lundback&title=N-Benzyl-indolo+carboxylic+acids%3A+Design+and+Synthesis+of+Potent+and+Selective+Adipocyte+Fatty-Acid+Binding+Protein+%28A-FABP%29+Inhibitors&doi=10.1016%2Fj.bmcl.2009.01.084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">N-Benzylindolocarboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors</span></div><div class="casAuthors">Barf, Tjeerd; Lehmann, Fredrik; Hammer, Kristin; Haile, Saba; Axen, Eva; Medina, Carmen; Uppenberg, Jonas; Svensson, Stefan; Rondahl, Lena; Lundbaeck, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1745-1748</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Small mol. inhibitors of adipocyte fatty-acid binding protein (A-FABP) have gained renewed interest following the recent publication of pharmacol. beneficial effects of such inhibitors.  Despite the potential utility of selective A-FABP inhibitors within the fields of metabolic disease, inflammation and atherosclerosis, there are few examples of useful A-FABP inhibitors in the public domain.  The optimization of N-benzy-tetrahydrocarbazole derivs. through the use of co-crystal structure guided medicinal chem. efforts is described.  This led to the identification of a potent and selective class of A-FABP inhibitors as illustrated by N-benzylhexahydrocyclohepta[b]indole I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5iydyKyirabVg90H21EOLACvtfcHk0ligVQdD_hWkfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSltL8%253D&md5=1bd54a829937f3e4ab30bebf79256310</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.01.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.01.084%26sid%3Dliteratum%253Aachs%26aulast%3DBarf%26aufirst%3DT.%26aulast%3DLehmann%26aufirst%3DF.%26aulast%3DHammer%26aufirst%3DK.%26aulast%3DHaile%26aufirst%3DS.%26aulast%3DAxen%26aufirst%3DE.%26aulast%3DMedina%26aufirst%3DC.%26aulast%3DUppenberg%26aufirst%3DJ.%26aulast%3DSvensson%26aufirst%3DS.%26aulast%3DRondahl%26aufirst%3DL.%26aulast%3DLundback%26aufirst%3DT.%26atitle%3DN-Benzyl-indolo%2520carboxylic%2520acids%253A%2520Design%2520and%2520Synthesis%2520of%2520Potent%2520and%2520Selective%2520Adipocyte%2520Fatty-Acid%2520Binding%2520Protein%2520%2528A-FABP%2529%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1745%26epage%3D1748%26doi%3D10.1016%2Fj.bmcl.2009.01.084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tagami, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ejima, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeshita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyanaga, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokumasu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashiwagi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizukoshi, T.</span></span> <span> </span><span class="NLM_article-title">Interaction Analysis of FABP4 Inhibitors by X-ray Crystallography and Fragment Molecular Orbital Analysis</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">439</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00040</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFGntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=435-439&author=U.+Tagamiauthor=K.+Takahashiauthor=S.+Igarashiauthor=C.+Ejimaauthor=T.+Yoshidaauthor=S.+Takeshitaauthor=W.+Miyanagaauthor=M.+Sugikiauthor=M.+Tokumasuauthor=T.+Hatanakaauthor=T.+Kashiwagiauthor=K.+Ishikawaauthor=H.+Miyanoauthor=T.+Mizukoshi&title=Interaction+Analysis+of+FABP4+Inhibitors+by+X-ray+Crystallography+and+Fragment+Molecular+Orbital+Analysis&doi=10.1021%2Facsmedchemlett.6b00040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction Analysis of FABP4 Inhibitors by X-ray Crystallography and Fragment Molecular Orbital Analysis</span></div><div class="casAuthors">Tagami, Uno; Takahashi, Kazutoshi; Igarashi, Shunsuke; Ejima, Chieko; Yoshida, Tomomi; Takeshita, Sen; Miyanaga, Wataru; Sugiki, Masayuki; Tokumasu, Munetaka; Hatanaka, Toshihiro; Kashiwagi, Tatsuki; Ishikawa, Kohki; Miyano, Hiroshi; Mizukoshi, Toshimi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">435-439</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">X-ray crystal structural detn. of FABP4 in complex with four inhibitors revealed the complex binding modes, and the resulting observations led to improvement of the inhibitory potency of FABP4 inhibitors.  However, the detailed structure-activity relationship (SAR) could not be explained from these structural observations.  For a more detailed understanding of the interactions between FABP4 and inhibitors, fragment MO analyses were performed.  These analyses revealed that the total interfragment interaction energies of FABP4 and each inhibitor correlated with the ranking of the Ki value for the four inhibitors.  Furthermore, interactions between each inhibitor and amino acid residues in FABP4 were identified.  The oxygen atom of Lys58 in FABP4 was found to be very important for strong interactions with FABP4.  These results might provide useful information for the development of novel potent FABP4 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdOU8yYHj0WrVg90H21EOLACvtfcHk0ligVQdD_hWkfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFGntbg%253D&md5=4a0f406d4a3a4342e2a33f1f52be05cc</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00040%26sid%3Dliteratum%253Aachs%26aulast%3DTagami%26aufirst%3DU.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DIgarashi%26aufirst%3DS.%26aulast%3DEjima%26aufirst%3DC.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DTakeshita%26aufirst%3DS.%26aulast%3DMiyanaga%26aufirst%3DW.%26aulast%3DSugiki%26aufirst%3DM.%26aulast%3DTokumasu%26aufirst%3DM.%26aulast%3DHatanaka%26aufirst%3DT.%26aulast%3DKashiwagi%26aufirst%3DT.%26aulast%3DIshikawa%26aufirst%3DK.%26aulast%3DMiyano%26aufirst%3DH.%26aulast%3DMizukoshi%26aufirst%3DT.%26atitle%3DInteraction%2520Analysis%2520of%2520FABP4%2520Inhibitors%2520by%2520X-ray%2520Crystallography%2520and%2520Fragment%2520Molecular%2520Orbital%2520Analysis%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D435%26epage%3D439%26doi%3D10.1021%2Facsmedchemlett.6b00040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation of Thiazole- and Indole-Based Derivatives for the Treatment of Type II Diabetes</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.ejmech.2012.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=22483089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtlSks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=70-81&author=Q.+Xuauthor=L.+Huangauthor=J.+Liuauthor=L.+Maauthor=T.+Chenauthor=J.+Chenauthor=F.+Pengauthor=D.+Caoauthor=Z.+Yangauthor=N.+Qiuauthor=J.+Qiuauthor=G.+Wangauthor=X.+Liangauthor=A.+Pengauthor=M.+Xiangauthor=Y.+Weiauthor=L.+Chen&title=Design%2C+Synthesis+and+Biological+Evaluation+of+Thiazole-+and+Indole-Based+Derivatives+for+the+Treatment+of+Type+II+Diabetes&doi=10.1016%2Fj.ejmech.2012.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of thiazole- and indole-based derivatives for the treatment of type II diabetes</span></div><div class="casAuthors">Xu, Qinyuan; Huang, Li; Liu, Juan; Ma, Liang; Chen, Tao; Chen, Jinying; Peng, Fei; Cao, Dong; Yang, Zhuang; Qiu, Neng; Qiu, Jingxiang; Wang, Guangcheng; Liang, Xiaolin; Peng, Aihua; Xiang, Mingli; Wei, Yuquan; Chen, Lijuan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">70-81</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Present studies have shown that the lipid carrier has a significant role in several aspects of metabolic syndrome in A-FABP/ap2-deficient mice, including type 2 diabetes and atherosclerosis.  Thiazole- and indole-based derivs. were synthesized and investigated for their inhibitory effects on the prodn. of LPS-stimulated TNF-α.  Among them, (E)-1-(2-fluorobenzyl)-1H-indole-3-acrylic acid (I) exhibited an excellent inhibitory efficiency compared to BMS309403 (95% vs. 85%) at the concn. of 10 μM and a binding affinity for ap2 with the apparent Ki values 33 nM.  Oral administration of I at a dosage of 50 mg/kg effectively reduced the levels of plasma blood glucose, triglycerides, insulin, total cholesterol and alanine aminotransferase in high-fat/diet-induced obesity model.  The results highlighted that I was a potent anti-diabetic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_l5BLkyy5XrVg90H21EOLACvtfcHk0ligVQdD_hWkfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtlSks7g%253D&md5=70378aef257370e72017a6cc00e3e539</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DF.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DQiu%26aufirst%3DN.%26aulast%3DQiu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DA.%26aulast%3DXiang%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Thiazole-%2520and%2520Indole-Based%2520Derivatives%2520for%2520the%2520Treatment%2520of%2520Type%2520II%2520Diabetes%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D52%26spage%3D70%26epage%3D81%26doi%3D10.1016%2Fj.ejmech.2012.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. X.</span></span> <span> </span><span class="NLM_article-title">Benzbromarone, an Old Uricosuric Drug, Inhibits Human Fatty Acid Binding Protein 4 <i>in vitro</i> and Lowers the Blood Glucose Level in <i>db/db</i> Mice</span>. <i>Acta Pharmacol. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1397</span>– <span class="NLM_lpage">1402</span>, <span class="refDoi"> DOI: 10.1038/aps.2013.97</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1038%2Faps.2013.97" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=24077632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslajsLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1397-1402&author=H.+Y.+Caiauthor=T.+Wangauthor=J.+C.+Zhaoauthor=P.+Sunauthor=G.+R.+Yanauthor=H.+P.+Dingauthor=Y.+X.+Liauthor=H.+Y.+Wangauthor=W.+L.+Zhuauthor=K.+X.+Chen&title=Benzbromarone%2C+an+Old+Uricosuric+Drug%2C+Inhibits+Human+Fatty+Acid+Binding+Protein+4+in+vitro+and+Lowers+the+Blood+Glucose+Level+in+db%2Fdb+Mice&doi=10.1038%2Faps.2013.97"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Benzbromarone, an old uricosuric drug, inhibits human fatty acid binding protein 4 in vitro and lowers the blood glucose level in db/db mice</span></div><div class="casAuthors">Cai, Hai-yan; Wang, Ting; Zhao, Jian-chun; Sun, Peng; Yan, Gui-rui; Ding, Hai-peng; Li, Ying-xia; Wang, He-yao; Zhu, Wei-liang; Chen, Kai-xian</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1397-1402</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aim: Fatty acid-binding protein 4 (FABP4) plays an important role in maintaining glucose and lipid homeostasis.  The aim of this study was to find new inhibitors of FABP4 for the treatment of type 2 diabetes.  Methods: Human FABP4 protein was expressed, and its inhibitors were detected in 1,8-ANS displacement assay.  The effect of the inhibitor on lipolysis activity was examd. in mouse 3T3-L1 preadipocytes.  The db/db mice were used to evaluate the anti-diabetic activity of the inhibitor.  Mol. docking and site-directed mutagenesis studies were carried out to explore the binding mode between the inhibitor and FABP4.  Results: From 232 compds. tested, benzbromarone (BBR), an old uricosuric drug, was discovered to be the best inhibitor of FABP4 with an IC50 value of 14.8 μmol/L.  Furthermore, BBR (25 μmol/L) significantly inhibited forskolin-stimulated lipolysis in 3T3-L1 cells.  Oral administration of BBR (25 or 50 mg/kg, for 4 wk) dose-dependently reduced the blood glucose level and improved glucose tolerance and insulin resistance in db/db mice.  Mol. docking revealed that the residues Ser55, Asp76, and Arg126 of FABP4 formed important interactions with BBR, which was confirmed by site-directed mutagenesis studies.  Conclusion: BBR is an inhibitor of FABP4 and a potential drug candidate for the treatment of type 2 diabetes and atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPc1KuHAqyu7Vg90H21EOLACvtfcHk0ljpo4iwFFiw-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslajsLbO&md5=1b74d2a1ef0044929dbc6fd35addda51</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Faps.2013.97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2013.97%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%2BY.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DJ.%2BC.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DG.%2BR.%26aulast%3DDing%26aufirst%3DH.%2BP.%26aulast%3DLi%26aufirst%3DY.%2BX.%26aulast%3DWang%26aufirst%3DH.%2BY.%26aulast%3DZhu%26aufirst%3DW.%2BL.%26aulast%3DChen%26aufirst%3DK.%2BX.%26atitle%3DBenzbromarone%252C%2520an%2520Old%2520Uricosuric%2520Drug%252C%2520Inhibits%2520Human%2520Fatty%2520Acid%2520Binding%2520Protein%25204%2520in%2520vitro%2520and%2520Lowers%2520the%2520Blood%2520Glucose%2520Level%2520in%2520db%252Fdb%2520Mice%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2013%26volume%3D34%26spage%3D1397%26epage%3D1402%26doi%3D10.1038%2Faps.2013.97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span> <span> </span><span class="NLM_article-title">Novel Fatty Acid Binding Protein 4 (FABP4) Inhibitors: Virtual Screening, Synthesis and Crystal Structure Determination</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.11.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.ejmech.2014.11.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=25461324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFWis7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2015&pages=241-250&author=H.+Caiauthor=Q.+Liuauthor=D.+Gaoauthor=T.+Wangauthor=T.+Chenauthor=G.+Yanauthor=K.+Chenauthor=Y.+Xuauthor=H.+Wangauthor=Y.+Liauthor=W.+Zhu&title=Novel+Fatty+Acid+Binding+Protein+4+%28FABP4%29+Inhibitors%3A+Virtual+Screening%2C+Synthesis+and+Crystal+Structure+Determination&doi=10.1016%2Fj.ejmech.2014.11.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Novel fatty acid binding protein 4 (FABP4) inhibitors: Virtual screening, synthesis and crystal structure determination</span></div><div class="casAuthors">Cai, Haiyan; Liu, Qiufeng; Gao, Dingding; Wang, Ting; Chen, Tiantian; Yan, Guirui; Chen, Kaixian; Xu, Yechun; Wang, Heyao; Li, Yingxia; Zhu, Weiliang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">241-250</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Fatty acid binding protein 4 (FABP4) is a potential drug target for diabetes and atherosclerosis.  For discovering new chem. entities as FABP4 inhibitors, structure-based virtual screening (VS) was performed, bioassay demonstrated that 16 of 251 tested compds. are FABP4 inhibitors, among which compd. m1 are more active than endogenous ligand linoleic acid (LA).  Based on the structure of m1, new derivs. were designed and prepd., leading to the discovery of two more potent inhibitors, compds. 9 and 10.  To further explore the binding mechanisms of these new inhibitors, we detd. the X-ray structures of the complexes of FABP4-9 and FABP4-10, which revealed similar binding conformations of the two compds.  Residue Ser53 and Arg126 formed direct hydrogen bonding with the ligands.  We also found that 10 could significantly reduce the levels of lipolysis on mouse 3T3-L1 adipocytes.  Taken together, in silico, in vitro and crystallog. data provide useful hints for future development of novel inhibitors against FABP4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE7DhX10SNGLVg90H21EOLACvtfcHk0ljpo4iwFFiw-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFWis7%252FL&md5=a308af0c76eb61b2d91ec79b06c0a4ce</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.11.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.11.020%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DGao%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DW.%26atitle%3DNovel%2520Fatty%2520Acid%2520Binding%2520Protein%25204%2520%2528FABP4%2529%2520Inhibitors%253A%2520Virtual%2520Screening%252C%2520Synthesis%2520and%2520Crystal%2520Structure%2520Determination%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D90%26spage%3D241%26epage%3D250%26doi%3D10.1016%2Fj.ejmech.2014.11.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hertzel, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juhlmann, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohlendorf, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suttles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernlohr, D. A.</span></span> <span> </span><span class="NLM_article-title">Identification and Characterization of a Small Molecule Inhibitor of Fatty Acid Binding Proteins</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6024</span>– <span class="NLM_lpage">6031</span>, <span class="refDoi"> DOI: 10.1021/jm900720m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900720m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjtrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6024-6031&author=A.+V.+Hertzelauthor=K.+Hellbergauthor=J.+M.+Reynoldsauthor=A.+C.+Kruseauthor=B.+E.+Juhlmannauthor=A.+J.+Smithauthor=M.+A.+Sandersauthor=D.+H.+Ohlendorfauthor=J.+Suttlesauthor=D.+A.+Bernlohr&title=Identification+and+Characterization+of+a+Small+Molecule+Inhibitor+of+Fatty+Acid+Binding+Proteins&doi=10.1021%2Fjm900720m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Characterization of a Small Molecule Inhibitor of Fatty Acid Binding Proteins</span></div><div class="casAuthors">Hertzel, Ann V.; Hellberg, Kristina; Reynolds, Joseph M.; Kruse, Andrew C.; Juhlmann, Brittany E.; Smith, Anne J.; Sanders, Mark A.; Ohlendorf, Douglas H.; Suttles, Jill; Bernlohr, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6024-6031</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. disruption of the lipid carrier AFABP/aP2 in mice results in improved insulin sensitivity and protection from atherosclerosis.  Because small mol. inhibitors may be efficacious in defining the mechanism(s) of AFABP/aP2 action, a chem. library was screened and identified HTS01037 as a pharmacol. ligand capable of displacing the fluorophore 1-anilinonaphthalene 8-sulfonic acid from the lipid binding cavity.  The X-ray crystal structure of HTS01037 bound to AFABP/aP2 revealed that the ligand binds at a structurally similar position to a long-chain fatty acid.  Similar to AFABP/aP2 knockout mice, 1 inhibits lipolysis in 3T3-L1 adipocytes and reduces LPS-stimulated inflammation in cultured macrophages.  HT01037 acts as an antagonist of the protein-protein interaction between AFABP/aP2 and hormone sensitive lipase but does not activate PPARγ in macrophage or CV-1 cells.  These results identify HT01037 as an inhibitor of fatty acid binding and a competitive antagonist of protein-protein interactions mediated by AFABP/aP2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVrYehE6FSarVg90H21EOLACvtfcHk0lhT7tOeDZAPUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjtrjM&md5=8df9c672c8f589be20febcc34c1f266f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm900720m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900720m%26sid%3Dliteratum%253Aachs%26aulast%3DHertzel%26aufirst%3DA.%2BV.%26aulast%3DHellberg%26aufirst%3DK.%26aulast%3DReynolds%26aufirst%3DJ.%2BM.%26aulast%3DKruse%26aufirst%3DA.%2BC.%26aulast%3DJuhlmann%26aufirst%3DB.%2BE.%26aulast%3DSmith%26aufirst%3DA.%2BJ.%26aulast%3DSanders%26aufirst%3DM.%2BA.%26aulast%3DOhlendorf%26aufirst%3DD.%2BH.%26aulast%3DSuttles%26aufirst%3DJ.%26aulast%3DBernlohr%26aufirst%3DD.%2BA.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520a%2520Small%2520Molecule%2520Inhibitor%2520of%2520Fatty%2520Acid%2520Binding%2520Proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6024%26epage%3D6031%26doi%3D10.1021%2Fjm900720m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ringom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uppenberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundback, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondahl, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barf, T.</span></span> <span> </span><span class="NLM_article-title">Substituted Benzylamino-6-(trifluoromethyl)pyrimidin-4(1<i>H</i>)-ones: a Novel Class of Selective Human A-FABP Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4449</span>– <span class="NLM_lpage">4452</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.06.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.bmcl.2004.06.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=15357970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Kitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4449-4452&author=R.+Ringomauthor=E.+Axenauthor=J.+Uppenbergauthor=T.+Lundbackauthor=L.+Rondahlauthor=T.+Barf&title=Substituted+Benzylamino-6-%28trifluoromethyl%29pyrimidin-4%281H%29-ones%3A+a+Novel+Class+of+Selective+Human+A-FABP+Inhibitors&doi=10.1016%2Fj.bmcl.2004.06.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted benzylamino-6-(trifluoromethyl)pyrimidin-4(1H)-ones: a novel class of selective human A-FABP inhibitors</span></div><div class="casAuthors">Ringom, Rune; Axen, Eva; Uppenberg, Jonas; Lundbaeck, Thomas; Rondahl, Lena; Barf, Tjeerd</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4449-4452</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and evaluation of human A-FABP inhibitors based on 6-(trifluoromethyl)pyrimidine-4(1H)-ones, e.g., I, is described.  Two series of compds., bearing either an amino or carbon substituent in the 2-position of the pyrimidine ring were investigated.  Modification of substituents and chain length optimization led to compds. with low micromolar activity and good selectivity for human A-FABP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLWvuxTS4SfbVg90H21EOLACvtfcHk0lhT7tOeDZAPUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Kitbs%253D&md5=7d94da2afbacfabb843edea968e4e488</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.06.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.06.058%26sid%3Dliteratum%253Aachs%26aulast%3DRingom%26aufirst%3DR.%26aulast%3DAxen%26aufirst%3DE.%26aulast%3DUppenberg%26aufirst%3DJ.%26aulast%3DLundback%26aufirst%3DT.%26aulast%3DRondahl%26aufirst%3DL.%26aulast%3DBarf%26aufirst%3DT.%26atitle%3DSubstituted%2520Benzylamino-6-%2528trifluoromethyl%2529pyrimidin-4%25281H%2529-ones%253A%2520a%2520Novel%2520Class%2520of%2520Selective%2520Human%2520A-FABP%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4449%26epage%3D4452%26doi%3D10.1016%2Fj.bmcl.2004.06.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhne, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obst-Sander, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceccarelli, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidhart, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottaviani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, M.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Selective, Dual Fatty Acid Binding Protein 4 and 5 Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5092</span>– <span class="NLM_lpage">5097</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.08.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.bmcl.2016.08.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=27658368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFems77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5092-5097&author=H.+Kuhneauthor=U.+Obst-Sanderauthor=B.+Kuhnauthor=A.+Conteauthor=S.+M.+Ceccarelliauthor=W.+Neidhartauthor=M.+G.+Rudolphauthor=G.+Ottavianiauthor=R.+Gasserauthor=S.+S.+Soauthor=S.+Liauthor=X.+Zhangauthor=L.+Gaoauthor=M.+Myers&title=Design+and+Synthesis+of+Selective%2C+Dual+Fatty+Acid+Binding+Protein+4+and+5+Inhibitors&doi=10.1016%2Fj.bmcl.2016.08.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitors</span></div><div class="casAuthors">Kuhne, Holger; Obst-Sander, Ulrike; Kuhn, Bernd; Conte, Aurelia; Ceccarelli, Simona M.; Neidhart, Werner; Rudolph, Markus G.; Ottaviani, Giorgio; Gasser, Rodolfo; So, Sung-Sau; Li, Shirley; Zhang, Xiaolei; Gao, Lin; Myers, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5092-5097</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dual inhibition of fatty acid binding proteins 4 and 5 (FABP4 and FABP5) is expected to provide beneficial effects on a no. of metabolic parameters such as insulin sensitivity and blood glucose levels and should protect against atherosclerosis.  Starting from a FABP4 selective focused screening hit, biostructure information was used to modulate the selectivity profile in the desired way and to design potent dual FABP4/5 inhibitors with good selectivity against FABP3.  With very good pharmacokinetic properties and no major safety alerts, compd. 12 was identified as a suitable tool compd. for further in vivo investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowTC5cLtieLLVg90H21EOLACvtfcHk0lhT7tOeDZAPUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFems77F&md5=10a14beab261cb39e28d89dfaaa3e669</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.071%26sid%3Dliteratum%253Aachs%26aulast%3DKuhne%26aufirst%3DH.%26aulast%3DObst-Sander%26aufirst%3DU.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DConte%26aufirst%3DA.%26aulast%3DCeccarelli%26aufirst%3DS.%2BM.%26aulast%3DNeidhart%26aufirst%3DW.%26aulast%3DRudolph%26aufirst%3DM.%2BG.%26aulast%3DOttaviani%26aufirst%3DG.%26aulast%3DGasser%26aufirst%3DR.%26aulast%3DSo%26aufirst%3DS.%2BS.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DMyers%26aufirst%3DM.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Selective%252C%2520Dual%2520Fatty%2520Acid%2520Binding%2520Protein%25204%2520and%25205%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5092%26epage%3D5097%26doi%3D10.1016%2Fj.bmcl.2016.08.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorbenko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span> <span> </span><span class="NLM_article-title">Discovery of Highly Selective Inhibitors of Human Fatty Acid Binding Protein 4 (FABP4) by Virtual Screening</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">3675</span>– <span class="NLM_lpage">3679</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.04.095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.bmcl.2010.04.095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=20471252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVCmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3675-3679&author=H.+Caiauthor=G.+Yanauthor=X.+Zhangauthor=O.+Gorbenkoauthor=H.+Wangauthor=W.+Zhu&title=Discovery+of+Highly+Selective+Inhibitors+of+Human+Fatty+Acid+Binding+Protein+4+%28FABP4%29+by+Virtual+Screening&doi=10.1016%2Fj.bmcl.2010.04.095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screening</span></div><div class="casAuthors">Cai, Haiyan; Yan, Guirui; Zhang, Xiaodong; Gorbenko, Olena; Wang, Heyao; Zhu, Weiliang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3675-3679</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this study, a series of small mol. inhibitors of human FABP4 were identified through virtual screening.  Compd. 1 (I) is the most potent hit against FABP4 with a selectivity of more than 144-fold preferences over human FABP3.  In addn., MD simulation and mutation studies revealed key residues for inhibitory potency and selectivity, which provides a guideline for further drug design against obesity, diabetes and atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNCYdJr0F3mLVg90H21EOLACvtfcHk0liwK_yb7pmg6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVCmtLs%253D&md5=78f0b24702a07af5b811de2099416ed0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.04.095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.04.095%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGorbenko%26aufirst%3DO.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520Highly%2520Selective%2520Inhibitors%2520of%2520Human%2520Fatty%2520Acid%2520Binding%2520Protein%25204%2520%2528FABP4%2529%2520by%2520Virtual%2520Screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3675%26epage%3D3679%26doi%3D10.1016%2Fj.bmcl.2010.04.095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kowalski, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas-Triana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bober, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipps, G. W.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, J. A.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of FABP4/5 Ameliorate Dyslipidemia but not Insulin Resistance in Mice with Diet-Induced Obesity</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1194/jlr.M012757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1194%2Fjlr.M012757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=21296956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVOlt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=646-656&author=H.+Lanauthor=C.+C.+Chengauthor=T.+J.+Kowalskiauthor=L.+Pangauthor=L.+Shanauthor=C.+C.+Chuangauthor=J.+Jacksonauthor=A.+Rojas-Trianaauthor=L.+Boberauthor=L.+Liuauthor=J.+Voigtauthor=P.+Orthauthor=X.+Yangauthor=G.+W.+Shippsauthor=J.+A.+Hedrick&title=Small-Molecule+Inhibitors+of+FABP4%2F5+Ameliorate+Dyslipidemia+but+not+Insulin+Resistance+in+Mice+with+Diet-Induced+Obesity&doi=10.1194%2Fjlr.M012757"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity</span></div><div class="casAuthors">Lan, Hong; Cheng, Cliff C.; Kowalski, Timothy J.; Pang, Ling; Shan, Lixin; Chuang, Cheng-Chi; Jackson, James; Rojas-Triana, Alberto; Bober, Loretta; Liu, Li; Voigt, Johannes; Orth, Peter; Yang, Xianshu; Shipps, Gerald W., Jr.; Hedrick, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">646-656</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">Fatty acid binding protein-4 (FABP4) and FABP5 are two closely related FA binding proteins expressed primarily in adipose tissue and/or macrophages.  The small-mol. FABP4 inhibitor BMS309403 was previously reported to improve insulin sensitivity in leptin-deficient Lepob/Lepob (ob/ob) mice.  However, this compd. was not extensively characterized in the more physiol. relevant animal model of mice with diet-induced obesity (DIO).  Here, we report the discovery and characterization of a novel series of FABP4/5 dual inhibitors represented by Compds. 1-3.  Compared with BMS309403, the compds. had significant in vitro potency toward both FABP4 and FABP5.  In cell-based assays, Compds. 2 and 3 were more potent than BMS309403 to inhibit lipolysis in 3T3-L1 adipocytes and in primary human adipocytes.  They also inhibited MCP-1 release from THP-1 macrophages as well as from primary human macrophages.  When chronically administered to DIO mice, BMS309403 and Compd. 3 reduced plasma triglyceride and free FA levels.  Compd. 3 reduced plasma free FAs at a lower dose level than BMS309403.  However, no significant change was obsd. in insulin, glucose, or glucose tolerance.  Our results indicate that the FABP4/5 inhibitors ameliorate dyslipidemia but not insulin resistance in DIO mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyZVUoUyaoRLVg90H21EOLACvtfcHk0liwK_yb7pmg6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVOlt74%253D&md5=3e1d382cd198d4904a8d9b3974cf195d</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M012757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M012757%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DH.%26aulast%3DCheng%26aufirst%3DC.%2BC.%26aulast%3DKowalski%26aufirst%3DT.%2BJ.%26aulast%3DPang%26aufirst%3DL.%26aulast%3DShan%26aufirst%3DL.%26aulast%3DChuang%26aufirst%3DC.%2BC.%26aulast%3DJackson%26aufirst%3DJ.%26aulast%3DRojas-Triana%26aufirst%3DA.%26aulast%3DBober%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DShipps%26aufirst%3DG.%2BW.%26aulast%3DHedrick%26aufirst%3DJ.%2BA.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520FABP4%252F5%2520Ameliorate%2520Dyslipidemia%2520but%2520not%2520Insulin%2520Resistance%2520in%2520Mice%2520with%2520Diet-Induced%2520Obesity%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2011%26volume%3D52%26spage%3D646%26epage%3D656%26doi%3D10.1194%2Fjlr.M012757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. X.</span></span> <span> </span><span class="NLM_article-title">From Hit to Lead: Structure-Based Discovery of Naphthalene-1-Sulfonamide Derivatives as Potent and Selective Inhibitors of Fatty Acid Binding Protein 4</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.ejmech.2018.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=29775936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVShtb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2018&pages=44-59&author=D.+D.+Gaoauthor=H.+X.+Douauthor=H.+X.+Suauthor=M.+M.+Zhangauthor=T.+Wangauthor=Q.+F.+Liuauthor=H.+Y.+Caiauthor=H.+P.+Dingauthor=Z.+Yangauthor=W.+L.+Zhuauthor=Y.+C.+Xuauthor=H.+Y.+Wangauthor=Y.+X.+Li&title=From+Hit+to+Lead%3A+Structure-Based+Discovery+of+Naphthalene-1-Sulfonamide+Derivatives+as+Potent+and+Selective+Inhibitors+of+Fatty+Acid+Binding+Protein+4&doi=10.1016%2Fj.ejmech.2018.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">From hit to lead: Structure-based discovery of naphthalene-1-sulfonamide derivatives as potent and selective inhibitors of fatty acid binding protein 4</span></div><div class="casAuthors">Gao, Ding-Ding; Dou, Hui-Xia; Su, Hai-Xia; Zhang, Ming-Ming; Wang, Ting; Liu, Qiu-Feng; Cai, Hai-Yan; Ding, Hai-Peng; Yang, Zhuo; Zhu, Wei-Liang; Xu, Ye-Chun; Wang, He-Yao; Li, Ying-Xia</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44-59</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Fatty acid binding protein 4 (FABP4) plays a crit. role in metab. and inflammatory processes and therefore is a potential therapeutic target for immunometabolic diseases such as diabetes and atherosclerosis.  Herein, the authors reported the identification of naphthalene-1-sulfonamide derivs. as novel, potent and selective FABP4 inhibitors by applying a structure-based design strategy.  The binding affinities of compds. 16dk (2-fluoro-5-((4-methoxynaphthalene)-1-sulfonamido)benzoic acid), 16do (4-fluoro-3-((4-methoxynaphthalene)-1-sulfonamido)benzoic acid) and 16du (2,4-difluoro-5-((4-methoxynaphthalene)-1-sulfonamido)benzoic acid) to FABP4, at the mol. level, are equiv. to or even better than that of BMS309403.  The x-ray crystallog. complemented by the isothermal titrn. calorimetry studies revealed the binding mode of this series of inhibitors and the pivotal network of ordered water mols. in the binding pocket of FABP4.  Moreover, compds. 16dk and 16do showed good metabolic stabilities in liver microsomes.  Further extensive in vivo study demonstrated that 16dk and 16do exhibited a dramatic improvement in glucose and lipid metab., by decreasing fasting blood glucose and serum lipid levels, enhancing insulin sensitivity, and ameliorating hepatic steatosis in obese diabetic (db/db) mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYH7hb6xtVpbVg90H21EOLACvtfcHk0liwK_yb7pmg6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVShtb7N&md5=ef54a76e0af9794d9a04ebe4998b4944</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DD.%2BD.%26aulast%3DDou%26aufirst%3DH.%2BX.%26aulast%3DSu%26aufirst%3DH.%2BX.%26aulast%3DZhang%26aufirst%3DM.%2BM.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%2BF.%26aulast%3DCai%26aufirst%3DH.%2BY.%26aulast%3DDing%26aufirst%3DH.%2BP.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DW.%2BL.%26aulast%3DXu%26aufirst%3DY.%2BC.%26aulast%3DWang%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DY.%2BX.%26atitle%3DFrom%2520Hit%2520to%2520Lead%253A%2520Structure-Based%2520Discovery%2520of%2520Naphthalene-1-Sulfonamide%2520Derivatives%2520as%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Fatty%2520Acid%2520Binding%2520Protein%25204%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D154%26spage%3D44%26epage%3D59%26doi%3D10.1016%2Fj.ejmech.2018.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span> <span> </span><span class="NLM_article-title">Hepatic Induction of Fatty Acid Binding Protein 4 Plays a Pathogenic Role in Sepsis in Mice</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>187</i></span>,  <span class="NLM_fpage">1059</span>– <span class="NLM_lpage">1067</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2017.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.ajpath.2017.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=28279656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvFWqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2017&pages=1059-1067&author=B.+Huauthor=Y.+Liauthor=L.+Gaoauthor=Y.+Guoauthor=Y.+Zhangauthor=X.+Chaiauthor=M.+Xuauthor=J.+Yanauthor=P.+Luauthor=S.+Renauthor=S.+Zengauthor=Y.+Liuauthor=W.+Xieauthor=M.+Huang&title=Hepatic+Induction+of+Fatty+Acid+Binding+Protein+4+Plays+a+Pathogenic+Role+in+Sepsis+in+Mice&doi=10.1016%2Fj.ajpath.2017.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic Induction of Fatty Acid Binding Protein 4 Plays a Pathogenic Role in Sepsis in Mice</span></div><div class="casAuthors">Hu, Bingfang; Li, Yujin; Gao, Li; Guo, Yan; Zhang, Yiwen; Chai, Xiaojuan; Xu, Meishu; Yan, Jiong; Lu, Peipei; Ren, Songrong; Zeng, Su; Liu, Yulan; Xie, Wen; Huang, Min</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1059-1067</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sepsis is defined as the host's deleterious systemic inflammatory response to microbial infections.  Herein, we report an essential role of the fatty acid binding protein 4 (FABP4; alias adipocyte protein 2 or aP2), a lipid-binding chaperone, in sepsis response.  Bioinformatic anal. of the Gene Expression Omnibus data sets showed the level of FABP4 was higher in the nonsurvival sepsis patients' whole blood compared to the survival cohorts.  The expression of Fabp4 was induced in a liver-specific manner in cecal ligation and puncture (CLP) and lipopolysaccharide treatment models of sepsis.  The induction of Fabp4 may have played a pathogenic role, because ectopic expression of Fabp4 in the liver sensitized mice to CLP-induced inflammatory response and worsened the animal's survival.  In contrast, pharmacol. inhibition of Fabp4 markedly alleviated the CLP responsive inflammation and tissue damage and improved survival.  We conclude that FABP4 is an important mediator of the sepsis response.  Early intervention by pharmacol. inhibition of FABP4 may help to manage sepsis in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocEZNvsJ9zwbVg90H21EOLACvtfcHk0lg__BCdZdSQyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvFWqs7o%253D&md5=42c6a37bc368e02b39cba39187a1b0aa</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2017.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2017.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChai%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DRen%26aufirst%3DS.%26aulast%3DZeng%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DM.%26atitle%3DHepatic%2520Induction%2520of%2520Fatty%2520Acid%2520Binding%2520Protein%25204%2520Plays%2520a%2520Pathogenic%2520Role%2520in%2520Sepsis%2520in%2520Mice%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2017%26volume%3D187%26spage%3D1059%26epage%3D1067%26doi%3D10.1016%2Fj.ajpath.2017.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R.</span>; <span class="NLM_string-name">Shi, M.</span>; <span class="NLM_string-name">Guo, F.</span>; <span class="NLM_string-name">Feng, Y.</span>; <span class="NLM_string-name">Feng, Y.</span>; <span class="NLM_string-name">Liu, J.</span>; <span class="NLM_string-name">Li, L.</span>; <span class="NLM_string-name">Liang, Y.</span>; <span class="NLM_string-name">Xiang, J.</span>; <span class="NLM_string-name">Lei, S.</span>; <span class="NLM_string-name">Ma, L.</span>; <span class="NLM_string-name">Fu, P.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Inhibition of Fatty Acid-Binding Protein 4 (FABP4) Protects Against Rhabdomyolysis-Induced Acute Kidney Injury</span>.  <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume">9</span>.<span class="refDoi"> DOI: 10.3389/fphar.2018.00917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.3389%2Ffphar.2018.00917" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&author=R.+Huang&author=M.+Shi&author=F.+Guo&author=Y.+Feng&author=Y.+Feng&author=J.+Liu&author=L.+Li&author=Y.+Liang&author=J.+Xiang&author=S.+Lei&author=L.+Ma&author=P.+Fu&title=Pharmacological+Inhibition+of+Fatty+Acid-Binding+Protein+4+%28FABP4%29+Protects+Against+Rhabdomyolysis-Induced+Acute+Kidney+Injury&doi=10.3389%2Ffphar.2018.00917"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.00917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.00917%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DR.%26atitle%3DPharmacological%2520Inhibition%2520of%2520Fatty%2520Acid-Binding%2520Protein%25204%2520%2528FABP4%2529%2520Protects%2520Against%2520Rhabdomyolysis-Induced%2520Acute%2520Kidney%2520Injury%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D9%26doi%3D10.3389%2Ffphar.2018.00917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beneton, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berdini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudit, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grondin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manas, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMenamin, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potvain, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trottet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10738</span>– <span class="NLM_lpage">10749</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01427</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01427" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVCjsL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10738-10749&author=A.+J.+Woolfordauthor=P.+J.+Dayauthor=V.+Benetonauthor=V.+Berdiniauthor=J.+E.+Coyleauthor=Y.+Duditauthor=P.+Grondinauthor=P.+Huetauthor=L.+Y.+Leeauthor=E.+S.+Manasauthor=R.+L.+McMenaminauthor=C.+W.+Murrayauthor=L.+W.+Pageauthor=V.+K.+Patelauthor=F.+Potvainauthor=S.+J.+Richauthor=Y.+Sangauthor=D.+O.+Somersauthor=L.+Trottetauthor=Z.+Wanauthor=X.+Zhang&title=Fragment-Based+Approach+to+the+Development+of+an+Orally+Bioavailable+Lactam+Inhibitor+of+Lipoprotein-Associated+Phospholipase+A2+%28Lp-PLA2%29&doi=10.1021%2Facs.jmedchem.6b01427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)</span></div><div class="casAuthors">Woolford, Alison J.-A.; Day, Philip J.; Beneton, Veronique; Berdini, Valerio; Coyle, Joseph E.; Dudit, Yann; Grondin, Pascal; Huet, Pascal; Lee, Lydia Y. W.; Manas, Eric S.; McMenamin, Rachel L.; Murray, Christopher W.; Page, Lee W.; Patel, Vipulkumar K.; Potvain, Florent; Rich, Sharna J.; Sang, Yingxia; Somers, Don O.; Trottet, Lionel; Wan, Zehong; Zhang, Xiaomin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10738-10749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lp-PLA2 has been explored as a target for a no. of inflammation assocd. diseases, including cardiovascular disease and dementia.  This article describes the discovery of a new fragment derived chemotype that interacts with the active site of Lp-PLA2.  The starting fragment hit was discovered through an x-ray fragment screen and showed no activity in the bioassay (IC50 > 1 mM).  The fragment hit was optimized using a variety of structure-based drug design techniques, including virtual screening, fragment merging, and improvement of shape complementarity.  A novel series of Lp-PLA2 inhibitors was generated with low lipophilicity and a promising pharmacokinetic profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7XfI60qIk2bVg90H21EOLACvtfcHk0lg__BCdZdSQyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVCjsL7E&md5=01a8c762daf07c10f2928d41d1ff8257</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01427%26sid%3Dliteratum%253Aachs%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DBeneton%26aufirst%3DV.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DDudit%26aufirst%3DY.%26aulast%3DGrondin%26aufirst%3DP.%26aulast%3DHuet%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DL.%2BY.%26aulast%3DManas%26aufirst%3DE.%2BS.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DPage%26aufirst%3DL.%2BW.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DPotvain%26aufirst%3DF.%26aulast%3DRich%26aufirst%3DS.%2BJ.%26aulast%3DSang%26aufirst%3DY.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DTrottet%26aufirst%3DL.%26aulast%3DWan%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DFragment-Based%2520Approach%2520to%2520the%2520Development%2520of%2520an%2520Orally%2520Bioavailable%2520Lactam%2520Inhibitor%2520of%2520Lipoprotein-Associated%2520Phospholipase%2520A2%2520%2528Lp-PLA2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10738%26epage%3D10749%26doi%3D10.1021%2Facs.jmedchem.6b01427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">10231</span>– <span class="NLM_lpage">10244</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01530</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01530" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWhsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=10231-10244&author=Q.+Liuauthor=F.+Huangauthor=X.+Yuanauthor=K.+Wangauthor=Y.+Zouauthor=J.+Shenauthor=Y.+Xu&title=Structure-Guided+Discovery+of+Novel%2C+Potent%2C+and+Orally+Bioavailable+Inhibitors+of+Lipoprotein-Associated+Phospholipase+A2&doi=10.1021%2Facs.jmedchem.7b01530"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2</span></div><div class="casAuthors">Liu, Qiufeng; Huang, Fubao; Yuan, Xiaojing; Wang, Kai; Zou, Yi; Shen, Jianhua; Xu, Yechun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10231-10244</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipoprotein-assocd. phospholipase A2 (Lp-PLA2) is a promising therapeutic target for atherosclerosis, Alzheimer's disease, and diabetic macular edema.  Here the authors report the identification of novel sulfonamide scaffold Lp-PLA2 inhibitors derived from a relatively weak fragment.  Similarity searching on this fragment followed by mol. docking leads to the discovery of a micromolar inhibitor with a 300-fold potency improvement.  Subsequently, by the application of a structure-guided design strategy, a successful hit-to-lead optimization was achieved and a no. of Lp-PLA2 inhibitors with single-digit nanomolar potency were obtained.  After preliminary evaluation of the properties of drug-likeness in vitro and in vivo, compd. 37 (4-amino-N-(4-(4-chloro-3-(trifluoromethyl)phenoxy)-3-cyanophenyl)benzenesulfonamide) stands out from this congeneric series of inhibitors for good inhibitory activity and favorable oral bioavailability in male Sprague-Dawley rats, providing a quality candidate for further development.  The present study thus clearly demonstrates the power and advantage of integrally employing fragment screening, crystal structures detn., virtual screening, and medicinal chem. in an efficient lead discovery project, providing a good example for structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFXkQQ6O1QT7Vg90H21EOLACvtfcHk0lgnoEWTYwBCRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWhsrrP&md5=e17653f44c820a3feb70a1883ca53ff2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01530%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DF.%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DStructure-Guided%2520Discovery%2520of%2520Novel%252C%2520Potent%252C%2520and%2520Orally%2520Bioavailable%2520Inhibitors%2520of%2520Lipoprotein-Associated%2520Phospholipase%2520A2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D10231%26epage%3D10244%26doi%3D10.1021%2Facs.jmedchem.7b01530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coe, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernlohr, D. A.</span></span> <span> </span><span class="NLM_article-title">Targeted Disruption of the Adipocyte Lipid-Binding Protein (AP2 Protein) Gene Impairs Fat Cell Lipolysis and Increases Cellular Fatty Acid Levels</span>. <i>J. Lipid. Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">967</span>– <span class="NLM_lpage">972</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10224167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADyaK1MXjtlahurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1999&pages=967-972&author=N.+R.+Coeauthor=M.+A.+Simpsonauthor=D.+A.+Bernlohr&title=Targeted+Disruption+of+the+Adipocyte+Lipid-Binding+Protein+%28AP2+Protein%29+Gene+Impairs+Fat+Cell+Lipolysis+and+Increases+Cellular+Fatty+Acid+Levels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels</span></div><div class="casAuthors">Coe, Natalie Ribarik; Simpson, Melanie A.; Bernlohr, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">967-972</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">Lipid Research, Inc.</span>)
        </div><div class="casAbstract">The availability of mice contg. an adipocyte lipid-binding protein (ALBP/aP2) gene disruption allowed for a direct examn. of the presumed role of lipid-binding proteins in the mobilization and trafficking of intracellular fatty acids.  Total body and epididymal fat pad wts., as well as adipose cell morphol., were unaltered in male ALBP/aP2 disrupted mice when compared to their wild-type littermates.  Anal. of adipocytes isolated from wild-type and ALBP/aP2 null mice revealed that a selective 40- and 13-fold increase in the level of the keratinocyte lipid-binding protein (KLBP) mRNA and protein, resp., accompanied the ALBP/aP2 gene disruption.  Although KLBP protein was significantly up-regulated, the total lipid-binding protein level decreased 8-fold as a consequence of the disruption.  There was no appreciable difference in the rate of fatty acid influx or esterification in adipocytes of wild-type and ALBP/aP2 null animals.  To the contrary, basal lipolysis decreased approx. 40% in ALBP/aP2 nulls as compared to wild-type littermates.  The glycerol release from isoproterenol-stimulated ALBP/aP2 null fat cells was similarly reduced by ∼35%.  Consistent with a decrease in basal efflux, the non-esterified fatty acid (NEFA) level was nearly 3-fold greater in adipocytes from ALBP/aP2 nulls as compared to wild-type animals.  The significant decrease in both basal and isoproterenol-stimulated lipolysis in adipose tissue of ALBP/aP2 null mice supports the model whereby intracellular lipid-binding proteins function as lipid chaperones, facilitating the movement of fatty acids out of the fat cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvn0G3RYr_XLVg90H21EOLACvtfcHk0lgnoEWTYwBCRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtlahurc%253D&md5=1e41d854fee4aa974db6c42e4f929d2b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoe%26aufirst%3DN.%2BR.%26aulast%3DSimpson%26aufirst%3DM.%2BA.%26aulast%3DBernlohr%26aufirst%3DD.%2BA.%26atitle%3DTargeted%2520Disruption%2520of%2520the%2520Adipocyte%2520Lipid-Binding%2520Protein%2520%2528AP2%2520Protein%2529%2520Gene%2520Impairs%2520Fat%2520Cell%2520Lipolysis%2520and%2520Increases%2520Cellular%2520Fatty%2520Acid%2520Levels%26jtitle%3DJ.%2520Lipid.%2520Res.%26date%3D1999%26volume%3D40%26spage%3D967%26epage%3D972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortlund, E. A.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for Ligand Regulation of the Fatty Acid-Binding Protein 5, Peroxisome Proliferator-Activated Receptor Beta/Delta (FABP5-PPARBeta/Delta) Signaling Pathway</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">14941</span>– <span class="NLM_lpage">14954</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.514646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1074%2Fjbc.M113.514646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=24692551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BB3MXms1Kntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=14941-14954&author=E.+H.+Armstrongauthor=D.+Goswamiauthor=P.+R.+Griffinauthor=N.+Noyauthor=E.+A.+Ortlund&title=Structural+Basis+for+Ligand+Regulation+of+the+Fatty+Acid-Binding+Protein+5%2C+Peroxisome+Proliferator-Activated+Receptor+Beta%2FDelta+%28FABP5-PPARBeta%2FDelta%29+Signaling+Pathway&doi=10.1074%2Fjbc.M113.514646"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="#"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=&md5=9874b665cc7a056b8e2f928dd3112440</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.514646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.514646%26sid%3Dliteratum%253Aachs%26aulast%3DArmstrong%26aufirst%3DE.%2BH.%26aulast%3DGoswami%26aufirst%3DD.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26aulast%3DNoy%26aufirst%3DN.%26aulast%3DOrtlund%26aufirst%3DE.%2BA.%26atitle%3DStructural%2520Basis%2520for%2520Ligand%2520Regulation%2520of%2520the%2520Fatty%2520Acid-Binding%2520Protein%25205%252C%2520Peroxisome%2520Proliferator-Activated%2520Receptor%2520Beta%252FDelta%2520%2528FABP5-PPARBeta%252FDelta%2529%2520Signaling%2520Pathway%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D14941%26epage%3D14954%26doi%3D10.1074%2Fjbc.M113.514646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J. H.</span></span> <span> </span><span class="NLM_article-title">Upgrade of Macromolecular Crystallography Beamline BL17U1 at SSRF</span>. <i>Nucl. Sci. Tech.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">681</span>– <span class="NLM_lpage">687</span>, <span class="refDoi"> DOI: 10.1007/s41365-018-0398-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1007%2Fs41365-018-0398-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=681-687&author=Q.+S.+Wangauthor=K.+H.+Zhangauthor=Y.+Cuiauthor=Z.+J.+Wangauthor=Q.+Y.+Panauthor=K.+Liuauthor=B.+Sunauthor=H.+Zhouauthor=M.+J.+Liauthor=Q.+Xuauthor=C.+Y.+Xuauthor=F.+Yuauthor=J.+H.+He&title=Upgrade+of+Macromolecular+Crystallography+Beamline+BL17U1+at+SSRF&doi=10.1007%2Fs41365-018-0398-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs41365-018-0398-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs41365-018-0398-9%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%2BS.%26aulast%3DZhang%26aufirst%3DK.%2BH.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%2BJ.%26aulast%3DPan%26aufirst%3DQ.%2BY.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DSun%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DC.%2BY.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DHe%26aufirst%3DJ.%2BH.%26atitle%3DUpgrade%2520of%2520Macromolecular%2520Crystallography%2520Beamline%2520BL17U1%2520at%2520SSRF%26jtitle%3DNucl.%2520Sci.%2520Tech.%26date%3D2018%26volume%3D29%26spage%3D681%26epage%3D687%26doi%3D10.1007%2Fs41365-018-0398-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minor, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cymborowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otwinowski, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chruszcz, M.</span></span> <span> </span><span class="NLM_article-title">HKL-3000: the Integration of Data Reduction and Structure Solution–from Diffraction Images to an Initial Model in Minutes</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">859</span>– <span class="NLM_lpage">866</span>, <span class="refDoi"> DOI: 10.1107/S0907444906019949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1107%2FS0907444906019949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=16855301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVWksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=859-866&author=W.+Minorauthor=M.+Cymborowskiauthor=Z.+Otwinowskiauthor=M.+Chruszcz&title=HKL-3000%3A+the+Integration+of+Data+Reduction+and+Structure+Solution%E2%80%93from+Diffraction+Images+to+an+Initial+Model+in+Minutes&doi=10.1107%2FS0907444906019949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">HKL-3000: the integration of data reduction and structure solution - from diffraction images to an initial model in minutes</span></div><div class="casAuthors">Minor, Wladek; Cymborowski, Marcin; Otwinowski, Zbyszek; Chruszcz, Maksymilian</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">D62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">859-866</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A new approach that integrates data collection, data redn., phasing and model building significantly accelerates the process of structure detn. and on av. minimizes the no. of data sets and synchrotron time required for structure soln.  Initial testing of the HKL-3000 system (the beta version was named HKL-2000_ph) with more than 140 novel structure detns. has proven its high value for MAD/SAD expts.  The heuristics for choosing the best computational strategy at different data resoln. limits of phasing signal and crystal diffraction are being optimized.  The typical end result is an interpretable electron-d. map with a partially built structure and, in some cases, an almost complete refined model.  The current development is oriented towards very fast structure soln. in order to provide feedback during the diffraction expt.  Work is also proceeding towards improving the quality of phasing calcn. and model building.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0c0DYtjFP7rVg90H21EOLACvtfcHk0ljUdvHgLjuM2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVWksL8%253D&md5=2cd2fe288f954837abb4acae4c008a2f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1107%2FS0907444906019949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444906019949%26sid%3Dliteratum%253Aachs%26aulast%3DMinor%26aufirst%3DW.%26aulast%3DCymborowski%26aufirst%3DM.%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DChruszcz%26aufirst%3DM.%26atitle%3DHKL-3000%253A%2520the%2520Integration%2520of%2520Data%2520Reduction%2520and%2520Structure%2520Solution%25E2%2580%2593from%2520Diffraction%2520Images%2520to%2520an%2520Initial%2520Model%2520in%2520Minutes%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D859%26epage%3D866%26doi%3D10.1107%2FS0907444906019949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser Crystallographic Software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+Crystallographic+Software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0ljUdvHgLjuM2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520Crystallographic%2520Software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Coot: Model-Building Tools for Molecular Graphics</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+Model-Building+Tools+for+Molecular+Graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0ljUdvHgLjuM2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520Model-Building%2520Tools%2520for%2520Molecular%2520Graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauter, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span> <span> </span><span class="NLM_article-title">PHENIX: Building New Software for Automated Crystallographic Structure Determination</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1948</span>– <span class="NLM_lpage">1954</span>, <span class="refDoi"> DOI: 10.1107/S0907444902016657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1107%2FS0907444902016657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=12393927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVCksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2002&pages=1948-1954&author=P.+D.+Adamsauthor=R.+W.+Grosse-Kunstleveauthor=L.+W.+Hungauthor=T.+R.+Ioergerauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+J.+Readauthor=J.+C.+Sacchettiniauthor=N.+K.+Sauterauthor=T.+C.+Terwilliger&title=PHENIX%3A+Building+New+Software+for+Automated+Crystallographic+Structure+Determination&doi=10.1107%2FS0907444902016657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: building new software for automated crystallographic structure determination</span></div><div class="casAuthors">Adams, Paul D.; Grosse-Kunstleve, Ralf W.; Hung, Li Wei; Ioerger, Thomas R.; McCoy, Airlie J.; Moriarty, Nigel W.; Read, Randy J.; Sacchettini, James C.; Sauter, Nicholas K.; Terwilliger, Thomas C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">D58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1948-1954</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Munksgaard</span>)
        </div><div class="casAbstract">Structural genomics seeks to rapidly expand the no. of protein structures to ext. the max. amt. of information from genomic sequence databases.  The advent of several large-scale projects worldwide leads to many new challenges in the field of crystallog. macromol. structure detn.  A novel software package, called PHENIX (Python-based Hierarchical Environment for Integrated Xtallog.), is therefore being developed.  This new software will provide the necessary algorithms to proceed from reduced intensity data to a refined mol. model and to facilitate structure soln. for both the novice and expert crystallographer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOtuUfHXPmCbVg90H21EOLACvtfcHk0lgcWRVN7iCtnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVCksbc%253D&md5=9a3b66e1f7d064183f7a9ce108cb4e5e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0907444902016657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444902016657%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DSauter%26aufirst%3DN.%2BK.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26atitle%3DPHENIX%253A%2520Building%2520New%2520Software%2520for%2520Automated%2520Crystallographic%2520Structure%2520Determination%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2002%26volume%3D58%26spage%3D1948%26epage%3D1954%26doi%3D10.1107%2FS0907444902016657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurian, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prendergast, F. G.</span></span> <span> </span><span class="NLM_article-title">Affinity of Fatty Acid for rRat Intestinal Fatty Acid Binding Protein: Further Examination</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">3865</span>– <span class="NLM_lpage">3874</span>, <span class="refDoi"> DOI: 10.1021/bi952589y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi952589y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADyaK28XhsVGnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1996&pages=3865-3874&author=E.+Kurianauthor=W.+R.+Kirkauthor=F.+G.+Prendergast&title=Affinity+of+Fatty+Acid+for+rRat+Intestinal+Fatty+Acid+Binding+Protein%3A+Further+Examination&doi=10.1021%2Fbi952589y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Affinity of fatty acid for rat intestinal fatty acid binding protein: further examination</span></div><div class="casAuthors">Kurian, E.; Kirk, W. R.; Prendergast, F. G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3865-74</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The enhancement of the fluorescence quantum yield of 1,8-anilinonaphthalenesulfonic acid (ANS) upon binding to intestinal fatty acid protein (I-FABP) was exploited to devise an assay for free I-FABP.  With this assay, competition for free I-FABP between ANS and fatty acids was monitored and values for the dissocn. consts. (KFA) of fatty acids was for I-FABP were extd..  These consts. were obtained for the I-FABP ligands oleic acid, arachidonic acid, and palmitic acid.  In addn., the dependence of KFA for oleic acid upon temp. and at two pH values was measured.  From these data, the van't Hoff enthalpy of oleic acid binding was calcd..  This enthalpy was compared with the enthalpies of binding obtained directly from titrn. calorimetry.  The expts. with the fluorescence-based assay generate values of KFA disagreeing with older values obtained from calorimetry and other methods.  The calorimetric data were analyzed with a view to improving the technique involved in subtraction of a "ref." diln. of the ligand into soln. in the absence of the protein.  Thus, "cor." titrns. were obtained which could be fitted to values of KFA more in agreement with the values the authors detd. via the fluorescence-based assay than were the older literature values.  The new values for KFA also agree substantially with values derived using a complementary assay technique, one measuring the concn. of free fatty acid, that was developed recently by Richieri et al. [Richieri et al. (1995) J. Biol. Chem. 270, 15076-15084].  The values of ΔH°, ΔS°, and ΔCp° for fatty acid binding obtained in this work were compared with those the authors found in earlier work with ANS binding to I-FABP [Kirk et al. (1996) Biophys. J. 70, 69-83].  The interpretation of the origin of the thermodn. changes for ANS binding in the earlier work is here substantiated and extended to include an evaluation in phys. terms of the interaction of I-FABP with fatty acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5RbkwayP7XbVg90H21EOLACvtfcHk0lgcWRVN7iCtnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhsVGnsLo%253D&md5=af841cc11327ad918dadb4ce6ede2143</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fbi952589y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi952589y%26sid%3Dliteratum%253Aachs%26aulast%3DKurian%26aufirst%3DE.%26aulast%3DKirk%26aufirst%3DW.%2BR.%26aulast%3DPrendergast%26aufirst%3DF.%2BG.%26atitle%3DAffinity%2520of%2520Fatty%2520Acid%2520for%2520rRat%2520Intestinal%2520Fatty%2520Acid%2520Binding%2520Protein%253A%2520Further%2520Examination%26jtitle%3DBiochemistry%26date%3D1996%26volume%3D35%26spage%3D3865%26epage%3D3874%26doi%3D10.1021%2Fbi952589y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuatrecasas, P.</span></span> <span> </span><span class="NLM_article-title">Estimation of Hormone Receptor Affinity by Competitive Displacement of Labeled Ligand–Effect of Concentration of Receptor and of Labeled Ligand</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">687</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(75)90564-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2F0006-291X%2875%2990564-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=170929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADyaE28Xht1Oitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1975&pages=687-692&author=S.+Jacobsauthor=K.+J.+Changauthor=P.+Cuatrecasas&title=Estimation+of+Hormone+Receptor+Affinity+by+Competitive+Displacement+of+Labeled+Ligand%E2%80%93Effect+of+Concentration+of+Receptor+and+of+Labeled+Ligand&doi=10.1016%2F0006-291X%2875%2990564-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of hormone receptor affinity by competitive displacement of labeled ligand.  Effect of concentration of receptor and of labeled ligand</span></div><div class="casAuthors">Jacobs, Steven; Chang, Kwen-Jen; Cuatrecasas, Pedro</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">687-92</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">For both epidermal growth factor and insulin [9004-10-8], the concn. of unlabeled hormone at which a given fraction of bound labeled hormone was displaced from placenta membranes was increased by increasing the labeled hormone concn. or the placenta membrane concn.  The ligand concn. at which 50% of the bound, labeled ligand was displaced gave spuriously high ests. of the dissocn. consts. for these hormones if measured at high labeled hormone or binding site concns.  These considerations also have important implications for comparative studies of receptors in different species or metabolic states, and for the feasibility of radioreceptor assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8z6dWv8LiyLVg90H21EOLACvtfcHk0lgcWRVN7iCtnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28Xht1Oitg%253D%253D&md5=60db9b12656f6ac2f121e2f4737c9156</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2875%2990564-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252875%252990564-1%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DK.%2BJ.%26aulast%3DCuatrecasas%26aufirst%3DP.%26atitle%3DEstimation%2520of%2520Hormone%2520Receptor%2520Affinity%2520by%2520Competitive%2520Displacement%2520of%2520Labeled%2520Ligand%25E2%2580%2593Effect%2520of%2520Concentration%2520of%2520Receptor%2520and%2520of%2520Labeled%2520Ligand%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1975%26volume%3D66%26spage%3D687%26epage%3D692%26doi%3D10.1016%2F0006-291X%2875%2990564-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupyan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaus, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerutti, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krilov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+Y.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS3%3A+A+Force+Field+Providing+Broad+Coverage+of+Drug-like+Small+Molecules+and+Proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0liwc0T_XIZa_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS3%253A%2520A%2520Force%2520Field%2520Providing%2520Broad%2520Coverage%2520of%2520Drug-like%2520Small%2520Molecules%2520and%2520Proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frisch, M. J.</span>; <span class="NLM_string-name">Trucks, G. W.</span>; <span class="NLM_string-name">Schlegel, H. B.</span>; <span class="NLM_string-name">Scuseria, G. E.</span>; <span class="NLM_string-name">Robb, M. A.</span>; <span class="NLM_string-name">Cheeseman, J. R.</span>; <span class="NLM_string-name">Scalmani, G.</span>; <span class="NLM_string-name">Barone, V.</span>; <span class="NLM_string-name">Mennucci, B.</span>; <span class="NLM_string-name">Petersson, G. A.</span>; <span class="NLM_string-name">Nakatsuji, H.</span>; <span class="NLM_string-name">Caricato, M.</span>; <span class="NLM_string-name">Li, X.</span>; <span class="NLM_string-name">Hratchian, H. P.</span>; <span class="NLM_string-name">Izmaylov, A. F.</span>; <span class="NLM_string-name">Bloino, J.</span>; <span class="NLM_string-name">Zheng, G.</span>; <span class="NLM_string-name">Sonnenberg, J. L.</span>; <span class="NLM_string-name">Hada, M.</span>; <span class="NLM_string-name">Ehara, M.</span>; <span class="NLM_string-name">Toyota, K.</span>; <span class="NLM_string-name">Fukuda, R.</span>; <span class="NLM_string-name">Hasegawa, J.</span>; <span class="NLM_string-name">Ishida, M.</span>; <span class="NLM_string-name">Nakajima, T.</span>; <span class="NLM_string-name">Honda, Y.</span>; <span class="NLM_string-name">Kitao, O.</span>; <span class="NLM_string-name">Nakai, H.</span>; <span class="NLM_string-name">Vreven, T.</span>; <span class="NLM_string-name">Montgomery, J. A.,  Jr.</span>; <span class="NLM_string-name">Peralta, J. E.</span>; <span class="NLM_string-name">Ogliaro, F.</span>; <span class="NLM_string-name">Bearpark, M.</span>; <span class="NLM_string-name">Heyd, J. J.</span>; <span class="NLM_string-name">Brothers, E.</span>; <span class="NLM_string-name">Kudin, K. N.</span>; <span class="NLM_string-name">Staroverov, V. N.</span>; <span class="NLM_string-name">Keith, T.</span>; <span class="NLM_string-name">Kobayashi, R.</span>; <span class="NLM_string-name">Normand, J.</span>; <span class="NLM_string-name">Raghavachari, K.</span>; <span class="NLM_string-name">Rendell, A.</span>; <span class="NLM_string-name">Burant, J. C.</span>; <span class="NLM_string-name">Iyengar, S. S.</span>; <span class="NLM_string-name">Tomasi, J.</span>; <span class="NLM_string-name">Cossi, M.</span>; <span class="NLM_string-name">Rega, N.</span>; <span class="NLM_string-name">Millam, J. M.</span>; <span class="NLM_string-name">Klene, M.</span>; <span class="NLM_string-name">Knox, J. E.</span>; <span class="NLM_string-name">Cross, J. B.</span>; <span class="NLM_string-name">Bakken, V.</span>; <span class="NLM_string-name">Adamo, C.</span>; <span class="NLM_string-name">Jaramillo, J.</span>; <span class="NLM_string-name">Gomperts, R.</span>; <span class="NLM_string-name">Stratmann, R. E.</span>; <span class="NLM_string-name">Yazyev, O.</span>; <span class="NLM_string-name">Austin, A. J.</span>; <span class="NLM_string-name">Cammi, R.</span>; <span class="NLM_string-name">Pomelli, C.</span>; <span class="NLM_string-name">Ochterski, J. W.</span>; <span class="NLM_string-name">Martin, R. L.</span>; <span class="NLM_string-name">Morokuma, K.</span>; <span class="NLM_string-name">Zakrzewski, V. G.</span>; <span class="NLM_string-name">Voth, G. A.</span>; <span class="NLM_string-name">Salvador, P.</span>; <span class="NLM_string-name">Dannenberg, J. J.</span>; <span class="NLM_string-name">Dapprich, S.</span>; <span class="NLM_string-name">Daniels, A. D.</span>; <span class="NLM_string-name">Farkas, O.</span>; <span class="NLM_string-name">Foresman, J. B.</span>; <span class="NLM_string-name">Ortiz, J. V.</span>; <span class="NLM_string-name">Cioslowski, J.</span>; <span class="NLM_string-name">Fox, D. J.</span></span> <i>Gaussian 09</i><i>,</i> rev. D.01; <span class="NLM_publisher-name">Gaussian, Inc.</span>: <span class="NLM_publisher-loc">Wallingford, CT</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+J.+Frisch&author=G.+W.+Trucks&author=H.+B.+Schlegel&author=G.+E.+Scuseria&author=M.+A.+Robb&author=J.+R.+Cheeseman&author=G.+Scalmani&author=V.+Barone&author=B.+Mennucci&author=G.+A.+Petersson&author=H.+Nakatsuji&author=M.+Caricato&author=X.+Li&author=H.+P.+Hratchian&author=A.+F.+Izmaylov&author=J.+Bloino&author=G.+Zheng&author=J.+L.+Sonnenberg&author=M.+Hada&author=M.+Ehara&author=K.+Toyota&author=R.+Fukuda&author=J.+Hasegawa&author=M.+Ishida&author=T.+Nakajima&author=Y.+Honda&author=O.+Kitao&author=H.+Nakai&author=T.+Vreven&author=J.+A.+Montgomery&author=J.+E.+Peralta&author=F.+Ogliaro&author=M.+Bearpark&author=J.+J.+Heyd&author=E.+Brothers&author=K.+N.+Kudin&author=V.+N.+Staroverov&author=T.+Keith&author=R.+Kobayashi&author=J.+Normand&author=K.+Raghavachari&author=A.+Rendell&author=J.+C.+Burant&author=S.+S.+Iyengar&author=J.+Tomasi&author=M.+Cossi&author=N.+Rega&author=J.+M.+Millam&author=M.+Klene&author=J.+E.+Knox&author=J.+B.+Cross&author=V.+Bakken&author=C.+Adamo&author=J.+Jaramillo&author=R.+Gomperts&author=R.+E.+Stratmann&author=O.+Yazyev&author=A.+J.+Austin&author=R.+Cammi&author=C.+Pomelli&author=J.+W.+Ochterski&author=R.+L.+Martin&author=K.+Morokuma&author=V.+G.+Zakrzewski&author=G.+A.+Voth&author=P.+Salvador&author=J.+J.+Dannenberg&author=S.+Dapprich&author=A.+D.+Daniels&author=O.+Farkas&author=J.+B.+Foresman&author=J.+V.+Ortiz&author=J.+Cioslowski&author=D.+J.+Fox&title=Gaussian+09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DFrisch%26aufirst%3DM.%2BJ.%26jtitle%3DGaussian%252009%26pub%3DGaussian%252C%2520Inc%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheatham, T. E.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohlke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, K. M.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onufriev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmerling, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, R. J.</span></span> <span> </span><span class="NLM_article-title">The Amber Biomolecular Simulation Programs</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1668</span>– <span class="NLM_lpage">1688</span>, <span class="refDoi"> DOI: 10.1002/jcc.20290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1002%2Fjcc.20290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=16200636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=1668-1688&author=D.+A.+Caseauthor=T.+E.+Cheathamauthor=T.+Dardenauthor=H.+Gohlkeauthor=R.+Luoauthor=K.+M.+Merzauthor=A.+Onufrievauthor=C.+Simmerlingauthor=B.+Wangauthor=R.+J.+Woods&title=The+Amber+Biomolecular+Simulation+Programs&doi=10.1002%2Fjcc.20290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The amber biomolecular simulation programs</span></div><div class="casAuthors">Case, David A.; Cheatham, Thomas E., III; Darden, Tom; Gohlke, Holger; Luo, Ray; Merz, Kenneth M., Jr.; Onufriev, Alexey; Simmerling, Carlos; Wang, Bing; Woods, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1668-1688</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The authors describe the development, current features, and some directions for future development of the Amber package of computer programs.  This package evolved from a program that was constructed in the late 1970s to do Assisted Model Building with Energy Refinement, and now contains a group of programs embodying a no. of powerful tools of modern computational chem., focused on mol. dynamics and free energy calcns. of proteins, nucleic acids, and carbohydrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre0tZP_Umb7rVg90H21EOLACvtfcHk0liwc0T_XIZa_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbM&md5=93be29ff894bab96c783d24e9886c7d0</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20290%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26aulast%3DCheatham%26aufirst%3DT.%2BE.%26aulast%3DDarden%26aufirst%3DT.%26aulast%3DGohlke%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DR.%26aulast%3DMerz%26aufirst%3DK.%2BM.%26aulast%3DOnufriev%26aufirst%3DA.%26aulast%3DSimmerling%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWoods%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520Amber%2520Biomolecular%2520Simulation%2520Programs%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2005%26volume%3D26%26spage%3D1668%26epage%3D1688%26doi%3D10.1002%2Fjcc.20290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maier, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasavajhala, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickstrom, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauser, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmerling, C.</span></span> <span> </span><span class="NLM_article-title">ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3696</span>– <span class="NLM_lpage">3713</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00255</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00255" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFequ7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=3696-3713&author=J.+A.+Maierauthor=C.+Martinezauthor=K.+Kasavajhalaauthor=L.+Wickstromauthor=K.+E.+Hauserauthor=C.+Simmerling&title=ff14SB%3A+Improving+the+Accuracy+of+Protein+Side+Chain+and+Backbone+Parameters+from+ff99SB&doi=10.1021%2Facs.jctc.5b00255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB</span></div><div class="casAuthors">Maier, James A.; Martinez, Carmenza; Kasavajhala, Koushik; Wickstrom, Lauren; Hauser, Kevin E.; Simmerling, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3696-3713</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. mechanics is powerful for its speed in atomistic simulations, but an accurate force field is required.  The Amber ff99SB force field improved protein secondary structure balance and dynamics from earlier force fields like ff99, but weaknesses in side chain rotamer and backbone secondary structure preferences have been identified.  Here, we performed a complete refit of all amino acid side chain dihedral parameters, which had been carried over from ff94.  The training set of conformations included multidimensional dihedral scans designed to improve transferability of the parameters.  Improvement in all amino acids was obtained as compared to ff99SB.  Parameters were also generated for alternate protonation states of ionizable side chains.  Av. errors in relative energies of pairs of conformations were under 1.0 kcal/mol as compared to QM, reduced 35% from ff99SB.  We also took the opportunity to make empirical adjustments to the protein backbone dihedral parameters as compared to ff99SB.  Multiple small adjustments of φ and ψ parameters were tested against NMR scalar coupling data and secondary structure content for short peptides.  The best results were obtained from a phys. motivated adjustment to the φ rotational profile that compensates for lack of ff99SB QM training data in the β-ppII transition region.  Together, these backbone and side chain modifications (hereafter called ff14SB) not only better reproduced their benchmarks, but also improved secondary structure content in small peptides and reprodn. of NMR χ1 scalar coupling measurements for proteins in soln.  We also discuss the Amber ff12SB parameter set, a preliminary version of ff14SB that includes most of its improvements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgntnN9ES97rVg90H21EOLACvtfcHk0lgrbeb28yK2sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFequ7rN&md5=7b803577b3b6912cc6750cfbd356596e</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00255%26sid%3Dliteratum%253Aachs%26aulast%3DMaier%26aufirst%3DJ.%2BA.%26aulast%3DMartinez%26aufirst%3DC.%26aulast%3DKasavajhala%26aufirst%3DK.%26aulast%3DWickstrom%26aufirst%3DL.%26aulast%3DHauser%26aufirst%3DK.%2BE.%26aulast%3DSimmerling%26aufirst%3DC.%26atitle%3Dff14SB%253A%2520Improving%2520the%2520Accuracy%2520of%2520Protein%2520Side%2520Chain%2520and%2520Backbone%2520Parameters%2520from%2520ff99SB%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2015%26volume%3D11%26spage%3D3696%26epage%3D3713%26doi%3D10.1021%2Facs.jctc.5b00255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollman, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span></span> <span> </span><span class="NLM_article-title">Automatic Atom Type and Bond Type Perception in Molecular Mechanical Calculations</span>. <i>J. Mol. Graphics Modell.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">260</span>, <span class="refDoi"> DOI: 10.1016/j.jmgm.2005.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1016%2Fj.jmgm.2005.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=16458552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1Gis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=247-260&author=J.+Wangauthor=W.+Wangauthor=P.+A.+Kollmanauthor=D.+A.+Case&title=Automatic+Atom+Type+and+Bond+Type+Perception+in+Molecular+Mechanical+Calculations&doi=10.1016%2Fj.jmgm.2005.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Automatic atom type and bond type perception in molecular mechanical calculations</span></div><div class="casAuthors">Wang, Junmei; Wang, Wei; Kollman, Peter A.; Case, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-260</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">In mol. mechanics (MM) studies, atom types and/or bond types of mols. are needed to det. prior to energy calcns.  The authors present here an automatic algorithm of perceiving atom types that are defined in a description table, and an automatic algorithm of assigning bond types just based on at. connectivity.  The algorithms have been implemented in a new module of the AMBER packages.  This auxiliary module, antechamber (roughly meaning "before AMBER"), can be applied to generate necessary inputs of leap-the AMBER program to generate topologies for minimization, mol. dynamics, etc., for most org. mols.  The algorithms behind the manipulations may be useful for other mol. mech. packages as well as applications that need to designate atom types and bond types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqizj6F18nBYbVg90H21EOLACvtfcHk0lgrbeb28yK2sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1Gis7g%253D&md5=8031a21d2784d5dea12e70868522aa61</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.jmgm.2005.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmgm.2005.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DAutomatic%2520Atom%2520Type%2520and%2520Bond%2520Type%2520Perception%2520in%2520Molecular%2520Mechanical%2520Calculations%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2006%26volume%3D25%26spage%3D247%26epage%3D260%26doi%3D10.1016%2Fj.jmgm.2005.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hess, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bekker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berendsen, H. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraaije, J.</span></span> <span> </span><span class="NLM_article-title">LINCS: A Linear Constraint Solver for Molecular Simulations</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1463</span>– <span class="NLM_lpage">1472</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1002%2F%28SICI%291096-987X%28199709%2918%3A12%3C1463%3A%3AAID-JCC4%3E3.0.CO%3B2-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADyaK2sXlvV2nu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=1463-1472&author=B.+Hessauthor=H.+Bekkerauthor=H.+J.+C.+Berendsenauthor=J.+Fraaije&title=LINCS%3A+A+Linear+Constraint+Solver+for+Molecular+Simulations&doi=10.1002%2F%28SICI%291096-987X%28199709%2918%3A12%3C1463%3A%3AAID-JCC4%3E3.0.CO%3B2-H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">LINCS: a linear constraint solver for molecular simulations</span></div><div class="casAuthors">Hess, Berk; Bekker, Henk; Berendsen, Herman J. C.; Fraaije, Johannes G. E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1463-1472</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">We present a new LINear Constraint Solver (LINCS) for mol. simulations with bond constraints using the enzyme lysozyme and a 32-residue peptide as test systems.  The algorithm is inherently stable, as the constraints themselves are reset instead of derivs. of the constraints, thereby eliminating drift.  Although the derivation of the algorithm is presented in terms of matrixes, no matrix matrix multiplications are needed and only the nonzero matrix elements have to be stored, making the method useful for very large mols.  At the same accuracy, the LINCS algorithm is 3-4 times faster than the SHAKE algorithm.  Parallelization of the algorithm is straightforward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk6h4pdV0Nx7Vg90H21EOLACvtfcHk0lgrbeb28yK2sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvV2nu7g%253D&md5=890f8af0d2ca1f65aa93db5a3a0bacf2</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%28199709%2918%3A12%3C1463%3A%3AAID-JCC4%3E3.0.CO%3B2-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%2528199709%252918%253A12%253C1463%253A%253AAID-JCC4%253E3.0.CO%253B2-H%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DB.%26aulast%3DBekker%26aufirst%3DH.%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26aulast%3DFraaije%26aufirst%3DJ.%26atitle%3DLINCS%253A%2520A%2520Linear%2520Constraint%2520Solver%2520for%2520Molecular%2520Simulations%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1997%26volume%3D18%26spage%3D1463%26epage%3D1472%26doi%3D10.1002%2F%28SICI%291096-987X%28199709%2918%3A12%3C1463%3A%3AAID-JCC4%3E3.0.CO%3B2-H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">York, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, L.</span></span> <span> </span><span class="NLM_article-title">Particle Mesh Ewald - an N.Log(N) Method for Ewald Sums in Large Systems</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">10089</span>– <span class="NLM_lpage">10092</span>, <span class="refDoi"> DOI: 10.1063/1.464397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1063%2F1.464397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADyaK3sXks1Ohsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1993&pages=10089-10092&author=T.+Dardenauthor=D.+Yorkauthor=L.+Pedersen&title=Particle+Mesh+Ewald+-+an+N.Log%28N%29+Method+for+Ewald+Sums+in+Large+Systems&doi=10.1063%2F1.464397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Particle mesh Ewald: an N·log(N) method for Ewald sums in large systems</span></div><div class="casAuthors">Darden, Tom; York, Darrin; Pedersen, Lee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">10089-92</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">An N·log(N) method for evaluating electrostatic energies and forces of large periodic systems is presented.  The method is based on interpolation of the reciprocal space Ewald sums and evaluation of the resulting convolution using fast Fourier transforms.  Timings and accuracies are presented for three large cryst. ionic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDIJavf7AZPbVg90H21EOLACvtfcHk0lgsPfzG80-P7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1Ohsr0%253D&md5=3c9f230bd01b7b714fd096d4d2e755f6</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1063%2F1.464397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.464397%26sid%3Dliteratum%253Aachs%26aulast%3DDarden%26aufirst%3DT.%26aulast%3DYork%26aufirst%3DD.%26aulast%3DPedersen%26aufirst%3DL.%26atitle%3DParticle%2520Mesh%2520Ewald%2520-%2520an%2520N.Log%2528N%2529%2520Method%2520for%2520Ewald%2520Sums%2520in%2520Large%2520Systems%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1993%26volume%3D98%26spage%3D10089%26epage%3D10092%26doi%3D10.1063%2F1.464397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Essmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkowitz, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, L. G.</span></span> <span> </span><span class="NLM_article-title">A Smooth Particle Mesh Ewald Method</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">8577</span>– <span class="NLM_lpage">8593</span>, <span class="refDoi"> DOI: 10.1063/1.470117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1063%2F1.470117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADyaK2MXptlehtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1995&pages=8577-8593&author=U.+Essmannauthor=L.+Pereraauthor=M.+L.+Berkowitzauthor=T.+Dardenauthor=H.+Leeauthor=L.+G.+Pedersen&title=A+Smooth+Particle+Mesh+Ewald+Method&doi=10.1063%2F1.470117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A smooth particle mesh Ewald method</span></div><div class="casAuthors">Essmann, Ulrich; Perera, Lalith; Berkowitz, Max L.; Darden, Tom; Lee, Hsing; Pedersen, Lee G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8577-93</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">The previously developed particle mesh Ewald method is reformulated in terms of efficient B-spline interpolation of the structure factors.  This reformulation allows a natural extension of the method to potentials of the form 1/rp with p ≥ 1.  Furthermore, efficient calcn. of the virial tensor follows.  Use of B-splines in the place of Lagrange interpolation leads to analytic gradients as well as a significant improvement in the accuracy.  The authors demonstrate that arbitrary accuracy can be achieved, independent of system size N, at a cost that scales as N log(N).  For biomol. systems with many thousands of atoms and this method permits the use of Ewald summation at a computational cost comparable to that of a simple truncation method of 10 Å or less.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Bp1XlSY32LVg90H21EOLACvtfcHk0lgsPfzG80-P7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptlehtrw%253D&md5=092a679dd3bee08da28df41e302383a7</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1063%2F1.470117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.470117%26sid%3Dliteratum%253Aachs%26aulast%3DEssmann%26aufirst%3DU.%26aulast%3DPerera%26aufirst%3DL.%26aulast%3DBerkowitz%26aufirst%3DM.%2BL.%26aulast%3DDarden%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DPedersen%26aufirst%3DL.%2BG.%26atitle%3DA%2520Smooth%2520Particle%2520Mesh%2520Ewald%2520Method%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1995%26volume%3D103%26spage%3D8577%26epage%3D8593%26doi%3D10.1063%2F1.470117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pronk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjelkmar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apostolov, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirts, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasson, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Spoel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hess, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindahl, E.</span></span> <span> </span><span class="NLM_article-title">GROMACS 4.5: a High-Throughput and Highly Parallel Open Source Molecular Simulation Toolkit</span>. <i>Bioinformatics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">845</span>– <span class="NLM_lpage">854</span>, <span class="refDoi"> DOI: 10.1093/bioinformatics/btt055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1093%2Fbioinformatics%2Fbtt055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=23407358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFWmsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2013&pages=845-854&author=S.+Pronkauthor=S.+Pallauthor=R.+Schulzauthor=P.+Larssonauthor=P.+Bjelkmarauthor=R.+Apostolovauthor=M.+R.+Shirtsauthor=J.+C.+Smithauthor=P.+M.+Kassonauthor=D.+van+der%0ASpoelauthor=B.+Hessauthor=E.+Lindahl&title=GROMACS+4.5%3A+a+High-Throughput+and+Highly+Parallel+Open+Source+Molecular+Simulation+Toolkit&doi=10.1093%2Fbioinformatics%2Fbtt055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit</span></div><div class="casAuthors">Pronk, Sander; Pall, Szilard; Schulz, Roland; Larsson, Per; Bjelkmar, Paer; Apostolov, Rossen; Shirts, Michael R.; Smith, Jeremy C.; Kasson, Peter M.; van der Spoel, David; Hess, Berk; Lindahl, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">845-854</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Motivation: Mol. simulation has historically been a low-throughput technique, but faster computers and increasing amts. of genomic and structural data are changing this by enabling large-scale automated simulation of, for instance, many conformers or mutants of biomols. with or without a range of ligands.  At the same time, advances in performance and scaling now make it possible to model complex biomol. interaction and function in a manner directly testable by expt.  These applications share a need for fast and efficient software that can be deployed on massive scale in clusters, web servers, distributed computing or cloud resources.  Results: Here, we present a range of new simulation algorithms and features developed during the past 4 years, leading up to the GROMACS 4.5 software package.  The software now automatically handles wide classes of biomols., such as proteins, nucleic acids and lipids, and comes with all commonly used force fields for these mols. built-in.  GROMACS supports several implicit solvent models, as well as new free-energy algorithms, and the software now uses multithreading for efficient parallelization even on low-end systems, including windows-based workstations.  Together with hand-tuned assembly kernels and state-of-the-art parallelization, this provides extremely high performance and cost efficiency for high-throughput as well as massively parallel simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr71lQgYMm017Vg90H21EOLACvtfcHk0lgsPfzG80-P7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFWmsrg%253D&md5=4b25fd6ab4e33725ae56b5da63f4ad68</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbtt055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbtt055%26sid%3Dliteratum%253Aachs%26aulast%3DPronk%26aufirst%3DS.%26aulast%3DPall%26aufirst%3DS.%26aulast%3DSchulz%26aufirst%3DR.%26aulast%3DLarsson%26aufirst%3DP.%26aulast%3DBjelkmar%26aufirst%3DP.%26aulast%3DApostolov%26aufirst%3DR.%26aulast%3DShirts%26aufirst%3DM.%2BR.%26aulast%3DSmith%26aufirst%3DJ.%2BC.%26aulast%3DKasson%26aufirst%3DP.%2BM.%26aulast%3Dvan%2Bder%2BSpoel%26aufirst%3DD.%26aulast%3DHess%26aufirst%3DB.%26aulast%3DLindahl%26aufirst%3DE.%26atitle%3DGROMACS%25204.5%253A%2520a%2520High-Throughput%2520and%2520Highly%2520Parallel%2520Open%2520Source%2520Molecular%2520Simulation%2520Toolkit%26jtitle%3DBioinformatics%26date%3D2013%26volume%3D29%26spage%3D845%26epage%3D854%26doi%3D10.1093%2Fbioinformatics%2Fbtt055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skolnik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span> <span> </span><span class="NLM_article-title">Towards Prediction of in vivo Intestinal Absorption Using a 96-well Caco-2 Assay</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">3246</span>– <span class="NLM_lpage">3265</span>, <span class="refDoi"> DOI: 10.1002/jps.22080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=10.1002%2Fjps.22080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=20166204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVSrsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2010&pages=3246-3265&author=S.+Skolnikauthor=X.+Linauthor=J.+Wangauthor=X.+H.+Chenauthor=T.+Heauthor=B.+Zhang&title=Towards+Prediction+of+in+vivo+Intestinal+Absorption+Using+a+96-well+Caco-2+Assay&doi=10.1002%2Fjps.22080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay</span></div><div class="casAuthors">Skolnik, Suzanne; Lin, Xuena; Wang, Jianling; Chen, Xiao-Hui; He, Timothy; Zhang, Bailin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3246-3265</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">We systematically validated a robust 96-well Caco-2 assay via an extended set of 93 marketed drugs with diverse transport mechanisms and quantified by LC/MS/MS, to investigate its predictive utility while dealing with challenging discovery compds.  Utilizing nonlinear fit, the validation led to a good correlation (R2 = 0.76) between absorptive permeability, log Papp(A-B), from in vitro Caco-2 assay and reported human fraction of dose absorbed.  We obsd. that paracellular compds. could be flagged by log Papp(A-B) (<-5.5 cm/s) and physicochem. property space (c log P < 1).  Of 8000 Novartis discovery compds. examd. 13% were subject to low recovery (<30%).  Compd. loss was investigated by comparing cell monolayer and artificial membrane, while 0.5% bovine serum albumin (in both donor and acceptor compartments) was utilized to improve recovery.  The second focus of this study was to investigate the advantages and limitations of the current Caco-2 assay for predicting in vivo intestinal absorption.  Caco-2 measurements for compds. with high aq. soly. and low in vitro metabolic clearance were compared to 88 in vivo rat bioavailability studies.  Despite the challenges posed by discovery compds. with suboptimal physicochem. properties, Caco-2 data successfully projected low intestinal absorption.  This platform sets the stage for mechanistically evaluating compds. towards improving in vitro-in vivo correlations. © 2010 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci 99:3246-3265, 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqio9beUaITm7Vg90H21EOLACvtfcHk0ljWbQrh1SMd4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVSrsr0%253D&md5=43f7e35544e7b4a348271a53e958d3b9</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fjps.22080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22080%26sid%3Dliteratum%253Aachs%26aulast%3DSkolnik%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%2BH.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DB.%26atitle%3DTowards%2520Prediction%2520of%2520in%2520vivo%2520Intestinal%2520Absorption%2520Using%2520a%252096-well%2520Caco-2%2520Assay%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2010%26volume%3D99%26spage%3D3246%26epage%3D3265%26doi%3D10.1002%2Fjps.22080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJW','PDB','6LJW'); return false;">PDB: 6LJW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJX','PDB','6LJX'); return false;">PDB: 6LJX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJS','PDB','6LJS'); return false;">PDB: 6LJS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJT','PDB','6LJT'); return false;">PDB: 6LJT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJU','PDB','6LJU'); return false;">PDB: 6LJU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJV" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6LJV','PDB','6LJV'); return false;">PDB: 6LJV</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NNT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NNT','PDB','4NNT'); return false;">PDB: 4NNT</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i67"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02107">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_37624"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b02107?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02107</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Figures of multiple X-ray crystal structures, tables, HPLC spectra, NMR spectra, and MS spectra (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02107/suppl_file/jm9b02107_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02107/suppl_file/jm9b02107_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02107/suppl_file/jm9b02107_si_001.pdf">jm9b02107_si_001.pdf (3.72 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02107/suppl_file/jm9b02107_si_002.csv">jm9b02107_si_002.csv (1.48 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The atomic coordinates and structure factors have been deposited into the Protein Data Bank with accession codes 6LJW (FABP4-<b>1</b>), 6LJX (FABP4-<b>1</b>), 6LJS (FABP4-<b>3</b>), 6LJT (FABP4-<b>6</b>), 6LJU (FABP4-<b>11</b>), and 6LJV (FABP4-<b>17</b>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b02107&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-8%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b02107%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b02107" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679ac68ddf243cb8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
